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ABSTRACT 
 
Incidence of endocrine disruption in wild fish species has been documented globally 
and is well characterised in the UK, where the occurrence of intersex in roach (Rutilus 
rutilus) is widespread. Although this has been associated with concentrations of steroid 
oestrogens, research indicates that anti-androgenic chemicals may also play a role in 
inducing these effects. Anti-androgenic activity is commonly detected in wastewater 
treatment works effluents and some receiving waters, but the chemicals responsible 
remain largely uncharacterised. This thesis aimed to identify environmental anti-
androgens in UK and South Australian catchments and to produce environmentally 
relevant exposures to assess their potential impacts on sexual disruption in fish, alone 
and in combination with steroid oestrogens. By using hydrological modelling 
techniques, pharmaceuticals with an anti-androgenic mode of action were predicted to 
occur in the ng/L concentration range in UK and South Australian wastewater treatment 
works effluents and river catchments. This work included analysis of future trends in 
environmental concentrations of the pharmaceuticals and the steroid oestrogens in 
these catchments. Modest increases in concentrations by 2050 were predicted in the 
absence of mitigation, which could increase in the risk posed to fish health by the 
steroid oestrogens in the future. The effects of the predicted concentrations of two 
pharmaceuticals, bicalutamide and cyproterone acetate, were then assessed in fathead 
minnows (Pimephales promelas) and Japanese medaka (Oryzias latipes) based on the 
UK modelling for the present day. These concentrations did not contribute to endpoints 
characteristic of sexual disruption, alone or in combination with steroid oestrogens. 
However, the results did support an environmental role for the steroid oestrogens in 
intersex induction. Concurrently, effect directed analysis identified some highly potent 
anti-androgens, such as triclosan and pyrene, in wastewater treatment works effluents 
from the UK. However, they are likely to make a minor contribution to overall anti-
androgenic activity due to their low concentrations. Consequently, more work is 
required to identify the causes of this activity in the environment and its implications for 
wild fish health. 
  
 
 
X 
 
ACKNOWLEDGEMENTS 
 
Time seems to have gone by incredibly fast since I was first lucky enough to join 
Brunel's Institute for the Environment and I now find myself finally at the end of my 
thesis and looking retrospectively at my experiences over the last four years.  Firstly, I 
would like to extend a general thanks to the members of IFE.  It has been both a 
pleasure and a privilege to work with such a dedicated and passionate group of people.  
Your input, advice and motivation has been a constant support to me throughout my 
PhD and I wish you all the best of luck in the future.   
I am indebted to my supervisor, Professor Susan Jobling, for putting her faith in a 
recently graduated bachelors student and providing a research project which has 
spanned multiple aspects of ecotoxicology.  Sue has been a guide and an inspiration 
throughout my project and I have learnt a huge amount from her.  Dr Jayne Brian and 
Dr Alice Baynes have also had a major impact as second supervisors, training and 
advising me as well as assisting with the interpretation of fractionation data and the 
smooth running of my in vivo experiments.  These experiments were also supported by 
the Animal Husbandry team and I am very grateful for the time and support lent by 
Julie Walker and Steve Pash.  My thanks also go to Nicola Beresford for help with 
ELISAs and yeast screening, Richard Williams of the Centre for Ecology and 
Hydrology, for assistance with hydrological modelling and Martin Scholze for statistical 
analysis.  Erin Losty also deserves mention for continuing to answer my chemistry 
questions, as does Professor Rakesh Kanda for guiding me through what has been a 
very eventful chemistry experience.  I am grateful for the funding from Severn Trent 
Water, the Commonwealth Scientific and Industrial Research Organisation and DEFRA 
which provided the backing for this UK-Australian collaboration.  On the Australian side 
I would also like to thank Dr Anu Kumar of CSIRO for her input in the project, as well as 
her willingness to take me on in Adelaide in 2011.  My thanks are also extended to the 
members of SETAC Australasia for making me feel so welcome during my visit.  Back 
at Brunel, special thanks goes to Dr Liz Nicol, who has been my desk buddy from the 
start, as well as the group of usual suspects, Liz Lawton, Alice, Graham Harris, Tara 
Thrupp, Thomas Hoyle, Satwant Kaur, Dr Lourdes Lopez-Merino and the inspirational 
Adam Lynch.   
Finally, my thanks go to my family for their faith in me and their support over the years.  
This thesis is dedicated to them. 
XI 
 
PUBLICATIONS 
 
Research published in peer reviewed journals and presented at conferences which 
originated from this thesis is shown below:  
 Green, C., Brian, J., Kanda, R., Scholze, M., Williams, R. and Jobling, S. 
Environmental concentrations of anti-androgenic pharmaceuticals do not impact 
sexual disruption in fish alone or in combination with steroid oestrogens. 2014 
Aquatic Toxicology. In Press.  
 Green, C., Williams, R., Kanda, R., Churchley, J., He, Y., Thomas, S., Goonan, 
P., Kumar, A. and Jobling S. Modelling of steroid estrogen contamination in UK 
and South Australian rivers predicts modest increases in concentrations in the 
future. Environmental Science and Technology. 2013, 47 (13), 7224–7232. 
DOI: 10.1021/es3051058. 
 Green, C., Brian, J., Williams, R., Scholze, M. and Jobling, S. The Effects of 
Anti-Androgenic Pharmaceuticals on Oestrogen Induced Feminisation in Model 
Fish Species. Platform presentation. 23rd SETAC European Meeting, Glasgow, 
2013. 
 Green, C., Williams, R., Kanda, R., Churchley, J., He, Y., Thomas, S., Goonan, 
P., Kumar, A. and Jobling S. Predictive modelling of steroid oestrogens in 
sewage effluent demonstrates the potential for endocrine disruptive effects in 
wild fish populations in South Australia. Poster Presentation. 6th SETAC World 
Congress, Berlin, 2012.  
 Green, C., Baynes, A., Kanda, R., Churchley, J. and Jobling, S. Wastewater 
analysis may provide clues to the chemical causes of endocrine disruption. 
Poster Presentation. SETAC UK Branch Annual Meeting 2011. 
Additional research published but not included in this thesis: 
 Baynes, A.; Green, C.; Nicol, E.; Beresford, N.; Kanda, R.; Henshaw, A.; 
Churchley, J.; Jobling, S. Additional Treatment of Wastewater Reduces 
Endocrine Disruption in Wild Fish: A Comparative Study of Tertiary and 
Advanced Treatments. Environmental Science and Technology. 2012, 46 
(10), 5565-5573. DOI: 10.1021/es204590d 
 
XII 
 
LIST OF FIGURES 
 
Figure 1.1 An overview of hormone producing glands, organs and tissues (from 
WHO/UNEP, 2013). ...................................................................................................... 8 
Figure 1.2 A theoretical example of the non-linear, sigmoidal dose-response of 
hormone binding. ........................................................................................................ 10 
Figure 1.3 The effects of DEHP on hypothalamic/preoptic area aromatase activity in 
male rats at post natal day one ................................................................................... 15 
Figure 1.4 The number of chemicals detected by chemical class in a subsample of 54 
pregnant US women from the Health and Nutritional Examination Survey conducted 
from 2003-04. ............................................................................................................. 19 
Figure 1.5 Sexual disruption observed in the gonads of roach (Rutilus rutilus). .......... 26 
Figure 1.6 The hormonal control of the hypothalamic-pituitary-gonadal (HPG) axis in 
the male teleost fish. ................................................................................................... 31 
Figure 1.7 The Steroid Oestrogens: 17β-oestradiol (E2), oestrone (E1) and 17α-
ethinylestradiol (EE2) .................................................................................................. 35 
Figure 1.8 The alkylphenols: 4-nonylphenol (NP) and octyphenol (OP) ..................... 38 
Figure 1.9 Additional examples of weakly oestrogenic environmental contaminants. 
Bisphenol A, dibutyl phthalate and o,p’-dichlorodiphenyltrichloroethane (DDT) ........... 41 
Figure 1.10 The combined effects of five oestrogenic chemicals on egg production in 
fathead minnows......................................................................................................... 44 
Figure 1.11 The steriodogenesis pathway expanded to include a simplified depiction of 
the conversion of testosterone to other functional androgens in fish. .......................... 50 
Figure 1.12 A surface plot illustrating the results of statistical modelling of the 
association between exposure to oestrogenic (YES) and anti-androgenic chemicals 
(anti-YAS) ................................................................................................................... 55 
Figure 2.1 The non-steroidal anti-androgens: flutamide, bicalutamide and nilutamide 
 ................................................................................................................................... 62 
Figure 2.2 The steroidal anti-androgen, cyproterone acetate. .................................... 63 
Figure 2.3 The predicted risk classes of modelled river stretches in the Thames region 
based on the E2 equivalent concentration of the steroid oestrogens combined .......... 66 
Figure 2.4 Source Catchments software showing the link-node representation of part 
of the Onkaparinga River downstream of SA2. ........................................................... 77 
Figure 2.5 The change in population to the year 2050 in the UK and Australia under 
the three population projections .................................................................................. 79 
XIII 
 
Figure 2.6 Incidence of prostate cancer per 100,000 of the population in England, and 
Australia ..................................................................................................................... 80 
Figure 2.7 The average predicted effluent concentrations of anti-androgenic 
pharmaceuticals and steroid oestrogens in the UK and South Australia.. ................... 85 
Figure 2.8 The daily average modelled and measured oestrogen concentrations with 
the EEQ (ng/L) in effluent from UK2 over 19 sampling points from July to December 
2009 ........................................................................................................................... 89 
Figure 2.9 Location maps showing the Onkaparinga River, South Australia (above) 
and the River Erewash, UK (below). Produced in ArcMap 10. .................................... 90 
Figure 2.10 Heat maps showing the risk categories of modelled stretches on the 
Onkaparinga River and the River Erewash in the present day based on the EEQ of the 
steroid oestrogens. ..................................................................................................... 92 
Figure 2.11 The range of concentrations of anti-androgenic pharmaceuticals in 
effluents from UK and South Australian WWTWs under present day and future 
projections assuming no change in DWF. ................................................................... 95 
Figure 2.12 The change in the total load (mg/day) of E1, E2 and EE2 arriving at 
WWTW’s (UK2 and SA2) in the UK and Australia up to 2050 under the three population 
projections. ................................................................................................................. 97 
Figure 2.13 The predicted steroid oestrogen and EEQ concentrations of effluents in 
the UK and South Australia under present day and future projections assuming no 
change in DWF at the WWTWs. ................................................................................. 98 
Figure 2.14 Predicted river concentrations (ng/L) of anti-androgenic pharmaceuticals 
on the Onkaparinga River, South Australia and the River Erewash, UK. ................... 100 
Figure 2.15 The average predicted EEQs (ng/L) for the present day compared with the 
three future population projections, high (2050A), principal (2050B) and low (2050C), 
with river flows reduced for medium range climate change scenarios ....................... 102 
Figure 3.2 Male (upper) and female (lower) fathead minnows (Pimephales promelas) 
showing their differences in morphology ................................................................... 115 
Figure 3.3 The experimental set up for dosing exposure tanks ................................ 117 
Figure 3.4 Adult Japanese medaka (Oryzias latipes) maintained in a stock tank...... 122 
Figure 3.5 The stages of the histological process showing a preserved male and a 
female with the body cavity opened .......................................................................... 127 
Figure 3.6 Chromatograms of bicalutamide and the internal standard d7 propranolol in 
an aquarium water sample from the mixture treatment in experiment one ................ 134 
Figure 3.7 Chromatograms showing the presence of cyproterone acetate and the 
internal standard d10 carbamazepine in an aquarium water sample from the mixture 
treatment from experiment two ................................................................................. 136 
XIV 
 
Figure 3.8 The condition factor, GSI and HSI of fathead minnows in each treatment 
group ........................................................................................................................ 141 
Figure 3.9 Secondary sexual characteristics of fathead minnows in each treatment 
group. ....................................................................................................................... 143 
Figure 3.10 Log. vitellogenin concentrations (ng/mL) in the blood plasma of fathead 
minnows in each treatment group quantified by ELISA. ............................................ 145 
Figure 3.11 (A) the combined E2 equivalent (EEQ) of water samples from experiment 
two determined from the measured E1 and E2 concentrations and the predicted EE2 
concentrations .......................................................................................................... 149 
Figure 3.12 Length, weight and condition factor of fish in each treatment group. ..... 152 
Figure 3.13 The proportions of male, female, intersex and unknown Japanese medaka 
within each treatment group. ..................................................................................... 154 
Figure 3.14 Images showing the gonad histopathology of fish sampled during this 
experiment ................................................................................................................ 156 
Figure 3.15 Statistical comparisons of the intersex severity in Japanese medaka 
between treatment groups ........................................................................................ 157 
Figure 3.16 A map showing the predicted concentrations of bicalutamide in river 
catchments in England and Wales based on 2009 prescriptions ............................... 159 
Figure 3.17 A map showing the predicted concentrations of cyproterone acetate in 
river catchments in England and Wales based on 2009 prescriptions ....................... 160 
Figure 4.1 The process employed to identify the causes of oestrogenic activity in 
WWTW effluent which was directed towards the steroid oestrogens ......................... 176 
Figure 4.2 The Effect Directed Analysis process used in this study to identify anti-
androgenic chemicals in UK effluent and river water samples................................... 179 
Figure 4.3 Images of the WWTWs and the waterways they discharge to. ................ 181 
Figure 4.4 Determining the flutamide equivalents of pyrene using logarithmic 
regression. ................................................................................................................ 186 
Figure 4.5 A comparison of (anti-) androgenic activity in effluent fractions from the 
WWTWs UK1 and UK3, as indicated by their dose response curves in the YAS ...... 188 
Figure 4.6 Responses of active chemicals in the yeast screen. Corrected absorbance 
at 540 nm quantifying colour change. ....................................................................... 194 
Figure 4.7 Turbidity readings (620 nm) responses from active chemicals in the yeast 
screen showing proliferative and toxic effects. .......................................................... 195 
Figure 5.1 Bicalutamide and cyproterone acetate tested in the YAS, serially diluted 
from 1 mM with a background of 2 nM DHT. ............................................................. 214 
Figure 5.2 Experimental design for exposure of Japanese medaka embryos to WWTW 
effluent fractions to assess the multi-factorial aetiology of sexual disruption. ............ 221 
XV 
 
Figure 5.3 Fluorescent microscopy observing the GFP response, linked to the oocyte 
gene osp1, in the excised testes of transgenic Japanese medaka following exposure to 
increasing doses of EE2 ........................................................................................... 222 
 
 
 
  
XVI 
 
LIST OF TABLES 
 
Table 2.1 The prescriptions of pharmaceuticals in the England and Wales (2009) and 
Australia (2008). ......................................................................................................... 70 
Table 2.2 The population breakdown of the oestrogen excreting cohorts by criteria and 
the composition of each census population: UK 2001 and Australia 2006. ................. 71 
Table 2.3 The parameters for UK and South Australian WWTW for the present day. . 73 
Table 2.4 Average (minimum – maximum) flow rates from UK2 at sampling points 
between July and December 2009, provided by Severn Trent Water .......................... 74 
Table 2.5 Cohort percentages based on census data from 2001 (UK), 2008 (Australia) 
and under the three population projections for 2050. .................................................. 81 
Table 2.6 Fold changes in population from 2011-2050 applied to WWTWs in the UK 
and Australia based on the three population projections ............................................. 82 
Table 2.7 The mean average (upper-lower) oestrogen concentrations measured in 
effluents from 43 WWTWs in the UK and over 70 WWTWs in Australia based on the 
available literature.. ..................................................................................................... 87 
Table 2.8 The per capita loads of the steroid oestrogens in µg/day for the present day 
and under the three population projections ................................................................. 96 
Table 3.1 The scoring system for tubercle prominence............................................. 120 
Table 3.2 The dilutions of plasma from fish in each treatment group used in the ELISA.
 ................................................................................................................................. 121 
Table 3.3 The constituents of Modified FETAX Solution (MFS) required for producing 
2.5 L of solution. ....................................................................................................... 124 
Table 3.4 The tissue processing protocol for the histology of Japanese medaka using 
the Leica TP1020. ..................................................................................................... 128 
Table 3.5 The staining protocol for histology of Japanese medaka using the Stainmate.
 ................................................................................................................................. 128 
Table 3.6 The intersex index scoring system used to quantify severity in the gonad 
sections from sampled fish ....................................................................................... 129 
Table 3.7 Optimised instrumental conditions for LC-MS/MS analysis of anti-androgenic 
pharmaceuticals and steroid oestrogens ................................................................... 137 
Table 3.8 Concentrations (ng/L) of anti-androgenic pharmaceuticals and steroid 
oestrogens in samples from treatment tanks collected on the first and final day of the 
experiment and quantified by LC-MS/MS .................................................................. 139 
XVII 
 
Table 3.9 Concentrations of anti-androgenic pharmaceuticals and steroid oestrogens in 
treatment tanks compared to their nominal concentrations ....................................... 146 
Table 3.10 The survival of fish in the replicate tanks from each treatment group. Each 
tank started with 25 embryos. ................................................................................... 150 
Table 4.1 Internal standards added to fractions prior to GC-MS analysis, including their 
concentrations in the fractions, retention time and mass/charge ratio ....................... 184 
Table 4.2 The number of chemicals in detected effluent, river and blank samples. This 
includes the number of unknown and tentatively identified known chemicals, as well as 
their uses or origins where they could be determined. .............................................. 189 
Table 4.3 Chemicals identified in UK effluent fractions with suspected anti-androgenic 
activity based on literature sources which were advanced to in vitro testing. ............ 191 
Table 4.4 Chemicals with confirmed anti-androgenic activity in the YAS. This shows 
their retention times and fragment ions from GC-MS analysis as well as their 
concentrations in the samples................................................................................... 198 
 
  
XVIII 
 
DEFINITIONS 
 
ABS  Australian Bureau of Statistics 
ADHD  Attention Deficit/Hyperactivity Disorder 
AhR  Aryl Hydrocarbon Receptor 
ANOVA One Way Analysis of Variance 
AP-1  Activator protein 1  
AR  Androgen Receptor 
ASP  Activated Sludge Process 
BPA  Bisphenol A 
COX  Cyclooxygenase 
CPRG  Chlorophenol Red β-Galactopyranoside 
CSIRO  Commonwealth Scientific and Industrial Research Organisation 
DBP  Di Butyl Phthalate 
DDT  Dichlorodiphenyltrichloroethane 
DEHP  Di (2-ethylhexyl) Phthalate 
DES   Diethylstilbestrol 
DHT  5α-Dihydrotestosterone 
DWF  Dry Weather Flow 
E1  Oestrone 
E2  17β-Oestradiol 
EDA  Effect Directed Analysis 
EDC  Endocrine Disrupting Chemical 
EE2  17α-Ethinylestradiol 
EEQ  17β-oestradiol equivalent 
ELISA  Enzyme Linked Immunosorbant Assay 
EQS  Environmental Quality Standards 
EU  European Union 
FluEQ  Flutamide Equivalent Concentration 
FSH  Follicle Stimulating Hormone 
GAC  Granular Activated Carbon 
GC-MS Gas Chromatography-Mass Spectrometry 
GFP  Green Fluorescent Protein 
GnRH  Gonadotrophin Releasing Hormone 
GSI  Gonadosomatic Index 
HHCB  Galaxolide 
HPG axis Hypothalamic-Pituitary-Gonadal Axis 
HPLC  High Performance Liquid Chromatography 
HRT  Hormone Replacement Therapy 
HSI  Hepatosomatic Index 
LC-MS/MS Liquid Chromatography-Tandem Mass Spectrometry 
LF2000-WQX The Low Flows 2000 Water Quality eXtension model 
LH  Luteinising Hormone 
LOD  Limit of Detection 
LOEC  Lowest Observed Effect Concentration 
MFS  Modified FETAX (Frog Embryo Teratogenesis Assay-Xenopus) Solution 
MRM  Multiple Reaction Monitoring 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NOEC  No Observed Effect Concentration 
NP  4-Nonylphenol 
NSAID  Non-Steroidal Anti-Inflammatory Inhibitors 
ONS  Office for National Statistics 
XIX 
 
OP  Octylphenol 
PAH  Poly Aromatic Hydrocarbons 
PBDE  Polybrominated Diphenyl Ethers 
PCB  Polychlorinated Biphenyls 
PFOA  Perfluorooctanoic acid 
PNEC  Predicted No Effect Concentration 
POP  Persistent Organic Pollutants 
PPAR  Peroxisome Proliferating Activated Receptor 
REACH  Registration, Evaluation, Authorisation & Restriction of Chemicals 
SPE  Solid Phase Extraction 
TIE  Toxicity Identification Evaluation 
UNEP  United Nations Environmental Program 
WWTW Wastewater treatment Works 
YAS  Yeast Androgen Screen 
YES  Yeast Oestrogen Screen 
1 
 
1. CHAPTER 1: GENERAL INTRODUCTION 
 
  
2 
 
1.1 Background 
Between 2000 and 2009, annual global sales of products from the chemical industry 
doubled and projections anticipate a 3% annual rise up to 2050. The exact number of 
chemicals on the global market is unknown, although 143,835 have been preregistered 
for the European Union (EU) regulation REACH (Registration, Evaluation, 
Authorisation & Restriction of Chemicals) and this is likely to be an underestimation of 
the total. These chemicals are diverse in their uses and include basic/commodity 
chemicals (such as petrochemicals and inorganic chemicals), speciality chemicals 
derived from basic compounds (such as plasticisers and catalysts), pesticides, 
pharmaceuticals and personal care products (Sigman et al., 2012). Some of these 
chemicals are beneficial to human health and wellbeing and they all benefit the 
economy. However, many have been shown to have negative impacts on human and 
environmental health as emission from industry, agriculture and human waste has 
made anthropogenic chemical contamination of the environment ubiquitous. 
In the past, awareness of the negative impacts of anthropogenic pollution was 
characterised by direct effects on human health. In particular, there was a focus on 
localised events which caused significant mortality, such as the Great Smog in London 
in 1952, which caused 4,000 deaths during its five day course and provided the 
impetus for legislation in the form of the Clean Air Act in 1956 (Hoffmann, 1993). The 
same can be said for awareness of the effects of pollution on wildlife, which focussed 
on localised poisoning events, such as maritime oil spills, mining discharges and lead 
toxicity linked to the death of birds (Rattner, 2009). However, the publication of Silent 
Spring by Rachel Carson in 1962 brought the issue of pollution and wildlife health to 
the forefront of public and political attention. This broadened the scope for chemical 
effects by linking pollutants, such as the organochlorine insecticide 
dichlorodiphenyltrichloroethane (DDT), not just to death but also to reproductive 
failures in non-target organisms. It highlighted the ability of these compounds to persist 
and bioaccumulate in food webs, leading to dramatic population declines in bird 
species (Carson, 1962). In particular, it considered that pollutants could have effects on 
entire ecosystems and that the human body could also become contaminated. Indeed, 
even in countries where bans have been implemented for decades, a legacy of the use 
of DDT remains as it is still detected in breast milk, (Shen et al., 2007).  
It is only in the last few decades that the ability of some chemicals to interfere with the 
endocrine system in humans and animals has been recognised. These chemicals are 
termed “endocrine disruptors” and are defined as: “an exogenous substance or mixture 
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that alters function(s) of the endocrine system and consequently causes adverse health 
effects in an intact organism, or its progeny, or (sub) populations. A potential endocrine 
disruptor is an exogenous substance or mixture that possesses properties that might 
be expected to lead to endocrine disruption in an intact organism, or its progeny, or 
(sub) populations” (International Programme on Chemical Safety, 2002). Endocrine 
disrupting chemicals (EDCs) consist of a diverse range of over 800 chemicals from 
different classes which include, but are not limited to, pesticides, plasticisers, 
pharmaceuticals and personal care products, polychlorinated biphenyls, polycyclic 
aromatic hydrocarbons, flame retardants, natural hormones and heavy metals. These 
can enter the environment during their production, use and disposal, at point sources 
such as wastewater treatment works (WWTWs) (e.g. pharmaceuticals) or through 
runoff from urban or agricultural settings (e.g. pesticides). Others can leach from a 
product during its lifespan (e.g. plasticisers) or they can be released from the 
environment by human activity (e.g. heavy metal contamination from mining). Many 
persist for long periods after their release, whilst others are constantly released into the 
environment, making them “pseudopersistent”. Furthermore, some EDCs can be 
transported long distances through natural processes, whilst others are in use around 
the world, leading to global exposure of humans and wildlife to these pollutants 
(WHO/UNEP, 2013).  
In response to the realisation that a variety of chemicals could exert effects through 
endocrine disruption, some countries have set up frameworks to assess suspected 
endocrine disruptors. These include the chemicals regulation REACH in the EU, the 
Endocrine Disruptor Screening Program run by the US Environmental Protection 
Agency and the Japanese Ministry for the Environment’s Extend 2005 and 2010 
programs. The science behind endocrine disruption and EDCs has also recently been 
assessed in a number of reports from the World Health Organisation and the United 
Nations Environmental Program (UNEP) (State of the Science of Endocrine Disrupting 
Chemicals – 2012), the European Commission (State of the Art Assessment of 
Endocrine Disrupters, 2011) and the European Environment Agency (The Impacts of 
Endocrine Disrupters on Wildlife, People and Their Environments: the Weybridge+15 
[1996–2011] Report). These conclude that EDCs are capable of affecting human and 
wildlife health and constitute a global threat. However, continued research is required 
to advance our understanding of these pollutants. Indeed, expanding the identification 
of potential EDCs, characterising their exposure to humans and wildlife and 
determining how and when they act both singularly and in combination with other 
EDCs, is increasingly important. What is more, there have been calls from scientists for 
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regulatory action to mediate their potential risks and to avoid irreversible harm in the 
future in the 2013 Berlaymont Declaration. 
 
1.2 Example classes of endocrine disruptors 
1.2.1 Persistent and bioaccumulative halogenated chemicals 
The Stockholm Convention was set up by UNEP in 2001 to reduce and eventually 
eliminate the global use of persistent organic pollutants (POPs). This initially included 
12 chemicals but this has since been updated to 22. These include pesticides, such as 
DDT, dieldrin and endosulfan, as well as industrial chemicals and byproducts, such as 
the polychlorinated biphenyls (PCBs), which are complex mixtures used primarily as 
insulating agents, and polybrominated diphenyl ethers (PBDEs), which are used as 
flame retardants. All are highly persistent in the environment and bioaccumulate in food 
chains, which has led to them being identified in animals at higher trophic levels and 
humans globally, even following bans on their use (Shen et al., 2007). They are also 
subject to long range atmospheric transport, which has led to their detection in 
“pristine” areas far from their origin. Indeed, these contaminants have been detected in 
the Arctic and its wildlife, as well as the people who depend on these animals as a food 
source, demonstrating the global relevance of the issue (Fisk et al., 2005; Van 
Oostdam et al., 2005). In addition to the initial POPs, other persistent and 
bioaccumulative chemicals are now under review for inclusion in the Stockholm 
Convention. These include perfluorooctanoic acid (PFOA) and brominated flame 
retardants, for which evidence of endocrine effects are increasing and their detection in 
the human body has occurred globally (White et al., 2011; Watanabe and Sakai, 2003).  
 
1.2.2 Less persistent and less bioaccumulative chemicals  
Whilst these chemicals are easier to break down than POPs and do not have the same 
potential to bioaccumulate, their use and release into the environment is widespread 
and constant. As a result, they have been termed “pseudo-persistent.” For example, 
plasticisers including the phthalate esters, di(2-ethylhexyl)phthalate (DEHP) and 
dibutylphthalate (DBP), as well as bisphenol A (BPA), are some of the most abundant 
anthropogenic chemicals in the environment (Oehlmann et al., 2009; Murature et al., 
1987). They are used in manufacturing to increase flexibility in polymers and are found 
in many everyday objects including food wrapping, pesticides and medical equipment 
(Lovekamp-Swan and Davis, 2003). However, they are not covalently bound to the 
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product and can leach out into the environment. Alkylphenolic chemicals, such as 
nonylphenol (NP), octylphenol (OP) and their ethoxylates, also have an industrial 
usage as non-ionic surfactants and enter the aquatic environment through industrial 
discharge. Although they have now had their use restricted in the EU, due to concerns 
for their acute toxicity, they are still detected at lower concentrations (Soares et al., 
2008). Similarly, some personal care products enter the environment through disposal 
routes from households, such as the biocide triclosan, which originates from soaps, 
skin creams and toothpastes (von der Ohe et al., 2012). In contrast, polycyclic aromatic 
hydrocarbons, such as benzo[a]pyrene and anthracene, originate from industrial 
processes as byproducts of the incomplete combustion of fossil fuels, including vehicle 
emissions (Kizu et al., 2003b; Vinggaard et al., 2000). Although they are combustion 
products, they are not only air pollutants and can be detected in other environmental 
media, particularly following their discharge in industrial effluents or urban runoff 
(Eisler, 1987). 
 
1.2.3 Current use pesticides and pharmaceuticals 
Both pesticides and pharmaceuticals are designed to be biologically active and have 
become contaminants of emerging concern due to their potential effects on non-target 
organisms and their constant release into the environment. Whilst current use 
pesticides do not have the same persistence or ability to bioaccumulate as their 
predecessors, many still have endocrine activity and experience extensive use in 
agriculture as well as in building material and garden care (WHO/UNEP, 2013). Indeed, 
almost 60 pesticides are now listed for testing in the US Environmental Protection 
Agency's Endocrine Disruptor Screening Program, many of which are in current use in 
the USA, such as atrazine and vinclozolin. However, this is only a proportion of the 
plethora of pesticides with known endocrine activity. Indeed, one study tested over 200 
pesticides in vitro, including many in current use, and found 80 with oestrogenic 
activity, 66 with anti-androgenic activity and 34 with combined activity (Kojima et al., 
2004). Pharmaceuticals are of particular relevance to the aquatic environment since 
they are discharged constantly through wastewater treatment works effluent following 
human excretion. Improper disposal and manufacturing can also have an impact and 
there are some exceptional cases where effluents from manufacturing plants in third 
world countries contained very high concentrations of antibiotics (Larsson et al., 2007). 
Consequently, a plethora of drugs have now been detected worldwide and include beta 
blockers, antibiotics, progestagens, non-steroidal anti-inflammatory drugs and selective 
serotonin reuptake inhibitors (reviewed by Corcoran et al., 2010). One of the most 
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notable is 17α-ethinylestradiol (EE2), the active oestrogen in the contraceptive pill 
hormone, which will be subject to further discussion for its implication in the sexual 
disruption of wild fish.  
 
1.2.4 Natural hormones, phytoestrogens and heavy metals 
Natural hormones are highly active chemicals as they are natural ligands for hormone 
receptors within the endocrine system. In a majority of cases, this makes them more 
potent than other EDCs that mimic hormone action (Metcalfe et al., 2001). The 
exceptions are some pharmaceuticals, which are designed to interact with receptors 
and to resist metabolic degradation, such as EE2 (Caldwell et al., 2012). Natural 
hormones including testosterone, 17β-oestradiol (E2) and oestrone (E1) are all 
excreted by humans and animals. As a result, they constantly enter the aquatic 
environment via wastewater treatment works effluent and agricultural runoff from 
livestock farming and can also be described as pseudo-persistent (Matthiessen et al., 
2006; Johnson and Williams, 2004). Similarly, phytoestrogens derive naturally from 
plants and include isoflavonoids, such as genistein, and coumestans, such as 
coumestrol. Exposure of humans to these chemicals can occur through the diet, from 
foods including nuts and oils, soy products, cereals and breads (Thompson et al., 
2006). Exposure and effects in livestock has also been demonstrated through grazing, 
which can lead to infertility (Adams, 1995). Heavy metals also have a natural origin and 
are released from rocks through weathering processes. Their environmental presence 
is also arguably one of the oldest forms of anthropogenic pollution following the 
discovery of mining techniques. Indeed, environmental contamination increased 
dramatically following the industrial revolution, as the demand for metals rose along 
with their release through industrial processes (Nriagu, 1996). The use of heavy metals 
has since broadened, with cadmium used in batteries, arsenic used as a pesticide and 
lead incorporated into paints and fuels, producing a variety of exposure pathways for 
both humans and wildlife (WHO/UNEP, 2013).  
 
1.3 The endocrine system 
To understand the global concern surrounding EDCs, it is necessary to understand the 
function of the endocrine system. This has been well characterised in the WHO/UNEP 
report (WHO/UNEP, 2013), which states that human and wildlife health depends on the 
ability to reproduce and develop normally, and that this is not possible without a healthy 
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endocrine system. The endocrine system is a chemical messaging system made up of 
networks of ductless glands, organs, tissues and cells, which secrete hormones directly 
into the blood to regulate various bodily functions. This includes specialised endocrine 
glands, such as the thyroid or pituitary, as well as organs with secondary endocrine 
functions, such as the heart and liver (shown in Figure 1.1 below). Hormones are 
molecules derived from amino acids, cholesterol or phospholipids, which are produced 
by endocrine glands and travel via the blood to produce effects on distant target 
organs, tissues and cells (Melmed et al., 2011). Whilst this can be described as 
endocrine action, hormones can also act on their parent cells (autocrine action), 
adjacent cells (paracrine action) and the nervous system (neuroendocrine action). 
Their circulating concentrations and actions within the body are controlled by complex 
feedback loops which determine their rate of production and secretion, as well as their 
metabolism and excretion.  
Hormones have multiple functions within the human body in the control of physiological 
processes. Some are critical to the normal development of an organism and cause 
irreversible changes to morphology. For example, during male development in 
mammals, a bipotential gonad differentiates into the testes based on the presence of 
the Y encoded gene sry, without which an ovary forms. Secondary development of the 
reproductive tract, including the development of the male duct system and external 
genitalia is then driven by the testicular hormones, testosterone, anti-müllerian 
hormone and insulin-like peptide 3 (insl3) (Wilhelm et al., 2007; Nef and Parada, 2000). 
Aspects of post-natal development, such as secondary sexual characteristics, are also 
linked to sex hormones controlled by the hypothalamic-pituitary-gonad axis, which also 
plays an important role in the reproductive cycle in later life (Ankley and Johnson, 
2004). The endocrine system also maintains the internal environment through the 
feedback loops of hormones. For example, insulin plays a key role in controlling the 
metabolism and storage of glucose. It is secreted from the pancreas in response to 
increased plasma glucose concentrations, inhibits glucose production in the liver and 
promotes its uptake, utilisation and conversion to glycogen for storage in fat and 
muscle tissue. The reduction in blood glucose then negatively feeds back on the 
pancreas to reduce insulin secretion (Saltiel and Kahn, 2001). This regulation of the 
internal environment also allows an organism to adapt to changes in the external 
environment. For example, under stressful situations the glucocorticoid cortisol is 
released, which mobilises energy reserves by promoting gluconeogenesis and lipolysis 
to overcome the increased metabolic demand (Kudielka and Kirschbaum, 2005).  
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Figure 1.1 An overview of hormone producing glands, organs and tissues (from 
WHO/UNEP, 2013). 
 
Because of its critical physiological functions, disruption to the endocrine system by 
altering the availability of a hormone or its action at a target site can have severe 
effects on an organism, some of which can be irreversible. Indeed, a number of 
endocrine disorders have been observed in humans, which can cause abnormal 
development. For example, congenital hypothyroidism can cause neurological damage, 
including intellectual deficits and cretinism, if it is not identified and treated early 
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(Zoeller et al., 2002). Similarly, deficiency in the enzyme 5α-reductase, which converts 
testosterone to the more potent 5α-dihydrotestosterone (DHT), can result in ambiguous 
external genitalia, micropenis, prostate hypoplasia, reduced spermatogenesis and 
scarce facial and body hair (Cheon, 2011). In addition, disruption to homeostatic 
regulation can have serious implications for survival, such as insulin resistance 
occurring in type 2 diabetes and cases of obesity, which results in a loss of control of 
glucose regulation and hypoglycaemia. As a result, diabetic individuals are more likely 
to be afflicted with heart disease, kidney failure, limb amputation and blindness (Smyth 
and Heron, 2006).  
Hormones bind to specific receptors with a high affinity to become signal transduction 
systems mediating hormonal responses (Welshons et al., 2003). Hormone receptors 
are found on cell membranes or within the cell cytoplasm or nucleus. Hydrophilic 
hormones, such as hypothalamic and pituitary hormones, are not lipid soluble and are 
therefore unable to pass through the cell membrane. Instead, they bind to receptors on 
the cell membrane and stimulate or inhibit a second messenger system. This induces a 
cascade of protein phosphorylations, producing transcription factors to allow the 
hormone to indirectly regulate the transcription of its response genes. In contrast, 
lipophilic hormones, such as the sex steroids, can pass through the cell membrane to 
bind to intracellular receptors. The hormone-receptor complex then becomes a 
transcription factor itself by binding to a hormone response element on the DNA within 
the nucleus of a cell to activate transcription (Welshons et al., 2003). These genomic 
responses are slow and can take a number of hours due to the time taken to 
synthesise and accumulate the protein (Schmidt et al., 2000), although faster 
responses can be achieved via the membrane receptors. Indeed, there is now a large 
body of evidence to suggest that lipophilic steroid hormones can also act on receptors 
in the membrane to induce these fast responses (Falkenstein et al., 2000). For 
example, aldosterone can rapidly activate ion transport mechanisms to cause changes 
in cell volume (Lösel and Wehling, 2003). 
Due to the high affinity and specificity between receptors and their hormone ligands, 
they are capable of producing a response at the low concentrations at which they are 
present in the blood (pg/mL) (Vandenberg et al., 2012). In addition, the number of 
receptors with bound hormones, receptor occupancy, has a non-linear relationship with 
the concentration of available hormones (Figure 1.2), which can bind up to the point of 
receptor saturation when a maximal response is reached. As a result, a small change 
in hormone concentration at the low end will have a much greater impact on receptor 
occupancy than a change at the high end of the concentration range. In most cases, 
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fewer than 5% of all receptors are bound to their ligand, meaning that the system is 
prepared to have large effects from small changes in hormone concentrations 
(Vandenberg et al., 2013; Nussey and Whitehead, 2001). Receptor occupancy also 
has a non-linear relationship with the response, in part due to the saturation of the 
response at lower concentrations than those required to reach saturation of the 
receptor. This is termed the “spare receptor” hypothesis, which suggests that there are 
surplus receptors to those required to produce a biological response (Welshons et al., 
2003). Hormones have at least a sigmoidal relationship with the response, as shown in 
Figure 1.2, but in some cases non-monotonic dose-responses can also occur, in that 
the slope of the dose-response curve changes from positive to negative or vice versa 
(Kohn and Melnick, 2002). This can result from a reduction in the abundance of 
receptors as a result of hormone mediated downregulation, degradation, or 
desensitisation of the receptor to reduce its binding affinity (Vandenberg et al., 2012). 
When these receptor interactions occur at higher concentrations than those that induce 
the maximal response, it results in a drop in the response curve. 
 
Figure 1.2 A theoretical example of the non-linear, sigmoidal dose-response of 
hormone binding. At the low end, an increase in hormone concentration by 1x causes a 
50% increase in receptor occupancy (yellow), in comparison to 4% at the high end 
(red) (from Vandenberg et al., 2012). 
 
The presence of receptors within the endocrine system is subject to both spatial and 
temporal variation, with the magnitude of a biological response depending on the 
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number of available receptors, as well as the hormone concentration (Zoeller et al., 
2012). In some cases these receptors are expressed only in specific tissues, such as 
receptors for thyroid stimulating hormone, which are only found in the thyroid. Others, 
like the thyroid hormone receptor are found throughout the body (Vandenberg et al., 
2012; Cheng et al., 2010). This spatial spread of receptors determines the scope for 
hormone action within the endocrine system, which can be broad, such as thyroid 
hormone or localised, such as thyroid releasing hormone. Temporal variation in the 
expression of receptors specifies hormone action at different stages of development as 
well as throughout the duration of physiological processes. Indeed, the expression of 
the gene coding for oestrogen receptor β was found to fluctuate during oestrus in the 
rat ovary (Hiroi et al., 1999). In addition, some receptors have a number of different 
subtypes, which can have distinct roles and mediate different responses to a single 
hormone. For example, the thyroid hormone receptor has two isoforms, with receptor α 
regulating heart rate and receptor β modulating serum cholesterol, amongst other 
subtype specific effects (Lin et al., 2013). In this case, analysis of thyroid hormone 
gene regulation failed to find any receptor specific differences, suggesting that their 
differential effects may be mediated by differences in the magnitude of the gene 
expression that each subtype could induce.  
 
1.4 Endocrine disrupting chemicals and the endocrine system 
To recap, an EDC is defined as “an exogenous substance or mixture that alters 
function(s) of the endocrine system and consequently causes adverse health effects in 
an intact organism, or its progeny, or (sub) populations” (International Programme on 
Chemical Safety, 2002). Early research on EDCs suggested that they exerted their 
effects through interaction with nuclear receptors, such as the androgen, oestrogen 
and thyroid receptors. However, in the last ten years it has been accepted that the 
scope for the action of EDCs is in fact much broader. It is now considered that they can 
exert their effects through direct action with hormone receptors and/or by controlling 
hormone delivery to the receptors (WHO/UNEP, 2013). This has opened all aspects of 
the endocrine system in both males and females to disruption by these exogenous 
chemicals, which can have serious physiological implications for both the development 
and function of an organism. 
Direct genomic interactions of EDCs with hormone receptors can occur in an agonistic 
fashion to stimulate a transcriptional response in a hormone sensitive gene. In many 
cases these chemicals are less potent than natural hormones, in that greater 
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concentrations are required to induce a maximal response equal to that of the 
endogenous hormone. Indeed, xenoestrogenic EDCs, such as NP, OP and BPA, are 
10,000 to 100,000 times less potent than endogenous E2, respectively. However, other 
chemicals can be considerably more potent, such as the pharmaceutical oestrogens 
diethylstilbestrol (DES) and EE2, that latter being ten times more potent than E2 in fish 
models (Caldwell et al., 2012; Gutendorf and Westendorf, 2001). Non-genomic actions 
of EDCs have also been demonstrated but are less well studied, such as BPA binding 
to membrane receptors in pancreatic β cells to increase calcium ion oscillations and 
insulin secretion (Watson et al., 2011; Nadal et al., 2000). Other chemicals can interact 
antagonistically with the receptor, binding without activating a response and blocking 
the binding of endogenous hormone agonists to inhibit their action. In addition, some 
EDCs are only partial agonists to a receptor, in that they have a lower intrinsic activity 
and therefore produce a submaximal response compared with the endogenous 
hormone (Soto et al., 2006). At appropriate concentrations, partial agonists can act in 
an agonistic fashion when there are sufficient spare receptors to bind to, but at higher 
concentrations they can also act as antagonists by blocking the binding of the more 
potent, natural ligands. This is highlighted by the pharmaceutical tamoxifen, which is 
used as an oestrogen receptor antagonist to treat breast cancer, although it is also a 
partial agonist. At therapeutic concentrations it can inhibit proliferation of oestrogen 
stimulated breast cancer cells, but it can also promote proliferation at lower sub-
therapeutic concentrations, as a result of its weak agonistic activity. It therefore 
produces a “flare” in cancer cell proliferation early in treatment, before the therapeutic 
dose is achieved in the patient (Vandenberg et al., 2012; Howell et al., 2001). This 
produces a non-monotonic dose response curve, which will be further discussed. To 
further complicate the issue, single EDCs can interact with the endocrine system 
through multiple mechanisms involving multiple receptors. For example, some 
pesticides and plasticisers act as both androgen receptor (AR) antagonists and 
oestrogen receptor agonists (Kojima et al., 2004; Sohoni and Sumpter, 1998). Some 
parent compounds can also break down to produce active metabolites, such as the 
anti-androgenic DDT metabolite p,p’-DDE (Kelce et al., 1995). In addition, disruption of 
hormone synthesis, transport and elimination can reduce hormone concentrations at 
the target receptor. By limiting any or all of these factors, the amount of hormone 
available to bind to the receptor will decrease, reducing the magnitude of the response. 
In the case of the phthalate ester DEHP, exposure of male rats during foetal life causes 
reproductive tract malformations due to the suppression of testosterone concentrations. 
This is thought to be caused by a reduction in cholesterol uptake and steroid synthesis 
(Borch et al., 2006).  
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Since EDCs can act like hormones, it has been proposed that testing and regulation of 
these substances adheres to principles of endocrinology (Vandenberg et al., 2013; 
Zoeller et al., 2012; Diamanti-Kandarakis et al., 2009). This stance has caused much 
debate amongst researchers and regulators since this viewpoint contrasts with the long 
held dogma in toxicological testing of “the dose makes the poison” (Holmes, 2013). 
This principle assumes that the effects of low doses can be predicted from the effects 
of high doses, based on a linear, monotonic relationship (Myers et al., 2009; Hotchkiss 
et al., 2008). Low doses have been defined as either an environmentally relevant dose 
or a dose below the concentration at which a biological effect occurs in traditional 
toxicological tests (Melnick et al., 2002). However, research suggests that, like 
hormones, EDCs can act at low doses and produce non-linear or even non-monotonic 
dose response curves, making the effects of low doses difficult to predict. As 
discussed, the non-linear relationships between hormone and receptor and receptor 
and effect (Figure 1.2) mean that the endocrine system is very sensitive to changes at 
the low end of the dose response curve, where it can produce a large response 
(Vandenberg et al., 2013; Nussey and Whitehead, 2001). EDCs obey the same rules 
when interacting with receptors and so some can also induce effects at low 
concentrations (Vandenberg et al., 2012; Welshons et al., 2003). Some EDCs also 
have a high affinity to hormone receptors, such as EE2, which preferentially binds with 
a high affinity to oestrogen receptor α (Gutendorf and Westendorf, 2001). Other 
proposed mechanisms for low dose effects include additive action with endogenous 
hormones, greater bioavailability of EDCs, which show low binding affinity to high 
affinity protein transporters, and changes in receptor abundance (Vandenberg et al., 
2012). Some examples of EDCs which can exhibit low dose effects were highlighted in 
a review by an expert panel from the US National Toxicology Program and include: 
DES, methoxychlor, NP and genistein (Melnick et al., 2002). However, a more recent 
review has found evidence for low dose effects in a more diverse set of chemicals, 
including industrial chemicals, plasticizers, pesticides, phytoestrogens, preservatives, 
surfactants and flame retardants (Birnbaum, 2012; Vandenberg et al., 2012).  
As well acting in a non-linear fashion, non-monotonic dose response curves also seem 
to be common amongst EDCs. These have been reviewed by Vandenberg et al. who 
collected several hundred examples of non-monotonic dose response curves reported 
in cell lines, whole organisms and human populations (Birnbaum, 2012; Vandenberg et 
al., 2012). Multiple mechanisms have been proposed to explain this phenomenon, 
which can produce “U shaped” or “inverted U shaped” curves as well as other curves 
which can be more complex. These include cytotoxicity at high concentrations, which 
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negatively impact the positive endocrine response achieved at lower concentrations, 
particularly in studies employing cell lines (Welshons et al., 2003). Changes in the 
association between an EDC and the receptor from agonism at low doses to 
antagonism at high doses, such as in the case of tamoxifen, can produce similar 
effects (Howell et al., 2001). Alternatively, an EDC may act on multiple receptors at 
high concentrations to produce different responses through multiple gene pathways 
(Kojima et al., 2004). Changes in receptor abundance with up-regulation at low 
concentrations and downregulation or desensitization at high concentrations can also 
occur (Vandenberg et al., 2012). Whilst it is clear that replicable non monotonic dose 
response curves occur through exposures to EDCs, more work is needed to elucidate 
the exact endocrine mechanisms through which this occurs for specific chemicals. In 
addition, testing should ensure that a sufficient range of doses are employed to ensure 
that significant adverse effects are detected (Myers et al., 2009). This is highlighted by 
an in utero exposure of rats to DEHP, where brain aromatase was inhibited at low 
doses, below the perceived no observed effect concentration (NOEC), and stimulated 
at high doses in males on postnatal day 1 (Andrade et al., 2006). This is displayed in 
Figure 1.3.  
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Figure 1.3 The effects of DEHP on hypothalamic/preoptic area aromatase activity in 
male rats at post natal day one. The box plots indicate medians (horizontal lines) with 
25 and 75% quartiles and error bars extending to the maximum and minimum values. * 
indicates a significant difference from the control group. The low dose region [–] started 
at a similar concentration to the estimated median intake of the general German 
population (Koch et al., 2003). The high dose region [–] ended with the highest dose at 
405 mg/kg/d, which is known to cause reproductive defects without maternal toxicity. 
The inverse U shape of the response curve is also displayed (adapted from Andrade et 
al., 2006).  
 
Additional observations of the differential effects of chemicals at different life stages 
further contrasts with the “dose makes the poison” principle. The effects of EDCs 
depend on the stage of development of an organism and the timing of the exposure 
within its life cycle, where some developmental stages may be more sensitive to 
perturbation than others (Zoeller et al., 2012). Like natural hormones, this can 
potentially induce irreversible changes if exposures occur during sensitive “critical 
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windows,” such as when organs are forming or differentiating. For example, an 
androgen programming window has been identified in rats during foetal development 
when androgens induce masculinisation of the reproductive tract. It was only by 
exposing males during this specific time point that disrupting endogenous androgens 
with anti-androgenic chemicals could cause reproductive tract malformations and a 
reduction in penile length (Welsh et al., 2008). Indeed, disruption during the sensitive 
period of early development may also have adverse effects that only present 
themselves in later life. This is a well-known concept in human health termed the 
“foetal basis of adult disease,” which linked conditions such as coronary heart disease 
and type 2 diabetes to undernutrition during foetal life (Barker and Clark, 1997). It is 
supported by life history theory, which suggests that undernutrition leads to a reduction 
in the available energy allocation and can permanently alter the body’s structure, 
function, and metabolism (Barker, 2004). One of the best examples in human health is 
the case of the pharmaceutical DES, which was prescribed to pregnant women to 
prevent miscarriage between 1940 and 1971. As well as causing reproductive 
abnormalities, the in utero exposure of DES daughters was linked to clear cell 
adenocarcinoma and increased likelihood of miscarriage, ectopic pregnancies and 
premature births in later life (Hotchkiss et al., 2008). In addition, there is increasing 
concern for a role of EDCs in the obesity epidemic, which cannot be solely explained 
by overeating and inactivity (Baillie-Hamilton, 2002). A number of chemicals, including 
DES, BPA and organotins, have been found to disrupt the normal developmental and 
homeostatic controls over adipogenesis and energy balance. This has led to weight 
gains in experimental animals following in utero exposures (Newbold et al., 2008; Grün 
and Blumberg, 2006). In addition, a recent epidemiology study has linked prenatal 
exposure of PCBs and DDT to obesity in the daughters of women from the Faroe 
Islands in Denmark (Tang-Péronard et al., 2014). 
Advances in research also suggest that the effects of exposure to EDCs can be more 
long term than just the lifetime of an exposed individual, as evidence of 
transgenerational effects is growing. Indeed, maternal exposure not only affects the 
mother (F0), but also the embryo (F1) and the F2 generation present as germ cells 
within the embryo (Patisaul and Adewale, 2009). One mechanism by which 
transgenerational effects can occur is through epigenetic changes in the germ line. 
These are inheritable changes in gene expression patterns by molecular processes 
such as DNA methylation or histone modification, which can occur without changing 
the gene sequence itself. Indeed, methylation of a gene promoter region can reduce 
transcription, whilst acetylation of the histone tail can have a promoting effect (Gore, 
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2008). This has been observed in exposures of rats to the anti-androgenic vinclozolin 
or oestrogenic methoxychlor pesticides during foetal development. Here, a 
spermatogenic cell defect leading to subfertility in F1 males was transferred to 
subsequent generations, from F1 to F4, and correlated with DNA methylation in the 
germ line (Anway and Skinner, 2006; Anway et al., 2005). DES has also demonstrated 
inheritable traits in rodent studies, where the offspring of rodents exposed in utero were 
found to be more susceptible to tumour formation. Again, this was thought to occur 
through epigenetic mechanisms and has caused concern for DES granddaughters 
(Newbold et al., 2006).  
 
1.5 Endocrine disruption in humans and wildlife  
In the last few decades, increased research on endocrinology and toxicology has 
expanded the scope of endocrine disruption to encompass the entire endocrine 
system. There is also increasing evidence for long term impacts of EDCs, low dose 
effects, and the combined action of mixtures. Consequently, the implication of chemical 
pollutants in the aetiology of endocrine disorders in humans and wildlife is an 
increasing cause for concern. The research contributing to this thesis surrounds 
endocrine disruption specifically in terms of reproductive effects in fish and therefore 
the bulk of this section mainly focuses on sexual disruption in fish. However, it should 
be recognised that endocrine disruptive effects have been observed across a wide 
variety of vertebrate and invertebrate taxa and there are an increasing number of cases 
in which effects in wildlife can be attributed to EDCs (WHO/UNEP, 2013).  
 
1.5.1 Endocrine disruption in humans 
Research suggests that like other vertebrates, humans are also susceptible to 
endocrine disruption by exogenous chemicals. This is highlighted by the case of DES, 
which failed to fulfil its purpose of preventing miscarriage and was found to cause 
reproductive disorders and cancers in children born to DES mothers. Indeed, clear cell 
adenocarcinoma, abnormalities of the cervix, uterus and fallopian tubes, as well as 
increased likelihood of miscarriage, ectopic pregnancies and premature birth were 
observed in daughters (Hotchkiss et al., 2008). Effects were also reported in sons, 
including hypospadias (the abnormal placement of the male urethral orifice) and 
cryptorchidism (undescended testes), as well as reductions in sperm count, the number 
of motile sperm and sperm with normal morphology, although fertility appeared 
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unaffected (Toppari et al., 1996). The link to these disorders is supported by studies in 
rodents, where similar effects were observed, such as cancers, reduced fertility and 
reproductive tract malformations (Newbold, 2001). These studies also demonstrated 
transgenerational inheritance of cancers through epigenetic changes in the maternal 
germ line, which has caused concern for the health of DES granddaughters (Newbold 
et al., 2006). In addition to DES, some environmental chemicals have also been 
associated with endocrine disorders following occupational exposures or poisoning 
events. For example, cryptorchidism in male newborns has been associated with 
occupational pesticide exposure of mothers involved in agriculture and gardening in 
Norway and Denmark (Weidner et al., 1998; Kristensen et al., 1997). Hypospadias and 
other congenital anomalies have been associated with proximity to hazardous waste 
sites in Europe (Dolk et al., 1998), whilst in Minamata, Japan, methylmercury poisoning 
of residents consuming contaminated fish resulted in severe neurological problems 
(Ekino et al., 2007).  
Like wildlife populations, humans globally are constantly exposed to pollutants in food, 
soil, water, air and dust, which can enter the body by inhalation, ingestion and dermal 
contact (WHO/UNEP, 2013). In 1951, the detection of DDT in human fat and milk was 
first reported in non-occupationally exposed mothers (Laug et al., 1951). Since then it 
has become increasingly appreciated that the general human population has a body 
burden of a wide range of contaminants, which has led to an increase in biomonitoring. 
Of particular concern is the presence of these contaminants in pregnant women, since 
chemicals are capable of crossing the placenta into the foetus and have been detected 
in amniotic fluid, umbilical cord blood and meconium (Woodruff et al., 2011; Barr et al., 
2007). Indeed, the ubiquitous exposure to some environmental chemicals was 
demonstrated in the US Health and Nutritional Examination Survey conducted from 
2003-4. Here, certain PCBs, organochlorine pesticides, perfluorinated compounds, 
phenols, PBDEs, phthalates, polyaromatic hydrocarbons (PAHs), and perchlorate were 
detected in 99–100% of the 268 pregnant women studied (Woodruff et al., 2011). 
Some of the chemical classes detected in a subsample of this study are shown below 
in Figure 1.4. 
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Figure 1.4 The number of chemicals detected by chemical class in a subsample of 54 
pregnant US women from the Health and Nutritional Examination Survey conducted 
from 2003-04 (from Woodruff et al., 2011). Each vertical bar represents one study 
participant. 
 
Although much of the evidence for endocrine disruption in humans comes from 
accidental or occupational exposures to adverse chemicals, such as DES, there is 
evidence for increasing trends in hormone related disorders in the general human 
population. Indeed, EDCs may be contributing to the increasing trends in reproductive 
disorders, hormone related cancers, neurobehavioral disorders and even obesity, 
which have been observed in a number of countries in the last century (WHO/UNEP, 
2013). In males, increasing trends in the incidence of testicular germ cell cancers, 
cryptorchidism and hypospadias, as well as reductions in semen quality have been 
observed in a number of countries and are well characterised in Europe (Jørgensen et 
al., 2006; Richiardi et al., 2004; Sharpe and Irvine, 2004; Toppari et al., 2001). Since 
these disorders have been associated as risk factors of one another, they have been 
hypothetically linked as symptoms of a single, underlying condition termed testicular 
dysgenesis syndrome (Skakkebæk et al., 2001). In humans, the symptoms may vary 
dependant on the severity of the condition and although genetic factors can be 
involved, a majority of newborns with malformations of the genitalia were found to have 
no known genetic defects. This, combined with the speed of increased incidence of 
these symptoms, suggests that lifestyle and environmental factors, such as EDCs, are 
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likely to be involved (Skakkebæk et al., 2001). In fact, testicular dysgenesis syndrome 
is thought to have a foetal origin, resulting from disruption to prenatal testicular 
development during the androgen programing window. This is the point during foetal 
development in which androgens induce masculinisation of the reproductive tract and 
when disruption of androgen control can lead to abnormal development (Welsh et al., 
2008). Indeed, in mammalian studies, disruption of androgen production and/or 
androgen action at the receptor by EDCs has been shown to induce these disorders in 
the male offspring of exposed pregnant females (Wilson et al., 2008; Earl Gray Jr. et 
al., 2006). For example, di (n-butyl) phthalate caused a dose dependent induction of 
cryptorchidism, hypospadias and impaired spermatogenesis (Sharpe and Skakkebaek, 
2008). In humans, prenatal exposure to phthalates, BPA and p,p’-DDE were also 
associated with lower ano-genital distance (Miao et al., 2011; Torres-Sanchez et al., 
2008; Swan et al., 2005). This measurement is normally higher in males than females 
and so a decrease indicates demasculinisation. As a result, whilst it was originally 
considered that these effects could be a result of exposure to environmental 
oestrogens, it now seems more likely they are caused by disruption of the oestrogen-
androgen balance. Critically, the increase in focus on the role of androgens also 
implicates environmental anti-androgenic chemicals, which are capable of disrupting 
endogenous androgens (Sharpe, 2003). From this perspective, a cumulative risk 
assessment of 15 AR antagonists, including pesticides, phthalates and parabens was 
conducted to determine their possible impact on human reproductive health. Based on 
the median intake of these chemicals in the general human population and the 
concentrations required to cause adverse effects in rodent models, this study found 
that adverse effects were unlikely to occur in the general human population. In 
comparison, for individuals at the high end of the exposure range the cumulative risk 
from the combination of these chemicals was determined to exceed an acceptable 
level (Kortenkamp and Faust, 2010). However, when a mixture of 22 AR antagonists 
were combined at levels observed in human plasma, they failed to produce an anti-
androgenic effect in vitro. This indicates an explanation gap between the cause and 
effects of testicular dysgenesis syndrome, which suggests that other as yet unknown 
chemicals would need to be contributing to the observed effects (Kortenkamp et al., 
2014).  
Adverse female reproductive health trends include increases in the incidence of 
endometriosis, the preterm birth rate, uterine fibroids and difficulty in achieving or 
maintaining pregnancy, as well as the earlier onset of puberty (WHO/UNEP, 2013). As 
with male reproductive health issues, it is thought that EDCs could play a role in 
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inducing these effects through disruption of the hormonal control of development and 
function of the female reproductive system. Indeed, the human body burden of some 
pesticides has been associated with shorter menstrual cycle, earlier age of menarche 
and later menopause (Farr et al., 2006; Ouyang et al., 2005; Farr et al., 2004). 
Exposure to p,p’-DDE in early life is also considered to be a risk factor for breast 
cancer in later life (Cohn et al., 2007). In addition, thyroid disruption and effects on 
neurodevelopment in males and females have also been observed in animal models 
following exposure to chemicals such as brominated flame retardants, PBDEs, BPA 
and PCBs (Boas et al., 2012; Zoeller, 2010; Legler, 2008). There is concern that these 
could be linked to increasing incidence of attention deficit/hyperactivity disorder 
(ADHD). Indeed, in the US there is evidence that children with higher serum 
concentrations of polyfluoroalkyl chemicals, such as PFOS and PFOA, have greater 
odds of having ADHD (Hoffman et al., 2010). There is also evidence of a link between 
organochlorines and behavioural deficits in children following prenatal exposure 
(González-Alzaga et al., 2013). 
 
1.5.2 Endocrine disruption in wild vertebrates 
Endocrine disorders have also been observed in a variety of wild vertebrate species, 
some of which show similarities to those observed in humans. Genital abnormalities 
and altered secondary sexual characteristics have been observed in wildlife in 
contaminated areas, causing concern for impacts on reproductive fitness. For example, 
abnormal ovarian morphology, increased E2 concentrations and multioocyte follicles 
have been identified in female American alligators (Alligator mississippiensis) in Lake 
Apopka (Milnes and Guillette Jr., 2008). Reproductive success in this population is low 
and a loss of sexually dimorphic gene expression has been observed (Milnes et al., 
2008). In males from this site, a reduction in phallus size compared with control lakes 
has also been observed. Similarly, reduced baculum (penile bone) size has been 
observed in otters in the UK and Canada, where baculum size was negatively 
correlated to hepatic organochlorine concentrations in both countries (Grove and 
Henny, 2008; Simpson, 2007). The body burdens of these chemicals have also been 
correlated with uterine obstructions and reduced pregnancies in Baltic grey seals 
(Halichoerus grypus) (O'Hara and Becker, 2003) and organohalogens have been 
negatively correlated with the size of both the baculum and testes in male polar bears 
and the ovaries and reproductive tract in females (Sonne et al., 2012). Cryptorchidism, 
occurs with abnormally high incidence in a population of sitka black-tailed deer 
(Odocoileus hemionus sitkensis) on Kodiak Island in Alaska, and was associated with 
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antler abnormalities (Veeramachaneni et al., 2006). In other cases where 
cryptorchidism is abnormally high, including that of the Florida panther, low genetic 
diversity and inbreeding may be a contributing factor. However, in the case of the 
Kodiak Island deer, the data favours an impact of environmental contaminants on 
embryonic development since there is no evidence of excessive inbreeding or genetic 
drift (Latch et al., 2008). Nonetheless a genetic vulnerability in this population to a 
contaminant remains plausible and with a majority of the effected animals being 
reproductively sterile, there is a risk of population level effects and a reduction in 
genetic diversity (Veeramachaneni et al., 2006).  
Intersexuality, the simultaneous presence of male and female tissue within the gonad 
of an individual, has also been observed in amphibian populations globally, where it is 
also considered to be a feminisation response in males. In Canada, the occurrence of 
intersex in two frog species has been associated with agricultural areas and was 
correlated with the presence of pesticides (McDaniel et al., 2008). Indeed, historical 
data on intersex in cricket frogs (Acris crepitans) in the US suggests that the greatest 
incidence occurred in periods associated with high use of DDT and PCBs (1946-1959). 
Incidence declined as the use of these chemicals and their environmental presence 
reduced from 1960 onwards. However, in other localities, higher incidence of intersex 
in frogs has been observed in urban and industrial areas compared to agricultural 
areas, suggesting that there are likely to be multiple chemical causes (Skelly et al., 
2010; Reeder et al., 2005). Intersex has also been observed in reptiles, such as red 
bellied turtles (Pseudemys nelsoni) in the pesticide contaminated Lake Apopka, Florida 
(Guillette Jr. et al., 1995). There is also evidence of intersex in birds, although this 
could be occurring naturally since it seems to regress and was not present in 21 day 
old hatchlings from a PCB contaminated site (Hart et al., 2003). In mammals, true 
hermaphroditism has been discovered in a beluga whale (Delphinapterus leucas), with 
two testis and two ovaries, in the St Lawrence estuary, Canada (De Guise et al., 1994). 
In addition, one case of ova-testes intersex has been observed in a stranded common 
dolphin (Delphinus delphis), in which ovarian tissue was developing normally and the 
testicular tissue was degenerating (Murphy et al., 2011). Pseudohermaphroditism has 
also been identified in other cetaceans (Tarpley et al., 1995), as well as polar bears 
(Ursus maritimus) (Wiig et al., 1998), American black bears (Ursus americanus) and 
brown bears (Ursus arctos) (Cattet, 1988). The incidence of these abnormalities in the 
tested populations seems to be considerably lower than that of intersex in wild fish, 
although this could be affected by sampling much fewer individuals. For example, the 
study of abnormalities in black bears and brown bears only assessed 38 and four 
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individuals respectively, of which abnormal sexual differentiation was observed in four 
black bears and one brown bear. In addition, in polar bears, female 
pseudohermaphroditism was only observed in four out of 269 individuals (Wiig et al., 
1998).  
An indicator of feminisation is the presence of an abnormally high blood plasma 
concentration of vitellogenin in male oviparous vertebrates. High concentrations of 
vitellogenin are normally detected in females since it is an egg yolk precursor molecule, 
but its production can also be induced in males by EDCs. Indeed, vitellogenin induction 
in male peregrine falcons (Falco peregrinus) in Spain was hypothesised to be linked to 
organochlorine chemicals (e.g. PCBs and DDTs). However, the implications of this are 
as yet unknown and since the peregrine falcon is on the International Union for the 
Conservation of Nature’s red list as "threatened," negative impacts of pollutants remain 
a cause for concern (Jiménez et al., 2007). There is also some evidence of altered 
vitellogenin concentrations in reptiles at contaminated sites, including male snapping 
turtle (Chelydra serpentina) in Canada (Environment Canada, 2003) and female 
freshwater turtles (Chrysemys picta) in North America (Rie et al., 2005). However, this 
is not as well researched as vitellogenin induction in wild fish, which will be further 
discussed. 
One of the most notable cases of a set of EDCs adversely affecting wildlife is the case 
of organochlorine pesticides and their link to widespread population declines in higher 
trophic level birds (Lundholm, 1997). Following the onset of prevalent organochloride 
use in the late 1940’s, adult mortality due to accumulated pesticide residues and nest 
failure through eggshell thinning were first observed in North America, in species 
including bald eagles (Haliaeetus leucocephalus), osprey (Pandion haliaetus) and 
peregrine falcon (Henny et al., 2010; Brown et al., 2007). Similarly, in the UK incidence 
of broken eggs in the nests of predatory birds such as sparrowhawk (Accipiter nisus) 
and golden eagle (Aquila chrysaëtos) increased considerably between 1951 and 1966 
(Ratcliffe, 1967). This is thought to occur due to the inhibition of prostaglandin 
synthesis in the egg shell mucosa by p’p-DDE, which in turn reduces calcium transport 
to the egg shell (Lundholm, 1997). In some species over a 19% reduction in egg shell 
thickness was observed, which was associated with organochlorine residues and 
resulted in increasing egg breakage and eventually population declines (Hickey and 
Anderson, 1968). Peregrine falcons, for example were completely extirpated from the 
eastern part of the US by 1964 (Clark et al., 2009). Following the ban on DDT in 
western countries in 1972, as well as human intervention with breeding programs and 
reduced persecution, many species have now recovered (Henny et al., 2010; Brown et 
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al., 2007). There is now evidence for trends of increasing egg shell thickness, although 
organochlorine residues and also PCBs still continue to be detected and remain 
negatively correlated with shell thickness (Clark et al., 2009).  
As in humans, endocrine disorders in vertebrates which have been linked to EDCs are 
not limited to the reproductive system. Abnormalities indicative of thyroid disruption 
have been observed in marine mammals and linked to exposure to organochlorines, 
such as fibrosis of the thyroid gland in harbour porpoises (Phocoena phocoena) 
(Schnitzler et al., 2008). Similarly, lesions of the thyroid gland were found in beluga 
whales from St Lawrence estuary and Hudson’s Bay, Canada, which were unique to 
these populations (Mikaelian et al., 2003). Enlarged thyroid glands were observed in 
herring gulls at sites highly contaminated with PCBs in the Great Lakes, Canada, in 
what is thought to be a response to reductions in available thyroid hormone (McNabb 
and Fox, 2003). Furthermore, disruption to thyroid hormone, vitamin D, calcium and 
phosphate, which are linked to bone homeostasis, have been correlated with hepatic 
PCBs and DDT in Baltic grey seals. This is thought to be linked to bone abnormalities 
including skull lesions and reduced bone density (Routti et al., 2008). Impacts on the 
immune system have also been linked to pollutants, where PCB concentrations in the 
blubber of harbour porpoises were significantly higher in individuals that died through 
infectious disease in comparison to mortality through physical trauma (Jepson et al., 
2005). PCBs and other organochlorines are also hypothesised to have played a role in 
the phocine distemper virus outbreaks in European seal species. Indeed, at some sites 
higher concentrations of organochlorines were detected in the bodies of harbour seals 
(Phoca vitulina) that had died during the zoonotic compared to the survivors (Hall et al., 
1992). So far a causal relationship has not been firmly established (Härkönen et al., 
2006), although seal populations have been rising as POPs in the environment have 
reduced (WHO/UNEP, 2013). In addition, PAH exposure has been suggested as a 
significant cause of the abnormally high cancer rate identified in beluga whales in the 
St Lawrence estuary, Canada. Indeed, 27% of the stranded whales analysed contained 
cancerous tissue, which is the highest incidence in any cetacean population ever 
recorded (Martineau et al., 2002). Similarly, the concentration of PCBs in the blubber of 
California sealions (Zalophus californianus) has been linked to the probability of the 
animals dying of cancer. Here, PCBs concentrations were 85% higher in the blubber of 
sealions affected with carcinoma (Ylitalo et al., 2005). 
 
25 
 
1.5.3 Endocrine disruption in wild fish 
Endocrine disruption in fish has become one of the best researched areas of the field, 
following the identification of widespread reproductive abnormalities in wild fish 
populations. This was particularly well characterised in the UK, where abnormally high 
concentrations of vitellogenin were observed in male fish caged downstream of WWTW 
effluent outfalls in the 1990’s. This effect persisted for several kilometres downstream 
of the outfalls and was thought to be indicative of a feminisation response to 
oestrogenic EDCs originating from the WWTW effluent (Harries et al., 1997; Purdom et 
al., 1994). Further sampling of wild roach (Rutilus rutilus) in rivers across the UK also 
identified vitellogenin induction in males, which varied between sites and occurred at 
the highest concentrations downstream of wastewater treatment works (WWTWs). 
Critically, surveys also identified the widespread, abnormal occurrence of intersex in 
male fish, characterised by mixtures of both ovarian and testicular germ cells in the 
gonads and by the development of ovarian ducts (ovarian cavities) (Jobling et al., 
2006; Jobling et al., 1998). At sites with high incidence of intersex the number of 
normal males was low, which in conjunction with the observed vitellogenin induction, 
suggested that this was also a feminisation response to effluent contamination. Indeed, 
the incidence of intersex was found to be correlated with the proportion of effluent in 
the river. In control sites with little effluent contamination, intersex still occurred but at a 
much lower rate of 4-18% compared with 16-100% at contaminated sites, which could 
suggest a low natural occurrence or another pollution source. However, roach are a 
dioecious species (Jafri and Ensor, 1979) and a study of their reproductive cycle at a 
site where oestrogenic activity was not detected found no cases of intersex in the 474 
fish sampled. This suggested that intersex does not occur naturally in this species 
(Geraudie et al., 2010).  
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Figure 1.5 Sexual disruption observed in the gonads of roach (Rutilus rutilus). Normal 
male testicular tissue (A); normal female ovarian tissue (B); an ovarian cavity (OC) in 
the testis of a juvenile roach exposed to oestrogenic WWTW effluent (C) (from Baynes 
et al., 2012); abundant testicular oocytes in a fish from an effluent contaminated river 
site in the UK (D).  
 
Intersex (as shown in Figure 1.5) and elevated vitellogenin has since been identified in 
other fish species in the UK, such as the gudgeon (Gobio gobio) (van Aerle et al., 
2001), as well as in freshwater species in European countries including France 
(Maltret-Geraudie et al., 2008; Minier et al., 2000), Germany (Hecker et al., 2002), 
Denmark (Bjerregaard et al., 2006), Czech Republic (Randak et al., 2009), Spain (Solé 
et al., 2003) and Italy (Viganò et al., 2010). Intersex fish have also been reported 
further afield in North America (Hinck et al., 2009; Vajda et al., 2008; Woodling et al., 
2006), Japan (Hashimoto et al., 2000), Brazil (De Sá et al., 2008) and South Africa 
(Barnhoorn et al., 2004). Species specific differences in the occurrence of these traits 
have also been demonstrated. For example, assessments of fish in the Great Lakes, 
Canada, found no gonadal abnormalities in goldfish (Carassius auratus), common carp 
(Cyprinus carpio), gizzard shad (Dorosoma cepedianum), brown bullhead (Ictalurus 
ameiurus), pumpkinseed (Lepomis gibbosus), and bluegill (Lepomis macrochirus), but 
OC 
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did find widespread intersex (43-83% prevalence) and vitellogenin induction in white 
perch (Morone americana) (Kavanagh et al., 2004). Furthermore, fish in the estuarine 
environment also seem to be affected, with elevated vitellogenin occurring in flounder 
(Platichthys flesus) and viviparous blenny (Zoarces viviparus) (Kirby et al., 2004; 
Matthiessen et al., 1998a). In several UK estuaries, a few sites also exhibited intersex 
in these species (Kirby et al., 2004; Matthiessen et al., 1998a). More recently, 
vitellogenin induction has also been observed in marine species including male cod 
(Gadus morhua) and dab (Limanda limanda) in the North Sea (Scott et al., 2007; Scott 
et al., 2006), swordfish (Xiphias gladius) and northern bluefin tuna (Thunnus thynnus) 
in the Mediterranean (Fossi et al., 2006; Fossi et al., 2004) and Chilean flounder 
(Paralichthys adspersus) in the South Pacific (Leonardi et al., 2012), suggesting that 
the marine environment is also impacted by EDCs. 
A concerning implication of sexual disruption is the possible impact at a population 
level since the intersex condition is associated with other reproductive problems in 
males, particularly in the most severe cases. Indeed, reductions in spermiation, milt 
volume, sperm density and gamete quality are associated with intersex in wild roach. 
Interestingly, the maturation of ovaries was less obviously effected in female fish 
sampled in the UK river surveys, although ovarian atresia was identified in fish from 
effluent contaminated sites (Jobling et al., 2002b; Jobling et al., 2002a). In addition, 
breeding studies using wild caught roach also demonstrated a negative correlation 
between intersex severity, fertilisation success and reproductive performance. 
However, reproductive performance only correlated significantly when severely intersex 
individuals were included, where a 76% reduction in reproductive performance was 
observed (Harris et al., 2011). Assessing whether population level impacts are 
occurring in wild populations through reductions in reproductive fitness, individual 
survival or reductions in genetic diversity remains an important research question. 
Other changes to genital structure and secondary sexual characteristics have also 
been reported in wild fish, causing concern for potential impacts on the reproductive 
fitness of these individuals. The development and morphology of these characteristics 
are hormonally controlled and are sexually dimorphic in nature, making them good 
biomarkers for the impacts of EDCs. For example, abnormalities indicative of 
feminisation in the morphology of the urogenital papilla, a copulatory organ, occurred in 
up to 75% of sampled male sand gobies (Pomatoschistus minutus and P. lozanoi) in 
UK estuaries associated with oestrogenic activity and vitellogenin induction in flounder 
(Kirby et al., 2003). Similarly, in male mosquitofish (Gambusia a. holbrooki), reductions 
in the length of the gonopodium, a modified anal fin used in copulation, have been 
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associated with effluent contamination in Australia (Batty and Lim, 1999). This was also 
observed in mosquitofish in the pesticide contaminated Lake Apopka, Florida, 
alongside feminised American alligators, which also showed reductions in penile length 
(Toft et al., 2003; Guillette et al., 2000). Reduced secondary sexual characteristics of 
structures without direct reproductive function have also been observed in fathead 
minnows (Pimephales promelas), where reductions in the size of the dorsal fatpad and 
tubercles occurred in WWTW effluent contaminated rivers (Tetreault et al., 2012). 
Although they play no role in copulation, the feminisation of these traits could still lead 
to reductions in reproductive fitness by reducing their ability to compete adequately for 
nesting sites and females. Conversely, the development of male secondary sexual 
characteristics in female fish can be attributed to masculinisation by EDCs. This has 
been observed in female mosquitofish, which have developed gonopodia downstream 
of androgenic pulp and paper mill effluents in a number of countries (Hewitt et al., 
2008). Indeed, in the Fenholloway River, Florida, assessment of gonopodium length in 
female mosquitofish found 80% of individuals to be partially masculinised and 10% to 
be completely masculinised (Parks et al., 2001). Skewed sex ratios in favour of males 
have also been observed in viviparous eelpout (Zoarces viviparus) near pulp and paper 
mills in Sweden, in comparison to a set of reference sites where a stable sex ratio of 
around 50/50 had been observed over four years. In this case the sex ratio near the 
mill recovered following a 17 day shutdown, which coincided with the period of sexual 
differentiation in the development of the eelpout (Larsson and Förlin, 2002).  
Non-reproductive effects of EDC contamination are less well studied in wild fish. 
Nonetheless, there is evidence of significantly reduced prey capture by mummichogs 
(Fundulus heteroclitus) in a mercury polluted tidal creek in New Jersey, USA (Smith 
and Weis, 1997). These fish made significantly fewer attempts to capture prey in 
comparison to those from a reference site, suffered significantly greater predation and 
had significantly higher concentrations of methylmercury in their brain tissue (Zhou et 
al., 2000). These effects were thought to be mediated through disruption to the thyroid 
system, which has also been documented in walleye (Sander vitreus) in the Ottawa 
River (Picard-Aitken et al., 2007). This was also observed in mummichog in San 
Francisco Bay where thyroid parameters were significantly correlated to hepatic PCBs 
(Brar et al., 2010). In addition, fish chronically exposed to pollutants in the aquatic 
environment were also found to be incapable of eliciting a stress response through the 
elevation of cortisol in response to capture (Hontela et al., 1995; Hontela et al., 1992). 
In these cases, evidence suggested that this endocrine axis had reached an 
exhaustion phase due to prolonged hyperactivity. As a result, there were concerns for 
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effects on the survival of exposed individuals, since this response has been linked to 
immunosuppression and changes in behaviour.  
Under laboratory conditions, exposures of fish to WWTW effluents for prolonged 
periods have been shown to cause other adverse health effects. In roach, these 
included alterations in kidney development, as well as genotoxic and immunotoxic 
effects, which occurred during exposure to lower effluent concentrations than those 
required to induce reproductive abnormalities (Liney et al., 2006). Genotoxic effects 
have also been observed in carp exposed to water samples from the heavily polluted 
Noyyal River, India, where the number of DNA strand breaks increased with the 
duration of exposure (Rajaguru et al., 2003). The immune system has also been 
demonstrated as a target for EDCs in a number of laboratory studies, and there is 
increasing evidence of an immune-endocrine system association. Indeed, during 
spawning in rainbow trout (Oncorhynchus mykiss) the decrease in immune parameters, 
such as the number of anti-body producing cells and plasma immunoglobulin 
concentrations, was correlated with plasma sex steroid concentrations (Hou et al., 
1999). Experimentally, leukocyte proliferation, macrophage activity and proteins 
relating to innate and acquired immunity can all be affected by EDCs. Interestingly, 
there is also evidence of positive effects on immune parameters, such as the 
stimulation of phagocytosis by some oestrogenic EDCs (Milla et al., 2011). Some 
immune parameters are very sensitive to exposure to PAHs, which can cause an 
increase in the susceptibility of a fish to bacterial pathogens (Reynaud and Deschaux, 
2006). Finally, there is also experimental evidence for neuroendocrine disruption in fish 
by EDCs, with pollutants affecting gonadotrophin releasing hormone (GnRH), as well 
as neurotransmitters, such as serotonin and dopamine. As a result, it is plausible that 
this could adversely affect development and the sexual differentiation of the brain 
(reviewed in Le Page et al., 2011). 
 
1.6 Sexual disruption in male fish: disruption to the HPG axis 
and the role of oestrogenic contaminants  
1.6.1 The hypothalamic-pituitary-gonadal axis and sexual development 
Sexual disruption occurring in wild fish is thought to occur through disruption of the 
hypothalamic-pituitary-gonadal (HPG) axis (Figure 1.6), which plays an important role 
in sexual development and reproduction in vertebrates. In fish, the HPG axis is made 
up of a set of tissues: the hypothalamus, pituitary, testes or ovary, as well as the liver in 
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females, which are connected by vascular and neuronal linkage (Ankley and Johnson, 
2004). It is a dynamic but stable system under the control of hormonal feedback loops, 
which responds to external cues by bringing the organism to a new dynamic state, 
such as the initiation of a reproductive state. In this case, the hypothalamus produces 
GnRH, which stimulates the pituitary to produce gonadotrophic hormones, luteinising 
hormone (LH) and follicle stimulating hormone (FSH). Whilst FSH initiates 
gametogenesis, LH stimulates the production of sex steroids and causes gamete 
maturation, as well as ovulation or sperm release (Ankley and Johnson, 2004). Sex 
steroids negatively feedback on the hypothalamus to control the system by reducing 
the synthesis of gonadotrophins. In the ovary, LH stimulates oestrogen production (E2), 
from the thecal and granulosa cells, which in turn stimulates oocyte development, 
vitellogenin production in the liver and the initiation of female secondary sexual 
characteristics. These effects are mediated by oestrogen receptors, where E2 binds 
agonistically to initiate a transcriptional response. In males, LH increases androgen 
production (testosterone and 11-ketotestosterone) in the Leydig cells, which stimulate 
male secondary sexual characteristics and spermatogenesis, mediated through ARs. 
However, in the target tissue testosterone can also be converted to the more potent 
androgen, DHT; the major androgen in humans, the function of which is subject to 
increasing research in fish (Martyniuk et al., 2013). 
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Figure 1.6 The hormonal control of the hypothalamic-pituitary-gonadal (HPG) axis in 
the male teleost fish (from Ankley and Johnson, 2004). GnRH = gonadotrophin 
releasing hormone; LH = luteinising hormone, FSH = follicle stimulating hormone.  
 
Sexual differentiation in fish can be triggered by genetics or environmental factors and 
there are a variety of mechanisms through which this is achieved (Herpin and Schartl, 
2009; Devlin and Nagahama, 2002). Some species are gonochoristic, developing as 
males or females and remaining that way throughout their lifespans. In most 
gonochorists the gonad develops into a testis or ovary from an undifferentiated state, 
such as in Japanese medaka (Oryzias latipes). However, the gonad in other 
gonochorists can initially develop ovarian tissue, before either continuing development 
to become female or regressing and developing testicular tissue, such as in zebrafish 
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(Danio rerio) (Maack and Segner, 2004). Other fish naturally undergo complete sex 
reversal as part of their hermaphroditic life cycle with protandrous species, such as the 
cinnamon clownfish (Amphiprion melanopus), changing from males to females (Kim et 
al., 2013). Vice versa, protogynous fish such as the three spotted wrasse (Halichoeres 
trimaculatus) start life as females (Kobayashi et al., 2011). Sex change in these 
species can be a result of aging and increasing body size but can also be affected by 
social change, such as the loss of a dominant female in a protandric group. This can 
initiate male to female sex change in other individuals (Avise and Mank, 2009). Other 
hermaphroditic fish are termed simultaneous hermaphrodites, such as in mangrove 
killifish (Rivulus marmoratus) (Devlin and Nagahama, 2002; Sakakura and Noakes, 
2000). These have functional ova-testes and can reproduce by alternating sperm or 
egg delivery or even by internal, self-fertilisation. 
Sexual differentiation occurs by the differential stimulation or inhibition of components 
of a network of highly conserved genes downstream of a master regulatory gene. 
Critical to this process is the steroidogenic enzyme cytochrome P450 aromatase 
(cyp19a1), which converts androgens to oestrogens. This can be stimulated by the 
transcription factor foxl2 to drive ovarian development, or inhibited by dmrt1 to drive 
testicular development (Piferrer et al., 2012; Piferrer and Guiguen, 2008). The 
endocrine system is integral to this process, where oestrogens produced by aromatase 
are considered as a primary cause for differentiation and maintenance of the female 
phenotype. In comparison, androgens are viewed as the consequence of male 
differentiation, since they are produced in the Leydig cells of the testes after 
differentiation (Piferrer et al., 2012). Nonetheless, oestrogens are also produced in 
males and in rodent models they have been found to play an important role in normal 
germ cell development and fertility (Nef and Parada, 2000). Similarly, androgens in 
females are also thought to play a role in the development and regulation of the 
reproductive system, but this is not as well characterised (Margiotta-Casaluci et al., 
2013b; Staub and De Beer, 1997). As a result, it can be considered that the processes 
of normal sexual development are dependent on the balance of endogenous sex 
hormones, with oestrogens promoting ovarian development and androgens driving 
testicular development (reviewed in Devlin and Nagahama, 2002). This is 
demonstrated during the female to male sex change of the protogynous honeycomb 
grouper (Epinephelus merra). Here, low serum oestradiol and the degeneration of 
oocytes occur synchronously with increasing 11-ketotesosterone and the proliferation 
of spermatogenic germ cells prior to sex change (Nakamura et al., 2007). Similarly, 
exposure of fish to oestrogens or androgens under laboratory conditions (in vivo) can 
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disrupt sexual differentiation, producing complete sex reversal or the intermediate 
intersex condition. Although it is clear that oestrogens and androgens can promote 
gonad development, exactly how the HPG axis is involved in sexual differentiation and 
the induction of intersex is still not fully understood (Ankley and Johnson, 2004). 
Indeed, alongside androgens and oestrogens, recent research suggests that anti-
müllerian hormone may also be implicated. In the protandrous black porgy 
(Acanthopagrus schlegeli), low concentrations of anti-müllerian hormone were 
associated with the male to female sex reversal, which occurs in this species naturally 
during its life cycle (Wu et al., 2010). Furthermore, reduced anti-müllerian hormone was 
also associated with the inhibition of male gonadal development in zebrafish (Schulz et 
al., 2007). 
 
1.6.2 Wastewater treatment works effluents and the feminisation of wild 
fish 
The chemical causation of widespread intersex in wild fish populations remains subject 
to continuing research. In the UK, the presence of intersex fish was thought to be the 
result of feminisation of males or masculinisation of females. However, there are four 
major lines of evidence described by Jobling and Tyler (2008) which indicate that the 
feminisation of males is occurring. (1) When the populations were surveyed, the 
number of intersex roach was inversely proportional to the number of normal males. (2) 
The blood concentrations of 11-ketotestosterone and E2 in intersex fish were also 
similar to those of the normal males. (3) Vitellogenin induction was observed in wild 
male and intersex fish. (4) Effluents surveyed in the UK that were contaminating river 
networks tended to have oestrogenic activity, although more recently, anti-androgenic 
activity has also been detected (Tyler and Jobling, 2008).  
Due to its continuous discharge, WWTW effluent contamination of river networks is 
widespread and has been strongly associated with sexual disruption in fish globally 
(Tetreault et al., 2011; Maltret-Geraudie et al., 2008; Jobling et al., 2006; Woodling et 
al., 2006; Batty and Lim, 1999). Indeed, effluent concentrations at river sites have been 
correlated with the incidence of intersex in fish in the UK (Jobling et al., 1998). It is 
clear that EDCs within effluent can significantly impact reproductive health in fish and 
with the effects associated with feminisation, oestrogenic EDCs are likely to be 
significant contributors. These are oestrogen receptor agonists which can bind to 
oestrogen receptors to activate the transcription of oestrogen responsive genes. 
Indeed, oestrogenic activity is widespread in WWTW effluents globally, with a UK 
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survey finding activity in all 43 of its tested effluents (Johnson et al., 2007b). The 
discharge of these effluents into the aquatic environment has also been shown to 
cause oestrogenic activity in rivers downstream of their outfalls (Harries et al., 1997). 
Furthermore, in vivo exposures to WWTW effluents from a number of countries have 
been shown to induce the effects observed in the aquatic environment. Indeed, the 
induction of ovarian cavities occurred in roach exposed during early development in a 
dose dependent manner, with 100% of fish exhibiting the condition in 100% effluent 
(Rodgers-Gray et al., 2001). In a longer term in vivo exposure of 3.5 years, 100% 
effluent produced a roach population which was phenotypically 98% female. Those 
suspected of being sex reversed males contributed poorly to the next generation in a 
competitive breeding study, although their original sex could not be confirmed (Lange 
et al., 2011). In the same study, exposure of roach to 50% diluted WWTW effluent also 
found intersex induced in 21% of males.  In addition, reductions in secondary sexual 
characteristics (Vajda et al., 2011) and spermatogenesis (Kumar et al., 2012) have also 
been observed. 
Following the discovery of oestrogenic WWTW effluent, fractionation of domestic 
WWTW effluent samples and gas chromatography mass-spectrometry was completed 
to identify the chemicals responsible for this activity. This detected three steroid 
oestrogens including two natural oestrogens, E1 and E2 and the synthetic oestrogen 
and constituent of the contraceptive pill, EE2 (Desbrow et al., 1998). In addition, 
concern was also raised about the impact of alkylphenols, which were found to be 
oestrogenic in vitro and were also common in effluents and rivers, particularly in 
industrial areas (White et al., 1994; Jobling and Sumpter, 1993). Further investigation 
has also detected steroid oestrogens, alkylphenols and the plasticiser BPA in the bile 
of fish exposed to WWTW effluents (Pettersson et al., 2006; Gibson et al., 2005) and 
oestrogenic activity has been identified as a characteristic of a number of other 
chemicals found in WWTW effluent. Nonetheless, in vitro data suggests that it is the 
steroid oestrogens that are the main cause of oestrogenic activity in effluents, 
contributing up to 96% of the observed activity (Kinani et al., 2010; Salste et al., 2007; 
Snyder et al., 2001). However, this may be different in some localities dependent on 
the presence of other contaminants. For example, the alkylphenols have been shown 
to play a greater role in industrial areas associated with their discharge (Sheahan et al., 
2002b).  
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1.6.3 The role of steroid oestrogens 
 
 
Figure 1.7 The Steroid Oestrogens: 17β-oestradiol (E2) (left), oestrone (E1) (centre) 
and 17α-ethinylestradiol (EE2) (right) (sourced from Sigma Aldrich). 
 
The presence of the steroid oestrogens E1, E2 and EE2 (Figure 1.7) in WWTW effluent 
is a direct result of human excretion. Although they are excreted in their inactive 
conjugated forms, it is hypothesised that they are deconjugated back to their active 
parent compounds by Escherichia coli through their synthesis of the enzyme β-
glucuronidase. Indeed, this occurred when activated sludge from a WWTW in Germany 
was spiked with oestrogen-glucuronide complexes, which proceeded to form active, 
free oestrogens (Ternes et al., 1999). This process of activation was also demonstrated 
when fathead minnows were exposed to a laboratory generated effluent spiked with the 
the inactive oestradiol-3-glucuronide.  Here, a vitellogenin induction was achieved, 
which supported the hypothesis of microbial deconjugation to produce active ostrogens 
(Panter et al., 1999). 
The constant release of steroid oestrogens from WWTWs has led to the widespread 
contamination of river networks where these chemicals are arguably pseudo-persistent 
(Williams et al., 2009; Sumpter et al., 2006). In effluents, their concentrations occur in 
the low ng/L, as demonstrated by a survey of 42 UK WWTW effluents which measured 
concentrations of <1 to 100 ng/L for E1, <1 to 22 ng/L for E2 and <1 to 3.2 ng/L for EE2 
(Johnson et al., 2007b). In addition, localised contamination of rivers can also result 
from agricultural runoff through the excretion of E1 and E2 by livestock (Matthiessen et 
al., 2006).  
Under laboratory conditions, concentrations of steroid oestrogens relevant to the 
environmental scenario are capable of producing the characteristics associated with 
sexual disruption in the wild or following effluent exposure. This was demonstrated by a 
study of the induction of vitellogenin in rainbow trout following exposures to E1 and E2 
at 10 ng/L (Routledge et al., 1998). Similarly, in a study using Japanese medaka as a 
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model, induction of intersex was observed with exposure to 10 ng/L E1 or E2 and 0.1 
ng/L EE2. In fact, these effects have been observed following in vivo exposures with 
multiple fish species and predicted no effect concentrations (PNECs) derived from 
reproductive endpoints have been deduced as 6 ng/L E1, 2 ng/L E2 and 0.1 ng/L EE2 
(Caldwell et al., 2012). It was proposed that the steroid oestrogens could be major 
causal factors of endocrine disruption in wild fish; a hypothesis which was greatly 
strengthened by one of the UK river surveys assessing intersex in wild roach (Jobling 
et al., 2006). This found that both the incidence and severity of intersex in fish at 45 
river sites across the country were significantly correlated with the concentrations of 
steroid oestrogens predicted to occur at the sites. Moreover, the effects were 
associated with the predicted proportion of domestic effluent, from which the steroid 
oestrogens originate, and there was no correlation with industrial effluent. Interestingly, 
the correlation between the induction of vitellogenin in the sampled fish and the 
predicted oestrogen concentrations was not as strong, which could suggest that other 
factors are involved. Nonetheless, steroid oestrogen contamination is now considered 
to have a major impact on the reproductive health of wild fish. 
Further research on the in vivo and in vitro activity of the steroid oestrogens have 
broadened our understanding of how they interact with fish and their potential 
additional impacts on wild populations. All three have a strong agonistic affinity for the 
oestrogen receptors and so are able to bind and induce oestrogenic responses in 
target tissues. The HPG axis can also be further impacted by alterations to the 
expression of mRNA coding for steroid receptors and genes involved in reproductive 
function, as observed in an exposure of fathead minnows to E2 (Filby et al., 2006). In 
this study, increased expression of oestrogen receptor 1 (esr1) and a reduction in the 
expression of enzymes involved in androgen synthesis was observed. In addition, anti-
müllerian hormone, which inhibits the development of female genitalia and favours 
androgen production in the steroidogenic pathway, was downregulated. In another 
study, EE2 also inhibited the expression of genes involved in androgen biosynthesis, 
including cyp17, 11β-hsd and 17β-hsd, as well as those involved in testicular 
development, such as dmrt1. In comparison, the expression of genes related to 
oestrogen production was increased, including cyp19a1 (Filby et al., 2007b).  
It has been demonstrated that fish species differ in their sensitivity to steroid 
oestrogens, which is critical when interpreting results of in vivo studies using fish 
models in an environmental context. Indeed, an assessment of in vitro interactions with 
oestrogen receptor α from six fish species found that each species had different 
sensitivities to the three steroid oestrogens and that no one species was most sensitive 
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to all three. This was followed by in vivo exposures, which also found species 
differences in vitellogenin mRNA induction (Lange et al., 2012b). This corresponds with 
the environmental scenario, where reproductive abnormalities observed in some 
species at a contaminated site have not been observed in others (Kavanagh et al., 
2004). Furthermore, the timing of exposure appears to be important in determining the 
developmental effect, as critical windows of exposure are evident in fish, as well as in 
rodents and humans. Indeed, exposure of fathead minnows at various stages of early 
development found a window of sensitivity following EE2 exposure at 5-10 days post 
hatch, where 60% of sampled males developed ovarian cavities (van Aerle et al., 
2002). In contrast, the induction of testicular oocytes can also occur in later life with 
exposure during the post spawning regrowth period in roach (Baynes et al., 2012).  
More extreme effects can occur in long term exposures of fish to steroid oestrogens, 
which incorporate large proportions of the life cycle. For example, following exposure of 
roach to 4 ng/L EE2, post fertilisation for up to two years, complete sex reversal was 
observed when a phenotypically all-female population was produced (Lange et al., 
2009). In addition, reproductive failure with no fertilisation was observed in breeding 
populations of zebrafish in a full life cycle exposure to 5 ng/L EE2. This was caused by 
the high incidence of non-functional testes in the male population. Whilst this 
decreased fecundity it did not affect behaviour, allowing reproductively compromised 
males to compete with normal males (Nash et al., 2004). Similarly, but on a lager scale, 
a whole lake exposure to 5-6 ng/L EE2 over three consecutive years was completed in 
Canada’s Experimental Lakes Area, which caused delayed spermatogenesis and 
intersex in male fathead minnowss, as well as altered oogenesis in females. This 
resulted in two years of reproductive failure, with very low recruitment and eventually 
caused a complete population crash (Kidd et al., 2007). This has caused great concern 
for population level impacts on wild fish exposed to steroid oestrogens and whether this 
is already occurring in the wild remains an important research question.  
As a result of the concerns raised by steroid oestrogens in the environment, 
assessments have been made to determine whether the application of improved 
wastewater treatment technology can reduce concentrations and mitigate the effects of 
steroid oestrogens on fish. In the UK’s Endocrine Disruption Demonstration Program, a 
variety of wastewater treatment technologies, including advanced tertiary treatments, 
were assessed to determine their performance in removing steroid oestrogens (Butwell 
et al., 2010). The results showed that tertiary treatment technologies could reduce 
concentrations to below the PNECs for E1 and E2 as well as EE2, albeit with limited 
additional dilution. In addition, an in vivo assessment of fathead minnowss found that 
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the effects that occurred in an effluent treated through the activated sludge process 
(reduced secondary sexual characteristics and vitellogenin induction) did not occur in 
response to the tertiary treated effluents (Filby et al., 2010). In contrast, an assessment 
of roach exposed to some tertiary effluents still found intersex occurring, even when 
removal efficiency was high (Baynes et al., 2012). This suggests that there could be 
other chemicals acting on these endpoints alone or in combination with the steroid 
oestrogens in the complex mixtures that make up WWTW effluent.  
Research suggests that steroid oestrogens can act additively with other environmental 
oestrogens, such as alkylphenols and BPA (Thorpe et al., 2001). Indeed, one study 
found that vitellogenin could be induced in fathead minnowss by a mixture of steroid 
oestrogens and other oestrogenic chemicals present at equipotent concentrations, 
which would have been too low to induce a response individually (Brian et al., 2005). 
Crucially for this project, predictive modelling has also proposed a role for anti-
androgenic contaminants in the causation of endocrine disruption in fish, which will be 
further discussed (Jobling et al., 2009). Nonetheless, whilst they may be part of a more 
complex picture, steroid oestrogens still appear to be the major causal components of 
endocrine disruption in fish. As a result of this, in 2012, E2 and EE2 became the first 
pharmaceuticals to be considered for regulation under the European Water Framework 
Directive with their addition to a watch list by the European Commission (Owen and 
Jobling, 2012). 
 
1.6.4 Alkylphenols 
 
Figure 1.8 The alkylphenols: 4-nonylphenol (NP) (left) and octyphenol (OP) (right) 
(sourced from Sigma-Aldrich). 
 
Alkylphenolic chemicals are also thought to have contributed to feminisation of wild fish 
alongside steroid oestrogens and in some highly contaminated areas they have been 
more significant contributors to oestrogenic activity (Sheahan et al., 2002b). These 
include NP, OP (Figure 1.8), their mono to tri-ethoxylate derivatives (NPE1, NPE2 and 
NPE3) and carboxylate derivatives, which were found to be oestrogenic in vitro and 
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widespread in the aquatic environment. They are the persistent degradation products 
of alkylphenol polyethoxylates, which are used as non-ionic surfactants in a variety of 
industrial applications, including textiles, paints, pesticides and plastics, as well as 
industrial and household cleaning products (Ying et al., 2002b; White et al., 1994). Like 
the steroid oestrogens, they enter the aquatic environment through WWTW effluents, 
but they also have a direct input from their industrial use (Hale et al., 2000). Due to 
their high LogKow, they partition effectively into sediments following wastewater 
treatment, which in conjunction with the water concentrations provides an extensive 
reservoir in the environment (Ying et al., 2002b). Indeed, environmental concentrations 
have been observed which are much higher than the steroid oestrogens. In the UK, 
between 1993 and 1994, up to 330 µg/L of NP was detected in WWTW effluent 
discharging to the River Aire catchment. This contained discharge from the textiles 
industry and further assessment detected up to 180 µg/L in the river itself (Blackburn 
and Waldock, 1995). Similar concentrations have been observed worldwide but tend to 
vary extensively between WWTWs and between countries dependent on the regulation 
of alkylphenols, which is lacking outside of Europe (Ying et al., 2002b). 
The in vitro oestrogenic potency of the alkylphenols has been tested in multiple assays 
and was found to be over 1,000 times lower than E2 (Metcalfe et al., 2001; White et al., 
1994; Jobling and Sumpter, 1993). Furthermore, their association with the oestrogen 
receptor in exerting oestrogenic activity has been confirmed in co-exposures with the 
oestrogen receptor antagonist tamoxifen, which reduced NP induced vitellogenin 
induction by rainbow trout hepatocyte cell lines (Jobling and Sumpter, 1993). In vivo 
assessments of NP and OP have also demonstrated their capacity to induce sexual 
disruption in fish species, including intersex and vitellogenin induction, as well as a 
potential to bioaccumulate in tissues (Soares et al., 2008). Similarly to in vitro data, 
alkylphenols also require much greater concentrations than the steroid oestrogens to 
exert affects in vivo. For example, in one study of the effects of NP in rainbow trout, 
vitellogenin induction occurred at 20.3 µg/L (Jobling et al., 1996), whilst another study 
observed induction at 150 µg/L in exposures to NP and OP. In this case, OP produced 
a greater effect than NP based on vitellogenin measurements taken before and after 
exposure, which agrees with the higher oestrogenic activity of OP in vitro (Pedersen et 
al., 1999). However, a study of intersex induction in an early life exposure of Japanese 
medaka found their lowest effect concentrations (LOECs) to be similar; at 11.6 and 
11.4 µg/L for NP and OP, respectively (Seki et al., 2003). Furthermore, whilst in vitro 
effects on trout hepatocytes showed that some nonylphenol ethoxylate derivatives 
have equal or higher oestrogenic activity, they responded very weakly in vivo with 
40 
 
intersex induction at 100 µg/L, suggesting that NP and OP are a greater cause for 
concern (Metcalfe et al., 2001).  
Although the potency of the alkylphenols is lower than the steroid oestrogens, their 
concentrations are much higher and have reached levels in effluents and rivers where 
in vivo effects have been observed (Blackburn and Waldock, 1995). As a result, 
alkylphenols, and in particular NP and its ethoxylates due to its higher use, have been 
associated with oestrogenic activity and adverse effects on fish. Indeed, high 
vitellogenin responses and lower gonadosomatic indices (GSI) of caged rainbow trout 
on the River Aire was thought to be caused by contamination by alkylphenols. These 
occurred at concentrations sufficient to retard testicular growth in vivo due to the input 
of highly contaminated trade waste from the textiles industry to a WWTW discharging 
to the river (Sheahan et al., 2002b; Harries et al., 1997). However, discharge 
regulations were tightened on the River Aire, leading to improvements in the 
wastewater treatment process and a reduction in the output volume of effluent. 
Consequently, NP concentrations downstream of the discharge decreased from 180 
µg/L to 2 µg/L and improvements in GSI and reductions in vitellogenin in caged 
rainbow trout were also observed (Sheahan et al., 2002a). This strengthened the case 
for the environmental, endocrine disrupting impact of NP in wild fish. 
In part because of their endocrine activity, but primarily based of their acute toxicity, the 
EU passed legislation restricting the uses of non-ionic surfactants based on NP as part 
of the Water Framework Directive (Sumpter and Jobling, 2013). There is also 
increased monitoring in Japan and Canada, whilst the US EPA published guidelines on 
NP and its ethoxylates in the environment (Soares et al., 2008). More recently, the US 
EPA has also begun to support voluntary phase out and regulatory action to manage 
the risk posed by these chemicals (U.S. Environmental Protection Agency, 2010). 
Nonetheless, NP is still detectable in the aquatic environment in Europe, but at much 
lower concentrations than prior to regulation. Although its ability to induce significant 
impacts alone has probably reduced, it still may interact additively in a mixture scenario 
with other oestrogens. It may also function through other mechanisms and has been 
identified as anti-androgenic in vitro in the ASC1 yeast two hybrid system (Lee et al., 
2003). In addition, there are still no restrictions on use in a number of countries outside 
of Europe, with Australia, South America, China and India still using large quantities. 
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1.6.5 Other oestrogenic contaminants 
 
Figure 1.9 Additional examples of weakly oestrogenic environmental contaminants. 
Bisphenol A (left), dibutyl phthalate (centre) and o,p’-dichlorodiphenyltrichloroethane 
(DDT) (right) (sourced from Sigma Aldrich and Wikimedia Commons). 
 
Other low potency oestrogenic contaminants have also been identified in the aquatic 
environment, including plasticisers such as BPA and the phthalate esters, pesticides, 
parabens and PCBs (examples shown in Figure 1.9) (Turner and Sharpe, 1997). Their 
in vitro activity ranges widely, with the potencies of plasticisers and pesticides ranging 
from 5,000 to 2.5 million times lower than E2 (Hurst and Sheahan, 2003; Harris et al., 
1997). Indeed, vitellogenin induction caused by plasticisers required high 
concentrations that exceeded environmental concentrations (Oehlmann et al., 2009; 
Sohoni et al., 2001). However, some have been shown to act on multiple receptors, 
including antagonistically with the AR (Sohoni and Sumpter, 1998). This suggests that 
other mechanisms of action may be more relevant in causing the effects of phthalates 
at lower concentrations. In the case of BPA, a number of studies have observed effects 
at environmentally relevant concentrations, including two multi-generational studies, 
which found altered spermatogenesis and reduced hatching success in F1 fathead 
minnowss at 16 µg/L (Staples et al., 2011; Mandich et al., 2007; Kwak et al., 2001; 
Sohoni et al., 2001). Intersex was also induced, with a LOEC of 10 µg/L (Metcalfe et 
al., 2001), in comparison to the highest detected environmental concentration of 21 
µg/L in surface water from the Netherlands (Belfroid et al., 2002). This suggests that 
BPA could affect fish reproductive health at its higher environmental concentrations. In 
contrast, phthalate esters have not been detected in the environment at concentrations 
where intersex could be induced in laboratory studies (Norman et al., 2007). However, 
there is some evidence of adverse effects on sperm at lower concentrations, although 
this may be mediated through the PPARs (Oehlmann et al., 2009). This suggests that 
phthalates may not be significant contributors to sexual disruption observed in wild fish 
by an oestrogenic mechanism. 
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Pesticides are similar in this respect, where the concentrations occurring in agricultural 
headwaters in the UK were only found to make a small contribution to the total 
oestrogenic activity observed (Hurst and Sheahan, 2003). In addition, concentrations of 
the persistent oestrogenic pesticide DDT have dramatically reduced in the western 
world, limiting its impact in the aquatic environment in recent years. Nonetheless, in 
parts of the world where DDT is still in use, biomonitoring programs are continuing in 
areas where DDT spraying still occurs (Brink et al., 2012) and assessments of the 
concentrations reached in the Pearl River Delta in China, suggest that there is risk of 
adverse effects in fish (Guo et al., 2009). However, it is important to note that DDT 
represents a mixture of isomers and whilst o,p’-DDT is oestrogenic, it has also been 
shown to have anti-androgenic activity, as has the DDT metabolite p,p’-DDE (Sohoni 
and Sumpter, 1998; Kelce et al., 1995). Indeed, in an environmental scenario at Lake 
Apopka, Florida, the reduced phallus size in alligators is thought to be a result of anti-
androgenic demasculinisation due to the accumulation of p,p’-DDE (Guillette Jr. et al., 
1996). 
Interestingly, equine oestrogens have been also detected in the bile of fish exposed to 
WWTW effluents, alongside the steroid oestrogens and nonylphenol (Gibson et al., 
2005). Further assessment identified equilenin and its metabolite 17β-dihydroequilenin, 
which was first detected in fish bile, in sewage influents at sub ng/L to low ng/L 
concentrations (Tyler et al., 2009). Whilst their origins are equine, they are extracted 
from horse urine for use in pharmaceuticals for hormone replacement therapy, which 
seems a likely origin for the compounds in influent and effluent.  In addition, their low 
concentrations suggested that they were being bioconcentrated in fish and in vivo 
testing found that they could induce vitellogenin in rainbow trout at 0.6 and 4.2 ng/L, 
respectively. Consequently, they are still considered highly likely that they could 
contribute towards feminisation in wild fish (Tyler et al., 2009). 
 
1.6.6 Mixture effects of oestrogenic chemicals 
In the last decade there has been an increasing appreciation of the importance of 
testing chemicals in combination in environmentally relevant exposure scenarios. 
Indeed, both humans and wildlife are exposed to mixtures of environmental 
contaminants simultaneously. As a result, it has been argued that the use of single 
chemical studies could lead to the underestimation of the risk that a chemical could 
pose in a real world scenario and that a cumulative risk assessment approach would 
be more applicable (Kortenkamp and Faust, 2010). This has led to an increase in the 
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importance of understanding mixture effects from both research and regulatory 
perspectives and the growth of the field of mixtures toxicology (WHO/UNEP, 2013; 
Kortenkamp, 2007).  
When combined, mixtures of chemicals can act additively according to the concept of 
dose addition, which has been well documented in interpreting the effects of mixtures 
of endocrine disrupting chemicals. This states that one chemical can be replaced totally 
or in part by an equal fraction of an equieffective concentration of another without 
diminishing the overall combined effect (Kortenkamp, 2007). Based on this assumption, 
the mixture effect of a defined set of chemicals known to impact an endpoint can be 
calculated from the dose responses of single chemicals. However, mixtures may also 
act synergistically (causing effects greater than if they acted additively) or 
antagonistically (causing effects below the expected additivity) (Kortenkamp, 2007). 
Additive action has been demonstrated for a set of environmental oestrogens, which 
were described as producing a "something from nothing" effect. Here, a group of 
xenoestrogenic chemicals, including parabens, bisphenol A (BPA) and genistein, were 
combined at concentrations below their individual NOECs but still produced a 
significant effect in vitro (Silva et al., 2002). Further in vitro study also found that the 
combined effect of 11 xenoestrogens at concentrations below their individual NOECs 
dramatically enhanced the action of 17β-oestradiol (E2) (Rajapakse et al., 2002).  
Consequently, whilst some oestrogens in the environment may not be present at 
sufficient concentrations to act alone, they may act in combination to cause a 
significant biological effect.  
This concept was eventually demonstrated in vivo using fathead minnows under 
singular and combined exposures to five oestrogenic chemicals (E2, EE2, BPA, 
nonylphenol and octylphenol) using the endpoint of vitellogenin induction. In this case, 
when the individual chemicals were dosed at concentrations equal to a fifth of their 
EC50 values, they failed to induce a significant vitellogenin response. However, a 
significant response was induced when they were combined, which was consistent with 
the predictions made based on dose addition (Brian et al., 2005). Further study of 
these five oestrogenic chemicals showed that they also affected fitness and fecundity, 
with secondary sexual characteristics and egg production reduced in mixture 
treatments (Brian et al., 2007). This is shown below in Figure 1.10. 
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Figure 1.10 The combined effects of five oestrogenic chemicals on egg production in 
fathead minnows, with the pre and post exposure spawning period represented by 
clear and shaded bars respectively. The concentrations were 70 ng/L E2, 1.5 ng/L 
EE2, 500 µg/L bisphenol A (BPA), 5 µg/L nonylphenol (NP) and 5 µg/L octylphenol 
(OP). BPA caused a significant reduction in egg count alone. However, the magnitude 
of the difference in egg production between the pre and post-spawning period indicate 
a more pronounced response in the mixture (from Brian et al., 2007). 
 
1.7 Sexual disruption in male fish: demasculinisation and a 
role for anti-androgens 
Although oestrogenic activity has been strongly associated with sexual disruption of 
fish in the aquatic environment, it is not the only mechanism of endocrine disruption 
through which these effects can be induced. In the UK, the number of intersex roach 
was found to be inversely proportional to the number of normal males, suggesting that 
this is a change of male fish to an intersex state in a “feminisation” process. However, 
the same effects can also occur through “demasculinisation,” as a result of exposure to 
anti-androgens. These are substances which can reduce the concentrations of 
circulating androgens and/or can interrupt their activity at the target site, disrupting the 
function of the HPG axis. In recent years, interest has been growing regarding the 
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increasing number of environmental chemicals being identified as anti-androgens and 
the presence of anti-androgenic activity in environmental samples. Indeed, an 
estimated 8% of all known chemicals are thought to be anti-androgenic, a number 
which based on the European chemical market could run into thousands (Kortenkamp 
and Faust, 2010; Vinggaard et al., 2008). However, the chemicals responsible for this 
activity in the environment remain unknown to a large extent and their effect on wild 
fish populations is still under research. Nonetheless, androgens including testosterone, 
11-ketotestosterone and possibly DHT play a crucial role in development and 
reproduction in fish (Martyniuk et al., 2013). These effects are mediated through the 
ARs, of which two isoforms have been identified in some teleost species (Sone et al., 
2005; Sperry and Thomas, 1999). Androgens are produced by Leydig cells in the 
testes, although there is evidence for other sources in fish. They are subject to 
seasonal changes, reaching their highest concentrations during spawning. As well as 
promoting male gonad development, androgens also promote male sexual behaviour, 
secondary sexual characteristics and somatic growth (Borg, 1994). As a result, they 
can determine the reproductive strategy of a male (Brantley et al., 1993). They are also 
present in females as precursors to oestrogens and are thought to play an important 
role in the development and regulation of the reproductive system (Staub and De Beer, 
1997). In addition, a survey of microarray and proteomic studies shows that there are a 
number of additional pathways regulated by androgens, including lipid metabolism and 
oxidation, immune response, protein metabolism and muscle proliferation (Martyniuk 
and Denslow, 2012). As a result, the potential for disruption to endogenous androgens 
in wild fish is a cause for concern. 
 
1.7.1 The modes of action of anti-androgens 
Traditionally, anti-androgens have been considered as substances which can block 
androgen action at the receptor in an antagonistic fashion. However, it is now clear that 
anti-androgenic activity has a much wider scope than this. Indeed, as well as 
interactions at the receptor, some anti-androgens can act by testosterone synthesis 
inhibition or catabolism of androgen precursors of testosterone itself. There is also 
evidence of mixed mechanism anti-androgens, as well as anti-androgenic interactions 
between the aryl hydrocarbon receptor (AhR) and the AR (Crago and Klaper, 2012; 
Wilson et al., 2008; Kizu et al., 2003a). However, whilst these mechanisms are well 
studied in mammalian models and in in vitro assays, there are less available data on 
mechanisms of action in fish that could cause a demasculinising response.  
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1.7.1.1 Interactions at the androgen receptor 
Many anti-androgens act as receptor antagonists, which are considered to be ligands 
that bind to a receptor without inducing a biological effect. Consequently, evidence for 
AR antagonism tends to originate from androgen responsive in vitro cell lines 
transfected with an AR. However, these may not necessarily correspond to activity in 
vivo. Anti-androgenic AR antagonists can bind competitively to the receptor site to 
block the action of androgens in the target cell, inhibiting androgen induced 
transcriptional activation. This is generally considered to occur by preventing the 
binding of the receptor to the androgen response element of the DNA, a mechanism 
which has been demonstrated for anti-androgens including the DDT metabolite p,p’-
DDE and the pesticides vinclozolin and methoxychlor (Kelce et al., 1998; Kelce and 
Wilson, 1997). However, there are relatively few anti-androgens which have purely 
antagonistic activity in their receptor binding (Singh et al., 2000), such as the human 
pharmaceuticals flutamide, bicalutamide and nilutamide. Most anti-androgens appear 
to have a mixture of agonistic and antagonistic activity, meaning that in the absence of 
an androgen they are weakly androgenic at higher concentrations. As a result they 
could also be considered as partial AR agonists, causing an anti-androgenic response 
by blocking the binding of more potent endogenous androgens (Nguyen et al., 2007). 
In addition, there is also evidence for non-competitive antagonism of the AR by NP and 
BPA. In this case, whilst they could interfere with AR translocation to the nucleus and 
inhibit AR mediated transcription, they only partially inhibited the binding of DHT, 
suggesting that they could also be binding to an allosteric site (Lee et al., 2003). This 
work also highlighted an inhibitory effect of these chemicals on the AR interaction with 
enzyme co-activators, which would normally enhance the androgenic response. 
Indeed, there is also in vitro evidence that anti-androgen action at the AR can be 
enhanced by an interaction with co-repressors. These are transcription factor proteins 
which can inhibit the ability of the receptor to activate gene expression. In one in vitro 
study, the co-infection of an anti-androgen and nuclear receptor co-repressor 1 caused 
a significantly greater decrease in AR activity than during exposure to the anti-
androgen alone (Berrevoets et al., 2002). Indeed, there is some evidence that the in 
vitro anti-androgenic effects of some PAHs may be mediated through co-repressors. In 
this case, it was found that some PAHs which were shown to induce an anti-
androgenic response in the LNCaP cell line did not bind to the AR itself. However, they 
were AhR agonists and it was suggested that the anti-androgenic effect was caused by 
47 
 
AhR activation of the transcription factor, activator protein 1 (AP-1), which interacted 
with the AR to inhibit its binding to the androgen response element (Kizu et al., 2003a). 
Blocking the function of androgens at the AR causes deficient androgen action at a 
target site and can have significant impacts on development, which are similar to those 
induced by oestrogenic chemicals following exposure during a critical window. Indeed, 
maternal exposure of rats to flutamide caused reproductive malformations to occur in 
the male offspring, including cryptorchidism, hypospadias and reductions in ano-genital 
distance (Welsh et al., 2008). The blockade of androgens has also been observed in 
fish where exposure to AR antagonists mitigates the effects of androgen exposure. For 
example, the development of male secondary sexual characteristics induced in female 
fathead minnowss by exposure to the androgenic chemical trenbolone was blocked by 
flutamide (Ankley et al., 2004). Furthermore, the induction of the androgen dependent 
protein spiggin in female stickleback (Gasterosteus aculeatus) by DHT was reduced by 
exposure to anti-androgens such as flutamide, vinclozolin, the herbicide linuron and the 
insecticide fentitrothion (Jolly et al., 2009). In exposures to AR antagonists alone, 
demasculinisation effects also occur in fish that show similarities to those observed in 
oestrogen exposures. For example, inhibited gonopodium length, reduced male 
colouration and sperm count, as well as suppression of courtship behaviour have all 
been identified in male guppies (Poecilia reticulata) fed p,p’-DDE, vinclozolin or 
flutamide (Bayley et al., 2002; Baatrup and Junge, 2001). However, the concentrations 
used in these studies exceeded environmental relevance for these chemicals. 
Nonetheless, the anti-androgenic effects of flutamide have been observed in fish at 
concentrations equivalent to the activity detected in the aquatic environment by in vitro 
assays. These include reductions in secondary sexual characteristics (939 µg/L) and 
fecundity (651 µg/L) in fathead minnowss (Jensen et al., 2004; Panter et al., 2004), 
reduced courtship (100-500 µg/L) and nest building (100 µg/L) behaviour in stickleback 
(Sebire et al., 2008) and intersex induction in Japanese medaka with a LOEC of 202 
µg/L (León et al., 2007; Kang et al., 2006).  
AR antagonists can produce an internal environment that favours the action of 
oestrogen due to feedback mechanisms within the endocrine system. By blocking the 
AR in the brain, the negative feedback of testosterone is inhibited and as a result, 
increased concentrations of gonadotropins are produced, which can positively 
stimulate sex steroid production. Whilst this increases androgen concentrations, they 
remain ineffective due to the anti-androgenic blockade of the AR. However, circulating 
E2 concentrations also increase, which have been linked to adverse “feminisation” 
effects, such as gynocomastia, in human male patients treated with anti-androgenic 
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pharmaceuticals (Staiman and Lowe, 1997). Indeed, the steroid profiles indicative of 
this mechanism have also been observed in both fish and rats in response to anti-
androgen exposure (Jensen et al., 2004; O'Connor et al., 2002). Furthermore, 
flutamide has also been shown to upregulate genes coding for steroidogenic enzymes, 
as well as oestrogen receptors β and γ, in fathead minnowss (Filby et al., 2007b). It is 
therefore highly plausible that this mechanism could also play a role in 
demasculinisation effects in fish. Interestingly, this study also showed some 
commonalities in the mechanisms of action of flutamide and EE2. These both 
increased expression of genes coding for oestrogen-producing enzymes (cyp19a and 
cyp19b) and decreased expression of genes involved in testis differentiation, such as 
anti-müllerian hormone and dmrt1.  
It is important to note that species differences exist in the responses of fish to AR 
antagonists identified in mammals due to subtle differences in AR’s between species. 
Indeed, mammalian AR antagonists including flutamide, vinclozolin and procymidone 
did not bind to goldfish (Carassius auratus) or rainbow trout ARs in cytosolic fractions 
(Wells and Van Der Kraak, 2000). However, a study of fathead minnowss and rainbow 
trout AR transfected into cell lines found that flutamide, vinclozolin and its metabolites 
bound to both receptors (Wilson et al., 2007). Indeed, these chemicals have both been 
found to have anti-androgenic activity in fathead minnowss in vivo (Martinović et al., 
2008). Whilst this demonstrates that differences in test methods may produce different 
results, it also shows that different fish species can also differ in their response to anti-
androgens. Indeed, cyproterone acetate, methoxychlor and p,p’-DDE were found to 
bind to the AR in goldfish but not rainbow trout, with the binding affinity of p,p’-DDE 
being similar to its affinity to mammalian receptors (Wells and Van Der Kraak, 2000). 
This clearly demonstrates the need to better understand which anti-androgens could 
impact fish health and the importance of testing these chemicals in relevant fish 
species. 
 
1.7.1.2 Reducing concentrations of circulating androgens 
As well as interactions with the AR, some anti-androgens can induce effects by 
reducing the concentrations of available circulating androgens. Mechanisms include 
the reduction of androgen synthesis or an increase in their catabolism through 
interactions with enzyme function or gene expression, which have been assessed in 
whole animals through molecular techniques and gene expression profiling. For 
example, in mammalian models, phthalate esters are generally considered to be 
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testosterone synthesis inhibitors. Indeed, DEHP and DBP can both reduce foetal 
testosterone production and downregulate genes coding for steroidogenic enzymes, 
such as cyp17 and cyp11, and those involved in cholesterol transport, such as StAR 
(steroidogenic acute regulatory protein) (Figure 1.11). In addition, a reduction in the 
expression of insl3, a hormone secreted by the Leydig cells that promotes testicular 
descent, has also been linked with cryptorchidism (Nef and Parada, 2000). This genetic 
effect has not been observed with AR antagonists, such as vinclozolin, reflecting the 
higher incidence of cryptorchidism in mammalian phthalate exposures (Wilson et al., 
2008; Borch et al., 2006). These effects are thought to be linked to downregulation of 
transcription factors such as PPARs and steroidogenic factor 1, which regulate these 
enzymes (Borch et al., 2006). Indeed, the interactions of anti-androgens with the 
PPARs have also been linked to disruption of enzymes involved in steroid catabolism 
and could affect circulating androgens though their production and degradation (Fan et 
al., 2004).  
The effects on fish are not as well researched. There is evidence that the 5α-reductase 
enzyme, which converts testosterone to DHT in target tissues, can be inhibited by 
DEHP and DBP in in vitro assays using carp testicular tissue (Thibaut and Porte, 
2004). However, in vivo, no effects on steroidogenic enzymes have been observed in 
stickleback exposed to DBP (Aoki et al., 2011) nor in zebrafish and fathead minnowss 
exposed to DEHP (Crago and Klaper, 2012; Uren-Webster et al., 2010). Nonetheless, 
in the DEHP exposure of fathead minnows, an increase in enzymes involved in steroid 
catabolism in the liver and testes occurred, which was thought to contribute to the 
significant reduction in plasma testosterone observed when DEHP was combined in an 
exposure with the herbicide linuron (Crago and Klaper, 2012). However, the exposure 
of stickleback to DBP did show anti-androgenic effects, in terms of a reduction in 
spiggin production in males at concentrations near the highest environmental 
concentrations (Aoki et al., 2011). Consequently, the mechanisms of anti-androgenic 
action of phthalates in fish remain unclear and may differ from those observed in 
mammals.  
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Figure 1.11 The steriodogenesis pathway (from Celander et al., 2011) expanded to 
include a simplified depiction of the conversion of testosterone to other functional 
androgens in fish (top-right) (from Martyniuk et al., 2013). T = testosterone; 5α-DHT = 
5α-dihydrotestosterone; 11β-OHT = 11β-hydroxytestosterone; 11-KT = 11-
ketotestosterone. Srb5α1,2,3 = 5α-reductase; P45011β = cytochrome P450 11β-
hydroxylase (CYP11β); 11β-HSD: 11β -hydroxysteroid dehydrogenase. 
 
1.7.1.3 Mixed mechanisms 
Many chemicals do not act solely via a single mechanism of action and instead work 
through multiple mechanisms to induce their effects. For example, the fungicide 
prochloraz is an AR antagonist but has also been observed to reduce plasma 
testosterone in fathead minnows, potentially via inhibition of the activity of the 
steroidogenic enzyme cyp17 (Ankley et al., 2009). In addition, many AR antagonists 
can also act as 5α-reductase inhibitors in mammalian cell lines, including p,p’-DDE, 
vinclozolin, prochloraz and even flutamide at high concentrations (Lo et al., 2007). This 
mechanism of action has only been recently explored in fish and there is evidence that 
5α-reductase inhibitors can cause adverse effects in fish, with exposure to the 
pharmaceutical dutasteride causing reduced fecundity in fathead minnows (Margiotta-
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Casaluci et al., 2013b). Moreover, interactions can occur with other receptors and 
hormone types, with a number of pesticides acting as both AR antagonists and 
oestrogen receptor agonists (Kojima et al., 2004), whilst effects of cyproterone acetate, 
vinclozolin and p,p’-DDE on thyroid parameters have also been observed in male rats 
(O'Connor et al., 2002).  
 
1.7.1.4 Mixture effects of anti-androgens 
Anti-androgenic environmental contaminants have also been shown to act additively in 
vitro in mixture scenarios, even when a variety of chemical structures from 17 
compunds were involved (Ermler et al., 2011). Similar results have also been achieved 
in vivo in F1 rats where maternal exposure to a mixture of three AR antagonists 
(flutamide, vinclozolin and procymidone) exacerbated demasculinisation effects. These 
included reductions in anogenital distance and nipple retention, which occurred to a 
much greater extent than in single chemical exposures (Hass et al., 2007). More 
recently, additive effects have also been confirmed in fish, where a mixture of four AR 
antagonists (vinclozolin, fenitrothion, flutamide and linuron) caused a significantly 
greater inhibition of 5α-dihydrotestosterone induced spiggin in female stickleback than 
they could alone. Again, this agreed well with the concept of dose addition (Pottinger et 
al., 2013).  
Interestingly, mixture studies have also shown that chemicals with similar mechanisms 
of action can act additively on common endpoints. In these cases, an alternative 
concept of independent action can be used as well as dose addition to predict additive 
effects. This uses a statistical concept of independent events, where individual 
components produce effects independent of the other agents within the mixture (Bliss, 
1939). However, this can still produce similar predictions to those of dose addition 
(Hadrup et al., 2013). One example of a study using these concepts was a maternal 
exposure of rats, which found that exposure to DBP (a testosterone synthesis inhibitor) 
and procymidone an (AR antagonist), still had dose additive effects on the same 
endpoints (Hotchkiss et al., 2010).  A second example is another maternal exposure of 
rats to a mixture of AR antagonists (vinclozolin and prochloraz), a testosterone 
synthesis inhibitor (di[2-ethylhexyl] phthalate)  and a 5α-reductase inhibitor (finasteride) 
to assess impacts on sexual development. Additive effects were observed for 
increasing nipple retention and reduced prostate weight and ano-genital distance in 
rats, consistent with dose addition. However, synergistic effects were also observed for 
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genital malformations, where the mixture caused a greater response than those 
predicted based on dose addition and independent action (Christiansen et al., 2009). 
 
1.7.2 Anti-androgenic activity in the environment 
The use of in vitro bioassays containing ARs has been used globally to detect anti-
androgenic activity in a similar fashion to those used for assessing oestrogenic 
contamination. The resultant activity has tended to be reported as the flutamide 
equivalent concentration (FluEQ), which is widely used as a positive control in these 
assays. Nonetheless, anti-androgenic activity in the environment is not as well 
documented as oestrogenic activity. In the UK, the survey of 43 effluents completed by 
the Environment Agency to evaluate oestrogenic contamination also discovered anti-
androgenic activity in all samples ranging from 21.3 to 1,231 µg/L FluEQ (Johnson et 
al., 2007b). Similarly, anti-androgenic activity has also been observed in tertiary treated 
WWTW effluents in Australia, which could suggest that the causal chemicals were 
difficult to remove in sufficient concentrations (Kumar et al., 2012). However, a study of 
domestic wastewater and greywater in China found a high rate of removal with 
membrane bioreactors, but due to the high anti-androgenic activity detected pre-
treatment (3.1 and 1.1 mg/L FluEQ respectively), the activity in effluent was still 
detectable at 69 and 54 µg/L FluEQ (Ma et al., 2013). Combined, these data suggest 
that the sources of anti-androgens are likely to be domestic and potentially consist of a 
low number of high volume chemicals or a high number of low volume use chemicals. 
However, high concentrations of anti-androgenic activity (up to 8000 µg/L FluEQ) have 
also been detected in offshore produced water discharges from oil platforms in the 
North Sea (Thomas et al., 2009; Tollefsen et al., 2007). Here, effect directed analysis 
identified a set of polycyclic aromatic hydrocarbons and napthenic acids as AR 
antagonists, which suggests that there could also be industrial and even natural 
sources for anti-androgens, since napthenic acids occur naturally in crude oil and oil 
sands (Thomas et al., 2009).  
There are some reports of anti-androgenic activity occurring in river networks. At sites 
on the Pearl River system in China, anti-androgenic activity alongside oestrogenic 
activity was detected in all samples with up to 935 µg/L FluEQ. In contrast, androgenic 
and anti-oestrogenic activity was found in only 41% and 29% of samples, respectively 
(Zhao et al., 2011). In the UK, similar concentrations were detected with a maximum of 
1,070.5 µg/L FluEQ occurring 0.1 km downstream of a WWTW effluent outfall prior to 
its treatment upgrade (Grover et al., 2011). Furthermore, anti-androgenic activity in the 
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River Lambro in Italy was detected in both surface water and sediment, although 
following fractionation and in vitro screening, the chemicals causing the activity 
remained unknown (Urbatzka et al., 2007). Similar findings occurred in France, where 
the anti-androgenic activity detected in sediment from the Rhonelle River could not be 
explained by the presence of BPA, alkylphenols or a set of pesticides which were 
analysed (Kinani et al., 2010). However, an alternative method for detecting anti-
androgens through the analysis of fish bile, following exposure of rainbow trout to an 
anti-androgenic effluent, identified a novel set of anti-androgens. These accounted for 
around 61% of the activity detected, with 51% made up by the biocides triclosan and 
chlorophene (Rostkowski et al., 2011). Nonetheless, it is clear that the causes of anti-
androgenic activity still remain largely unknown and it should also be considered that 
activity based on AR binding may not be representative of all environmental anti-
androgens since some can exert their effects through alternative mechanisms. 
Based on in vivo exposures of fish to flutamide alone, the anti-androgenic activity 
identified in environmental samples from the studies described above could be 
sufficient to induce effects in wild fish. Supporting this is one recent study of wild 
stickleback in the River Ray, which found that the concentrations of spiggin in females 
increased with the distance away from the WWTW effluent outfall. Moreover, when the 
treatment process at this WWTW was upgraded to a tertiary treatment, up to a two fold 
increase in spiggin in wild female stickleback was observed in comparison to 
measurements taken prior to the upgrade. Although this demonstrates anti-androgenic 
activity in wild fish, since spiggin production is androgen dependent, it does not 
necessarily constitute a negative impact on reproductive health (Katsiadaki et al., 
2012). Nonetheless, some adverse effects have been observed in exposures of fish to 
anti-androgenic effluent in vivo. For example, in stickleback exposed to an effluent with 
328 µg/L FluEQ, reductions in male courtship behaviour and nest building were both 
observed. However, due to the lack of response in spiggin production it was considered 
that these effects may not have been due to anti-androgens and could have been 
impacted by the nature of the effluent. For example, its turbidity could have potentially 
affected visual signalling (Sebire et al., 2011). Alternatively, behavioural effects could 
just have been a more sensitive endpoint than spiggin production, as observed during 
exposure to flutamide alone (Sebire et al., 2008). In addition, two Australian studies 
which exposed fish to anti-androgenic WWTW effluent found potential impacts on the 
fecundity of male fish (Kumar et al., 2012). In these studies, reductions or even 
absence of spermatozoa and increases in fibrotic tissue were found in the gonads of 
male zebrafish and Murray rainbowfish (Melanotaenia fluviatilis) exposed on site or 
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under laboratory conditions to effluents with strong anti-androgenic activity. Once 
again, in these examples, the cause of the activity remained unknown.  
Crucially for this thesis, recent research has linked anti-androgenic activity to sexual 
disruption observed in wild roach in the UK (Jobling et al., 2009). This used 
concentrations of steroid oestrogens, NP and its ethoxylates measured in UK effluents, 
as well as bioassay assessments of their (anti-) oestrogenic and (anti-) androgenic 
activity. It then modelled concentrations and activities occurring downstream of their 
outfalls at sites where fish were sampled as part of one of the nationwide surveys 
(Jobling et al., 2006), and statistically modelled associations between the potential 
causes and effects. Unsurprisingly, this found that steroid oestrogens were strong 
predictors of vitellogenin induction, the occurrence of feminised ducts (ovarian cavities) 
and the incidence and severity of the oocytes in the testes. However, it also suggested 
that anti-androgens had a strong additive effect on these endpoints in combination with 
the oestrogens (see Figure 1.12 below for an example). In addition, anti-androgenic 
activity was also found to be significantly associated with vitellogenin induction alone. 
This has had implications for our knowledge of the causes of sexual disruption in wild 
fish, suggesting that the steroid oestrogens may be part of a bigger picture. So far 
there are no fully published in vivo studies to support this argument, although some 
preliminary data are available which indicates that a combination of anti-androgens 
detected in fish bile, including triclosan and chlorophene, could enhance the incidence 
of ovarian cavity induction in roach in combination with EE2. However, androgen 
induced spiggin production in female stickleback was not reduced by the mixture of 
these chemicals and so anti-androgenic activity was not confirmed in this species 
(Lange et al., 2012a). 
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Figure 1.12 A surface plot illustrating the results of statistical modelling of the 
association between exposure to oestrogenic (YES) and anti-androgenic chemicals 
(anti-YAS) (from Jobling et al., 2009). This indicates effects of anti-YAS alone and in 
combination with YES on the probability of feminised ducts in wild fish. 
 
1.8 Summary 
EDCs are exogenous chemicals or mixtures which can negatively impact any aspect of 
the hormone system to cause adverse effects on an organism. They are ubiquitous 
pollutants which remain a cause for concern due to the increasing trends in endocrine 
related disorders in humans and observations of endocrine related effects in wildlife. In 
laboratory studies they have been linked to reproductive and developmental disorders, 
behaviour, obesity, cancers and immune disorders and new evidence is beginning to 
suggest that they can not only affect individuals, but may also have multigenerational 
and even population level impacts.  
In fish, widespread oestrogenic activity in the environment has been strongly linked 
with sexual disruption observed in wild fish species globally. Steroid oestrogens are 
generally considered to be the major contributors, although some circumstances exist 
where other oestrogenic contaminants, such as alkylphenols, have also been linked to 
significant feminisation effects. However, anti-androgenic activity has recently been 
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found to be widespread in WWTW effluents in the UK and has also been detected in a 
number of other countries. In laboratory studies, anti-androgens can induce similar 
abnormalities to those caused by oestrogen exposure and those observed in the 
environment. Furthermore, it has been suggested that they may play a significant role 
in sexual disruption in wild fish alone or in combination with steroid oestrogens. 
Nonetheless, our understanding of environmental anti-androgens is still limited in 
comparison to the steroid oestrogens and it is important that they are identified and 
their impacts on fish are assessed, particularly in association with steroid oestrogens.  
 
1.9 Thesis aim 
The work presented in this thesis has contributed to a UK-Australian collaboration on 
EDCs in the aquatic environment. As a country, Australia has its own unique biota and 
climatic and environmental conditions which vary regionally. It is currently adapting to 
water scarcity and this may be exacerbated in the future by changing climate and its 
increasing population. Consequently, interest in EDCs in Australia has increased in 
recent years, in the context of climatic threats to the aquatic environment and its unique 
biota.  
Wastewater treatment works effluent (WWTW) effluent contamination of the Australian 
aquatic environment is widespread across the country from temperate to tropical 
regions. Like in the UK, this can be characterised by a large contribution of effluent to 
river flow following discharge to small creeks or during periods of low rainfall, which can 
reach up to 100% downstream of WWTWs (Kumar et al., 2012). In these effluents, 
oestrogenic activity is common and the steroid oestrogens have been detected at 
concentrations up to 54 ng/L E1 (Braga et al., 2005), 18.5 ng/L E2 (Allinson et al., 
2010) and 1.3 ng/L EE2 (Ying et al., 2009). Their concentrations show little variance 
between WWTWs in different regions with different climates, with similar 
concentrations detected in temperate South Australia, cool temperate Australian 
Capital Territory and subtropical Queensland (Williams et al., 2007). They also 
compare well with the range of concentrations observed in the UK and other European 
countries (Johnson et al., 2007b; Johnson et al., 2005; Ying et al., 2002b). In addition, 
other oestrogenic contaminants have also been detected, such as bisphenol A (BPA) 
and the alkylphenols, which are not subject to the same restrictions as in the EU (Ying 
et al., 2009). Strong anti-androgenic activity was also detected in effluent from 
Queensland, which caused gonadal fibrosis and a reduction in spermatids in fish 
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exposures (Kumar et al., 2012). However, there is little data available that quantifies 
this activity in environmental samples in Australia.  
As a consequence of effluent discharge, oestrogenic activity has been detected in the 
aquatic environment and the concentrations of steroid oestrogens have been found to 
exceed their singular and combined PNECs for endocrine disruption in fish at WWTWs 
outfalls and downstream river sites (Ying et al., 2009; Young et al., 2004). However, 
concentrations have also been detected upstream of WWTW discharges, which 
suggests that multiple inputs should be considered. Indeed, in some localities such as 
small rural streams, agriculture has been shown to have a significant impact on steroid 
oestrogen concentrations (Williams et al., 2007). How these discharges impact the 
aquatic environment is largely unknown, but there is already some evidence of 
estrogenic endocrine disruption in the pest species, eastern mosquitofish (Gambusia 
holbrooki), in effluent contaminated areas (Reitsema et al., 2010; Rawson et al., 2008; 
Batty and Lim, 1999). However, there have been no studies to determine the effects on 
wild native species, in part due to the limited understanding of their baseline biology, 
endocrinology and the lack of available tools for ecotoxicology testing. This situation is 
improving and recent research has developed tools for measuring vitellogenin in the 
barramundi (Lates calcarifer) and black bream (Acanthopagrus butcheri) (Codi King et 
al., 2008), which found that they were susceptible to oestrogen exposure. Work has 
also been completed on the Murray rainbowfish (Melanotaenia fluviatilis) to assess 
baseline reproduction and the use of molecular methods and biomarkers has also been 
investigated (Woods and Kumar, 2011; Pollino et al., 2007; Pollino and Holdway, 
2003). This found that these fish could be affected by oestrogens and consequently, 
the Murray rainbowfish has been proposed for use as an Australian fish model to 
assess endocrine disruptors. Nonetheless, so far there have been no assessments of 
intersex in wild native fish in oestrogen contaminated areas. Indeed, the closest 
example is a study of invasive common carp on the River Yarra, which found no 
evidence of vitellogenin induction or gonadal abnormalities. However, this was 
unsurprising due to the dilution of tertiary treated effluent within this catchment, which 
resulted in no oestrogenic activity being detected at capture sites (Kumar et al., 2012).  
In both the UK and Australia, anti-androgenic activity occurring in the environment is an 
emerging topic. The causes remain largely unknown and so it is important that 
significant environmental anti-androgens are identified in both countries and their 
effects assessed in fish models.  Additional consideration should also be made for the 
possibility of mixture effects with steroid oestrogens on common endpoints. 
Consequently, the overall aim of this thesis project was to identify anti-androgens in UK 
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and South Australian catchments and to produce environmentally relevant exposures 
to assess their impacts on sexual disruption in fish alone and in combination with 
steroid oestrogens. The hypothesis was that anti-androgens would be detected in the 
environment and that they could cause sexual disruption in fish under experimental 
conditions. The null hypothesis was that anti-androgenic compounds would not be 
detected in the environment and that antiandrogens would not affect sexual disruption 
in fish in vivo. Work towards the overall project aim was completed under three 
objectives:  
Objective One: Predictive modelling of anti-androgenic pharmaceuticals  
This represented a targeted approach to identifying environmental anti-androgens by 
focussing on a set of pharmaceuticals with an anti-androgenic mode of action. Effluent 
and river concentrations of these pharmaceuticals were estimated in a UK and a South 
Australian catchment using predictive modelling techniques.  Concentrations of steroid 
oestrogens were modelled alongside the anti-androgenic pharmaceuticals. The models 
were then adapted to analyse future trends in their concentrations and associated risks 
to fish health under climate and population change scenarios up to 2050.  
Objective Two: In vivo assessment of pharmaceuticals 
The two major anti-androgenic pharmaceuticals, bicalutamide and cyproterone 
actetate, were applied in two in vivo assessments with two appropriate fish models. 
The exposure concentrations were informed by the predictive modelling in objective 
one to produce environmentally relevant exposure scenarios. This aimed to determine 
the impacts of these pharmaceuticals on sexual disruption alone and in combination 
with steroid oestrogens, using endpoints including vitellogenin induction, secondary 
sexual characteristics and intersex.  
Objective Three: Effect Directed Analysis of WWTW effluents 
As part of a broader approach to identifying anti-androgens, the chemical constituents 
of UK WWTW effluent and river samples were identified following extraction, 
fractionation and gas chromatography-mass spectrometry. Potential anti-androgens 
were identified through literature searches and in vitro bioassays and their contribution 
to the identified activity was determined. 
59 
 
2. CHAPTER 2: PREDICTING CONCENTRATIONS 
OF ANTI-ANDROGENIC PHARMACEUTICALS 
AND STEROID OESTROGENS IN WWTW 
EFFLUENTS AND RIVER CATCHMENTS 
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2.1 Introduction 
Pharmaceutically active chemicals have become contaminants of emerging concern in 
the last decade as a result of their widespread presence in the environment and their 
potential ability to interact with non-target organisms. Endocrine disruption in wild fish is 
a major example of this, having been linked to the steroid oestrogens 17α-
ethinylestradiol (EE2), 17β-oestradiol (E2) and oestrone (E1). As natural ligands for the 
oestrogen receptor, E1 and E2 are highly active chemicals in comparison to 
xenoestrogen mimics both in vitro and in vivo (Metcalfe et al., 2001; Harris et al., 1997; 
White et al., 1994). However, the pharmaceutical EE2 remains the most potent steroid 
oestrogen in vivo as a designed oestrogen receptor agonist with the addition of an 
ethinyl group which reduces its rate of metabolism (Routledge et al., 1998). This is 
reflected in the most recently proposed predicted no effect concentrations (PNECs) of 
0.1, 2 and 6 ng/L for EE2, E2 and E1 respectively, derived from reproductive endpoint 
data from fish studies and supplemented with data on vitellogenin induction (Caldwell 
et al., 2012). 
Based on these data, it is plausible that some of the most active environmental 
endocrine disruptors with anti-androgenic activity could be pharmaceuticals with an 
androgen receptor (AR) antagonistic mode of action. Consequently, investigating the 
presence of anti-androgenic pharmaceuticals in the environment presented the 
possibility for a targeted approach to identifying and assessing environmental anti-
androgens. One set of methods that can be used to make these assessments are 
predictive modelling techniques, which have been successfully applied to the issue of 
environmental steroid oestrogens and their risk assessment in the UK (Williams et al., 
2009). These methods provide fast, preliminary risk assessment tools and therefore 
provide a good starting point for assessing these pharmaceuticals and their potential 
risk to wild fish in river catchments. However, in Australia, predictive modelling and its 
associated risk assessments have not yet been utilised since the hydrological models 
to enable this process have not been developed. Nonetheless, their development could 
prove to be highly informative in assessing concentrations of anti-androgens and 
steroid oestrogens when applied to catchments in this water stressed continent. 
Indeed, the development of desktop based modelling of endocrine disrupting chemical 
(EDC) exposure in Australia is one of the research priorities identified in the Black 
Mountain Declaration. This originated from a workshop on EDCs incorporating 
researchers, policy makers, regulators, water suppliers and research investors. 
Moreover, the anticipated global population growth during this century alone (United 
Nations, 2011), coupled with climate induced changes in precipitation (Bates et al., 
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2008), provides an additional need to assess the consequences of changing water 
availability on EDC concentrations to ensure that any mitigation options proposed are 
of an appropriate scale to be effective in the longer term.  
 
2.1.1 Pharmaceuticals as emerging contaminants 
Pharmaceuticals are complex molecules with a relatively specific biological activity, 
which enter the aquatic environment following patient excretion and incomplete 
removal during wastewater treatment. In addition, hospitals, manufacturers, landfills 
and improper disposal by patients can also be prominent sources (Kümmerer, 2009; 
Larsson et al., 2007; Bound and Voulvoulis, 2005). Due to their constant use they are 
also constantly released into the aquatic environment.  Their concentrations have a 
tendency to be positively correlated to prescription frequency and are generally within 
the ng/L to µg/L range. Whilst they can occur in their parent form, some may form 
active metabolites and biotransformation products through human or bacterial 
metabolism or environmental degradation. Due to their widespread and increasing use 
globally, pharmaceuticals have been detected in WWTW effluent, surface waters, 
ground water and drinking water (Heberer, 2002). Indeed, a nationwide US survey 
found that the occurrence of pharmaceuticals in sampled streams was widespread 
(Kolpin et al., 2002a). This study achieved significant interest from both the public and 
the scientific community, highlighting the issue of pharmaceuticals as emerging 
contaminants of concern. However, it also caused some controversy due to the high 
concentrations of EE2 reported, with a maximum concentration of 831 ng/L (later 
modified to 273 ng/L) (Kolpin et al., 2002b). This greatly exceeded values reported 
elsewhere in the literature, which in review ranged from <0.5 – 15 ng/L and it was 
suggested that this could be caused by another substance interfering during chemical 
analysis (Ericson et al., 2002). Nonetheless, the concentrations of other drugs, such as 
ibuprofen and fluoxetine, compared well with a review of pharmaceuticals in the 
environment, which demonstrates the range of drugs that have been identified 
(Corcoran et al., 2010). 
There is concern that some drugs could induce adverse effects in non-target organisms 
through their specific interactions with conserved drug targets (Rand-Weaver et al., 
2013; Gunnarsson et al., 2008). Indeed, drug targets such as steroid receptors and the 
hypothalamic-pituitary-gonadal (HPG) axis are highly conserved between vertebrates, 
increasing the plausibility of pharmaceutical interactions in other species (LaLone et al., 
2013; Perkins et al., 2013; Gunnarsson et al., 2008). As a result, groups of 
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pharmaceuticals that interact with steroid receptors other than the oestrogen receptor, 
including anti-androgens, are also in significant use by the human population and have 
been recommended as high priorities for research (Runnalls et al., 2010). In many 
cases research suggests that pharmaceutical concentrations in the aquatic 
environment tend to be at least one magnitude lower than the concentrations required 
in vivo (µg/L to mg/L) to cause effects in fish. However, there are some exceptions, 
such as EE2 and ibuprofen (Corcoran et al., 2010). Indeed, EE2 is being considered 
for regulation under the European Water Framework Directive with its addition to the 
list of “priority substances” by the European Commission. In contrast, there is no data 
available on the concentrations of anti-androgenic pharmaceuticals in UK or Australian 
WWTW effluents and surface waters. These pharmaceuticals are prescribed in both 
countries to treat androgen dependent disorders and they have been suggested as 
high priorities for research due to their prescriptions and mode of action (Runnalls et 
al., 2010). They can be split into two classes: pure, non-steroidal anti-androgens and 
steroidal derivatives (Singh et al., 2000). 
 
2.1.1.1 Non-steroidal anti-androgens 
 
Figure 2.1 The non-steroidal anti-androgens: flutamide (A), bicalutamide (B) and 
nilutamide (C) (sourced from Sigma-Aldrich). 
 
The non-steroidal anti-androgens (Figure 2.1) are pure AR antagonists. They do not 
exert any agonistic activity on the receptor, nor do the show any binding capability with 
other nuclear receptors (Singh et al., 2000). In human medicine, they are all used to 
treat androgen dependent advanced prostate cancer, the second most common cause 
of cancer deaths in men. They are generally able to preserve sexual function but 
gynecomastia can be a problematic side effect (Mahler et al., 1998). Out of the three, 
nilutamide is not prescribed in the UK and flutamide has been recently discontinued by 
the NHS in favour of the prescription of bicalutamide. Nonetheless, all three 
pharmaceuticals are still prescribed in Australia. 
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Both flutamide and bicalutamide have been subject to in vivo testing with fish models, 
but there is no data available for nilutamide. The majority of in vivo data exists for 
flutamide, which has been used as a model anti-androgen in a number of studies, 
where it has been shown to cause reductions in secondary sexual characteristics and 
fecundity (Jensen et al., 2004; Panter et al., 2004), changes to reproductive behaviour 
(Sebire et al., 2008) and intersex (León et al., 2007; Kang et al., 2006). In contrast, 
there is only one published exposure study of bicalutamide, which also caused 
reductions in secondary sexual characteristics and reproductive parameters (Panter et 
al., 2012). Both pharmaceuticals induced these effects in the µg/L range.  Whilst 
flutamide produces an active metabolite, hydroxyflutamide, bicalutamide is a racemic 
mixture with anti-androgenic activigy occurring almost exclusively in the R enantiomer 
(Cockshott, 2004). 
 
2.1.1.2 Steroidal anti-androgens 
 
Figure 2.2 The steroidal anti-androgen, cyproterone acetate (sourced from TRC 
Canada). 
 
As well as binding the AR antagonistically, cyproterone acetate (Figure 2.2) also has 
some agonistic activity and interacts with other hormone receptors. In fact, it can also 
block gonadotropin secretion through its gestagenic activity and can therefore reduce 
the availability of circulating androgens, as well as blocking androgen activity at the 
target site. Consequently, cyproterone acetate has multiple uses, as well as the 
treatment of prostate cancer. These include the treatment of hirsuitism and acne in 
women, where is it prescribed in conjunction with EE2 in a combined contraceptive pill, 
and in the treatment of sexual deviation in males (Unluhizarci et al., 2013; Arowojolu et 
al., 2012; Schneider, 2003; Bradford, 1999; Mahler et al., 1998). Like flutamide, it also 
has an active metabolite: 15β-hydroxy-cyproterone (Huber et al., 1988).  Cyproterone 
acetate is prescribed in both the UK and Australia. In vivo exposures of fish models 
have been completed and like the non-steroidal anti-androgens, cyproterone acetate 
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also caused intersex and other gonadal abnormalities, as well as changes to plasma 
sex steroid and urinary metabolite profiles and male parental behaviour (Dey et al., 
2010; Collette et al., 2010; Kiparissis et al., 2003) in the µg/L range. However, there is 
also some evidence of effects on plasma sex steroid concentrations in both males and 
females in the ng/L range (Sharpe et al., 2004), which may be closer to environmental 
concentrations.  
 
2.1.2 Predictive modelling of contaminants in the environment 
Identifying at risk regions where pharmaceuticals pose a risk to environmental and 
human health at present or in the future is one of the top 20 research questions 
regarding these contaminants (Boxall et al., 2012). Predictive modelling of river 
catchments is one of the methods which can provide the tools to do this, potentially at a 
national scale, detecting “hot spots” of chemical contamination, which could pose a 
threat to aquatic biota. In European rivers, the concentrations of steroid oestrogens 
(Williams et al., 1999), pharmaceuticals (Kugathas et al., 2012; Schowanek and Webb, 
2002) and chemicals originating from personal care products and household cleaners 
(Wind et al., 2004) have all been assessed by predictive modelling. These techniques 
have been used alongside or as an alternative to analytical chemistry and have the 
advantage of being cheap and fast first tier assessment tools. In comparison, analytical 
chemistry is an expensive and time consuming process and detection limits can 
provide difficulties, particularly with substances which are highly active at low 
concentrations. This has been a particular issue with EE2, where a limit of detection 
below the environmental quality standard of 0.1 ng/L is required for robust analysis. In 
many cases this can only be achieved through extraction of large sample volumes, 
which becomes even more time consuming (Johnson et al., 2008). However, producing 
more complex river catchment models is also a time consuming process and requires 
extensive data and specialists to program them in their initial set up. The output of 
these models is also only as good as their input data, so time investment at this point is 
crucial. Once a catchment model has been set up it can be easily used to assess 
multiple chemicals simultaneously and they can be modified to assess different 
environmental scenarios, such as the effects of perturbations like climate change 
(Johnson et al., 2008). Nonetheless, it should be considered that whilst modelling 
procedures work well as a guide, it is only robust analytical chemistry that can confirm 
the presence of a chemical in the environment (Johnson et al., 2008).  
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In a basic modelling procedure, data are required on the consumption of a chemical 
and the population served at a WWTW to determine the chemical load arriving at the 
works. The effluent flow and potential removal rates are then taken into account to 
determine the effluent concentration and the receiving river flow can be used to 
calculate concentrations in surface water downstream of the outfall. Some of these 
techniques were pioneered in the UK to assess concentrations of steroid oestrogens. 
Here, Johnson and Williams produced a method to determine the amount of each 
steroid oestrogen entering a WWTW based on their excretion from different cohorts 
within the human population (Johnson and Williams, 2004; Johnson et al., 2000). This 
was used as the basis for predictions of effluent concentrations as well as river 
concentrations at capture sites from the UK survey of intersex roach, which were based 
on the available effluent dilution (Jobling et al., 2006). This study identified significant 
relationships between the predicted concentrations of steroid oestrogens and both the 
prevalence and severity of intersex within the captured roach, adding further evidence 
to the hypothesis that steroid oestrogens were significant factors in the causation of 
sexual disruption. Following on from this, a national risk assessment of steroid 
oestrogens was completed using the Johnson and Williams model in conjunction with a 
geographic referenced point source water quality model: the LowFlows 2000 Water 
Quality eXtention Model (LF200-WQX). This is a digitised river network which 
incorporates WWTW discharge points as well as confluences, bifurcations, abstraction 
points and runoff data to simulate the input and dilution of contaminants (Williams et 
al., 2009). In this study, the model included 10,313 river reaches (21,452 km length) in 
England and Wales with 2,000 WWTWs which served over 29 million people. It 
produced a map of oestrogen concentrations on these stretches and found that 39% 
were potentially at risk of endocrine disruptive effects by exceeding the 1 ng/L 
combined E2 equivalent on average (Young et al., 2004). It also used data from fish 
exposure studies and PNECs to determine a risk class for each stretch based on the 
E2 equivalent concentration of the three steroid oestrogens, which is demonstrated 
below in Figure 2.3. In addition, further investigation of this hydrological modelling 
technique on the Rivers Erewash and Avon found that measurements by analytical 
chemistry of samples taken from along the river adequately matched the predicted 
concentrations in terms of their risk level (Williams et al., 2012).  
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Figure 2.3 The predicted risk classes of modelled river stretches in the Thames region 
based on the E2 equivalent concentration of the steroid oestrogens combined. No risk 
(<1 ng/L), at risk (1-10 ng/L) and high risk (>10 ng/L). SB denotes WWTWs using a 
secondary biological filter as a treatment process (from Williams et al., 2009). 
 
These techniques have also been applied to investigate a range of mitigation options at 
WWTWs in the UK (Johnson et al., 2007a), as well as the mixture effects of oestrogens 
and xenoestrogens in a UK river catchment (Sumpter et al., 2006). Similar modelling 
studies have also been completed in Japan and the USA where lower concentrations 
and therefore risk of endocrine disrupting effects occurring in fish were predicted. This 
is likely to be due to the significantly greater dilution available per capita in both 
countries, although in Japan, the lower use of the contraceptive pill was also a smaller 
contributing factor. Indeed, in the USA only effluent dominated streams with low dilution 
were considered to be at risk of endocrine disruption (Anderson et al., 2012; Johnson 
et al., 2011). 
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2.1.3 Predicting future changes in environmental EDC concentrations 
Human population density and the available dilution in the aquatic environment are key 
factors responsible for producing concentrations of environmental contaminants 
(Williams et al., 2009; Jobling et al., 2006), both of which are predicted to dramatically 
change during the course of this century. Indeed, many countries are anticipating 
increasing population pressure with the global population expected to reach 9.3 billion 
by 2050. This will put increasing pressure on WWTWs as the population they are 
required to serve increases, which will in turn increase the anthropogenic pollutant load 
that will require treatment before release into the aquatic environment. This is likely to 
occur in the context of increasing demand on water resources, which for many 
catchments are already considered to be under stress. In fact, nearly 80% of the global 
population is estimated to be exposed to a high threat to their water security 
(Vorosmarty et al., 2010), which could increase reliance on treated wastewater for 
domestic use, potentially leading to greater human exposure to contaminants (Kookana 
et al., 2007). In both the UK and Australia, many regions are already experiencing 
degrees of water stress and management plans are being enacted to ensure that water 
is adequately supplied to both the human population and the environment (National 
Water Commission, 2012; Government of South Australia, 2010; Environment Agency, 
2008c; HM Government and DEFRA, 2008).  
In the future, in some regions the anticipated effects of climate change include 
reductions in precipitation, runoff and river flows, adding to water stress and reducing 
the available dilution of the increasing contaminant load (Bates et al., 2008). Indeed, 
widespread reductions in total annual river flow of 10-15% are expected throughout 
England and Wales by the 2050’s based on low to high emissions scenarios 
(Environment Agency, 2008a). This compares well with a more specific study focussing 
on the effects of low to high emissions scenarios on the River Thames and the Ouse by 
2080, which anticipated flow reductions in all seasons, except winter on the Ouse, and 
a decrease in the duration of high flow events. However, on the Thames the reduction 
in flow was predicted to be higher than those projected in the national report (30-50%) 
(Johnson et al., 2009). In Australia, flow on the Murray River, Australia’s largest river 
basin which accounts for 70% of irrigated crops and pastures, is predicted to decrease 
by 10-25% by 2050 and 16-48% by 2100 (Bates et al., 2008; Beare and Heaney, 
2002). Reductions have also been predicted in south west and eastern Australia, 
although an increase in runoff is expected to occur in northern Australia (Milly et al., 
2005). As well as a reduction in baseline flows, reducing precipitation and runoff is also 
anticipated to increase the frequency of drought events. Although both countries 
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already experience drought, increasing frequency, intensity and their spatial extent will 
impact environmental pollutants and add a significant challenge to water resource 
management in the future (Rahiz and New, 2013; Fowler et al., 2003; Hughes, 2003). 
To maintain river flows that will be sufficient to sustain environmental health and suit 
anthropogenic need, the importance of WWTW effluent flow will increase, as will 
potential trade-offs between water quality and quantity (Land and Water Australia, 
2008). This will have implications for aquatic biota, for which biodiversity loss is linked 
to reduced flows (Xenopoulos et al., 2005). In the UK, one study found that low 
dissolved oxygen and increased water temperature associated with low flows were 
linked to migratory decline in Atlantic salmon. In this case over 50% of the salmon run 
was lost during these low flow events (Solomon and Sambrook, 2004). Nonetheless, 
Australian data suggests that there may be some advantages to low flow scenarios for 
recruitment of some species due to the concentration of prey species, such as 
zooplankton, during the larval stage (Humphries et al., 1999). However, early 
development is very sensitive to endocrine disruption by pollutants and for many 
aquatic species this life stage occurs during periods of low flow in summer months, 
when contaminant concentrations are likely to be at their highest. Consequently, to 
ensure that appropriate management action and mitigation responses are made, it is 
important that endocrine disruptors and their risks to fish in the future are properly 
assessed under multiple scenarios.  
 
2.1.4 Aims and objectives 
This study aimed to investigate the input of anti-androgenic pharmaceuticals into the 
aquatic environment via WWTW effluents and their resultant concentrations in a river 
catchment in the UK and one in South Australia using predictive modelling techniques. 
This represented a targeted approach to identifying environmental anti-androgens, in 
which the concentrations were compared with in vivo data to determine their potential 
risks to wild fish health. Since these techniques have not yet been employed to assess 
EDCs in Australia, concentrations of steroid oestrogens were modelled alongside the 
anti-androgenic pharmaceuticals. This would also allow combined exposures of fish to 
anti-androgens and steroid oestrogens, detailed in Chapter 3, to be informed by 
appropriate concentrations. Finally, the projected changes in climate and human 
populations in the future provided the impetus to assess how contamination of river 
catchments by these chemicals could change in both countries up to 2050. The 
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impacts of contamination of these catchments on fish in both the present day and 
future scenarios were also explored. 
 
2.2 Materials and methods 
2.2.1 Sites 
Four UK WWTWs (UK1-4) located in the Severn-Trent catchment was compared with 
12 WWTWs in South Australia (Table S1).  Both represented a variety of rural and 
urban scenarios and both catchments are considered to be moderately water stressed, 
since the demand and allocation of water is a high proportion of the total availability 
(National Water Commission, 2012; Government of South Australia, 2010; 
Environment Agency, 2008c; HM Government and DEFRA, 2008). The river hydrology 
of the two catchments contrast with cooler, permanently flowing waters in the UK and 
warmer more ephemeral hydrology dominated by winter flow in South Australia.  
 
2.2.2 Modelling pharmaceuticals  
The annual consumption of anti-androgenic pharmaceuticals and EE2 were calculated 
based on the number of prescriptions in the UK and Australia, which were determined 
from the National Health Service’s Prescriptions Cost Analysis (2009) for England (The 
NHS Information Centre, Prescribing Support Unit, 2010) and Wales (Welsh Assembly 
Government, 2010) and the Australian Statistics on Medicines (2008) (Australian 
Government Department for Health and Aging, 2009), using a method from Runnalls et 
al. (Runnalls et al., 2010). The per capita load in µg/d was then determined based on 
the annual consumption, the population of each country for the prescription year and 
the excretion rate of the chemical. These are shown in Table 2.1 below.  This assumes 
that patient compliance with their presciptions is 100%, in that all of the prescribed 
pharmaceuticals are consumed.  Nonetheless, given that these drugs are prescribed 
as cancer treatment or contraception it could be considerd that compliance is likely to 
be high.  
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Table 2.1 The prescriptions of pharmaceuticals in the England and Wales (2009) and 
Australia (2008). 
Pharmaceutical 
Consumption (kg)  
Excretion 
%
1
 
Per capita load (µg/day)
2
 
England and 
Wales (2009) 
Australia 
(2008) 
England and 
Wales (2009) 
Australia 
(2008) 
 
Bicalutamide 635.77 53.91 55.00% 17.43 3.68 
Cyproterone acetate 278.90 361.21 80.75% 11.23 36.22 
Flutamide 146.52 70.83 39.90% 2.91 3.51 
Nilutamide - 7.05 100% - 0.86 
   
 
  17α-ethinylestradiol 17.42 5.55 40.00% 0.35 0.28 
 
1 Excretion rates based on average urinary and biliary excretion of bicalutamide (Goa 
and Spencer, 1998), cyproterone acetate (Frith and Phillipou, 1985; Humpel et al., 
1977; Speck et al., 1976), flutamide (Wolters Kluwer Health, 2009; Schering-Plough 
Pty Limited, 2004; Solimando, 1997) and EE2 (Johnson and Williams, 2004). With no 
data available for nilutamide, a worst case scenario of 100% excretion was assumed. 
2 Based on a mid-2009 population of 54,809,100 for England and Wales and a 2008 
population of 22,000,000 for Australia from the ONS and ABS. 
 
2.2.3 Modelling natural oestrogens: oestrone (E1) and 17β-oestradiol (E2) 
This model was based on an approach provided by Johnson and Williams, which has 
been applied to predict environmental concentrations of steroid oestrogens in effluents 
in Europe (Johnson and Williams, 2004), as well as in hydrological models used for 
national risk assessments of endocrine disruptors in rivers in the UK, Japan and the 
USA (Anderson et al., 2012; Johnson et al., 2011; Williams et al., 2009). Our modified 
model provides a per capita load for E1 and E2 in µg/d arriving at a WWTW, based on 
the proportions of different oestrogen-excreting cohorts within a population. This was 
calculated as follows: 
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Where S is the per capita load arriving at a WWTW (µg/d), n is the number of cohorts 
and U is the total oestrogen excreted in urine (in free, glucuronide and sulfate forms) 
and faeces for each cohort percentage (fi) of the population (Table 2.2). For E2, a 
factor of 0.5 is incorporated assuming that 50% will be degraded to E1 in transit 
through the sewerage system to a WWTW. The mean oestrogen excretion of each 
cohort percentage is shown in Table 2.2 and is based on a literature review for the 
original model that focused on Caucasian omnivorous women (Johnson and Williams, 
2004). Upper and lower excretion values were also used to provide a range in the load 
arriving at a WWTW. A worked example can be found in the Appendix One. 
 
Table 2.2 The population breakdown of the oestrogen excreting cohorts by criteria and 
the composition of each census population: UK 2001 and Australia 2006. 
Cohort Criteria Mean (range) excretion 
(µg/d) 
% of population 
E2 E1 UK Australia 
Menstrual 
females 
Age 15-50 
(minus pregnant women) 
3.2 
(1.7-4.6) 
11.7 
(7.5-15.4) 
23.5% 24.2% 
Menopausal 
females 
Age >51 
(minus menopausal 
women on HRT) 
 
1 
(0-3.5) 
1.8 
(0-5.7) 
16.1% 13.7% 
Menopausal 
females on 
HRT 
7.6% UK and 11.8% 
Australian menopausal 
females (>51) 
56.1 
(51.5-61.5) 
28.4 
(24-33) 
1.3% 1.8% 
 
Pregnant 
Females 
 
1/22 UK and 1/19 
Australian menstrual 
females 
 
 
393 
(340-445) 
 
550 
(432-668) 
 
1.1% 
 
1.3% 
Males 
 
Age >15 
 
1.8 
(1.3-2.4) 
2.6 
(1.4-2.9) 
39.0% 39.2% 
 
2.2.3.1 Cohort Criteria 
The percentages of the populations made up by each cohort were based on age and 
determined from national census data, which were assumed to be relevant to local 
demographics. This utilised the national report for England and Wales (age by sex and 
resident type) from the 2001 census by the Office for National Statistics (ONS) and the 
Australian 2006 census (age by sex based on place of usual residence) from the 
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Australian Bureau of Statistics (ABS). Pre-pubescent males and females were not 
incorporated since sex steroid production is low until puberty and their inclusion would 
have little effect on the final prediction (Johnson and Williams, 2004). As a result, the 
male cohort included those from age 15 onwards and menstrual females were 
assumed to be between 15 and 50 with menopausal females taken from the age of 51 
onwards. The number of females on hormone replacement therapy (HRT) using E2 
based pharmaceuticals was updated for this model where 11.8% of women over 50 
were estimated to use HRT in Australia (MacLennan et al., 2009) compared to 7.6% of 
women in the UK. This was calculated by combining population data from the 2001 
census with data on HRT use in the UK in 2004 (Watson et al., 2007). These 
percentages were applied to the menopausal female cohort to determine the number of 
women on HRT, although it should be taken into account that HRT use has fluctuated 
in the last decade in both countries (MacLennan et al., 2009; Watson et al., 2007). The 
number of pregnant females was estimated using the census data assuming that the 
number of live births (people aged 0) was representative of the number of pregnant 
females. Using this model, per capita loads of 3.4 (2.7-4.1) and 3.9 (3.2-4.7) µg/d were 
produced for E2 in the UK and Australia respectively, as well as 14 (10-18) and 16 (12-
20) µg/d for E1. 
 
2.2.4 Predicting concentrations in WWTW effluent  
The linear emission model was used to predict effluent concentrations (µg/L) of the 
pharmaceuticals and steroid oestrogens, which reflected a 24-hour composite sample 
of effluent. WWTW data used in this model is shown in Table 2.3 below. The total load 
arriving at a WWTW (the per capita load [pc] (µg/d) multiplied by the population (pop) 
serviced) was divided by the total flow (Q) (L/day) through the WWTW (domestic plus 
non-domestic flow). Since removal is reported to be low for bicalutamide (Brixham 
Environmental Laboratory, 1998) and no data was available for the other anti-
androgenic pharmaceuticals, a removal percentage (R) was not incorporated. This 
provided a worst case scenario where the total pharmaceutical load arriving at a 
WWTW was available to enter the aquatic environment. In contrast, removal rates of 
69% and 83% were incorporated for E1 and E2 respectively, based on a review of 
removal during the activated sludge process (ASP) (Williams et al., 2008). However, it 
should be recognized that in reality removal rates vary, even in a single WWTW, based 
on the treatment process and environmental conditions (Johnson et al., 2008). Flow 
and population data for the WWTWs were provided by Severn Trent Water, UK and 
South Australian Water Corporation, Australia (Table 2.3). 
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𝐶𝑒𝑓𝑓𝑙𝑢𝑒𝑛𝑡 =  
𝑝𝑐 ∙ 𝑝𝑜𝑝
𝑄𝑆𝑇𝑊
∙ (1 − 𝑅) 
Average, upper and lower effluent concentrations for E1 and E2 were produced by 
varying the per capita loads with the upper and lower excretion values (Table 2.2), 
whilst for EE2 different removal rates during the activated sludge process (83%, 71.2% 
and 94.8%) were assumed.  
 
Table 2.3 The parameters for UK and South Australian WWTW for the present day. 
WWTW Population 
Served 
Domestic 
Flow (Mega 
Litres/Day) 
Non-Domestic 
Flow (Mega 
Litres/Day) 
Total Flow 
(Mega 
Litres/Day) 
Per capita 
flow 
(L/Day) 
UK1 53,695 8.17 
 
8.17 152 
UK2 47,991 13.52 
 
13.52 282 
UK3 117,041 38.60 
 
38.60 330 
UK4 68,300 11.41 
 
11.41 167 
SA1 2,761 0.23 0.05 0.28 102 
SA2 4,163 0.86 
 
0.86 206 
SA3 9,294 1.79 
 
1.79 193 
SA4 3,300 0.76 
 
0.76 230 
SA5 9,965,58 145.03 11.35 156.38 157 
SA6 17,652 5.24 
 
5.24 297 
SA7 1,029 0.26 
 
0.26 257 
SA8 2,873 2.45 
 
2.45 852 
SA9 226 0.06 
 
0.06 273 
SA10 2,725 0.36 
 
0.36 134 
SA11 3,571 1.12 
 
1.12 313 
SA12 16,159 4.36   4.36 270 
 
1 The population serviced at UK WWTW’s was based on estimations from Severn Trent 
Water for the year 2010. At Australian WWTW’s, the average population was 
determined based on estimations from the years 2005-10. 
2 Flow rates at UK WWTW’s represent the average daily flow for the year 2010 
provided by Severn Trent Water. Australian WWTW’s used the average flow rate from 
the years 2005-10.  
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2.2.5 The relevance to real world effluents 
Since there is little data available on the concentrations of the anti-androgenic 
pharmaceuticals in effluents, comparisons were made between modelled and 
measured steroid oestrogens to determine the relevance of modelled data to real world 
concentrations in effluent. Modelled concentrations were compared with measured 
data from UK2, where data from 19, 24-hour composite samples of its activated sludge 
treated effluent were available from a previous study (Baynes et al., 2012). These were 
collected between July and December 2009 and analysed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) as described previously (Kanda and 
Churchley, 2008). These data were compared with daily average modelled 
concentrations based on flow data from UK2 provided by Severn Trent Water from the 
day of sampling (Table 2.4). Up to 96 flow measurements were taken daily so 
concentrations were produced for each flow rate based on the average per capita 
loads.  
 
Table 2.4 Average (minimum – maximum) flow rates from UK2 at sampling points 
between July and December 2009, provided by Severn Trent Water. No data was 
available from 27/8/09 to 21/9/09. 
Sampling Date Flow (Mega 
litres/day) 
Sampling Date Flow (Mega 
litres/day) 
10/07/2009 205 (95-620) 01/10/2009 190 (70-419) 
16/07/2009 362 (197-590) 06/10/2009 323 (77-638) 
22/07/2009 350 (213-591) 13/10/2009 173 (75-285) 
27/07/2009 331 (153-630) 23/10/2009 202 (82-369) 
05/08/2009 489 (334-629) 26/10/2009 185 (87-291) 
14/08/2009 230 (110-367) 04/11/2009 389 (269-618) 
18/08/2009 212 (95-361) 19/11/2009 407 (362-577) 
27/08/2009 - 20/11/2009 339 (191-602) 
02/09/2009 - 24/11/2009 465 (359-605) 
10/09/2009 - 02/12/2009 452 (366-603) 
18/09/2009 - 07/12/2009 506 (439-570) 
21/09/2009 - 15/12/2009 403 (290-629) 
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2.2.6 Predicting river concentrations  
2.2.6.1 UK, Low Flows 2000-WQX 
The LF2000-WQX model (Wallingford Hydrosolutions, UK) was used to predict 
concentrations of anti-androgenic pharmaceuticals and steroid oestrogens in the River 
Erewash (as described by Williams et al., 2009). LF2000-WQX provided a map of 
interconnected river reaches, a digitised river network, with artificial influences (e.g. 
abstractions and discharges) incorporated. Since gauging sites were not available to 
provide flow data for all modelled river stretches, the magnitude and variability of flows 
at ungauged sites were estimated from runoff and generalized against gauged sites. 
This was achieved using a statistical probability approach where Monte-Carlo 
simulations generated a flow distribution based on different flow rate scenarios from 
extensive historical flow and rainfall data (Johnson et al., 2008). The concentrations 
predicted by this modelling procedure were therefore output as a distribution. The 
mean was used in this study since it represented the predicted concentrations for 
average river conditions.  
The chemicals were assumed to enter the system continuously via the eight WWTWs 
on the Erewash including UK2 and 4. The per capita load arriving at these WWTWs 
was based on the effluent model with serviced populations updated with new estimates 
from Severn Trent Water. The dry weather flows (DWF) through the WWTWs in the 
LF2000-WQX model were updated in line with the population to maintain the per capita 
flow. Again, no removal was assumed for the anti-androgenic pharmaceuticals, whilst 
removal of steroid oestrogens at each WWTW was based on the ASP review used in 
the effluent model (Williams et al., 2008). The average concentrations on a given 
stretch were then determined based on an exponential decay model incorporating in-
stream temperature dependent degradation for steroid oestrogens only (Jürgens et al., 
2002) and dilution based on the spatial variability in flow. Loss through absorption to 
sediment was not included since it is not a cause of significant removal for oestrogens 
(Holthaus et al., 2002). Degradation of E2 to E1 was also incorporated based on 1 mol 
E2 degrading to 1 mol of E1. However, in the case of the anti-androgenic 
pharmaceuticals, the model produced a worst case scenario for their environmental 
concentrations based on average river flow, since no data was available on the in-
stream degradation of the drugs. Consequently, only the effect of dilution of the effluent 
in downstream river stretches was taken into account. 
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2.2.6.2 South Australia, Source Catchments  
A point source hydrological model of the Onkaparinga River in South Australia was 
implemented and run in Source Catchments version 2.0.4 (eWater CRC) (eWater 
Cooperative Research Centre, 2010b; eWater Cooperative Research Centre, 2010a) to 
predict concentrations on a 16 km stretch downstream of the discharge point of the 
WWTW SA2. The river itself is vital to the water supply of the city of Adelaide, 
supplying the Mount Bold and Happy Valley Reservoirs and the stretch receiving 
effluent from SA2 has been identified as a possible site for endocrine disruption by the 
South Australian Environmental Protection Agency (Goonan, 2008). Like LF2000-
WQX, Source Catchments also provided a digitised river network, with a node-link 
system (Figure 2.4) representing a series of interconnected river stretches with artificial 
influences incorporated. However, in this case flow through the stretches (links) was 
calculated based on the SIMHYD rainfall-runoff model with Laurenson flow routing 
(eWater Cooperative Research Centre, 2010a). Whilst this uses historical data, it does 
not provide a flow distribution for each stretch. Instead it produces flow scenarios 
based on past events using historic data. As a result, in this study the model was run 
from 1/1/2008-31/12/2008, the year on which prescriptions data were based, to predict 
the daily concentrations on each stretch. Chemical input was simulated with an inflow 
function at the node representing SA2 based on a time series of daily concentrations 
modelled using the daily flow rates from the WWTW in 2008 to simulate a continuous 
influx. Another inflow function was incorporated at a node downstream representing the 
inter-basin transfer of raw River Murray water from the Murray Bridge-Onkaparinga 
pipeline by adding flow only as no WWTWs discharge within 500 km from this 
additional water source. The chemicals were transported through the interconnected 
stretches from the source with their concentrations calculated on each stretch based on 
the available dilution from simulated flows. A simple exponential decay model was 
incorporated for the steroid oestrogens only, which used half-lives based on their 
typical degradation rates in UK rivers at 20oC water temperature (Jürgens et al., 2002). 
These were 2.99 days for E1, 2.78 days for E2 and 17 days for the less degradable 
EE2. However, this was not temperature dependent and it should be recognized that 
their degradation could differ in Australian rivers due to different environmental 
conditions. However, no data are available to support this possibility. Like in LF2000-
WQX no loss to sediment was assumed but in contrast, the conversion of E2 to E1 was 
not included, which could result in a small underestimation in concentrations of E1. In 
addition, the model did not incorporate the farm dam directly downstream of the 
WWTW which abstracts some water for irrigation, potentially affecting the 
concentrations of chemicals entering the main river stretch below this point particularly 
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during the summer months. However this could not be quantified. Once again, no 
removal at the WWTWs was assumed for the anti-androgens and no decay model was 
used to provide a worst case scenario. 
 
Figure 2.4 Source Catchments software showing the link-node representation of part 
of the Onkaparinga River downstream of SA2. 
 
2.2.7 Risk assessment of the equivalent oestrogenic activity 
Unlike the anti-androgenic pharmaceuticals, there is extensive data on the effects of 
steroid oestrogens in vivo, so their concentrations were compared with PNECs 
produced by the UK Environment Agency (Young et al., 2004). Since oestrogens exist 
in the environment in combination and act additively to induce similar biological effects, 
it is appropriate that a combined “toxic equivalent” is incorporated into any risk 
assessment (Young et al., 2004). This is presented as the E2 equivalent (EEQ) in ng/L 
which was calculated based on the following equation dividing the concentration of a 
steroid oestrogen by its PNEC: 
EEQ = (
EE2 (ng/L)
0.1
) + (
E2 (ng/L)
1
) + (
E1 (ng/L)
3
) 
The PNECs were based on in vivo studies of the effects of these chemicals on fish and 
are discussed in Young et al. (2004) Briefly, for EE2, a PNEC of 0.1 ng/L was derived 
from a full life cycle study of zebrafish based on the lowest observed effect 
concentration (LOEC) and no observed effect concentration (NOEC) for fertilisation 
success and incorporating a safety factor of five (Wenzel et al., 2001). A PNEC of 1 
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ng/L was derived for E2 based on an early life study of Japanese medaka where 10 
ng/L E2 produced an all-female population (Nimrod and Benson, 1998), incorporating a 
safety factor of 10. With less data available for E1, a PNEC of 3-5 ng/L was derived 
from studies of vitellogenin induction, such as Routledge et al., 1998. The more 
conservative PNEC of 3 ng/L was employed for estimating the EEQ in this study. 
To determine the risk to wild fish, the hydrological models of the rivers were used to 
map potential “hot spots” for oestrogen concentrations. Stretches were categorised as 
“no risk”, “at risk” or “high risk”, based on the EEQ (<1, 1-10 and >10 ng/L EEQ 
respectively) (Williams et al., 2009). Stretches were considered “at risk” if the EEQ 
exceeded 1 ng/L, based on the PNEC for E2. On these stretches, effects on individual 
fish, such as intersex, may be expected to occur. Additionally, stretches were identified 
as “high risk” when concentrations exceeded 10 ng/L EEQ, where effects on fish 
populations could be expected. This was based on in vivo evidence in which steroid 
oestrogens caused effects relevant to populations, which caused 100% feminisation of 
medaka exposed to 10 ng/L E2 and reduced fertilisation success at 1 ng/L EE2 (10 
ng/L EEQ) (Schäfers et al., 2007; Nimrod and Benson, 1998). This method of 
predicting the presence of “risk” stretches from the effluent model and LF2000-WQX 
has recently been compared with LC-MS/MS analysis on the Erewash, where modelled 
and measured concentrations both produced the same risk categories for the river 
stretches based on the EEQ (Williams et al., 2012). 
 
2.2.8 Predicting concentrations in 2050: the effects of population and 
climate change 
2.2.8.1 Population projections 
To determine how concentrations of these chemicals in effluents and rivers could 
change in the future, concentrations were modelled based on data relevant to 2050. 
These were then compared back to the predictions detailed above, produced from 
sources dating from 2001-2011, which are henceforth referred to as predictions for the 
present day. Data on population change was gathered from the “National Population 
Projections, 2010-based Projections” publication released in 2011 by the ONS, UK 
(Office for National Statistics, ) and “Population Projections Australia, 2006-2101” 
released in 2008 by the ABS (Australian Bureau of Statistics, 2008) (Figure 2.5). Since 
projections were available for 2051 for both countries, these were assumed to be 
representative of 2050 and relevant to the local catchment areas. Three main 
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projections were used for each country based on demographic assumptions of future 
fertility, mortality and migration to produce different scenarios for population change. 
These included a principal projection (B) which assumed that current trends in these 
demographic assumptions would prevail in the future and high (A) and low (C) 
population projections to provide a range. 
 
Figure 2.5 The change in population to the year 2050 in the UK (left) and Australia 
(right) under the three population projections: A (high), B (principle) and C (low). 
Sourced from the Office for National Statistics, UK and the Australian Bureau of 
Statistics, Australia. 
 
2.2.8.2 Anti-androgenic pharmaceuticals 
To predict the use of anti-androgenic pharmaceuticals in 2050, assumptions were 
made of the potential changes in the prevalence of the conditions for which they are 
prescribed. All four are used in the treatment of prostate cancer, although cyproterone 
acetate is also prescribed in other formulations to control male sexual desire and as 
part of the combined contraceptive pill with EE2. The incidence of prostate cancer by 
2050 for each population projection was predicted based on records from England 
(1971-2010) (Office for National Statistics, 2013) and Australia (1982-2009) (Australian 
Institute of Health and Welfare, 2012) using the linear regression model (Figure 2.6).  
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Figure 2.6 Incidence of prostate cancer per 100,000 of the population in England (A), 
and Australia (B). Data from England used age-standardised rates standardised using 
the European Standard Population, whereas Australian data was estimated based on 
the annual incidence within the total population. The linear regression equation is 
shown. 
 
For each population projection, the prescriptions of each pharmaceutical used in the 
treatment of prostate cancer were increased in line with the projected rise in the 
disease. However, in the UK flutamide has been recently discontinued by the NHS so it 
was assumed that bicalutamide would be used as a replacement, since it has the same 
mechanism of action and the same use as flutamide. In this case, the increase in 
prescriptions of flutamide was converted to bicalutamide, based on three doses of 250 
mg flutamide being equivalent to one dose of 50 mg bicalutamide. In Australia, the 
proportional use of the anti-androgens was assumed to stay the same. In the case of 
cyproterone acetate, the prescriptions of forms used in prostate cancer were also 
increased in line with the disease. However, in the UK data, those used in 
contraception were assumed to change in line with the proportion of menstrual females 
in each projection and those used to control male sexual desire were changed in line 
with the proportion of males over the age of 15 in the population (Table 2.5). In the 
Australian data, only prostate cancer and female contraceptive forms could be 
differentiated and their prescriptions were changed in the same way as the UK. The 
total population in each projection was then used alongside the original excretion data 
to produce new per capita loads. This method assumes that the age demographics of 
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the future population will remain constant and that the past trend will remain true to the 
future scenario. 
 
2.2.8.3 Steroid oestrogens  
The model for predicting the per capita load of steroid oestrogens is dependent on the 
composition of the population in terms of the different oestrogen excreting cohorts. 
Consequently, analysis of population projection data leading up to 2050 was completed 
to assess how they affected the per capita load and the total load of steroid oestrogens 
arriving at a WWTW. Since the projections data were available on an age by sex basis, 
new per capita loads for E1 and E2 were produced based on new oestrogen excreting 
cohorts relevant to 2050 to incorporate these changes in population composition (Table 
2.5). Additionally, the per capita load of EE2 was changed in line with the proportion of 
menstrual females: the users of the contraceptive pill.  
 
Table 2.5 Cohort percentages based on census data from 2001 (UK), 2008 (Australia) 
and under the three population projections for 2050: high (A), principle (B) and low (C). 
UK 
Cohort 2001 2050A 2050B 2050C 
Menstrual females 23.5% 19.6% 19.9% 20.1% 
Menopausal females 16.1% 18.7% 19.4% 20.3% 
Menopausal females on HRT 1.3% 1.5% 1.6% 1.7% 
Pregnant females 1.1% 1.3% 1.1% 1.0% 
Males 39.0% 41.1% 41.6% 42.0% 
 
Australia 
Cohort 2008 2050A 2050B 2050C 
Menstrual females 24.2% 21.4% 22.0% 21.3% 
Menopausal females 13.7% 18.7% 18.7% 20.0% 
Menopausal females on HRT 1.8% 2.5% 2.5% 2.7% 
Pregnant females 1.3% 1.3% 1.2% 1.0% 
Males 39.2% 43.7% 43.9% 44.5% 
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2.2.8.4 Predicting effluent concentrations for 2050 
The effluent concentrations at the WWTWs under each population projection relevant 
to 2050 were calculated using the new per capita loads and assuming that the 
populations serviced would change in line with the population change from 2011-2051 
(Table 2.6). No changes were made to the DWF at the WWTWs, which remained at the 
same volume as the present day to provide a worst case scenario by assuming that no 
additional water was available for dilution.  
 
Table 2.6 Fold changes in population from 2011-2050 applied to WWTWs in the UK 
and Australia based on the three population projections: A (High), B (principle) and C 
(low). 
 Population Change 2011-2050 
 
2050A 2050B 2050C 
UK 1.41 1.26 1.09 
Australia 1.80 1.55 1.39 
 
 
2.2.8.5 Climate change and river flow 
The river models used the new per capita loads at the WWTW inflows and were 
modified to incorporate predicted climate-induced changes to flow. In the UK, the flow 
on the Erewash in LF2000-WQX was modified with flow data from the UK Climate 
Projections (UKCP09) simulation afgcx, which is one of 11 physically plausible 
simulations relevant to a medium emissions scenario in the UK (Prudhomme et al., 
2012). As a result, the flows were on average 5.2% lower than the 2009 model on each 
stretch. Oestrogen concentrations along the river were again calculated with inflow 
from the WWTWs based on the updated population data relevant to each projection. 
Again, no changes were made to the DWF. Due to the lack of available data for South 
Australia, the Source Catchments model was modified by reducing flow on each stretch 
by 17.5% from its 2008 flow volume to provide a medium range climate model. This 
was based on a 15-25% reduction in annual stream flow for the Murray River projected 
for 2050 using two medium sensitivity climate scenarios, A1 and B1, from the Special 
Report on Emissions Scenarios (Beare and Heaney, 2002).  It should be emphasised 
that these are average flow values, which do not present a scenario for episodic high 
flow events, which have been predicted under climate change scenarios, particularly 
for the UK (Bates et al., 2008). 
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2.3 Results and discussion 
2.3.1 Predicted effluent concentrations in the present day 
Concentrations of anti-androgenic pharmaceuticals and steroid oestrogens were 
modelled in UK and South Australian WWTW effluents based on annual prescriptions 
data. These produced a single concentration estimate for each WWTW, for which 
similar patterns were predicted in the order of concentrations at the WWTWs from 
highest to lowest for all the modelled chemicals. The deviations in concentrations 
resulted from the differing per capita flows, which demonstrated the importance of 
dilution in predicting concentrations at a given WWTW. South Australian WWTWs 
tended to experience a lower chemical load arriving for treatment since they generally 
served smaller populations than the UK WWTWs. When combined with the lower flow 
rate at most of these WWTWs, the dilution factor (the per capita flow) tended to be 
similar to UK WWTWs. The relationship between these factors is displayed in Table 
2.3.  
Since removal rates were not incorporated, the differences in concentrations of anti-
androgenic pharmaceuticals between the two countries agreed with differences in their 
per capita loads (Table 2.1). In the UK this resulted in the highest concentrations being 
predicted for bicalutamide, which exceeded 100 ng/L at UK1 and 4 (Figure 2.7) with a 
range of 53-115 ng/L. However, concentrations in South Australian effluent were much 
lower, with a range of 4-36 ng/L. In contrast, cyproterone acetate concentrations were 
predicted to be much higher in South Australia, with a range of 42-356 ng/L in 
comparison to 34-74 ng/L in the UK. In addition, concentrations of flutamide were lower 
and showed a similar concentration range of 9-19 ng/L and 4-34 ng/L for the UK and 
South Australia respectively. In fact, unlike the UK, flutamide and bicalutamide were 
prescribed at relatively similar frequencies in Australia, which produced similar effluent 
concentrations. Nilutamide was only prescribed in Australia and was predicted to occur 
from 1-8.6 ng/L.  
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Figure 2.7 The average predicted effluent concentrations of anti-androgenic 
pharmaceuticals and steroid oestrogens in the UK and South Australia. Boxes 
represent the predictions based on the average per capita loads (squares). Error bars 
for the steroid oestrogens extended to the predicted concentrations based on the upper 
and lower per capita loads for E1 and E2 and excretion rates for EE2. 
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The steroid oestrogens were modelled based on population data for E1 and E2 and 
prescriptions data for EE2. Prescriptions of EE2 were also shown to differ between the 
two countries, which produced a higher per capita load in the UK. This differed from 
that of E1 and E2, where the differences in population demographics resulted in a 
higher per capita load in Australia (Table 2.1). However, due to the similar per capita 
flows at the WWTWs, the predicted concentrations of E1, E2, EE2 and the EEQ were 
similar in both the UK and South Australian effluents (Figure 2.7), corresponding with 
the measured data range from the two countries and a review of effluents globally 
(Allinson et al., 2010). Based on the steroid oestrogen data, discharge from these 
WWTWs could be cause for concern for fish health if there is insufficient dilution 
available in rivers, based on the Environment Agency PNECs (Young et al., 2004). In 
particular, SA1 showed very high concentrations as a result of its low per capita dilution 
and therefore warrants further investigation in the future.  
 
2.3.2 The relevance to real world effluents 
In previous studies, predictive modelling has been shown to produce environmentally 
relevant estimations for chemical pollutants originating from WWTWs (Johnson et al., 
2008). To assess the model, predicted concentrations of steroid oestrogens at UK2 
were compared with measured concentrations in the UK. There were no measured 
data available for the anti-androgenic pharmaceuticals, although modelled data 
estimated that cyproterone acetate could occur at relatively comparable concentrations 
of 10-40 ng/L in WWTW effluent in France (Besse and Garric, 2009). In addition, 
concentrations of flutamide in the UK are now likely to be significantly lower than those 
predicted, if it is present at all, since the drug has been discontinued.  
On a national scale the range of concentrations for the steroid oestrogens predicted by 
this study for both the UK and South Australia were within the range of measured 
concentrations from 43 UK WWTWs (Johnson et al., 2007b) and over 70 WWTWs in 
Australia (Allinson et al., 2010; Mispagel et al., 2009; Ying et al., 2009; Ying et al., 
2008; Tan et al., 2007; Williams et al., 2007; Leusch et al., 2006; Braga et al., 2005; Li 
et al., 2004) (Table 2.7). The exception to this was SA1, which exceeded the 54 ng/L 
reported maximum observed concentration of E1 in Australia (Braga et al., 2005). 
Although the range provided by the assessment of 70 effluents is relatively extensive, it 
only represents a small proportion of Australian WWTWs and it is plausible that higher 
concentrations could occasionally occur in some of the older WWTWs. 
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Table 2.7 The mean average (upper-lower) oestrogen concentrations measured in 
effluents from 43 WWTWs in the UK and over 70 WWTWs in Australia based on the 
available literature. These are compared with the range of modelled concentrations in 
effluents from both countries. 
 Measured Concentrations (ng/L) Modelled Concentrations (ng/L) 
  E1 E2 EE2 EEQ E1 E2 EE2 EEQ 
 
UK 
 
 
<0.5-100 
 
<1-22 
 
<1-3.20 
 
(11-87) 
 
21 
(10-36) 
 
2.8 
(0.6-4.7) 
 
0.28 
(0.05-0.66) 
 
13 
(5-23) 
Australia
 
 
20  
(0-54) 
3.5  
(0-18.5) 
0.41  
(0-1.3) 
14 
(0-50) 
23 
(4-60) 
3.2 
(0.6-7.9) 
0.22 
(0.02-0.78) 
13 
(2-36) 
 
 
In a review of comparisons between modelled and measured data, predicted 
concentrations of pollutants in effluent were routinely predicted within a factor of 5 of 
the measured values (Johnson et al., 2008). At UK2, when modelled concentrations 
were compared with measured concentrations from effluent samples collected between 
July and December 2009, clear temporal variation was observed in both datasets 
(Figure 2.8). The differences between measured and modelled concentrations at each 
sampling point also varied where predictions for E1 and E2 both tended to 
overestimate the measured by a factor of 0.9-54 (median 3.1) and 0.8-33 (median 4.7) 
respectively. However, modelled concentrations of EE2 tended to underestimate the 
measured by a factor of 0.2-1.5 (median 0.4). These deviations in opposing directions 
produced a smaller deviation in the modelled EEQ, which generally overestimated the 
measured by a factor of 0.5-3.0 (median 1.0). However, it is important to note that 
every WWTW is unique and that the deviations in the datasets observed at UK2 may 
be very different in another WWTW.  
Based on the linear emission model these deviations cannot be explained by varying 
flow alone. Indeed, a lower actual per capita load and/or a higher removal rate could 
explain the overestimation of E1 and E2 and vice versa for EE2. At UK2, removal rates 
are reported to be higher than those assumed in the model for E1 and E2 (95 and 98% 
respectively) and lower for EE2 (32%) (Butwell et al., 2010). When these measured 
removal values were input into the model, the deviation factor lowered to 0.2-9.4 
(median 0.53) for E1, 0.1-3.8 (median 0.55) for E2, 0.7-6.1 (median 1.53) for EE2 and 
0.5-3.0 (median 1.1) for the EEQ. This switched the original overestimation of E1, E2 
and the EEQ and the underestimation of EE2, which suggests that the real removal 
rates are likely to be somewhere between the modelled and measured. The deviations 
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between the modelled and the measured data continued to vary across sampling 
points and are likely to be caused by variation in removal rates, which can cause 10 
fold differences in day to day effluent concentrations (Williams et al., 2003). 
Nonetheless, with these removal rates incorporated, all modelled data was within the 
measured range, demonstrating that a simple calibration of model parameters with 
data specific to a WWTW can improve the model performance. In particular, this could 
impact risk assessment, since different removal rates will affect both the proportions of 
oestrogens in effluent as well as their total concentrations, which will impact the EEQ. 
This also implies that river models will be more accurate with up to date removal data. 
It could be argued that the deviation in the modelled concentrations in comparison to 
measured data negates the ability of such methods to provide an environmental risk 
assessment for oestrogens due to the low threshold values in the risk categories 
(Johnson et al., 2008). Previous studies drawing comparisons have also found similar 
deviation, with oestrogen concentrations in point source discharges also deviating by 
an average factor of up to five (Johnson et al., 2008). However, another study found 
that E2 was overestimated by a median factor of 10 in WWTW effluent (Williams et al., 
2012). Clearly, this model could not take into account the constant changes in the 
internal environment of an STW or the changing load, which are likely drivers of the 
fluctuating concentrations and the changing deviations between measured and 
modelled data. Indeed, variation in removal rates can cause 10 fold differences in day 
to day effluent concentrations (Williams et al., 2003). From the river perspective, this 
deviation could make it difficult to adequately determine a risk category. However, in 
this study it should be considered that the effluent model was most accurate for the 
most potent oestrogen, EE2, which is critical in determining the EEQ. It also generally 
overestimated the EEQ, indicating that “at risk” river stretches downstream of the 
discharge were unlikely to be wrongly categorised as “no risk”. In fact, in a majority of 
cases the modelled concentrations fell within the range of the measured and if not then 
they exceeded it for all three compounds. When the updated removal rates were 
incorporated, all modelled data were within the measured range, demonstrating that a 
simple calibration of model parameters with data specific to a WWTW can improve the 
model performance. Consequently, the model should be considered to provide a good 
representative value for concentrations of compounds in WWTW effluents that are 
unlikely to underestimate risk categories downstream of the outfall.  This basic effluent 
model is also supported by biological observations, where modelled steroid oestrogen 
concentrations at fish capture sites in the UK correlated well with intersex incidence 
and severity (Jobling et al., 2006).    
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It is important to note that analytical measurements also have flaws that can affect risk 
categorisation. For example, deviation from the “real” concentrations can be achieved 
by degradation of the sample prior to extraction and analysis or through ion 
enhancement or suppression due to the complex nature of the sample. In addition, a 
measured concentration may not be representative if it is collected at the wrong time, 
due to the diurnal nature of concentrations of chemicals in WWTW effluent.  There is 
also evidence for variation in the concentrations of chemicals in a single sample during 
inter-laboratory comparisons, which can have similar deviations to comparisons 
between measured and modelled data (Johnson et al., 2008).   
 
Figure 2.8 The daily average modelled (squares) and measured (dots) oestrogen 
concentrations with the EEQ (ng/L) in effluent from UK2 over 19 sampling points from 
July to December 2009. A data gap exists between 27/8/09 and 21/9/09 due to the lack 
of available flow data to produce modelled concentrations.  
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2.3.3 Predicted river concentrations  
Predictive hydrological modelling of anti-androgenic pharmaceuticals and steroid 
oestrogens in the River Erewash, UK and the Onkaparinga River South Australia was 
completed based on their entry into the system via WWTW effluent input. The locations 
of the two rivers and a heat map of at risk areas are shown below in Figure 2.10, where 
the maps were produced in the geospatial processing program ArcMap 10 (Esri, USA). 
 
Figure 2.9 Location maps showing the Onkaparinga River, South Australia (above) 
and the River Erewash, UK (below). Produced in ArcMap 10. 
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2.3.3.1 Anti-androgenic pharmaceuticals 
Hydrological modelling with LF2000-WQX found that the main river stretch of the 
Erewash was entirely contaminated with anti-androgenic pharmaceuticals, as a 
consequence of the assumption of constant influx from the eight WWTWs along the 
river (Figure 2.9). Accordingly, the upstream stretch and its tributaries remained 
unimpacted. Concentrations ranged dependent on the inflow from the WWTW and the 
available river dilution with an average of 26 (16-50) ng/L bicalutamide, 17 (10-32) ng/L 
cyproterone acetate and 4.3 (2.7-8.4) ng/L flutamide predicted on impacted stretches. 
On the Onkaparinga River, modelling with Source Catchments predicted high 
concentrations directly downstream of the single WWTW outfall, which reduced with 
dilution downstream along the entire 16 km stretch. Predicted concentrations on 
average were 4.3 (1.2-9.5) ng/L bicalutamide, 42 (12-94) ng/L, cyproterone acetate, 4.1 
(1.2-9.1) ng/L flutamide and 0.1 (0.03-0.23) ng/L nilutamide. 
 
2.3.3.2 Steroid oestrogen risk assessment 
Hydrological modelling of the UK and South Australia rivers was used to identify 
potential hot spots of “at risk” areas for endocrine disruption in fish based on predicted 
concentrations of steroid oestrogens and their potential biological effects (Figure 2.10). 
On the River Erewash, UK, in agreement with data from the Johnson and Williams 
model (Williams et al., 2012) almost the entire river was categorized as “at risk” of 
endocrine disruption in wild fish. The average EEQ was 2 (0-7) ng/L along the entire 
river, exceeding the 1 ng/L PNEC where effects on individuals such as intersex and 
vitellogenin induction are at risk of occurring (Williams et al., 2009). This resulted from 
the assumption of constant influx from the eight WWTWs along the river which 
maintained the EEQ above 1 ng/L. On the Onkaparinga River in South Australia, 
concentrations were also predicted to exceed the 1 ng/L EEQ PNEC downstream of 
SA2. Around 9 km of the river was categorized as “at risk,” with concentrations 
decreasing with the distance downstream due to degradation and dilution from 
tributaries, eventually dropping below the PNEC upstream of the Mount Bold reservoir. 
An average EEQ of 3 (0.4-9) ng/L was predicted over these river stretches and 
individual steroid oestrogen concentrations were comparable with those measured at 
five river sites in Queensland at effluent outfalls and 1 km downstream of WWTWs 
(Ying et al., 2009). They also compared with concentrations measured globally 
(reviewed by Ying et al., 2002a).  
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Figure 2.10 Heat maps showing the risk categories of modelled stretches on the 
Onkaparinga River (above) and the River Erewash (below) in the present day based on 
the EEQ of the steroid oestrogens. Risk levels are indicated where “at risk” stretches 
exceed 1 ng/L and “high risk” stretches exceed 10 ng/L EEQ. Produced in ArcMap 10. 
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2.3.4 Projected effluent concentrations by 2050 
In both countries, the use of anti-androgenic pharmaceuticals and EE2 were predicted 
based on the projected population changes and assumptions made regarding how their 
use patterns could change by 2050. An assessment of the steroid oestrogens was also 
completed to determine how the changing population size and composition between 
the present day and 2050 would affect their concentrations in effluent. High (A), 
principal/medium (B) and low (C) projections were included for each chemical. 
 
2.3.4.1 Anti-androgenic pharmaceuticals 
The per capita load for each 2050 population projection was calculated based on the 
population change and the anticipated increase in prostate cancer incidence. In the 
UK, linear regression showed a 127-193% increase in the incidence of prostate cancer 
within the population projections A and C respectively in comparison to a 176-261% 
increase under their respective Australian projections. However, fluctuations were 
observed in prostate cancer incidence in the Australian data set between 1993 and 
1995, which could reduce the accuracy of the projection (Figure 2.6). Nonetheless, this 
linear extrapolation method has been used by the Australian Institute for Health and 
Welfare for projecting future trends in a cancer incidence to the year 2020 to inform 
health service planning and future resource management (Australian Institute of Health 
and Welfare, 2012). However, the accuracy of these could be further improved in future 
studies by taking into account changes in population age demographics (Møller et al., 
2007).  
Based on these data, prescriptions of these pharmaceuticals were all projected to rise, 
causing increases in their per capita load. The exception to this was flutamide, which 
was discontinued in the UK with the assumption that it would be replaced by 
bicalutamide. Bicalutamide increased to 32.2 and 7.8 µg/d in the UK and Australia 
respectively for all projections since prostate cancer incidence was assumed to be the 
same in each projection. Cyproterone acetate varied between projections due to its 
different uses, which also took into account the changing number of menstrual females 
in each projection (Table 2.6). The per capita load increased to 15.3, 15.4 and 15.5 
µg/d for UK projections A, B and C and to 63.1, 64.0 and 57.5 µg/d under Australian 
projections A, B and C. Flutamide in Australia again had a similar per capita load to 
bicalutamide of 7.4 µg/d in each projection, whilst nilutamide remained low at 1.8 µg/d. 
The projected increase in per capita load, combined with increasing population served 
by each WWTW caused an increase in the concentrations of anti-androgenic 
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pharmaceuticals occurring in WWTW effluent in both countries in 2050 (Figure 2.11). 
This projected a greater chemical load available to enter the aquatic environment, with 
the worst case scenario in the high projection (A) as a result of its associated 
population growth. However, this assumes that the pharmaceuticals will remain in use 
at the same proportions as the present day, with the exception of flutamide, and that no 
alternative treatments become available. On the other hand, as generic and therefore 
cost effective drugs with a proven treatment history they are likely to remain popular for 
use in human medicine. Furthermore, alternatives may have similar mechanisms of 
action, which unless they degrade in an environmentally friendly fashion into inactive 
metabolites and transformation products, could still have similar impacts on fish health. 
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Figure 2.11 The range of concentrations of anti-androgenic pharmaceuticals in 
effluents from UK and South Australian WWTWs under present day and future 
projections assuming no change in DWF. Boxes represent the mean (squares) with 
error bars extending to the minimum and maximum predicted concentrations from the 
four UK WWTWs and 12 Australian WWTWs. High projection (A), principle projection 
B) and low projection (C). 
0
200
400
600
800
1000
1200
E
ff
lu
en
t 
co
n
ce
n
tr
at
io
n
(n
g
/L
)
Cyproterone actetate
0
50
100
150
200
250
300
350
E
ff
lu
en
t 
co
n
ce
n
tr
at
io
n
(n
g
/L
)
Bicalutamide
0
5
10
15
20
25
30
35
E
ff
lu
en
t 
co
n
ce
n
tr
at
io
n
(n
g
/L
)
Nilutamide
0
20
40
60
80
100
120
140
E
ff
lu
en
t 
co
n
ce
n
tr
at
io
n
(n
g
/L
)
Flutamide
96 
 
2.3.4.2 Steroid oestrogens 
Interestingly the change in population composition only had a small impact on the per 
capita load. A small increase occurred under the high projection and a small decrease 
occurred under the principle and low projections (Table 2.8), as a result of changes in 
the demographics of the female population. Specifically, whilst the proportion of higher 
oestrogen excreting cohorts, such as the menstrual females tended to decrease within 
the population, the lower oestrogen excreting groups, such as the menopausal females 
increased (Table 2.5). This caused a net reduction in per capita oestrogen load for the 
population. Interestingly, in the case of EE2 in the Australian scenario, the increase in 
the number of pregnant women in population projection A reduced the proportion of 
contraceptive pill users (menstrual females) relative to the other projections, causing a 
reduction in per capita load. Population growth had a much greater impact, resulting in 
an increase in the total oestrogen load arriving at the WWTW (Figure 2.12) and an 
increase in their subsequent concentrations in effluents to be discharged into the 
environment (Figure 2.13). The exception to this was the UK projection C, where 
effluent concentrations remained at similar levels since the increase in population was 
not sufficient to compensate for the lower per capita load. Again, the worst case 
scenario was observed with the high population projections, where effluent 
concentrations almost doubled by 2050 under the Australian projection A. 
 
Table 2.8 The per capita loads of the steroid oestrogens in µg/day for the present day 
and under the three population projections: A (high), B (principle) and C (low). These 
were used as the basis for effluent and river models.  
  Per capita load (µg/day) 
  Present Day 2050A 2050B 2050C 
UK 
    E1 14.02 14.66 13.76 12.78 
E2 3.39 3.66 3.42 3.17 
EE2 0.35 0.33 0.33 0.33 
 
    
Australia 
E1 15.71 15.91 15.08 13.8 
E2 3.9 4.08 3.85 3.55 
EE2 0.28 0.27 0.27 0.27 
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Figure 2.12 The change in the total load (mg/day) of E1, E2 and EE2 arriving at 
WWTW’s (UK2 and SA2) in the UK (left) and Australia (right) up to 2050 under the 
three population projections: High projection (A), principle projection B) and low 
projection (C).  
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Figure 2.13 The predicted steroid oestrogen and EEQ concentrations of effluents in 
the UK and South Australia under present day and future projections assuming no 
change in DWF at the WWTWs. Boxes represent the mean (squares) with error bars 
extending to the minimum and maximum concentrations from the four UK WWTWs and 
12 Australian WWTWs. 
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2.3.5 Projected river concentrations for 2050 
The river models were modified for medium range climate scenarios with reduced flow 
and used in conjunction with the projected populations and their associated per capita 
loads to determine how river concentrations may change by 2050. In both catchments, 
decreased dilution in conjunction with increased chemical input caused increased 
concentrations of all modelled contaminants.  
 
2.3.5.1 Anti-androgenic pharmaceuticals 
On the River Erewash, although concentrations increased, there was no change in the 
number of impacted stretches from the present day. Bicalutamide experienced a 2-3 
fold increase in its average concentration on impacted stretches from 26 (16-50) ng/L 
to 69 (42-135) ng/L in projection A, 62 (38-120) ng/L in projection B and 51 (32-100) 
ng/L. In comparison, cyproterone acetate only experienced a 1-2 fold increase from 17 
(10-32) ng/L to 33 (20-64) ng/L, 30 (18-57) ng/L and 25 (15-48) ng/L in projections A, B 
and C respectively (Figure 2.14). On the Onkaparinga, the change in concentration 
was higher, increasing 3-4 fold for each projection, with the entire modelled section of 
the river impacted. Cyproterone acetate was again predicted to occur at the highest 
concentrations, increasing from 42 (12-94) ng/L to 168 (83-397), 145 (71-342) and 130 
(64-307) ng/L. Bicalutamide increased from 4 (1-10) ng/L to 16 (4-49), 14 (3-42) and 12 
(3-38) ng/L and a similar increase occurred with flutamide, from 4(1-9) ng/L to 15 (4-47) 
ng/L, 13 (3-40) and 12 (3-36) ng/L. In contrast, nilutamide still showed very low 
concentrations and increased from 0.1 (0.03-0.23) to 0.4 (0.1-1.2) in projection A and 
similar concentrations for projections B and C with an average of 0.3 (0.1-0.9) ng/L. 
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Figure 2.14 Predicted river concentrations (ng/L) of anti-androgenic pharmaceuticals 
on the Onkaparinga River, South Australia (left) and the River Erewash, UK (right). 
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2.3.5.2 Steroid oestrogens 
The number of modelled stretches on the River Erewash predicted to be impacted and 
considered at risk (23/36) also did not change from the present day. However, in 
projection A, the EEQ increased to the point at which two stretches downstream of 
WWTWs became high risk. Under projections A and B increases in the average EEQ 
on impacted stretches from 3.7 (2.3-7.4) ng/L to 5.9 (3.6-11.6) and 4.9 (3-9.7) ng/L 
were predicted to occur respectively. However, in projection C the increase was 
smaller with an average EEQ on impacted stretches of 3.8 (2.3-7.5) ng/L due to the 
lower input of steroid oestrogens from the WWTWs. An increase in average EEQ was 
also predicted between the SA2 discharge and the Mount Bold reservoir on the 
Onkaparinga River under all population projections, from 2.9 (0.4-8.9) ng/L to 6.6 (1.8-
18), 5.5 (1.5-15) and 4.6 (1.2-12) ng/L EEQ for projections A, B and C respectively. 
Importantly, the length of river downstream of the WWTW considered “at risk” 
increased under all three projections to include the entire 16 km modelled stretch 
upstream of the reservoir, whilst in projections A and B the stretch immediately 
downstream of SA2 became “high risk” (Figure 2.15).  
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Figure 2.15 The average predicted EEQs (ng/L) for the present day compared with the 
three future population projections, high (2050A), principal (2050B) and low (2050C), 
with river flows reduced for medium range climate change scenarios. Risk levels are 
indicated where “at risk” stretches exceed 1 ng/L and “high risk” stretches exceed 10 
ng/L EEQ. 
 
Mitigation to combat these rising oestrogen concentrations may be achieved with 
increased removal efficiency at WWTWs with improved uptake of modern treatment 
technologies, many of which are already used for treating drinking water and recycled 
wastewater. This has already been demonstrated in the UK (Baynes et al., 2012; 
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Butwell et al., 2010; Johnson et al., 2007a) and similar results have been found in 
Australia (Kumar et al., 2012; Reitsema et al., 2010). Indeed, in Western Australia the 
induction of the estrogenic biomarker vitellogenin was found in male fish downstream 
of a secondary treated rural effluent but not downstream of tertiary treatment (Reitsema 
et al., 2010). However, a number of studies have also detected steroid oestrogen 
concentrations which exceed the PNECs upstream of WWTWs, demonstrating the 
importance of considering multiple origins of environmental steroid oestrogens 
(Reitsema et al., 2010; Ying et al., 2009; Williams et al., 2007), such as agricultural 
runoff (Matthiessen et al., 2006), as well as WWTW effluent. In addition, other 
chemicals with the potential to cause feminizing effects in wildlife, such as the 
alkylphenols, which have been restricted under EU legislation, are still in use in 
Australia and have been detected in surface water (Ying et al., 2009).  
It is important to note that there is still limited research on endocrine disruption caused 
by steroid oestrogens in native Australian fish species, although some have been 
shown to be susceptible under laboratory conditions (Woods and Kumar, 2011; Codi 
King et al., 2008). Indeed, study of the Murray rainbowfish indicated a LOEC of 10 ng/L 
for E2 and 5 ng/L for EE2 in the induction of vitellogenin, which compares well with 
other laboratory fish models such as fathead minnows, zebrafish and Japanese 
medaka (Woods and Kumar, 2011). The effects on vitellogenin mRNA were also 
assessed in this study and compare well with a comparative exposure of laboratory 
model species and wild fish species from the UK, including roach, three-spined 
stickleback and rainbow trout (Lange et al., 2012b). As a result, further investigation is 
warranted to determine how susceptible Australian species are to oestrogens from all 
sources. This should include laboratory exposures to chemical standards as well as 
WWTW effluents, although this should not be limited only to tertiary treated effluents. 
Indeed, by increasing the available data Australian PNECs could be derived that 
accurately reflect the risks and mitigation required to protect Australian biota. 
 
2.3.6 Predicted concentrations of anti-androgenic pharmaceuticals in 
present and future scenarios and effects on fish 
The anti-androgenic pharmaceuticals, with the possible exception of flutamide, have 
not been researched as extensively as oestrogenic contaminants and there is little 
knowledge of their potential effects at environmental concentrations. Nonetheless, the 
literature so far suggests that they exert adverse effects in fish in the µg/L range. In the 
case of bicalutamide, the single study published is a multigenerational study using 
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fathead minnows, which observed reductions in secondary sexual characteristics in the 
adults and impacted survival and reproduction in the F1 at 100 µg/L but not at 10 µg/L 
(Panter et al., 2012). On the other hand, flutamide has been more extensively studied 
and has shown effects at lower concentrations with a LOEC from the literature of 2 
µg/L, which caused testicular alterations in carp (Bottero et al., 2005). Other studies of 
flutamide have not tested concentrations this low, but effects on sex steroids, weight, 
condition factor and fecundity have been observed at the lowest tested concentrations 
between 32 and 67 µg/L (Rajakumar et al., 2012; Chakrabarty et al., 2012; León et al., 
2007; Jensen et al., 2004). There have been no studies of the effects of nilutamide on 
fish, but given its structural similarities to bicalutamide and flutamide it could cause 
effects at similar concentrations. In comparison, cyproterone acetate has been shown 
to cause adverse effects at lower concentrations than the other pharmaceuticals, 
inducing intersex at the lowest tested concentration of 1 µg/L in Japanese medaka 
(Kiparissis et al., 2003). Consequently, the very low concentrations predicted to occur 
in both countries may suggest that an impact on fish is unlikely. However, there is 
evidence of effects of cyproterone acetate on sex steroid concentrations in mummichog 
at 1-100 ng/L, within the range of the predicted concentrations for the modelled 
effluents and rivers in both countries (Sharpe et al., 2004). As a result, this drug 
presents an interesting topic for future research in both singular and mixture scenarios 
with other significant environmental EDCs known to co-occur with this chemical. 
 
2.3.7 Considering multiple stressors 
The projected concentrations for 2050 are based purely on population growth and 
changes in dilution, making no additional assumptions to how changing environmental 
variables may affect the availability of contaminants. For example, in the case of 
pesticides, increasing temperature can reduce their persistence (Bailey, 2004), whilst 
rising salinity can increase bioavailability by the “salting out” effect, where binding of 
water molecules to salts makes them unavailable for the dissolution of organic 
chemicals (Noyes et al., 2009; Schwarzenbach et al., 2005). In addition, the work does 
not make any assumptions regarding the effects of multiple stressors on fish, in which 
a combination of pollutants and adverse environmental conditions can have 
antagonistic, additive or even synergistic effects (reviewed in Holmstrup et al., 2010). 
Indeed, environmental variables can affect the susceptibility of organisms to chemical 
stressors by changing the toxicokinectics and dynamics of pollutants. For example, the 
toxicity of the organophosphate insecticide phorate was significantly higher in saline 
conditions due to enhanced metabolism of the chemical to toxic metabolites (Lavado et 
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al., 2011). Furthermore, pollutants affect the ability of organisms to cope with external 
change, which was observed during exposure of larval mummichog to atrazine at 
different salinities where their ability to osmoregulate collapsed (Fortin et al., 2008). 
These findings are summarised in a review by Hooper et al. (2013) who stated that: in 
simplest terms, GCC [global climate change] can make organisms more sensitive to 
chemical stressors, while alternatively, exposure to chemicals can make organisms 
more sensitive to GCC stressors (Hooper et al., 2013). 
In fish, adverse effects on reproduction and sexual development can be induced by 
changes to the ambient environmental conditions as well as chemical interference, 
particularly in the case of temperature change. Indeed, research suggests that 
temperature induced masculinisation is mediated by cortisol, which appears to reduce 
the production of hormones essential for ovarian development in vertebrates (Hayashi 
et al., 2010; Carragher and Sumpter, 1990). In addition, experiments conducted with 
fathead minnows found that the rearing temperature could affect secondary sexual 
characteristics in males and females, which were reduced outside of the ambient 
temperature. The investment of energy between somatic and gonadal growth also 
appears to differ at high and low temperatures, with fish in warmer conditions capable 
of reproducing at a younger age (Brian et al., 2011). Since fathead minnows are a 
thermo-tolerant species, this may suggest that they can respond to different 
environmental conditions to maximise their fitness. However, other species are not so 
thermo tolerant and globally changing environmental conditions could affect the 
abundance and distribution of fish species (Hooper et al., 2013). Indeed, shifts in 
community structure on the Upper Rhôhne River have already be observed as 
temperature has increased over the last few decades and more thermophillic fish have 
progressively replaced cold water species (Daufresne et al., 2004). Even though EDCs 
and environmental stress can affect these parameters, there has been little knowledge 
of how climate change could impact the effects of steroid oestrogens in fish. However, 
studies have shown that hypoxia has no effect on oestrogen induced vitellogenin 
induction in fathead minnows, whilst higher temperatures were shown to speed up this 
response, although the magnitude did not change (Brian et al., 2011; Brian et al., 
2005). Nonetheless, there is abundant evidence to suggest that sexual disruption by 
steroid oestrogens occurs in a dose dependant manner, supporting that suggestion 
that increasing concentrations in the future will increase the incidence and severity of 
intersex (Jobling et al., 2006; Metcalfe et al., 2001). This was also demonstrated on the 
intersex endpoint during the steroid oestrogen exposures in this study. 
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2.3.8 Conclusions 
This study demonstrated the use of predictive modelling as a tool for assessing 
potential EDCs originating from WWTW effluent in UK and South Australian 
catchments. This was the first time that these techniques had been applied to an 
Australian catchment. The results predicted that effluent discharge could cause 
concentrations of anti-androgenic pharmaceuticals to occur in river catchments in ng/L 
in both countries. However, with the exception of cyproterone acetate, the predicted 
concentrations are below those which have been shown to cause adverse effects in 
fish. The steroid oestrogens were modelled alongside these drugs in an assessment of 
the presence of river stretches at risk of endocrine disruptive effects occurring in fish. 
This demonstrated that the use of modelling techniques used in risk assessment in the 
UK could also be applied to Australian scenarios. Concentrations of steroid oestrogens 
in rivers in both countries were expected to exceed the 1 ng/L EEQ PNEC, implying 
that there is a risk of endocrine disruptive effects occurring in wild fish. This supports 
evidence in Australia of the feminization of non-native fish in effluent contaminated 
areas (Reitsema et al., 2010; Rawson et al., 2008; Batty and Lim, 1999). Furthermore, 
in the absence of mitigation strategies we anticipate an increase in the concentrations 
of environmental contaminants with human origins in UK and Australian river 
catchments by 2050. This was calculated based on population growth and reductions 
in river flow through climate change driving increases in environmental concentrations. 
Indeed, changes in these factors are expected to increase further by 2100 and beyond, 
so it is quite plausible that the magnitude of the change in concentrations of 
environmental contaminants will also increase further. However, it is important to note 
that additional variables may effect these predictions. For example, measures to 
conserve water may further reduce dilution of potential contaminants arriving at 
WWTWs, whilst increasing anthropogenic control of river flow and the use of recycled 
wastewater could result in additional changes to their dilution in rivers. In addition, an 
increasing occurrence of extreme weather events could cause greater changes in flow 
which could have more dramatic implications for concentrations than our modelling 
suggests. Indeed, variation in flow and dilution may be a much greater driver than 
population change alone, causing increases or decreases in concentrations that may 
differ from our model, depending on water availability. Since a better understanding of 
the drivers that cause at risk areas has been called for (Boxall et al., 2012), these 
scenarios may provide interesting subjects for more detailed assessment in the future. 
Overall, the prediction of increasing concentrations of these contaminants suggests 
that endocrine disruption in wild fish may be a long-term management issue for which 
effective investment in pre-emptive mitigation today may pay off in the future. 
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3. CHAPTER 3: ASSESSING SEXUAL 
DISRUPTION BY ANTI-ANDROGENIC 
PHARMACEUTICALS IN FISH MODELS  
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3.1 Introduction 
Anti-androgenic activity has been detected in environmental samples globally and 
commonly occurs in UK effluents, causing activity to be detected in downstream river 
stretches (Ma et al., 2013; Grover et al., 2011; Zhao et al., 2011; Johnson et al., 2007b; 
Urbatzka et al., 2007). The impacts of this activity on fish health are of increasing 
interest, since anti-androgenic chemicals can disrupt the androgen signalling pathway 
of an organism (Hotchkiss et al., 2008; Kelce and Wilson, 1997). By reducing the 
availability and function of androgens at the receptor site, anti-androgens 
demasculinise male fish under laboratory conditions, inducing traits associated with the 
widespread sexual disruption observed in wild fish populations. These include intersex, 
altered gene expression, and reductions in secondary sexual characteristics, sperm 
counts and fecundity (Filby et al., 2007b; Jobling et al., 2006; Ankley et al., 2004; 
Jensen et al., 2004; Kiparissis et al., 2003; Bayley et al., 2002). Furthermore, anti-
androgenic effects on the androgen-dependent protein, spiggin, in wild stickleback 
(Gasterosteus aculeatus) have been observed downstream of a wastewater treatment 
works (WWTWs) effluent outfall (Katsiadaki et al., 2012) and anti-androgenic activity 
has been detected in the bile of effluent-exposed fish (Rostkowski et al., 2011; Hill et 
al., 2010; Kinani et al., 2010). However, the chemicals responsible for this activity in the 
environment remain largely uncharacterised.  
Pharmaceutical anti-androgens seem likely candidates as potential contributors to anti-
androgenic sexual disruption in wild fish. Indeed, of the oestrogenic contaminants 
detected in the environment, it is the steroid oestrogens which are the most potent and 
these also have a natural or pharmaceutical origin from human excretion. From this 
perspective, in chapter two, concentrations of anti-androgenic pharmaceuticals were 
modelled in WWTWs effluents and river catchments in the UK and South Australia as 
part of a targeted approach to identifying likely environmental anti-androgens of 
concern. This found bicalutamide and cyproterone acetate to be the two dominant anti-
androgenic pharmaceuticals in both countries with concentrations occurring in ng/L. 
For example, along the River Erewash, UK, 26 (16-50) ng/L bicalutamide and 17 (10-
32) ng/L cyproterone acetate were predicted to occur, in comparison to 4.3 (2.7-8.4) 
ng/L flutamide on impacted stretches. Aside from this study, the likely environmental 
concentrations of these pharmaceuticals have been poorly documented and there have 
been few studies of their effects on fish. Consequently, it is important to determine 
what contribution these chemicals could make to sexual disruption observed in wild 
fish, particularly in the context of mixture effects with other contaminants with similar 
modes of action.  
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3.1.1 Anti-androgenic pharmaceuticals and sexual disruption 
Bicalutamide and cyproterone acetate have similar modes of action and are used in 
human medicine to treat androgen dependent disorders. Bicalutamide is a pure 
androgen receptor (AR) antagonist, in that it has no other receptor activity and 
specifically blocks the binding of circulating androgens to the AR. This in turn impacts 
androgen signalling within the HPG axis by blocking the negative feedback of 
circulating testosterone on ARs in the brain. This mimics androgen deficiency and 
causes an increase in the release of gonadotropin releasing hormone, which stimulates 
luteinising hormone secretion by the pituitary and causes a positive feedback on sex 
steroid production (Eri et al., 1995). Although this increases circulating concentrations 
of androgens, their action at receptor targets remains blocked. However, increasing 
concentrations of circulating oestrogens can result in demasculinising side effects such 
as gynaecomastia, although spermatogenesis and libido is still maintained, at least to a 
certain degree (Neumann and Kalmus, 1991). In contrast, whilst cyproterone acetate is 
an AR antagonist, it also targets androgen synthesis through its anti-gonadotrophic 
activity, which reduces the concentrations of circulating sex steroids. As a result, 
although it is used for prostate cancer treatment, its first established indication was the 
control of male sexual desire and the suppression of sexually deviant behaviour 
(Neumann and Kalmus, 1991). Indeed, in human patients its negative impact on both 
androgen synthesis and action can produce effects comparable with surgical 
castration, with the function of androgen-dependent organs completely inhibited at high 
doses. This significantly reduces libido as well as sexual function. In animal models, 
the sexual disruption of males by cyproterone acetate has been observed to a greater 
extent during early development following maternal exposure. In these studies, 
feminisation of external gonad morphology and reduced ano-genital distance were 
observed in male rat foetuses to the extent that they were barely distinguishable from 
control females. Similar effects were also found in male dog foetuses where the 
absence of a prostate and a blind ended vagina were observed (Neumann, 1994). 
 
3.1.2 Endpoints for assessing sexual disruption in fish 
3.1.2.1 Secondary sexual characteristics 
Secondary sexual characteristics are an important aspect of reproductive biology in 
many species. In males, they can be critical to an individual’s reproductive fitness by 
determining their ability to compete with rival males and to gain female preference in 
mate choice. Indeed, a behavioural study in stickleback has suggested that females 
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prefer males with a combination of concordant traits which indicate high male quality, 
including strong, red throat colouration, high courtship intensity and larger body size 
(Künzler and Bakker, 2001). As a result, these characteristics are linked to an 
individual’s fecundity and their mating strategy. In some species, alternative 
reproductive strategies exist in individuals who are less able to compete successfully in 
antagonistic bouts with rival males. One such strategy is female mimicry, in which 
“sneaky” males display secondary sexual characteristics, such as colouration, which 
mimic those of females. They then parasitize the efforts of other males to achieve 
“sneak” fertilisations by deception, a tactic which has been observed in a number of 
fish species (Gonçalves et al., 1996; Taborsky, 1994).  
For reproducing fathead minnows, males enter small, quiet waters on stream or lake 
margins to establish territories around spawning sites on the underside of vegetation or 
submerged objects. They aggressively compete for these sites and defend them from 
rival males by head butting behaviour, which makes the presence of the keratinous 
nuptial tubercles around the head and jaw advantageous (Cole and Smith, 1987; 
McMillan and Smith, 1974). A number of females can lay their eggs at a single male’s 
spawning site and after fertilisation the male guards and maintains the eggs until hatch. 
Here the fatpad plays an important role as it is used to clean the eggs and the 
spawning site. It also secretes a mucus that may improve the eggs attachment to the 
spawning surface, as well as their overall survival through increased disease and 
parasite resistance (McMillan and Smith, 1974; Smith and Murphy, 1974). As a result, 
tubercles and fatpads are important factors in an individual male’s reproductive fitness 
and fecundity.  
Secondary sexual characteristics are modulated by endogenous hormones and in 
fathead minnows it is clear that androgens play an important role in their development 
in males. Androgens have been shown to induce these characteristics in females in 
laboratory exposures (Margiotta-Casaluci et al., 2013b; Panter et al., 2004; Ankley et 
al., 2001) and this effect can be reversed by co-exposure to anti-androgens (Ankley et 
al., 2004). In addition, reductions in concentrations of circulating 11-ketotesterone and 
testosterone have been found to coincide with reductions in tubercles in males 
exposed to oestrogens, which can also cause reductions in the prominence of these 
characteristics (Salierno and Kane, 2009; Brian et al., 2007; Miles-Richardson et al., 
1999). Alterations to secondary sexual characteristics have also been observed in wild 
fathead minnows in WWTW effluent and pulp mill effluent contaminated areas 
(Tetreault et al., 2012; Munkittrick et al., 1998). Other species have also been affected, 
such as sand gobies captured from estuaries in the UK, where oestrogenic activity was 
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detected. In these fish, abnormalities in the morphology of the urogenital papilla, 
indicative of feminisation, occurred in over 50% of captured fish in some instances 
(Kirby et al., 2003). 
 
3.1.2.2 Gross indicies 
These gross indices are commonly used indicators of fish health which can provide an 
assessment of an animal’s energy allocation and stage of development. Whilst these 
are not as sensitive as more in depth techniques such as histology or plasma steroid 
and vitellogenin concentrations, they provide a good initial screening biomarker to 
indicate exposure effects (Lenhardt et al., 2009; Pope et al., 2007). Indeed, 
Gonadosomatic Index (GSI) provides an estimate of the gonadal development in a fish, 
which has been linked with reproductive status and can be disrupted by EDCs (Singh 
and Singh, 2008; Filby et al., 2007b; Hoffmann and Oris, 2006; Ankley et al., 2002; 
Ankley et al., 2001). In comparison, Hepatosomatic Index (HSI) is of interest since the 
liver is the production site for vitellogenin (Sumpter and Jobling, 1995). It mainly gives 
an indicator of fish health, since excess energy is stored in the liver (Pope et al., 2007; 
Plante et al., 2005).  
 
3.1.2.3 Blood plasma vitellogenin 
Vitellogenin is a glycolipophosphoprotein precursor to egg yolk proteins in oocytes 
which provide an energy reserve to the developing embryo (Marin and Matozzo, 2004). 
Its synthesis in the liver is under multi-hormone control, although E2 is dominant in this 
process (Sumpter and Jobling, 1995). It plays an important role in gametogenesis in 
female fish, as it is transported in the blood to the ovary where it is rapidly sequestered 
by maturing oocytes. Consequently, it is responsible for extensive oocyte growth and 
can make up 95% of the total oocyte size in some species dependant on their 
reproductive strategy. For example, in fish spawning and laying buoyant eggs, which 
are transported in the water column, there is less vitellogenin present than those that 
are laid in the substrate (Tyler and Sumpter, 1996). Seasonal variation in plasma 
concentrations have also been observed in wild fish species in both males and females 
(Katsiadaki et al., 2012; Hotta et al., 2003). Nonetheless, due to its association with 
oocyte development and circulating oestradiol, vitellogenin concentrations in males are 
normally significantly lower or even non-detectable. However, vitellogenin can be 
rapidly induced to concentrations comparable with normal females following exposure 
to oestrogens, making it a highly sensitive biomarker of oestrogenic contamination 
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(Sumpter and Jobling, 1995). Indeed, vitellogenin induction has been observed in male 
fish exposed to steroid oestrogens as well as other oestrogenic EDCs (Brian et al., 
2005; Routledge et al., 1998). It has also been observed in effluent-contaminated 
rivers, as well as in estuaries and the marine environment (Scott et al., 2007; Scott et 
al., 2006; Kavanagh et al., 2004; Kirby et al., 2004; Matthiessen et al., 1998b; Jobling 
et al., 1998). In addition, some anti-androgenic chemicals, such as flutamide, have also 
been shown to impact vitellogenin in males and females (Martyniuk et al., 2009; Kang 
et al., 2006; Panter et al., 2004; Jensen et al., 2004).  
 
3.1.2.4 Intersex 
Intersex is defined as the simultaneous presence of male and female gonadal tissue in 
a gonochoristic species (Bahamonde et al., 2013). Since the discovery of its 
widespread occurrence in wild roach in UK rivers, intersex has been identified in 37 
wild caught fish species from 17 families in 24 countries globally (reviewed by 
Bahamonde et al., 2013). In roach, the intersex condition has been described in detail 
based on the gonad histopathology of 150 wild caught fish by Nolan et al., which found 
variation in the severity of intersex amongst the sampled populations (Nolan et al., 
2001). A majority of fish exhibited low severity intersex, characterised by predominantly 
male gonad tissue with sporadically occurring primary or secondary oocytes at a 
varying frequency. However, more severely affected fish were found to have large 
proportions of the gonad made up of female oocyte tissue. Feminised reproductive 
ducts (ovarian cavities) were also observed in some fish alongside or independently of 
testicular oocytes. In females, these are characterised by two mesovarian connections 
between the gonad and the coelomic epithelium, creating a cavity which is used to 
store eggs before release during spawning (Nolan et al., 2001; Lahnsteiner et al., 
1997). In normal males, only one connection exists between the gonad and the 
coleomic epithelium but malformations have been identified in which the sperm duct 
also develops an attachment to produce the cavity. In some severe cases, the sperm 
duct can be blocked or even replaced by a complete ovarian cavity (Nolan et al., 2001). 
The presence or absence of these characteristics of intersex is dependent on the 
timing of exposure, with ovarian cavities only occurring after an exposure during early 
development (van Aerle et al., 2002; Rodgers-Gray et al., 2001). In contrast, although 
testicular oocytes can also be induced during early gonad development, they can also 
be produced by adults during post spawning gametogenesis (Baynes et al., 2012). 
Indeed, there is evidence of temporal differences in intersex with a cycle of 
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development where intersex increases prior to spawning and redevelops post 
spawning (Blazer et al., 2012). 
Following the observation of a low prevalence of intersex in reference sites, there has 
been some debate as to whether there is a natural background incidence of intersex 
within gonochoristic fish populations (Maltret-Geraudie et al., 2008; e.g. Jobling et al., 
1998). However, environmental influences, such as the migration of fish between 
pristine and polluted areas, are likely to impact such findings. In addition, a study 
completed at an enclosed former sand quarry in France, which received no 
anthropogenic discharge, did not detect intersex in the 474 roach sampled over 18 
months (Geraudie et al., 2010). In the Japanese medaka, histological examination of 
30,000 fish also found no intersex gonads (Yamamoto, 1975). Nonetheless, intersex 
has been observed in negative controls from chemical exposure studies (Grim et al., 
2007), although this was also thought to be a result of environmental factors, such as 
the use of fish food containing phytoestrogens.  
 
3.1.3 Aims and objectives 
Both anti-androgenic and oestrogenic contaminants occur simultaneously in the 
environment, where both activities have been detected together in environmental 
samples, such as WWTW effluent (Johnson et al., 2007b). Although these 
contaminants can affect common endpoints, such as intersex in fish (León et al., 2007; 
Metcalfe et al., 2001), there has been little in vivo study of their effects in combination. 
Nonetheless, an environmental modelling study of the effects of oestrogens and anti-
androgenic activity on sexual disruption in fish in UK rivers, conducted by Jobling et al., 
suggests that they could interact (Jobling et al., 2009). Indeed, modelling of the 
associations between the predicted environmental concentrations of steroid 
oestrogens, nonylphenol and anti-androgenic activity in flutamide equivalents, 
suggested that anti-androgens had a strong additive effect on vitellogenin induction 
and intersex in combination with the oestrogens (Jobling et al., 2009). It could be 
argued that a combination of bicalutamide and cyproterone acetate could result in total 
androgen blockade through the reduction in sex steroid synthesis and the antagonism 
of the receptor. This could make the fish more sensitive to sexual disruption by 
exogenous oestrogens.  
This modelling study, along with data from mixtures toxicology studies, provided the 
impetus to assess the anti-androgenic pharmaceuticals in an environmentally relevant 
mixture scenario, informed by modelled environmental concentrations from chapter 
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two. Consequently, this study aimed to determine whether the two anti-androgenic 
pharmaceuticals, bicalutamide and cyproterone acetate, could cause sexual disruption 
at predicted environmental concentrations in model fish species alone, or in 
combination with steroid oestrogens. This was assessed in two experiments using two 
appropriate fish models for the endpoints of vitellogenin induction, secondary sexual 
characteristics and intersex incidence and severity. Since the prescriptions of the two 
pharmaceuticals differed considerably in the UK and Australia, UK relevant exposure 
scenarios were employed in these studies based on predicted concentrations from 
effluents and the Erewash river catchment. 
 
3.2 Materials and methods 
3.2.1 Experimental test chemicals 
Bicalutamide ≥98% (CAS No. 90357-06-5), cyproterone acetate ≥98% (CAS No. 427-
51-0), oestrone (E1) ≥99% (CAS No. 53-16-7), 17β-oestradiol (E2) ≥99% (CAS No. 50-
28-2) and 17α-ethinylestradiol (EE2) ≥98% (CAS No. 57-63-6) were purchased from 
Sigma-Aldrich, Gillingham (UK). Concentrated stock solutions were prepared with N,N-
dimethylformamide (DMF) ≥99.8% (CAS No. 68-12-2) purchased from Fisher Scientific, 
UK for tank dosing. In experiment two, stocks were also prepared in Absolute Ethanol 
100 AR (CAS No. AR 64-17-5) purchased from Hayman Speciality Products, UK for 
petri dish dosing. 
 
3.2.2 Experiment one: secondary sexual characteristics and vitellogenin 
induction 
3.2.2.1 Test species: fathead minnows (Pimephales promelas) 
Pre-spawning, male fathead minnows of approximately seven months of age were 
obtained from stock maintained at Brunel University, London (UK). These were 
maintained in 150 L tanks under flow through conditions at 25±1oC with a photoperiod 
of 16:8 hours light:dark and a 20 minute simulated dusk/dawn period of low light. They 
were fed twice daily, to satiation, with flaked food (Tetramin Flake, ZM Fish Food, UK) 
supplemented with frozen brine shrimp (Tropical Marine Centre, Gamma irradiated) 
once daily. 
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Figure 3.1 Male (upper) and female (lower) fathead minnows (Pimephales promelas) 
showing their differences in morphology. The male shows secondary sexual 
characteristics including nuptial tubercles (black arrows) and the fatpad (white arrow), 
which are absent in the female.  
 
Fathead minnows are a small, freshwater species belonging to the Cyprinidae family 
and are found broadly distributed across North America (Ankley and Villeneuve, 2006). 
They are gonochoristic and show clear sexual dimorphism in their secondary sexual 
characteristics. In males, prominent secondary sexual characteristics include nuptial 
tubercles, which occur mainly between the mouth and nares as well as the lower jaw, 
and the fatpad between the head and dorsal fin (Jensen et al., 2001) (Figure 3.1). In 
addition, males have a much rounder head than the sharper snouted females and 
display black bands on the body with a black fin spot on the dorsal fin. 
Having been used in a variety of testing programs, there are a number of experimental 
protocols available for the use of fathead minnows in ecotoxicology studies, particularly 
those involving endocrine disrupting chemicals (EDCs). For this study, they are an 
ideal species since they are larger than other commonly used fish models, such as 
zebrafish or Japanese medaka, so a greater blood volume can be collected for analysis 
of vitellogenin. Indeed, a basic assay procedure can induce a vitellogenin response in 
♂
♀
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as little as 14 days and enzyme-linked immunosorbant assay (ELISA) is available 
specifically for this species for accurate and robust quantification (Eidem et al., 2005; 
Panter et al., 2002). In addition, their secondary sexual characteristics are androgen-
dependent and have been used in previous assessments of anti-androgens (e.g. 
Martinović et al., 2008; Filby et al., 2007b). Mechanistic studies have also used 
androgens to masculinise females with the induction of these secondary sexual 
characteristics, an effect which is blocked in combined exposure with anti-androgens 
(Ankley et al., 2004). 
 
3.2.2.2 Experimental design 
Experiment one was carried out using an experimental system (described by Brian et 
al., 2005) in which fathead minnows were exposed to defined mixtures of steroid 
oestrogens and anti-androgenic pharmaceuticals for 14 days at concentrations derived 
from the modelling studies. There were six treatment groups which included aquarium 
water and solvent controls, a steroid oestrogen treatment (E1, E2 and EE2), an anti-
androgenic pharmaceutical treatment (bicalutamide and cyproterone acetate) and a 
combined mixture treatment, containing both anti-androgenic pharmaceuticals and 
steroid oestrogens. A positive control of EE2 was also employed and all treatments 
were replicated in duplicate with eight male fish per tank (16 per treatment). The flow 
through dosing system is illustrated below in Figure 3.2. 
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Figure 3.2 The experimental set up for dosing exposure tanks. Solvent carrier from 
chemical stock bottles (A) was pumped through silicone tubing via peristaltic pump 
(0.01 mL/min) (B) to aspirator bottles (C), where it was diluted in aquarium water from 
the header tank flowing at 30 L/hour (D). This produced the desired experimental 
concentrations which flowed down to the exposure tanks (E) via silicone tubing. 
 
Chemical stocks were produced in amber bottles at 50,000× the required exposure 
concentration in 1 L DMF and were pumped by peristaltic pump through medical grade 
silicone tubing (Watson Marlow, UK) to mixing vessels at a rate of 0.01 mL/min. This 
was mixed with dechlorinated and filtered tap water from a header tank flowing at 30 
L/hour via medical grade silicone tubing (VWR, UK), to produce the desired 
concentrations in the 30 L exposure tank without exceeding 20 µL/L of DMF 
(Hutchinson et al., 2006). Each tank had its own mixing vessel, although single stock 
bottles fed both replicates and the negative control ran directly off the header tank. 
Physical and physicochemical conditions were maintained at 25±1oC with dissolved 
oxygen exceeding 70% of air saturation and a photoperiod of 16:8 hours light:dark with 
a 20 minute simulated dusk/dawn period of low light. The fish were fed to satiation 
twice daily with flaked food (Tetramin Flake, ZM Fish Food, UK) and once daily with 
D
A
B
C
E
118 
 
frozen adult brine shrimp (Tropical Marine Centre, Gamma irradiated). Nitrite, nitrate 
and ammonia concentrations, as well as pH, were also monitored throughout the 
experiment on a weekly basis. 
 
3.2.2.3 Experimental chemical concentrations 
An environmentally relevant exposure scenario of anti-androgenic pharmaceuticals 
was employed, based on the concentrations predicted in chapter two for the WWTW 
UK1: 115 ng/L bicalutamide and 74 ng/L cyproterone acetate. These were the highest 
concentrations predicted from the four UK WWTWs, assuming that no removal of the 
pharmaceuticals would take place during wastewater treatment. Since the steroid 
oestrogens occur in the environment together, E1, E2 and EE2 were combined in the 
oestrogen treatment. This mixture of oestrogens was required to be relevant to WWTW 
effluents and needed to induce a submaximal response to ensure that any additional 
impact of anti-androgens could be detected in the mixture treatment. A concentration of 
0.3 ng/L EE2 was employed based on the lowest detected concentration in WWTW 
effluents during a UK wide survey (Johnson et al., 2007b). This was combined with 9.6 
ng/L E1 and 2.1 ng/L E2, based on the ratios of the steroid oestrogens at the highest 
concentrations detected in the survey (3.2 ng/L EE2 : 22 ng/L E2 : 100 ng/L E1). This 
produced a mixture with a 17β-oestradiol equivalent concentration (EEQ) of 8.3 ng/L. 
To ensure that this would induce a submaximal response, the concentrations were 
input into the following equation for concentration addition (Thorpe et al., 2003). This 
found that the mixture potency was below the EC50 for vitellogenin induction.  
𝑃𝐸𝐶50 =  
𝐶𝐸1
𝐸𝐶50𝐸1
+  
𝐶𝐸2
𝐸𝐶50𝐸2
+  
𝐶𝐸𝐸2
𝐸𝐶50𝐸𝐸2
 
Where P is the proportion of the EC50 and C is the concentration of each steroid 
oestrogen in ng/L. The EC50 values were determined from the literature based on dose 
response studies of the effects of steroid oestrogens on vitellogenin induction in 
fathead minnows. These were 25 ng/L E2 and 0.9 ng/L EE2 (from Brian et al., 2005) 
and 75 ng/L E1 (estimated from Panter et al., 1998).  In comparison, a t concentration 
of 10 ng/L EE2 was employed in the positive control. 
Based on this the treatment groups and doses were as follows: 
 Control 
 Solvent Control 
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 Anti-Androgens (115 ng/L bicalutamide; 74 ng/L cyproterone acetate) 
 Steroid Oestrogens (0.3 ng/L EE2; 9.6 ng/L E1; 2.1 ng/L E2) 
 Mixture (115 ng/L bicalutamide; 74 ng/L cyproterone acetate; 0.3 ng/L EE2; 
9.6 ng/L E1; 2.1 ng/L E2) 
 Positive Control: 10 ng/L EE2  
 
3.2.2.4 Fish sampling 
After 14 days of chemical exposure, the fish were sacrificed by a lethal dose of MS222 
(500 mg/L) buffered to pH 7.4 according to UK Home Office Regulations. Blood was 
collected by caudal fin amputation with heparinised microhaematocrit tubes. The 
samples were then centrifuged at 7000 g for 5 minutes at 4oC to collect plasma, which 
was stored at -80oC. Fork length and wet weight were recorded to determine condition 
factor. Livers and gonads were excised following ventral incision and were weighed to 
assess liver and gonad development. Formulas for the condition factor, GSI and HSI 
are detailed below: 
𝐶𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 =
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔)
𝑏𝑜𝑑𝑦 𝑙𝑒𝑛𝑔𝑡ℎ (𝑐𝑚)3
 × 100 
𝐻𝑆𝐼 =
𝑙𝑖𝑣𝑒𝑟 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 × 100 
𝐺𝑆𝐼 =
𝑔𝑜𝑛𝑎𝑑 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 × 100 
 
3.2.2.5 Assessing secondary sexual characteristics 
In this experiment, the number of tubercles on each fish was counted and their 
prominence was scored based on criteria displayed in Table 3.1 (Smith, 1978). In 
addition, the fatpad was removed from each fish and its weight recorded to calculate 
fatpad index based on the equation below:  
𝐹𝑎𝑡𝑝𝑎𝑑 𝐼𝑛𝑑𝑒𝑥 =
𝑓𝑎𝑡𝑝𝑎𝑑 𝑤𝑒𝑖𝑔ℎ𝑡
𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 × 100 
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Table 3.1 The scoring system for tubercle prominence (based on Smith, 1978). 
Score Description of nuptial tubercles 
0 no visible sign of tubercles 
1 tubercles visible as white disks, not protruding above body surface 
2 tubercles project above body surface 
3 tubercles prominent but not sharp 
4 tubercles prominent and sharp 
5 tubercles have started to run together and not all individual tubercles can be 
distinguished 
 
 
3.2.2.6 Vitellogenin analysis  
In this experiment, 10 µL plasma samples from individual fish were analysed by ELISA, 
specific to fathead minnows vitellogenin (Biosense Laboratories AS, Norway) following 
the instructions of the manufacturer. The test kit employed is a sandwich ELISA, in 
which vitellogenin in plasma samples is bound between a capture antibody within the 
wells of 96 well microplates and an enzyme linked detection antibody, which is added 
later in the process. Binding of the detection antibody activates the enzyme to produce 
a colour change in the substrate within the wells, which is directly proportional to the 
amount of vitellogenin present in the sample (Biosense Laboratories, 2005). In this 
experiment, the colour absorbance was measured at 450 nm with a Spectramax Plate 
Reader (Molecular Devices, USA) and used to calculate the concentration of 
vitellogenin. Due to the high concentrations anticipated in some samples, particularly in 
oestrogen exposed groups, the plasma samples were diluted with buffer solution to 
keep the concentrations within the working range of the assay (Table 3.2). 
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Table 3.2 The dilutions of plasma from fish in each treatment group used in the ELISA.  
 Treatment Dilutions of 10 µL plasma sample 
Control 1:50 
Solvent Control 1:50 
Oestrogens 1:5000, 1:500,000 
Anti-Androgens 1:50, 1:5000 
Mixture 1:50, 1:5000, 1:500,000 
Positive Control 1:5,000,000, 1:50,000,000 
 
3.2.2.7 Statistical analysis 
To determine variation and differences between treatment groups, the data were tested 
for normality and equal variance. Parametric data then underwent one way analysis of 
variance (ANOVA) followed by post hoc all pairwise multiple comparison procedures 
(Holm-Sidak Method). Non-parametric data was assessed by Kruskall-Wallis one way 
ANOVA on ranks followed by post hoc all pairwise multiple comparison procedures 
(Dunn’s Method). Vitellogenin data were Log transformed prior to assessment and 
statistical significance was accepted at P≤0.05 for all tested endpoints. Treatment 
groups were all compared with the solvent control. These analyses were performed in 
SigmaStat 3.5 (Systat Software, Chicago IL). 
 
3.2.3 Experiment two: intersex induction in Japanese medaka  
3.2.3.1 Test species: Japanese medaka (Oryzias latipes) 
Japanese medaka were obtained from a stock maintained at Brunel University, London 
(UK), which originated from the National Institute for Environmental Studies, Japan. 
Broodstock were kept as triplets of one male to two females to maximise egg 
production under flow through conditions in 8 L tanks at 27±1oC, with a photoperiod of 
16:8 hours light:dark and a 20 minute simulated dusk/dawn period of low light. Their 
diet consisted of pellet food (ZM Granular, ZM Fish Food, UK) supplemented with 
frozen adult brine shrimp once daily (Tropical Marine Centre, Gamma irradiated). Fish 
in all tanks were fed to satiation. 
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Figure 3.3 Adult Japanese medaka (Oryzias latipes) maintained in a stock tank. 
 
Japanese medaka are a small, freshwater, gonochoristic fish species belonging to the 
Adrianchythyidae family (Figure 3.3). They originate from South East Asia and have 
also become a well-established model species for ecotoxicology testing programs, with 
a number of advantages supporting their use in early life studies and assessments of 
intersex induction (Urushitani et al., 2007). Critically, they have a short life cycle and 
can reach maturity within 100 days, with gonadal sexual differentiation observed at 
around 12 days post hatch in comparison to 80-90 days for fathead minnows (Hirai et 
al., 2006; Ankley and Johnson, 2004). In addition, unlike zebrafish, they do not go 
through a pseudo-hermaphroditic stage during early development (Maack and Segner, 
2004). The adults also show clear sexual dimorphism in their secondary sexual 
characteristics, which include differences in the shape of the anal fin, making them 
easy to pair in breeding scenarios. Some strains also show sex dependent colouration, 
such as the FLF-II strain, where males are orange and females are white. In addition, 
females are oviparous and can spawn daily with the right photoperiod and feeding 
regime (Arcand-Hoy and Benson, 1998), producing 10-30 eggs per day (Yamamoto, 
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1975) which ensures a relatively constant supply of embryos for early life studies. The 
embryos themselves are transparent so embryonic development can be observed 
throughout the process and abnormalities can be easily identified.  
Medaka are also sexually dimorphic at a genetic level with XX females and XY males 
as well as a sex specific DMY gene marker, which is present only in males. Indeed, 
medaka are one of the few fish species to have a well-established sex determining 
gene. In comparison, a sex determining gene has only been recently discovered in the 
fathead minnows (Olmstead et al., 2011). The use of this gene in medaka can 
overcome the diagnostic issue of determining whether intersex induction by complex 
mixtures can occur due to masculinisation of females or feminisation of males, which 
has caused complications in the interpretation of data collected from wild roach and 
those used in effluent exposures (Lange et al., 2009; Jobling and Tyler, 2003). Indeed, 
intersex can be induced in medaka by a variety of EDCs, including the steroid 
oestrogens, bisphenol A (BPA), pesticides and pharmaceuticals (Kiparissis et al., 2003; 
Metcalfe et al., 2001).  
 
3.2.3.2 Experimental design 
Japanese medaka were exposed from an embryonic to early adult stage over 98 days. 
As in experiment one, fish were treated with the anti-androgenic pharmaceuticals, the 
steroid oestrogens and a combined activity mixture. However, in this experiment, the 
treatment regime was repeated at two different doses termed “high” and “low.” These 
were run alongside solvent and aquarium water controls with a positive control of 50 
ng/L E2 to give a total of nine treatments. All treatment sets were replicated in duplicate 
with 25 fish per tank (50 per treatment). Embryos were collected and exposure was 
initiated at less than six hours post fertilisation. The embryos were maintained under 
static renewal in covered glass petri dishes with 15 mL of Modified FETAX (Frog 
Embryo Teratogenesis Assay-Xenopus) Solution (MFS) (Woods and Kumar, 2011) in 
an incubator maintained at 25±1oC with 16:8 hours light:dark ratio.  
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Table 3.3 The constituents of Modified FETAX Solution (MFS) required for producing 
2.5 L of solution, purchased from Sigma-Aldrich, UK (from Woods and Kumar, 2011). 
Compound CAS # Weight (mg) to add to 2.5 L double 
distilled water 
Magnesium Sulphate 7487-88-9  187.5 
Sodium Bicarbonate 144-55-8  240 
Calcium Chloride 10043-52-4  37.5 
Sodium Chloride 7647-14-5  1000 
Potassium Chloride 7447-40-7  75 
Calcium Sulphate dihydrate 10101-41-4  150 
 
MFS water was produced based on Table 3.3. Calcium sulphate dehydrate was added 
to 2.5 L of double distilled water in a 2.5 L Winchester bottle and was dissolved 
overnight using a magnetic stirrer. The rest of the salts were mixed in the following day 
and left for an additional 24 hours to dissolve fully. The solution was kept aerated with 
an air stone to ensure that there was sufficient dissolved oxygen available.  
Over the first three days of exposure in petri dishes, unfertilised or non-viable embryos 
were replaced with newly fertilised embryos to maintain a number of 25 embryos per 
dish/tank in the early phases of the study. Each petri dish was spiked with 10 µL of a 
concentrated stock solution in absolute ethanol, which was allowed to evaporate before 
15 mL of MFS was added. Although this could be described as a “solvent free” 
technique, the solvent control was still spiked with ethanol only. Embryos were 
transferred by pipette to new petri dishes, with new stocks replenished daily to provide 
24 hour renewal of the exposure mixtures. As the embryos hatched, larvae were 
transferred to 30 L exposure tanks run with the same water and chemical stock flow 
regimens as experiment one. They were maintained in mesh baskets for up to 14 days 
before being released into the aquarium itself. Temperature was maintained at 26±1oC 
throughout the majority of the study. However, a fault with the heating element in the 
header tank caused a drop in temperature of up to 2.7oC in the majority of the tanks, 
which was quickly fixed, causing the temperature to return to normal within 24 hours. 
Another temperature decrease was observed later in the experiment in the control tank 
(A), high anti-androgen (B) and low oestrogen (B). This was caused by a reduction in 
the inflow of water from header tank to the treatment tanks and was quickly rectified, 
with temperature returning to normal in the next daily measurement. Control tank (A) 
experienced much greater variation in temperature range (5.7oC) than the other tanks. 
Dissolved oxygen exceeded 70% saturation throughout the study in all tanks with the 
exception of the first high anti-androgen replicate, where 68% saturation was 
125 
 
experienced at one sampling point. In addition, a photoperiod of 16:8 hours light:dark 
with a 20 minute simulated dusk/dawn period of low light was applied and fish were fed 
twice daily to satiation with pellet food. This was supplemented with larval artemia and 
eventually frozen brine shrimp. Nitrite, nitrate and ammonia concentrations and pH 
were also monitored throughout the experiment. 
 
3.2.3.3 Experimental chemical concentrations 
As in experiment one, treatment concentrations of anti-androgenic pharmaceuticals 
were based on concentrations predicted from the UK WWTW effluents in chapter two. 
In this experiment, the predicted steroid oestrogen concentrations were also employed 
to simulate the predicted environmental scenarios. For the high doses, the treatment 
concentrations originated from UK1: 115 ng/L bicaltuamide, 74 ng/L cyproterone 
acetate, 29 ng/L E1, 4 ng/L E2 and 0.4 ng/L EE2 (18 ng/L EEQ). This was intended to 
produce an exposure scenario relevant to high WWTW effluent concentrations. 
However, since anti-androgenic pharmaceuticals were expected to occur at lower 
concentrations in UK rivers, based on data in chapter two, a second set of 
concentrations were used in the low dose treatments. These were based on the lowest 
predicted effluent concentrations, which occurred at UK3: 53 ng/L bicalutamide, 34 
ng/L cyproterone acetate, 13 ng/L E1, 2 ng/L E2, 0.2 ng/L EE2 (8 ng/L EEQ). These 
are very similar to the maximal concentrations predicted to occur in the River Erewash, 
which were 50 ng/L bicalutamide, 32 ng/L cyproterone acetate, 12 ng/L E1, 1.7 ng/L E2 
and 0.17 ng/L EE2 (7.4 ng/L EEQ). In addition, the steroid oestrogen concentrations 
were expected to induce a background incidence of intersex of around 10% and 20% 
respectively for the low and high concentrations, based on a comparison between their 
combined EEQ and a dose response of E2 in medaka for the induction of intersex 
(Metcalfe et al., 2001). Finally, the positive control was dosed at 50 ng/L E2 based on 
concentrations required for complete sex reversal of males (Kinoshita et al., 2009). 
To reiterate, the following treatments and doses were employed 
 Control 
 Solvent Control 
 Low Anti-Androgens (53 ng/L bicalutamide; 34 ng/L cyproterone acetate) 
 Low Steroid Oestrogens (13 ng/L E1; 2 ng/L E2; 0.2 ng/L EE2) 
 Low Mixture (53 ng/L bicalutamide; 34 ng/L cyproterone acetate; 13 ng/L 
E1; 2 ng/L E2; 0.2 ng/L EE2) 
126 
 
 High Anti-Androgens (115 ng/L bicaltuamide; 74 ng/L cyproterone acetate) 
 High Steroid Oestrogens (29 ng/L E1; 4 ng/L E2; 0.4 ng/L EE2) 
 High Mixture (115 ng/L bicalutamide; 74 ng/L cyproterone acetate; 29 ng/L 
E1; 4 ng/L E2;0.4 ng/L EE2) 
 Positive Control: 50 ng/L E2  
 
3.2.3.4 Fish sampling  
After 98 days exposure, medaka were sacrificed by a lethal dose of neutral buffered 
MS222 (500 mg/L). However, fish in the positive control treatment were sampled at 90 
days, due to sporadically occuring mortality throughout the exposure. The heads and 
tails were removed and the bodies were fixed in bouin’s solution (Sigma-Aldrich, UK) 
and stored in 70% IMS. Blood samples were also taken by caudal fin amputation using 
heparinised haematocrit tubes but were insufficient in volume to test for vitellogenin 
induction.  
 
3.2.3.5 Histological processing  
The preserved body cavity was opened from the right side to reveal the gonad (Figure 
3.4) before being processed in an automatic tissue processor (Leica TP1020, Leica 
Inc.) based on Table 3.4 and fixed in wax blocks. The blocks were then serial sectioned 
longitudinally from the start of the gonad, with 5 µm sections transferred to microscope 
slides at every 150 µm. For smaller fish, the entire body was sectioned and for females 
with large ovaries, the gonads were excised and split longitudinally into sections before 
being set in wax and serial sectioned in the same fashion as the males. The slides 
were allowed to dry for 48 hours before being stained with haemotoxylin and eosin 
(H&E) using an automatic modular linear batch stainer (Stainmate, Raymond A Lamb) 
according to Table 3.5. They were then coverslipped using histomount. 
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Figure 3.4 The stages of the histological process showing a preserved male (above-
left) and a female (above-right) with the body cavity opened. These were processed 
and set in wax (male below-left) and serial sectioned for microscopy (male below-right). 
The gonad is indicated with white arrows in each image. 
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Table 3.4 The tissue processing protocol for the histology of Japanese medaka using 
the Leica TP1020.  
Cycle Number Treatment Hours 
1 70% IMS 3 
2 90% IMS 2.5 
3 95% IMS 1.5 
4 100% IMS 1.5 
5 100% IMS 1.5 
6 100% IMS 1.5 
7 100% IMS 1.5 
8 HISTOCLEAR 1.5 
9 HISTOCLEAR 1.5 
10 HISTOCLEAR 1.5 
11 WAX 1.25 
12 WAX 1.25 
 
Table 3.5 The staining protocol for histology of Japanese medaka using the Stainmate. 
Step Chemical In bath time 
(secs) 
In bath 
agitation 
Out bath time 
(secs) 
Out bath 
agitation 
0 Histoclear 900 N 8 Y 
1 100% IMS 120 N 8 Y 
2 90% IMS 120 N 8 Y 
3 70% IMS 120 N 8 Y 
4 Flowing tap water 120 N 8 Y 
5 Haematoxylin 600 N 8 Y 
6 Flowing tap water 600 N 8 Y 
7 Acid alcohol
1
 20 N 8 Y 
8 Flowing tap water 20 Y 8 Y 
9 Saturated. Li2CO3 20 N 8 Y 
10 Flowing tap water 20 Y 8 Y 
11 Eosin 40 N 8 Y 
12 Flowing tap water 300 N 8 Y 
13 70% IMS 120 N 8 Y 
14 90% IMS 120 N 8 Y 
15 100% IMS 300 N 8 Y 
16 Histoclear 300 N 0 N 
17 Histoclear 0 N 0 N 
 
1Acid alcohol was produced by mixing 1% hydrochloric acid with 70% IMS in purite 
water. 
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3.2.3.6 Intersex analysis 
Intersex incidence was quantified based on the presence or absence of oocytes and 
ovarian cavities through light microscopy, using an Olympus BX51 compound light 
microscope. Intersex severity for each gonad section was then scored with an intersex 
index of 0-7 based on the abundance of oocytes within the gonad tissue (Table 3.6) 
(Jobling et al., 2006). All slides were blinded prior to microscopic analysis. 
 
Table 3.6 The intersex index scoring system used to quantify severity in the gonad 
sections from sampled fish (from Jobling et al., 2006). 
Score Description of the observed severity of intersex  
0 Normal male testis 
1 Multifocal ovotestis with 1-5 oocytes (usually singly) scattered amongst the testicular 
tissue 
 
2 Multifocal ovotestis, 6-20 oocytes often in small clusters scattered amongst the 
testicular tissue 
 
3 Multifocal ovotestis, 21-50 oocytes in clusters 
 
4 >50<100 oocytes. Section is usually multifocal and has the appearance of a mosaic of 
testicular and ovarian tissue 
 
5 >100 oocytes, usually multifocal but could also be focal with clearly identifiable zones 
of ovarian and testicular tissue separated from the testicular tissue 
 
6 >50% of the gonadal tissue on the section is ovarian and is clearly separated from the 
testicular tissue by epithelial cells and phagocytic tissues 
 
7 100% of gonadal tissue on the section is ovarian 
 
3.2.3.7 Statistical Analysis 
Binary responses (intersex incidence) were analysed using generalized linear 
modelling approaches, assuming that the numbers of intersex fish were binomial-
distributed. Mean effects were estimated by Maximum Likelihood, and treatment-
related differences to the controls were analysed by Williams contrast test (Hothorn, 
2004). Ordinal responses (intersex severity) were assumed to follow a common slopes 
model with a cumulative logit link function, and correlations from repeated 
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measurements were estimated according to the principles of Generalized Estimating 
Equations (Agresti, 1984). Odds ratio estimates were used to express relative 
differences between treatment means. For the log odds scale, the cumulative logit 
model is sometimes referred to as the proportional odds model. Comparisons were 
drawn between treatment groups and the solvent controls. Analysis was performed in 
SAS 9.3 (SAS Institute, Cary NC). 
 
3.2.4 Chemical Analysis 
3.2.4.1 Sample collection 
In experiment one, 500 mL aquarium water samples were collected on days 1 and 14 
and were refrigerated in amber winchester bottles below 6oC prior to extraction. These 
bottles had undergone silylation prior to use with 5% dimethyldichlorosilane in toluene 
(Sylon CT from Sigma-Aldrich, UK), to minimise chemical loss by adsorption onto the 
glass (Armarego and Chai, 2009). The protocol for this process can be found in 
appendix three. In experiment two, the sample volume was reduced to 100 mL. 
Samples were collected on day 20, when all fish had been transferred from petri dishes 
to tanks, as well as day 34, 62 and 90. These were held in silylated glass bottles and 
were extracted on the same day. A degradation test was also run to determine what 
concentrations were likely to occur in the petri dishes over a 24 hour period prior to 
their renewal. Here, two replicate samples containing 100 mL of aquarium water were 
spiked with the high concentrations of anti-androgens and oestrogens and were left in 
the incubator for 24 hours prior to extraction. All samples from both experiments were 
spiked with 5 ml/L of HPLC grade methanol (Fisher Scientific, UK) for preservation 
(Desbrow et al., 1998) as well as 100 ng/L of the deuterated internal standards d7 
propranolol and d10 carbamazepine prior to extraction. Ideally, deuterated standards for 
the chemicals of interest would have been used because they act in a very similar 
fashion during the sampling and analytical methodology (Wieling, 2002). However, 
since these were not available for purchase for bicalutamide and cyproterone acetate, 
d7 propranolol and d10 carbamazepine were used. These provided sufficient 
alternatives since they are both pharmaceutical chemicals with known and compatible 
analytical methods of detection.  
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3.2.4.2 Solid phase extraction 
In this study, solid phase extraction (SPE) was used to concentrate the experimental 
samples to improve their detection during liquid chromatography/tandem mass 
spectrometry (LC-MS/MS). Experimental samples underwent reverse phase SPE on 
C18 cartridges (Sep-Pak C18, 360 mg sorbent, 55-105 µm particle size; Waters, UK), 
which can capture compounds with a broad range of polarities. A blank of double 
distilled water and three spiked aquarium water samples were extracted alongside the 
experimental samples. The spikes contained anti-androgens and oestrogens at their 
low concentrations (low spike), high concentrations (high spike) and E2 and EE2 at 
their positive control concentrations dependent on the experiment. C18 cartridges were 
attached to an extraction manifold and conditioned with 5 mL of HPLC grade methanol 
followed by 5 mL of double distilled water in sequence. Each sample was then loaded 
onto the cartridge under vacuum before being thoroughly dried under air. The samples 
were then eluted into 7 mL glass collection tubes with 5 mL of methanol. A nitrogen 
stream was then used to further concentrate the samples, which were blown down to 
200 µL before being split into two 100 µL aliquots, stored in inserts in 1 mL 
autosampler vials for anti-androgen and steroid oestrogen testing respectively. 
Deuterated steroid oestrogen internal standards were also added to one set of aliquots 
at this point (2,4,16,16-d4-oestrone, 2,4,16,16-d4-17β-oestradiol and 2,4,16,16-d4-17α-
ethinylestradiol), at 100 ng/100 µL and samples were returned to a 100 µL volume by 
nitrogen blow down. This method was produced following extraction efficiency tests 
employing different three different pH’s (4, 7 and 11), two different SPE cartridges (C18 
and Oasis HLB, 500 mg sorbent, 50 µm particle size; Waters, UK) and three different 
elution solvents: methanol, acetonitrile and a 50/50 ethyl acetate/acetone mix. This 
found the use of C18 cartridges at a neutral pH with a methanol elution to be the best 
compromise in maintaining sufficient extraction efficiency for both anti-androgenic 
pharmaceuticals. 
The eluted samples from both experiments were accumulated prior to analysis. At this 
point it became evident that fine particulate matter was present in the eluted samples 
after the dry down procedure. These are referred to as fines, which are fractured 
particles from the silica sorbent in the C18 cartridge. Their occurrence is documented 
in the literature when using silica based cartridges and the levels vary between 
batches. This could be avoided in future study by using cartridges with an alternative 
solid phase, such as polymerics, or by using C18 disks. During the LC-MS/MS 
procedure the high concentrations of fines in the samples caused blockage of the 
instrument on a number of occasions. As a result, the decision was made to separate 
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the methanol eluent from the fines by centrifugation. Here, the samples were glass 
pipetted to centrifuge tubes and spun at 7,000× for three minutes to separate the 
eluent from the fines. The methanol eluent was then transferred back to the 
autosampler vials for analysis by LC-MS/MS.  
 
3.2.4.3 Liquid chromatography/tandem mass spectrometry 
As part of this study, identification and quantification methods for the anti-androgenic 
pharmaceuticals, bicalutamide and cyproterone acetate, were developed using LC-
MS/MS. Reference standard chemicals (1 µg/mL in methanol) were directly infused at 
5 µL/min into the LC-MS/MS to optimise conditions for analysis before experimental 
samples were run. The declustering potential of the chemicals was also optimised 
based on Table 3.7. In contrast, the steroid oestrogens were analysed based on a 
previously documented methodology (Environment Agency, 2008b). 
 Steroid oestrogens 
The method for analysing steroid oestrogens was taken from the Standing Committee 
of Analysts book on the detection of steroid oestrogens in water samples by mass 
spectrometry (Environment Agency, 2008b). One 100 µL aliquot of sample extract, 
containing deuterated internal standards, was used to assess these chemicals, of 
which 30 µL was injected. The high performance liquid chromatography (HPLC) system 
(Aglient 1100 series) was maintained at 40oC with a C18 based column (Aglient 
ZORBAX Eclipse XDB-C18, 150mm x 4.6 x 5µm. Part No. 993967-902). The mobile 
phase employed a gradient flow at 500 µL/minute using two eluents: (A) acetonitrile 
(Fisher Scientific, UK) and (B) 0.1% ammonium hydroxide in milliQ water. Separation 
started with 15% eluent A for three minutes, increasing to 40% for seven minutes, 75% 
for two minutes and 90% for four minutes before returning to 15%. The total sample 
acquisition time was 16 minutes. 
Detection and quantification was carried out using an Applied Biosystems API5000 
triple quadrupole mass spectrometer using negative ion electrospray in multiple 
reaction monitoring (MRM) mode. The use of electrospray ionisation here was 
particularly advantageous since it is considered to be a “soft” ionisation technique 
where little fragmentation occurs; making it easier to identify chemicals with common 
structural features (Pitt, 2009). The optimal settings were a source temperature of 
550oC and ion spray voltage at -4,500 V, whilst curtain gas and ion source gas one and 
two were set at 30, 50 and 60 psi respectively. The retention times and mass 
133 
 
transitions which were used to identify the chemicals are shown in Table 3.7. Since the 
internal standards were only added to experimental samples post extraction, 
quantitation was completed with a six point calibration set extracted with internal 
standards from 100 mL aquarium water using the extraction technique described. 
These contained concentrations equivalent to 0, 1, 2, 5, 10 and 50 ng/L, through which 
loss during extraction could be normalised in the experimental samples. Linearity was 
assessed by regression analysis, which found the following ions to be the most 
accurate to determine concentrations: E1 269.2/143.0 (R=0.9993); E2 271.1/143.1 
(R=0.9990) and EE2 295.2/143 (R=0.9993). The limit of detection (LOD) of this 
analytical method is reported as 0.05 ng/L (Williams et al., 2012). 
 Bicalutamide 
The HPLC system was maintained at 30oC using the same Agilent C18 based column 
used for the steroid oestrogens. The second 100 µL aliquot of sample extract was used 
to analyse the anti-androgenic pharmaceuticals, of which a 10 µL volume was injected. 
The mobile phase employed a gradient flow at 1000 µL/minute using two eluents: (A) 
acetonitrile (Fisher Scientific, UK) and (B) 0.1% ammonium hydroxide in milliQ water. 
Separation started with 15% eluent A for six minutes, increasing to 95% for another six 
minutes before returning to 15% for the remainder of the 15 minute samples acquisition 
time. 
Detection and quantification was carried out using an Applied Biosystems API5000 
triple quadrupole mass spectrometer using negative ion electrospray in MRM mode. 
The optimal settings were a source temperature of 550oC and ion spray voltage at -
4500 V, whilst curtain gas and ion source gas one and two were set at 25, 50 and 60 
psi respectively. Bicalutamide was identified by comparing the retention time and ion 
abundance ratios of the quantitation and confirmation mass transitions to those of 
reference standard chemicals (Table 3.7 and Figure 3.5). The concentrations were 
then calculated from a five point calibration curve using internal standard quantitation in 
Analyst 1.5.1 software (Thermo-Electron Corporation). The calibration curve was 
produced from extracts of a set of 100 mL aquarium water samples containing 0, 20, 
50, 100, 200 ng/L of bicalutamide and cyproterone acetate alongside internal standards 
as previously described. In this case, d7 propranolol was used as the internal standard 
since it was more accurately analysed in negative ion mode. Linearity was assessed by 
regression analysis, which found the 429.2/185.0 ion to be the most accurate 
determinate of concentration (R=0.9998). A LOD equivalent to 5 ng/L was determined 
from a solvent calibration which produced a signal to noise (S/N) ratio of 429.  
134 
 
 
Figure 3.5 Chromatograms of bicalutamide and the internal standard d7 propranolol in 
an aquarium water sample from the mixture treatment in experiment one. This was 
detected by LC-MS/MS run in negative ion mode. The mass transitions are also 
displayed. 
 
XIC of -MRM (14 pairs): 429.2/255.0 Da ID: Bicalutamide 1 from Sample 1 (FHM14.1 11) of R218272.wiff (Turbo Spray) Max. 4.7e6 cps.
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XIC of -MRM (14 pairs): 265.2/96.9 Da ID: d7-Propranolol from Sample 1 (FHM14.1 11) of R218272.wiff (Turbo Spray) Max. 4.5e5 cps.
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 Cyproterone acetate 
Extracts tested for bicalutamide analysis were retested for cyproterone acetate. The 
HPLC system was maintained at 30oC using the same Agilent C18 based column. A 20 
µL volume of sample was injected and the mobile phase employed a gradient flow at 
1,000 µL/minute using two eluents: (A) acetonitrile (Fisher Scientific, UK) and (B) milliQ 
water. Separation started with 15% eluent A for six minutes, increasing to 95% for 
another six minutes before returning to 15% for the remainder of the 15 minute sample 
acquisition time. 
Detection and quantification was carried out on the API5000 using positive ion 
electrospray in MRM mode. The optimal settings were a source temperature of 600oC 
and ion spray voltage at 4,500 V, whilst curtain gas and ion source gas one and two 
were set at 25, 70 and 60 psi respectively. Cyproterone acetate was identified by 
comparing the retention time and ion abundance ratios of the quantitation and 
confirmation mass transitions to those of reference standard chemicals (Table 3.7 and 
Figure 3.6). The concentrations were then calculated from the five point extraction 
calibration curve using internal standard quantitation with d10 carbamazepine, which is 
more accurately analysed in positive ion mode. Regression analysis assessing linearity 
found the 417.3/43.2 ion to be the most accurate determinate of the concentration 
(R=0.9960). An LOD of 10 ng/L was determined from a solvent calibration set, which 
had a signal to noise ratio of 11.9. 
Unfortunately due to a computer error, the results from the anti-androgen analysis were 
lost. This coincided with the shutdown of Severn Trent Services, Reading where this 
work was being completed, which meant access to the LC-MS/MS to reanalyse the 
samples was lost. Extract samples were stored at -20oC until they could be re-run over 
12 months later using the same methods and the same API5000 LC-MS/MS, which 
had been acquired by Brunel University in the meantime. However, it is possible that 
degradation of the samples occurred during this time as well as adsorption to the 
glassware. This, along with the high concentration of fines, could have created 
additional sources of analytical error. 
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Figure 3.6 Chromatograms showing the presence of cyproterone acetate and the 
internal standard d10 carbamazepine in an aquarium water sample from the mixture 
treatment from experiment two. This was detected by LC-MS/MS run in positive ion 
mode. The mass transitions are also displayed. 
 
XIC of +MRM (3 pairs): 417.3/43.2 Da ID: Cyproterone Acetate 1 from Sample 1 (FHM1.1 11) of R218424.wiff (Turbo Spray) Max. 2890.0 cps.
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Table 3.7 Optimised instrumental conditions for LC-MS/MS analysis of anti-androgenic 
pharmaceuticals and steroid oestrogens. Internal standards are italicised.  
 
Q1 mass (parent ion m/z); Q3 mass (daughter ion m/z); DP (declustering potential); EP 
(entrance potential); CE (collision energy); CXP (cell exit potential). 
 
3.2.5 UK catchment modelling of anti-androgenic pharmaceuticals 
In order to put the exposure concentrations into context and to produce a more 
extensive picture of environmental contamination by the anti-androgenic 
pharmaceuticals in the UK, predictive modelling techniques used in chapter two were 
expanded. The Low Flows 2000 Water Quality eXtension model (LF2000-WQX) was 
used to predict their concentrations in 14 major river catchments in England and 
Wales, which accounted for approximately 54% of land area and 69% of the population 
served by WWTWs. The per capita loads which were used in the Erewash model were 
used again for this catchment modelling with no removal incorporated at the WWTWs. 
Again, with no data available on the in-stream degradation of the drugs, the model 
produced a worst case scenario for their environmental concentrations, only taking into 
account the effects of dilution of the effluent in downstream river stretches. The 
predicted concentrations were compared to experimental concentrations used in the 
two experiments to further assess their environmental relevance.  
 
bicalutamide Negative 8.38 429.18 255 -115 -10 -20 -9
429.18 185 -115 -10 -48 -31
d 7 propanolol Negative 7.76 265.18 96.9 -125 -10 -36 -15
Positive 8.66 417.29 43.2 96 10 117 10
417.29 279.2 96 10 51 50
d 10  carbamazepine Positive 7.94 247.1 204.5 61 10 49 54
oestrone Negative 8.5 269.16 145 -210 -10 -52 -24
269.16 143 -210 -10 -68 -24
d 4 oestrone Negative 8.49 273.1 147.1 -210 -10 -68 -24
17β-oestradiol Negative 7.64 271.14 145.1 -195 -10 -54 -21
271.14 143.1 -195 -10 -54 -19
d 4  17β-oestradiol Negative 7.6 275.15 147.1 -195 -10 -54 -19
Negative 8.15 295.15 145.1 -190 -10 -54 -19
295.15 143 -190 -10 -54 -23
d 4  17α-ethinylestradiol Negative 8.12 299.15 147.1 -190 -10 -54 -23
CE (V) CXP (V)
cyproterone acetate
17α-ethinylestradiol
Compound
Ionisation 
Mode
Retention 
time (mins)
Q1 Mass 
(Da)
Q3 Mass 
(Da)
EP (V)DP (V)
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3.3 Results  
3.3.1 Experiment one 
3.3.1.1 Chemical analysis 
Aquarium water samples were collected from all treatment tanks on days 1 and 14 of 
the experiment. Concentrations and the % of the nominal concentrations achieved are 
displayed in Table 3.8. All chemicals were successfully detected in the appropriate 
samples. Cyproterone acetate was successfully detected in the anti-androgen and 
mixture treatment tanks with peaks exceeding three times the signal to noise ratio. 
However, it could not be accurately quantified due to the unreliable, variable detection 
and quantification of the internal standard (d10 carbamazepine). Concentrations of 
cyproterone acetate were instead predicted based on its expected ratio to 
bicalutamide, with which it had been combined in the stock solutions. This estimated 
concentrations to be between 47-107 ng/L (63-144% of nominal). For the other 
chemicals, concentrations in the tanks varied above and below the nominal, ranging 
from 3.9-12.8 ng/L (41-133% of nominal) for E1, 0.7-2.7 ng/L (32-133%) for E2, 0.2-0.3 
ng/L (33-113%) for EE2 and 73-166 ng/L (63-144%) for bicalutamide. In the positive 
control, concentrations of EE2 ranged from 7.0-11.6 ng/L (70-116% of nominal). 
Replicate tanks showed reasonably good agreement in the concentrations of 
bicalutamide and the steroid oestrogens, as did the single and combined mixture 
treatments at the start of the experiment. Concentrations decreased on day 14 in all 
treatments, with the greatest decrease occurring in mixture replicate B for the steroid 
oestrogens. In contrast, the steroid oestrogens in mixture replicate A all increased. 
When combined, the steroid oestrogens produced an estimated EEQ (based on Young 
et al., 2004), which also showed a good agreement between replicates and treatments. 
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Table 3.8 Concentrations (ng/L) of anti-androgenic pharmaceuticals and steroid 
oestrogens in samples from treatment tanks collected on the first (d1) and final day 
(d14) of the experiment and quantified by LC-MS/MS.  All test chemicals were below 
the LOD in the control and solvent control tanks  
Treatment Nominal (ng/L) Measured concentration (ng/L) % of nominal 
    d1 d14 d1 d14 
E1 
     Steroid Oestrogens A 9.6 11.1 9.5 116% 99% 
Steroid Oestrogens B 9.6 10.0 7.3 104% 76% 
Mixture A 9.6 8.5 12.8 88% 133% 
Mixture B 9.6 10.1 3.9 105% 41% 
E2  
     
Steroid Oestrogens A 2.1 2.7 1.2 130% 59% 
Steroid Oestrogens B 2.1 2.1 1.3 100% 60% 
Mixture A 2.1 1.9 2.1 90% 101% 
Mixture B 2.1 2.0 0.7 96% 32% 
EE2 
     
Steroid Oestrogens A 0.3 0.3 0.2 113% 69% 
Steroid Oestrogens B 0.3 0.3 0.2 94% 61% 
Mixture A 0.3 0.2 0.3 81% 110% 
Mixture B 0.3 0.2 0.1 78% 33% 
Positive Control A 10 11.6 7.7 116% 77% 
Positive Control B 10 7.0 10.9 70% 109% 
Bicalutamide 
     Anti-androgen A 115 113 75 98% 65% 
Anti-androgen B 115 166 76 144% 66% 
Mixture A 115 114 73 99% 63% 
Mixture B 115 102 77 89% 67% 
  Nominal  Predicted EEQ (ng/L)  % of nominal  
  (ng/L) d1 d14 d1 d14 
EEQ      
Steroid Oestrogens A 8.3 9.8 6.5 118% 78% 
Steroid Oestrogens B 8.3 8.3 5.5 99% 67% 
Mixture A 8.3 7.1 9.7 86% 117% 
Mixture B 8.3 7.7 3.0 93% 36% 
Positive Control A 100 116 77.1 116% 77% 
Positive Control B 100 70.3 109 70% 109% 
 
Nominal  Estimated CPA (ng/L) % of nominal 
  (ng/L) d1 d14 d1 d14 
Cyproterone acetate 
 
    Anti-androgen A 74 73 48 98% 65% 
Anti-androgen B 74 107 49 144% 66% 
Mixture A 74 73 47 99% 63% 
Mixture B 74 66 50 89% 67% 
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3.3.1.2 Somatic growth, GSI and HSI 
Differences in gross indices between treatment groups are displayed in Figure 3.7. In 
this experiment, fork length and weight did not vary between treatments, but 
statistically significant variance was found in the condition factor (one-way ANOVA, 
F5,90 = 2.66, P ≤ 0.05). However, post hoc analysis found that the only significant 
difference between treatment groups occurred between the mixture treatment and the 
solvent control, where condition factor of fish in the mixture treatment was significantly 
higher. In general, a condition factor over 1 is considered to indicate good health and 
nutritional status in a fish. Only two fish (one in the solvent control and one in the 
steroid oestrogen treatment) were found to have condition factors below 1, suggesting 
that the general health of the exposure population was good. In fact, with the exception 
of the single fish with a low condition factor (0.8) the solvent control values ranged from 
1.4-2.0 in comparison to 1.5-2.1 in the mixture treatment.  
For reproductively active male fathead minnows, GSI has been reported as around 1-
2% of total body weight (Watanabe et al., 2007; Jensen et al., 2001). This study found 
higher GSI in all treatment groups with the solvent control fish ranging from 0.4-3.6%, 
which varied significantly between treatment groups (one-way ANOVA, F5,90 = 4.38, P 
≤ 0.001). However, the GSI of fish in the solvent control was not significantly different 
from those in the other treatment tanks, although there were significant differences 
between anti-androgen, steroid oestrogen and mixture treatment groups. In contrast, 
HSI was not found to significantly vary between treatment groups.  
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Figure 3.7 The condition factor, GSI and HSI of fathead minnows in each treatment 
group (N=16). Boxes represent the median with 25th and 75th percentiles with error bars 
extending to the 95th percentile and outliers shown as dots. A,B and C denote 
statistically significant differences between groups at p≤0.05. 
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3.3.1.3 Secondary sexual characteristics 
In this experiment, nuptial tubercles and fatpads were observed in all fish from all 
treatments (Figure 3.8). No treatment effects were observed for the fatpad index, which 
did not significantly vary between treatment groups. However, both tubercle number 
and prominence were found to vary significantly (tubercle number: one-way ANOVA, 
F5,90 = 6.63, P ≤ 0.001; tubercle prominence: Kruskall-Wallis one-way ANOVA on 
ranks, P ≤ 0.001). Post hoc analysis found that the carrier solvent did not affect these 
endpoints and no significant effect of anti-androgenic pharmaceuticals, steroid 
oestrogens or the mixture treatments were detected in comparison to the solvent 
control. However, both characteristics were significantly lower in the positive control. 
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Figure 3.8 Secondary sexual characteristics of fathead minnows in each treatment 
group (N=8). Boxes represent the median with 25th and 75th percentiles with error bars 
extending to the 95th percentile and outliers shown as dots. A and B denote statistically 
significant differences between groups at p≤0.05. 
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3.3.1.4 Vitellogenin induction 
Vitellogenin concentrations were measured in blood plasma samples from male 
fathead minnowss by ELISA. Although there were 16 fish employed in each treatment, 
only individuals whose VTG measurements were within the working range of the test kit 
were included in statistical analysis. The number of samples (n) is indicated in Figure 
3.9 below. Statistical analysis found that vitellogenin concentrations varied significantly 
between treatments (Kruskall-Wallis one-way ANOVA, P ≤ 0.001, Figure 3.9). No 
significant induction was observed in the solvent control, which was statistically similar 
to the control with a median plasma vitellogenin concentration of 76 (8-3,855) ng/mL. 
These were comparable with the lower end scores for unexposed fathead minnows 
reported in a historical control database, where the median plasma vitellogenin was 
recorded as 2,500 ng/mL (Watanabe et al., 2007). The greatest induction was 
observed in the positive control, where the fish had a median plasma concentration of 
26 (13-50) mg/mL. This did not significantly differ from the oestrogen or mixture 
treatments. Fish treated with the anti-androgenic pharmaceuticals alone had a median 
vitellogenin concentration of 111 (4-3,223) ng/mL, 1.5 fold higher than the solvent 
control, but still statistically similar. In contrast, the steroid oestrogens caused a 
significantly greater induction than the anti-androgens alone, with a fold increase of 
around 30,000, based on the median plasma concentration of 2.5 (0.02-7) mg/mL. A 
100,000 fold increase was observed in the mixture treatment, which had a median 
concentration of 8 mg/mL, although the range of concentrations was more variable 
(0.03-27 mg/mL) due to the low concentration response of one fish. Nonetheless, 
vitellogenin concentrations in fish in the mixture treatment did not differ significantly 
from the oestrogens alone. Statistical analysis was repeated with the outlier in the 
mixture treatment discounted, to assess whether statistical differences between the 
oestrogen and mixture treatments would occur. However, the results were no different 
from the original analysis. When the induction of vitellogenin was compared with the 
historical control database, the induction observed in the oestrogen and mixture 
treatments compared well with the highest concentrations observed in normal female 
fish (median 16.5 mg/mL, maximum 47.5 mg/mL) (Watanabe et al., 2007). 
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Figure 3.9 Log. vitellogenin concentrations (ng/mL) in the blood plasma of fathead 
minnows in each treatment group quantified by ELISA. The number of samples 
accurately quantified and displayed for each treatment group is indicated (n). Boxes 
represent the median with 25th and 75th percentiles with error bars extending to the 95th 
percentile and outliers shown as dots. A and B denote statistically significant 
differences between groups at p≤0.05. 
 
3.3.2 Experiment two 
In this experiment, Japanese medaka were exposed from an embryonic to early adult 
stage to mixtures of anti-androgenic pharmaceuticals and steroid oestrogens in 
singular and combined activity mixture treatments. Two doses were employed using 
concentrations with environmental relevance to effluent and river concentrations, 
produced by predictive modelling.  
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3.3.2.1 Chemical analysis 
Aquarium water samples were collected from all treatment tanks at four time points 
throughout the experimental duration for detection and quantification of the chemicals. 
However, in some cases samples were discounted due to unreliable, variable detection 
of the internal standards, which affected quantification. This was a particular issue with 
cyproterone acetate where quantification of d10 carbamazepine was highly variable, 
which led to the data being discounted. Nonetheless, cyproterone acetate was 
identified as being present only in the appropriate tanks, with peaks exceeding three 
times the signal to noise ratio. Furthermore, the extraction of only a 100 mL sample 
was insufficient to accurately detect EE2. As a result, the concentrations of cyproterone 
acetate and EE2 were estimated based on the expected ratios to E2 and bicalutamide 
respectively. A summary of these data are shown in Table 3.9. 
 
Table 3.9 Concentrations of anti-androgenic pharmaceuticals and steroid oestrogens in 
treatment tanks compared to their nominal concentrations. Concentrations of EE2 and 
cyproterone acetate were estimated based on their expected ratios to E2 and 
bicalutamide respectively. n shows the number of samples analysed over the duration 
of the experiment. 
 
 
 
Treatment Replicate Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Solvent Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Oestrogen A 13 4 24 (20-30) 186% 2 4 3.2 (2.3-4.3) 160%
B 13 4 27 (17-35) 204% 2 4 3.4 (2.3-4.3) 172%
Low Mixture A 13 3 33 (25-44) 253% 2 4 3.9 (2.3-6.2) 196%
B 13 3 34 (24-39) 258% 2 4 3.7 (1.9-5.4) 183%
High Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
High Oestrogen A 29 4 63 (59-68) 217% 4 4 8.3 (6.3-9.8) 206%
B 29 4 66 (57-88) 229% 4 4 6.8 (6.1-8.1) 171%
High Mixture A 29 3 64 (45-82) 220% 4 4 8.7 (6.6-12.5) 216%
B 29 4 61 (43-75) 211% 4 4 9.5 (7.2-16.2) 238%
Positive Control A 0 4 3 (2-4) 50 4 76 (64-86) 152%
B 0 4 3 (<LOD-6) 50 4 80 (52-96) 160%
Treatment Replicate Nominal 
(ng/L)
n Mean (min-max) % of 
nominal
Nominal 
(ng/L)
n Mean (min-max) % of 
nominal
Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Solvent Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Oestrogen A 0.2 4 0.3 (0.2-0.4) 160% 8 4 14 (12-17) 174%
B 0.2 4 0.3 (0.2-0.4) 172% 8 4 16 (10-19) 189%
Low Mixture A 0.2 4 0.4 (0.2-0.6) 196% 8 3 20 (16-23) 239%
B 0.2 4 0.4 (0.2-0.5) 183% 8 3 20 (17-24) 236%
High Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
High Oestrogen A 0.4 4 0.8 (0.6-1.0) 206% 18 4 37 (32-40) 212%
B 0.4 4 0.7 (0.6-0.8) 171% 18 4 36 (32-46) 203%
High Mixture A 0.4 3 0.9 (0.7-1.3) 216% 18 3 39 (34-41) 216%
B 0.4 4 1.0 (0.7-1.6) 238% 18 4 39 (35-47) 223%
Positive Control A 0 4 <LOD 50 4 77 (66-87) 154%
B 0 4 <LOD 50 4 81 (52-98) 162%
E1 (ng/L) E2 (ng/L)
Estimated EE2 (ng/L) Predicted EEQ (ng/L)
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Table 3.9 continued… 
 
 
 
The degradation of the exposure chemicals in 100 mL of MFS water over 24 hours was 
first assessed to determine the probable conditions during petri dish dosing at the 
critical stages of early development. Following extraction, immediately after spiking the 
water sample, concentrations of 23 ng/L E1, 2.0 ng/L E2 and 149 ng/L bicalutamide 
were detected. These were all slightly above the nominal concentrations with the 
Treatment Replicate Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Solvent Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Oestrogen A 13 4 24 (20-30) 186% 2 4 3.2 (2.3-4.3) 160%
B 13 4 27 (17-35) 204% 2 4 3.4 (2.3-4.3) 172%
Low Mixture A 13 3 33 (25-44) 253% 2 4 3.9 (2.3-6.2) 196%
B 13 3 34 (24-39) 258% 2 4 3.7 (1.9-5.4) 183%
High Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
High Oestrogen A 29 4 63 (59-68) 217% 4 4 8.3 (6.3-9.8) 206%
B 29 4 66 (57-88) 229% 4 4 6.8 (6.1-8.1) 171%
High Mixture A 29 3 64 (45-82) 220% 4 4 8.7 (6.6-12.5) 216%
B 29 4 61 (43-75) 211% 4 4 9.5 (7.2-16.2) 238%
Positive Control A 0 4 3 (2-4) 50 4 76 (64-86) 152%
B 0 4 3 (<LOD-6) 50 4 80 (52-96) 160%
Treatment Replicate Nominal 
(ng/L)
n Mean (min-max) % of 
nominal
Nominal 
(ng/L)
n Mean (min-max) % of 
nominal
Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Solvent Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Oestrogen A 0.2 4 0.3 (0.2-0.4) 160% 8 4 14 (12-17) 174%
B 0.2 4 0.3 (0.2-0.4) 172% 8 4 16 (10-19) 189%
Low Mixture A 0.2 4 0.4 (0.2-0.6) 196% 8 3 20 (16-23) 239%
B 0.2 4 0.4 (0.2-0.5) 183% 8 3 20 (17-24) 236%
High Anti-androgen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
High Oestrogen A 0.4 4 0.8 (0.6-1.0) 206% 18 4 37 (32-40) 212%
B 0.4 4 0.7 (0.6-0.8) 171% 18 4 36 (32-46) 203%
High Mixture A 0.4 3 0.9 (0.7-1.3) 216% 18 3 39 (34-41) 216%
B 0.4 4 1.0 (0.7-1.6) 238% 18 4 39 (35-47) 223%
Positive Control A 0 4 <LOD 50 4 77 (66-87) 154%
B 0 4 <LOD 50 4 81 (52-98) 162%
E1 (ng/L) E2 (ng/L)
Estimated EE2 (ng/L) Predicted EEQ (ng/L)
Treatment Replicate Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Nominal 
(ng/L)
n Mean measured 
(min-max)
% of 
nominal
Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Solvent Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Low Anti-androgen A 53 3 99 (80-135) 187% 32 3 57 (48-82) 178%
B 53 4 71 (51-82) 134% 32 4 43 (31-50) 134%
Low Oestrogen A 0 4 <LOD 0 4 <LOD
B 4 <LOD 0 4 <LOD
Low Mixture A 53 3 107 (96-118) 201% 32 3 64 (58-71) 201%
B 53 3 85 (56-112) 161% 32 3 52 (34-68) 161%
High Anti-androgen A 115 2 133 (119-146) 115% 74 2 85 (77-94) 115%
B 115 3 152 (136-172) 132% 74 3 98 (88-111) 132%
High Oestrogen A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
High Mixture A 115 2 99 (69-129) 86% 74 2 64 (44-83) 86%
B 115 3 134 (124-139) 117% 74 3 86 (80-89) 117%
Positive Control A 0 4 <LOD 0 4 <LOD
B 0 4 <LOD 0 4 <LOD
Bicalutamide (ng/L) Estimated Cyproterone acetate (ng/L)
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exception of E2. After 24 hours, concentrations were 22 ng/L E1, 1.4 ng/L E2 and 115 
ng/L bicalutamide. This suggests that the exposure concentrations were maintained to 
an acceptable degree by the daily stock renewal. When tank water was sampled during 
the latter part of the experiment, no contamination of control or solvent control tanks 
was detected and no incidence of cross contamination between oestrogen and anti-
androgen treatment tanks was observed. For E1 and E2, concentrations varied and 
exceeded the nominal throughout the study by up to 158% for E1 and 138% for E2. It 
was estimated that this would be similar for EE2. Nonetheless, good agreement was 
achieved between replicate tanks and between oestrogen and mixture treatment tanks 
within the same dosing regimen (low or high). In addition, there was little overlap in the 
range of concentrations detected in the low and high treatments, which were clearly 
differentiated (demonstrated for the EEQ in Figure 3.10). Similar results were also 
found when the measured concentrations of E1 and E2 were combined with the 
estimated concentration of EE2 to determine the EEQ (based on Young et al., 2004).  
Bicalutamide was successfully quantified in fewer samples than the steroid oestrogens; 
in some cases only twice out of the four samples. It also exceeded the nominal by up to 
101%, less than the steroid oestrogens in some cases even though they were dosed 
from the same stocks in the mixture treatments. The differences between replicates 
tended to be greater than the steroid oestrogens. In addition, there was greater 
crossover between the two doses, as shown in Figure 3.10. The low doses ranged 
from 51-135 ng/L, whilst the high doses ranged from 69-172 ng/L where one of the 
samples in the high mixture A dropped below the nominal. The situation was expected 
to be similar for cyproterone acetate, since it was dosed alongside bicalutamide in all 
treatments and was analysed by LC-MS/MS at a similar time. Here, concentrations of 
31-82 ng/L were predicted to occur in the low doses in comparison to 44-111 ng/L in 
the high doses.  
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Figure 3.10 (A) the combined E2 equivalent (EEQ) of water samples from experiment 
two determined from the measured E1 and E2 concentrations and the predicted EE2 
concentrations (based on Young et al., 2004). A and B refer to replicate tanks. 
 
 
Figure 3.10 (B) The measured concentrations of bicalutamide. The median 
concentrations are shown with error bars extending to the minimum and maximum. A 
and B refer to replicate tanks. 
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3.3.2.2 Survival  
In most tanks, survival exceeded 80% following 98 days exposure (Table 3.10). This 
was considerably lower in the positive control (64% treatment survival), which led to the 
decision to sample the fish early following 90 days exposure. Lower survival was also 
observed in control tank A and solvent control tank A. In addition, there were 27 fish in 
the low anti-androgen treatment B that survived until the end of the experiment, 
suggesting that there was a miscount in the number of embryos employed at the start 
of the experiment. 
 
Table 3.10 The survival of fish in the replicate tanks from each treatment group. Each 
tank started with 25 embryos. 
Tank  n % Replicate Survival % Treatment Survival 
Control A 14 56% 78% 
 
B 25 100%  
Solvent Control A 18 72% 76% 
 
B 20 80%  
Low Anti-androgens A 20 80% 94% 
 
B 27 108%  
Low Steroid Oestrogens A 23 92% 92% 
 
B 23 92%  
Low Mixture A 24 96% 96% 
 
B 24 96%  
High Anti-androgen A 20 80% 88% 
 
B 24 96%  
High Steroid Oestrogens A 23 92% 92% 
 
B 23 92%  
High Mixture A 23 92% 88% 
 
B 21 84%  
Positive Control A 15 60% 64% 
 
B 17 68%  
 
 
3.3.2.3 Somatic growth 
Both the length and weight of fish significantly varied between treatment groups 
(Kruskall-Wallis one-way ANOVA, P ≤ 0.001). Interestingly, the fish in the high mixture 
treatment were significantly longer and heavier than the solvent control and the high 
anti-androgen treatment alone (Figure 3.11). However, these did not differ from the 
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high steroid oestrogen treatment, for which only the length was significantly higher than 
the solvent control. Condition factor was also shown to significantly vary amongst 
treatments (Kruskall-Wallis one-way ANOVA, P ≤ 0.001). However, post hoc analysis 
found that neither doses of the anti-androgenic pharmaceuticals or steroid oestrogens 
alone, or in the combined mixture, caused any effect. In contrast, condition factor in the 
positive control was significantly higher than all other treatments. In addition, in the 
control, high anti-androgen and positive control treatments, some fish experienced very 
low growth. They did not appear to have progressed from a fry stage and were below 
20 or even 10 mm in length. In comparison, the median lengths in all treatments 
exceeded 30 mm.  
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Figure 3.11 Length, weight and condition factor of fish in each treatment group. Boxes 
represent the median with 25th and 75th percentiles with error bars extending to the 95th 
percentile and outliers shown as dots. A,B,C and D denote statistically significant 
differences between groups at p≤0.05. 
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3.3.2.4 Sex ratio and intersex induction  
An intriguing result which became apparent during sampling was the excessive number 
of phenotypically male fish in the treatment groups. In fact, both the control and solvent 
control treatments appeared to be made up exclusively of male fish, in contrast to the 
positive control, where all fish appeared to be female. In fact, only a small number of 
females were identified in the other treatment groups (Figure 3.12). This unexpected 
result was confirmed with gonad histology, where females were confirmed. In a few fish 
in the control, high anti-androgen and positive control treatments, sex could not be 
identified. In these cases, the fish tended to be those that had failed to develop to an 
adult stage and their gonads were undifferentiated or not identified by the histological 
method.  
Intersex was defined only by the presence of oocytes in testicular tissue since ovarian 
cavities could not be properly quantified in the longitudinal sections. Treatment of 
medaka with steroid oestrogens alone caused intersex induction in 22% of the treated 
population for the low dose and 70% of those treated with the high dose respectively 
(Figure 3.12). However, only the high oestrogen treatment induced what was 
considered a significant induction of intersex in comparison to the solvent control 
(Williams contrast test p ≤ 0.0001), where intersex was identified in 6% of the treatment 
population. A small proportion of fish in the low anti-androgen treatment were also 
found to be intersex (6%), which did not significantly differ from the solvent control and 
no intersex fish were found in the high anti-androgen treatment. Interestingly, in both 
the low and high mixture treatments, the number of intersex individuals was 9% and 
10% higher, respectively, in comparison to their corresponding oestrogen treatments 
alone. However, whilst intersex incidence in these treatments was significantly higher 
than the solvent control (Williams contrast test: low treatment p ≤ 0.01; high treatment p 
≤ 0.001), there was no significant difference between the mixture treatments and their 
respective oestrogen treatments. 
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Figure 3.12 The proportions of male, female, intersex and unknown Japanese medaka 
within each treatment group. 
 
3.3.2.5 Intersex severity  
Intersex severity was scored for each fish based on the maximum intersex index 
(scored 1-6) identified in gonadal sections (Table 3.6). Images of histological 
characteristics typical to some of the treatments are shown in Figure 3.13. Statistical 
analysis of severity between treatment groups is displayed in Figure 3.14, in which a 
comparison with a modelled odds ratio and its 95% confidence limits exceeding 1 is 
determined as statistically significant.  
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Figure 3.13 Images showing the gonad histopathology of fish sampled during this 
experiment. (A) A typical gonad of a male from the solvent control. (B) Sporadic 
oocytes (shown with arrows) in the testes typical of the low oestrogen/mixture 
treatments (intersex index = 1). (C) The increased abundance and clustering of 
oocytes in the testes experienced in the high oestrogen/mixture treatment (intersex 
index = 6). (D) Extensive fibrosis which occurred in the testes of some high oestrogen 
and high mixture treated fish, in some casing taking up the entire gonad structure. (E) 
Connective tissue forming testicular lobules containing spermatozoa in a central 
efferent duct from a control fish compared with the disorganisation of lobule and duct 
formation in a fish from the high mixture treatment (F). (G) The sperm duct from a 
control fish containing high numbers of spermatozoa in comparison to the sperm duct 
of a fish from the high mixture which was empty apart from a single primary oocyte (H). 
 
Control fish showed healthy, lobulated gonads in the advanced stages of 
spermatogenesis, with high numbers of spermatozoa in the lumen and sperm ducts 
(Figure 3.13 A, E and G). This was also observed in the solvent controls, although a 
low incidence of intersex was observed in this treatment which was characterised by 
very few, sporadic primary oocytes (index 1). This was similar in the low anti-androgen 
treatment. In comparison, most intersex fish in the low oestrogen treatment also had an 
intersex index of 1 (Figure 3.13 B), although three fish scored higher with an intersex 
index of 6 occurring in two fish, where the oocytes were numerous and clustered. 
Unlike intersex incidence, intersex severity in fish from the low oestrogen treatment 
was significantly higher than those in the solvent control based on the odds ratios 
(Figure 3.14). In the low mixture treatment, more fish were identified with an intersex 
index over 1 than the oestrogen treatment alone (47% and 30% respectively). 
However, there was no statistically significant difference between these groups based 
on the odds ratio. 
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Figure 3.14 Statistical comparisons of the intersex severity in Japanese medaka 
between treatment groups. The boxes represent the odds ratio and extend to the 95% 
confidence limits where a significant difference between groups is judged when the 
boxes exceed the odds ratio of 1. Significantly different comparisons are indicated by 
an asterisk. No comparison was made between the solvent control and the high anti-
androgen treatment, since no intersex fish were identified. 
 
Although intersex fish were identified in the low anti-androgen treatment, none were 
found in the high anti-androgen treatment, where the gonads still appeared to be 
similar to the controls and solvent controls. In contrast, intersex incidence and severity 
significantly increased in both the high oestrogen and the high mixture treatments in 
comparison to the low doses (Figure 3.14). In these treatments, intersex index in the 
gonadal sections still varied from 1-6. However, there was an increased proportion with 
a higher index, characterised by large clusters of oocytes, which were separated from 
the testicular tissue (Figure 3.13 C). In the more severe cases, oocytes made up the 
majority of the gonad tissue and a few secondary oocytes were also observed in two 
fish from the high mixture treatment and one fish from the high oestrogen treatment. In 
addition, increased lobular disorganisation was observed in both intersex and non-
intersex males from these treatments (Figure 3.13 F). Fibrotic tissue was also identified 
and in some cases it was severe enough to make up a majority of the gonad tissue in 
the high oestrogen and mixture treatments. An example is shown in Figure 3.13 D and 
0.1 1 10 100 1000
 Oestrogens (High) vs Mixture (High)
Oestrogens (Low) vs Mixture (Low)
Mixture (Low) vs Mixture (High)
 Oestrogens (Low) vs Oestrogens (High)
Solvent Control vs Mixture (High)
Solvent Control vs Mixture (Low)
Solvent Control vs Oestrogens (High)
Solvent Control vs Oestrogens (Low)
Solvent Control vs Anti-androgen (High)
Solvent Control vs Anti-androgen (Low)
Odds Ratio with 95% Confidence Limits
*
*
*
*
*
*
158 
 
H, and further images are available in the Appendix (Figure A2.1). Due to the lack of 
functional testicular tissue in some cases where oocytes and extensive fibrotic tissue 
occurred, these sections were classified as index 6 in statistical analysis for severity. 
This was due to the lack of testicular tissue, which indicated a high level of gonadal 
malformation similar to that of individuals with a high proportion of ovarian tissue. In 
addition, fish within the high oestrogen and high mixture treatments showed reductions 
in spermatozoa in the sperm ducts in comparison to the solvent control and in some 
fish, particularly those with extensive fibrosis, the ducts were empty (Figure 3.13 H). 
When statistical analysis was employed, the odds ratio did not show a statistically 
significant increase in the overall intersex severity in the high mixture treatment in 
comparison to the high oestrogen treatment. In the positive control, the fish were found 
to be histologically female, with the exception of a few smaller fish where the gonads 
remained unidentified. Large, mature ovaries were identified where multiple stages of 
oogenesis were observed, which included vitellogenic, secondary oocytes. No 
testicular tissue was identified, although some contained interstitial proteinaceous fluid, 
which was likely to be vitellogenin. No obvious abnormalities were observed in 
phenotypically female fish in the positive control or any of the other treatments where 
they occurred.  
 
3.3.3 UK catchment modelling of anti-androgenic pharmaceuticals 
Subsequent hydrological modelling of river catchments in England and Wales with 
LF2000-WQX found that contamination with anti-androgenic pharmaceuticals is likely 
to be widespread, as indicated in Figure 3.15 and Figure 3.16. On these contaminated 
stretches, downstream of WWTW discharges, median concentrations of 9 (0.0002-157) 
ng/L bicalutamide and 5 (0.0001-86) ng/L of cyproterone acetate were predicted to 
occur. These exceeded the concentrations predicted on the River Erewash in chapter 
two of 26 (16-50) ng/L bicalutamide and 17 (10-32) ng/L cyproterone acetate, although 
the median concentration was lower. The five locations where the highest 
concentrations of anti-androgenic pharmaceuticals occurred were a mix of both rural 
and urban areas. The highest concentrations were achieved by effluent discharge into 
a tributary of the rural River Cole, Oxfordshire. Other stretches where concentrations 
exceeded 100 ng/L of bicalutamide were found on a tributary of the River Wye, 
Hertfordshire (urban), the Madford River, Devon (rural), the River Fos, Yorkshire 
(urban), a tributary to the River Ivel, Bedfordshire (urban) and Cuttle Brook, Oxfordshire 
(rural).  
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Figure 3.15 A map showing the predicted concentrations of bicalutamide in river 
catchments in England and Wales based on 2009 prescriptions (maps produced in 
ArcMap 10).  
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Figure 3.16 A map showing the predicted concentrations of cyproterone acetate in 
river catchments in England and Wales based on 2009 prescriptions (maps produced 
in ArcMap 10). 
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In experiments one and two, the measured concentrations of bicalutamide and those 
estimated for cyproterone acetate were generally found to be representative of the 
higher concentrations achieved on some river stretches. However, the predicted 
concentrations for the river catchments were exceeded on occasion in experiment one 
and in the high doses in experiment two. To recap, the maximum concentrations 
predicted to occur in the river catchments were 157 ng/L bicalutamide and 86 ng/L 
cyproterone acetate. In experiment one, bicalutamide was measured at 73-166 ng/L 
and cyproterone acetate was expected to be present at 47-107 ng/L. In this case, the 
predicted river concentrations were exceeded only once in the anti-androgen treatment 
A. Concentrations of bicalutamide predicted to occur in 30 of the modelled river 
stretches exceeded the lowest concentration measured in experiment one (73 ng/L), 
whilst 11 river stretches exceeded the 47 ng/L estimated for cyproterone acetate. 
In experiment two, bicalutamide was measured between 69 and 172 ng/L in the high 
dose treatment, whilst 31-82 ng/L of cyproterone acetate was also estimated to be 
present. Again, the predicted river concentrations were exceeded only at one sampling 
point in the high anti-androgen treatment replicate B. The river concentrations in 41 
river stretches exceeded the lowest concentration of bicalutamide measured in the high 
doses, in comparison to 16 stretches that were predicted to exceed cyproterone 
acetate. In the low dose treatments, the concentrations of anti-androgenic 
pharmaceuticals were within the range predicted to occur in the river catchments. 
Indeed, 115 river stretches exceeded the lowest measured concentration of 
bicalutamide (69 ng/L) and 87 stretches exceeded 31 ng/L cyproterone acetate.  
 
3.4 Discussion 
3.4.1 The environmental relevance of experimental concentrations 
The concentrations of bicalutamide were analysed by LC-MS/MS and used to estimate 
the concentrations of cyproterone acetate present in treatment tanks. At the high 
doses, which were employed in both experiments one and two, the concentration range 
for these chemicals mostly remained within their predicted range for river catchments in 
England and Wales. However, this was occasionally exceeded, suggesting that the 
high dose anti-androgen concentrations employed in experiments one and two were 
more relevant to an effluent exposure scenario. In comparison, the low dose 
concentrations assessed in experiment two were all within the range of the predicted 
river concentrations and were therefore more likely to be relevant to exposure to high 
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river concentrations. Previous assessments by modelling and analytical measurement 
are few in number but compare well with the range predicted to occur in the modelled 
river catchments in this study. Indeed, up to 55 ng/L and 76 ng/L were reported for 
cyproterone acetate in effluent and river samples from the Langat River, Indonesia. 
However, it was hypothesised that additional input through improper disposal of the 
drug and outflow from pharmaceutical production facilities could have impacted these 
concentrations (Al-Odaini et al., 2012). In addition, another study predicted that 10-40 
ng/L of cyproterone acetate was likely to occur in effluent in France based on its 
prescription rates (Besse and Garric, 2009). Similar concentrations have also been 
predicted for bicalutamide as part of an environmental risk assessment, which 
anticipated concentrations of up to 59 ng/L could occur in surface water (AZ.com, 
2013).  
In the case of the steroid oestrogens, the concentrations measured by LC-MS/MS in 
experiment one were all within the range of concentrations measured in WWTW 
effluents (Johnson et al., 2007b). They were also similar to the higher concentrations 
predicted to occur in river catchments in England and Wales (Williams et al., 2009). In 
experiment two, the steroid oestrogen concentrations were measured at around 200% 
of the nominal. Nonetheless, these concentrations still supported the relevance of the 
high doses to effluent concentrations and the low doses to river concentrations 
(Williams et al., 2009; Johnson et al., 2007b). Although the concentrations exceeded 
the nominal, they are still likely to be an accurate depiction of the exposure scenario.  
This is likely to be due to issues in maintaining sufficient pressure in the header tanks 
during the study, which led to sporadic reductions in flow that decreased dilution in the 
treatment tanks to produce an exposure to higher concentrations than planned.  The 
biological response in intersex induction to oestrogen exposure agreed with data from 
early life stage exposures of Japanese medaka to E2. At the low doses, the nominal 
EEQ was around 8 ng/L E2 equivalents, which would be expected to produce around 
10% incidence of intersex, based on an early life exposure of medaka to 10 ng/L E2 
(Metcalfe et al., 2001). In fact the estimated EEQ in these treatments was 14-20 ng/L, 
which caused over 20% intersex in males. In addition, at the high doses where an EEQ 
of 36-39 ng/L was estimated to be present in the tanks, over 80% of males were 
intersex. This agrees well with Hirai et al., who induced 56% intersex in medaka 
sampled between 14 and 20 days post hatch following exposure to 33.5 ng/L E2 (Hirai 
et al., 2006). 
Based on these data it may be questioned why the anti-androgenic pharmaceuticals 
did not always occur at a similar percentage of the nominal to the steroid oestrogens in 
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experiment two, as they had done in experiment one. Due to the length of time 
between the analysis of the oestrogens and the anti-androgenic pharmaceuticals, 
degradation of samples is a possibility. In addition, the presence of fines in the samples 
could have caused further, differential loss of the chemicals. Nonetheless, if these 
chemicals occurred at 200% of nominal, the low doses would still be within the range of 
the predicted river concentrations from catchments in England and Wales. The high 
concentrations would also still have relevance to WWTW effluents, particularly given 
that the use of bicalutamide is projected to increase in the future based on the data 
presented in chapter two.  
 
3.4.2 Experiment one: Vitellogenin and secondary sexual characteristics 
A range of endpoints were assessed during this study which have been associated with 
sexual disruption in fish. Experiment one employed a 14 day exposure of juvenile male 
fathead minnows and assessed gross indices, secondary sexual characteristics and 
vitellogenin induction. This experimental set up has previously been used successfully 
to evaluate the effect of oestrogenic endocrine disruptors on vitellogenin induction, in 
single chemical and mixture studies (Brian et al., 2005; Panter et al., 2002). The lack of 
effect of anti-androgens on GSI in fathead minnows in this experiment was not 
unexpected as results from previous studies have also found no effect of anti-
androgens on this endpoint. Indeed, flutamide, vinclozolin, p,p’-DDE and cyproterone 
acetate have failed to produce effects at higher concentrations than those used in this 
study (Hatef et al., 2012; Filby et al., 2007b; Panter et al., 2004; Sharpe et al., 2004; 
Mills et al., 2001). However, a combination of oestrogenic octylphenol and anti-
androgenic p,p’-DDE did significantly reduce GSI, but this was not assessed in 
comparison to single chemical treatments (Mills et al., 2001). Steroid oestrogens have 
been shown to affect GSI in fish (Filby et al., 2007b; Van den Belt et al., 2003), but no 
effect was observed in either the steroid oestrogen or positive control treatments in this 
study. This could be due to the length of exposure since Filby et al. found a reduction in 
GSI in male fish exposed to 10 ng/L EE2 after 21 days in comparison to our 14 day 
duration.  
The GSI, HSI and condition factor of the fish in this experiment were all high in 
comparison to a historical control database produced by the US Environmental 
Protection Agency (Watanabe et al., 2007; Jensen et al., 2001). This is likely to be 
reflective of the good nutritional status of fish held under our laboratory conditions. 
Indeed, HSI provides an indication of excess energy storage in the liver and GSI has 
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been shown to be higher when nutrient availability is not limited (Pope et al., 2007; 
Plante et al., 2005). Like GSI, no effect of anti-androgenic pharmaceuticals or steroid 
oestrogens was reflected in the HSI, which is of particular interest since the liver is also 
the site of vitellogenin production. Indeed, increases in HSI have been previously 
reported in oestrogen treated fish (Zha et al., 2007; Purdom et al., 1994), although the 
anti-androgen vinclozolin produced no effect in goldfish (Hatef et al., 2012). Whilst 
useful as an initial screening biomarker for fish health, particularly in field sampling, 
gross indices are not as sensitive to endocrine disruption as other endpoints 
(Pawlowski et al., 2004; Verslycke et al., 2002). Nonetheless, the significant differences 
in GSI observed between anti-androgen, steroid oestrogen and mixture treatment 
groups provided an interesting impetus for the histological analysis in experiment two. 
The steroid oestrogens and anti-androgenic pharmaceuticals also failed to cause a 
significant effect on secondary sexual characteristics and no effect was observed in the 
combined mixture treatment either. Tubercle number and prominence were significantly 
reduced in the positive control of 10 ng/L EE2, although fatpad index was unaffected. It 
could be argued that a longer study duration or exposure of younger fish, where these 
characteristics have not yet developed, could produce a significant effect following 
exposure to the oestrogen and anti-androgen treatments. However, previous studies 
have shown that anti-androgenic pharmaceuticals and steroid oestrogens affect these 
endpoints at higher concentrations than those employed in this experiment. Indeed, 27 
ng/L of E2 caused a reduction in both tubercles and fatpad in one study (Miles-
Richardson et al., 1999), whilst Salierno et al. found similar results to the positive 
control, with 10 ng/L EE2 causing a reduction in tubercle number and prominence 
(Salierno and Kane, 2009). In comparison, the concentrations of anti-androgenic 
pharmaceuticals capable of inducing similar effects are over 1,000 times above 
predicted environmental concentrations, based on previous studies. Indeed, flutamide 
caused a reduction in the tubercle number of males at 938 µg/L (Panter et al., 2004), 
whereas bicalutamide reduced tubercle prominence at a lower concentration of 100 
µg/L (Panter et al., 2012). However, cyproterone acetate at doses up to 200 µg/L failed 
to have any significant impact (Ankley et al., 2010). Taken together, these data suggest 
that it is unlikely that the secondary sexual characteristics of wild fish exposed to these 
pharmaceutical anti-androgens would be affected at their environmental 
concentrations. Nonetheless, cross species comparison for these endpoints should be 
made with caution as different fish species can respond differently to similar chemicals. 
Indeed, urogenital papilla and colouration in zebrafish were significantly feminised at 
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0.5 ng/L EE2, in comparison to 200 ng/L EE2 required to affect colouration in guppies 
(Larsen et al., 2008; Nielsen and Baatrup, 2006). 
As anticipated, vitellogenin induction provided a much more sensitive endpoint for 
disruption during this experiment, with the steroid oestrogen treatment inducing a 
statistically significant vitellogenic response in the fathead minnows. However, the anti-
androgenic pharmaceuticals failed to induce a statistically significant response alone. 
In the combined mixture treatment, the median vitellogenin concentration was three 
times that of fish in the steroid oestrogen treatment alone, but again this was not 
statistically significant. This showed that the addition of anti-androgens to steroid 
oestrogens in this exposure did not have a significant effect on vitellogenin induction.  
In comparison, previous studies have found that vitellogenin induction is less sensitive 
to exposure to anti-androgens than it is to the steroid oestrogens (Filby et al., 2007b; 
Ankley et al., 2004; Jensen et al., 2004). Indeed, one study induced around a six fold 
increase in male fathead minnows, but only when they were exposed to 500 µg/L 
flutamide (Jensen et al., 2004). Another study using 320 µg/L flutamide caused only a 
1.4 fold increase in males, which was not considered to be statistically significant, in 
comparison to a 345 fold increase following exposure to 10 ng/L EE2 (Filby et al., 
2007b). Induction of vitellogenin by anti-androgens is thought to occur through a similar 
mechanism to that observed in humans, where an AR antagonist can cause an 
increase in circulating concentrations of exogenous oestrogens. Indeed, in one fish 
study where vitellogenin was induced by flutamide, a small increase in plasma E2 was 
also observed (Jensen et al., 2004). In addition, other molecular mechanisms could be 
involved, such as the increased expression of the oestrogen receptor β (Filby et al., 
2007b), which is thought to be the main mediator of vitellogenin induction (Leaños-
Castañeda and Van Der Kraak, 2007). There are no other studies of bicalutamide 
available for comparison with this endpoint. However, given that it is also an AR 
antagonist and seems to impact fish at similar concentrations to flutamide, it is 
plausible that concentrations in the µg/L range may be required to produce similar 
changes in vitellogenin in male fish. In contrast, cyproterone acetate has been shown 
to reduce vitellogenin observed in female fathead minnows at 200 µg/L, potentially 
mediated by its anti-gonadotrophic activity and the associated reduction in plasma sex 
steroids (Ankley et al., 2010).  
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3.4.3 Experiment two: Intersex prevalence and severity 
Experiment two employed an exposure of Japanese medaka during development from 
embryonic to adult phases. Whilst survival was above 80% in most treatments, 
mortality was higher in one replicate from both the control and solvent control 
treatments. The exact cause for this remains unknown, although the affected control 
tank did experience higher and more frequent temperature fluctuations than the other 
tanks. High mortality also occurred in the positive control tanks where fish were all 
found to be phenotypically female. Previous study has also observed high mortality in 
fish exposed to E2 at concentrations high enough for complete sex reversal, where 
hypertrophy of the liver and kidneys occurred alongside an accumulation of 
proteinaceous fluid, which was assumed to be vitellogenin (Herman and Kincaid, 
1988).  
Interestingly, no female fish were identified in either the control or solvent control 
treatments of medaka and they were few in number in the rest of the treatments. Whilst 
previous studies have shown male majorities in control tanks (53-54% male) (Zha and 
Wang, 2006; Metcalfe et al., 2001), an additional pressure would be required to induce 
an all-male population. A likely explanation for this unexpected phenomenon is 
masculinisation of genotypic females by a cortisol induced stress response to 
temperature fluctuations (Hayashi et al., 2010; Hattori et al., 2007). Such fluctuations 
could have been caused during the period of embryonic development, where daily 
renewal of media in petri dishes occurred. Indeed, the fresh media stock was kept at 
room temperature (~20ºC) and used to renew the media in the petri dishes, which were 
constantly maintained between 25 and 26ºC. In addition, E2 has been shown to 
combat this temperature induced masculinisation response (Kitano et al., 2012), which 
could explain the presence of females within other treatment groups, particularly the 
positive control. The modification of characteristics of test organisms prior to or in 
conjunction with exposure to a chemical of interest is well established in endocrine 
disruption research, particularly when trying to identify modes of action. Indeed, some 
tests involve co-exposures of female fish, such as fathead minnows and stickleback, to 
androgens and anti-androgens, to determine whether the anti-androgen can inhibit 
masculinisation (Knag et al., 2013; Pottinger et al., 2013; Ankley et al., 2010; Jolly et 
al., 2009). From this perspective, statistical analysis of intersex induction and severity 
was repeated to include the presence of females as a treatment induced response, 
where female fish were considered as intersex index 7. However, the results of this 
analysis did not differ from the original analysis in terms of the differences in intersex 
incidence and severity between treatment groups.  
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The intersex condition has been identified in field surveys of multiple fish species in 
rivers downstream of anthropogenic input, particularly WWTW effluent discharge, 
globally (reviewed in Bahamonde et al., 2013). The steroid oestrogens are widely 
considered to be major contributors to intersex in wild fish. In the UK, their presence 
downstream of WWTW effluent discharge has been associated with the prevalence 
and severity of this condition (Jobling et al., 2006). Exposure of fish to effluents 
containing mixtures of steroid oestrogens have been shown to cause intersex and even 
complete sex reversal, as have individual chemical exposures (examples include: Zhao 
et al., 2014; Baynes et al., 2012; Lange et al., 2011; Lange et al., 2009; Kidd et al., 
2007; Liney et al., 2006; Balch et al., 2004; Nash et al., 2004; Metcalfe et al., 2001; 
Rodgers-Gray et al., 2001; Papoulias et al., 2000). However, to the author’s 
knowledge, there have been no other studies assessing intersex in fish exposed to a 
mixture of E1, E2 and EE2. 
This study demonstrated that mixtures of steroid oestrogens are capable of inducing an 
environmentally relevant incidence and severity of intersex at concentrations 
comparable with those observed in rivers and effluents. A dose dependant response in 
intersex incidence and severity was achieved by the low and high doses of both the 
steroid oestrogen and mixture treatments. This is consistent with studies exposing fish 
to single steroid oestrogens, increasing dilutions of oestrogenic WWTW effluents and 
the UK river survey conducted by Jobling et al. (Liney et al., 2006; Jobling et al., 2006; 
Metcalfe et al., 2001; Rodgers-Gray et al., 2001). At the low oestrogen doses in this 
study, which were established as being relevant to high river concentrations, 24% of 
males were found to be intersex. In studies of wild fish, the incidence of intersex varies 
between sites and species.  In wild roach from UK river stretches classed as being at 
high risk of intersex induction, 31.25% of the sampled male roach were found to be 
intersex in terms of the presence of oocytes in their testes. In annother fish survey from 
the USA 18-22% intersex occured in white suckers (Catostomus commersoni) 
immediately downstream of an oestrogenic WWTW effluent discharge in Colorado 
(Vajda et al., 2008). It should be considered that up to 100% intersex in males have 
been observed at some UK river sites, including individuals with ovarian cavities, which 
could not be assessed in this study (Jobling et al., 2006; Jobling et al., 1998). Intersex 
severity in gonad sections from fish in the low oestrogen and mixture groups was 
predominantly low (index 1-2), although higher severity (index 5-6) was also observed. 
Again, this corresponded well with data from river surveys (Jobling et al., 2006; Jobling 
et al., 1998).  
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At the higher doses, there was a greater proportion of fish with high severity intersex 
than the lower doses. Indeed, at the higher, effluent relevant doses, 80 and 88% of 
male fish were intersex in the oestrogen and mixture treatments respectively.   
Additional changes to gross morphology were also observed, including a high 
incidence of gonadal disorganisation and extensive fibrotic tissue, the prevalence of 
which was slightly greater in the high mixture treatment. These abnormalities have 
been observed previously in controlled exposures to steroid oestrogens (Kidd et al., 
2007) as well as anti-androgens, including cyproterone acetate and vinclozolin 
(Kiparissis et al., 2003). They have also been observed in wild caught fish from effluent 
contaminated areas (Björkblom et al., 2013; Nolan et al., 2001; Jobling et al., 1998). 
Fibrosis has also been observed in an exposure of fish to anti-androgenic effluent in 
Australia where no steroid oestrogens were detected (Kumar et al., 2012). It is likely 
that severely intersex fish from these higher doses were reproductively impaired due to 
the extent of disorganisation of the gonad and the observation of empty sperm ducts. 
This is supported by a study of wild roach, where individuals with high intersex severity 
were found to have a reduced reproductive performance (Harris et al., 2011). 
The induction of intersex by a mixture of steroid oestrogens invites the question of 
whether this was an effect of a single chemical or a combination of all three steroid 
oestrogens. Additive effects of steroid oestrogens are well documented and have been 
observed both in vitro and in vivo, on endpoints including vitellogenin production, 
fecundity and secondary sexual characteristics in combination with other 
xenoestrogens (Brian et al., 2007; Brian et al., 2005; Rajapakse et al., 2002; Silva et 
al., 2002; Thorpe et al., 2001). However, additive effects have not been demonstrated 
for intersex, although they are plausible. It should be noted that the concentrations of 
E2 and EE2 in the low oestrogen treatment were below their reported LOECs of 0.75 
ng/L EE2 (Zhao et al., 2014) and 10 ng/L E2 for intersex induction (Metcalfe et al., 
2001). In comparison, E1 was detected above its LOEC of 10 ng/L (Metcalfe et al., 
2001). However, the 10 ng/L E1 exposure of Japanese medaka during early life only 
induced 5% intersex, whilst 100 ng/L induced 7% intersex in the same study. In 
comparison, a much greater intersex incidence of 24% of male fish was observed in 
experiment two in this study. However, without detailed dose response curves from 
single chemical exposures it is not possible to mathematically prove additive effects for 
this endpoint in this study. Nonetheless, it remains clear that environmentally relevant 
concentrations of steroid oestrogens are major drivers of intersex induction.  
In comparison, the anti-androgenic pharmaceuticals failed to induce a statistically 
significant incidence of intersex in either the low or high anti-androgen treatment tanks. 
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Although there was a small incidence of low severity intersex in the low anti-androgen 
dose, this did not differ from the solvent control and no intersex was observed in the 
higher dose. As a result, this was not considered to be an effect of the anti-androgenic 
pharmaceuticals. Previous studies have suggested that oestrogenic food sources could 
impact this endpoint (Bahamonde et al., 2013). However, the ZM fish food used in both 
studies was not found to have oestrogenic activity in vitro (Beresford et al., 2011). 
Given that no intersex was observed in the second solvent control replicate or the 
aquarium water controls, contamination of these tanks at some stage in the experiment 
seems to be the most likely cause of intersex induction. Analytical chemistry found no 
evidence of such contamination, but with water samples taken and analysed on only 
four out of the 98 days of exposure, contamination still remains a plausible possibility. 
Intersex has been observed in control medaka from a number of studies from different 
laboratories (Grim et al., 2007), although this was considered to occur due to external 
factors and it is unlikely to be a natural occurrence in this species (Bahamonde et al., 
2013; Grim et al., 2007). 
It is likely that higher concentrations of anti-androgenic pharmaceuticals than those 
employed in experiment two are required to induce intersex in fish. Indeed, a 
multigenerational exposure of fathead minnows to bicalutamide, employing 
concentrations up to 100 µg/L did not observe any abnormal gonad histopathology in 
males (Panter et al., 2012). In addition, the other pure AR antagonist, flutamide, 
required concentrations of 202 µg/L in one study and 320 µg/L in another to induce 
intersex in Japanese medaka. (León et al., 2007; Kang et al., 2006). On the other 
hand, cyproterone acetate caused intersex induction at lower concentrations of 1 and 
10 µg/L (Kiparissis et al., 2003). This could be due to its additional ability to reduce 
concentrations of circulating androgens through anti-gonadotrophic effect, alongside its 
AR antagonism. Indeed, more pronounced effects of cyproterone acetate than 
flutamide have also been observed in mammalian models and in human trials for 
prostate cancer treatment at similar doses (Barradell and Faulds, 1994). However, the 
predictive hydrological modelling suggests that these concentrations greatly exceed 
those present in the aquatic environment. Nonetheless, cyproterone acetate has been 
shown to reduce both the testicular synthesis and plasma concentrations of 
testosterone and 11-ketotestosterone in mummichog at the concentrations employed in 
both experiments one and two (Sharpe et al., 2004). These endpoints were not 
assessed in this study and if plasma sex steroids were altered they did not translate 
into any significant impacts on other visible endpoints, such as secondary sexual 
characteristics. 
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Different chemicals with similar mechanisms of action, such as AR antagonists and 
steroidogenesis inhibitors, have been shown to act additively in vivo (Christiansen et 
al., 2009). Statistical modelling of the occurrence of steroid oestrogens and anti-
androgenic activity at capture sites with observed intersex and vitellogenin induction in 
wild fish has suggested that these two sets of chemicals could interact to cause sexual 
disruption (Jobling et al., 2009). Interestingly there was a 9-10% increase in intersex 
incidence in the mixture treatments at both doses in comparison to steroid oestrogen 
treatments alone. However, statistical analysis found that this was not a statistically 
significantly increase. At present, there is only one other study that assessed the 
effects of mixtures of anti-androgens and steroid oestrogens in fish, for which only 
preliminary data has been published (Lange et al., 2012a). This reported a significant 
increase in the incidence of ovarian cavities in juvenile roach following exposure to a 
combination of anti-androgens identified in WWTW effluents and steroid oestrogens. 
Unfortunately the longitudinal nature of the histological sectioning in medaka was not 
effective in accurately identifying ovarian cavities in males and so the Lange study 
could not be directly compared by this study. Consequently, a multi-causal aetiology 
behind intersex induction remains worthy of future study. This could perhaps employ a 
mixtures exposure examining both ovarian cavities and germ cells to determine 
definitively whether anti-androgens and oestrogens interact in an additive or synergistic 
fashion in fish.  
 
3.5 Conclusions 
This study used hydrological modelling to predict that bicalutamide and cyproterone 
acetate are likely to be contaminants of the aquatic environment which are widespread 
across river catchments in England and Wales. In the majority of cases, their 
concentrations are likely to occur below 10 ng/L but at some "hot spots," 
concentrations are likely to be higher, in some cases exceeding 100 ng/L for 
bicalutamide. When fish were exposed to high environmental concentrations of these 
pharmaceuticals alone and in combination with steroid oestrogens, no significant 
effects were observed on a set of endpoints indicative of sexual disruption. It is likely 
that higher concentrations in µg/L are required to induce significant effects, which are 
potentially up to 1,000 times greater than those identified in the environment. However, 
given the evidence for additive effects of anti-androgenic chemicals in whole 
organisms, these environmental contaminants should be considered as part of the 
wider issue of anti-androgenic activity in the environment. Critically, this study 
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demonstrates that a mixture of steroid oestrogens, at concentrations present in the 
aquatic environment, can induce intersex at a rate comparable with that observed in 
UK and European rivers. Additional exposures to anti-androgenic pharmaceuticals 
known to co-occur with these oestrogens did not exacerbate the incidence or severity 
of intersex. Taken together, these data support the role of steroid oestrogens as major 
contributors to intersex in wild fish. 
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4. CHAPTER 4: IDENTIFICATION OF 
ENVIRONMENTAL ANTI-ANDROGENS 
THROUGH EFFECT DIRECTED ANALYSIS  
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4.1 Introduction 
Anti-androgenic activity has been detected at a high frequency in wastewater treatment 
works (WWTWs) effluents, surface waters and sediments. In many cases, the 
flutamide equivalent concentrations (FluEQ) that these samples produce in vitro 
exceed concentrations of flutamide known to have adverse effects on fish in laboratory 
studies (Grover et al., 2011; Zhao et al., 2011; Johnson et al., 2007b; Urbatzka et al., 
2007). However, the causes of this activity remain to a large extent unidentified and 
targeted analysis of the concentrations of known anti-androgenic chemicals, such as 
bisphenol A (BPA), alkylphenols and pesticides, have failed to fully explain the 
detected activity (Kinani et al., 2010). Consequently, the identification of anti-
androgenic chemicals responsible for the observed anti-androgenic activity in complex 
environmental samples remains a key challenge, to which more in depth and broad 
ranging approaches need to be applied.  
 
4.1.1 Identifying the chemical causation of biological effects in complex 
environmental samples 
Complex environmental samples, such as WWTW effluents, can contain many 
thousands of chemicals (Jobling and Tyler, 2003). Due to the limitations of analytical 
chemistry, such as the need for multiple methods and the lack of available 
methodologies for some chemicals, it is not possible to identify every single chemical, 
particularly without prior knowledge of its likely contents. Even if this were possible, 
biological and chemical assessment of potentially thousands of chemicals would be 
vastly expensive and time consuming (Hecker and Hollert, 2009). Consequently, two 
different approaches have been developed to direct both chemical and biological 
analysis to identify the chemicals causing a biological effect in an active environmental 
sample. These are the Toxicity Identification Evaluation (TIE) and Effect Directed 
Analysis (EDA) (Burgess et al., 2013), both of which use tiered approaches employing 
a combination of analytical chemistry and bioassays, with the intention of including the 
maximum possible number of chemicals in their assessment. 
 
4.1.1.1 Toxicity Identification Evaluation (TIE) 
TIE was developed by the US EPA in response to the Clean Water Act to identify toxic 
chemicals in complex mixtures based on a three tiered approach of characterisation, 
identification and confirmation of toxicity. It is generally associated with whole organism 
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bioassays, mainly using invertebrates such as Daphnia magna, with endpoints such as 
reproduction and survival. In a TIE, when an environmental sample is found to be toxic 
in these bioassays, phase I analysis is completed to characterise the responsible class 
of chemicals through their physiochemical properties (Burgess et al., 2013; Ankley et 
al., 2011). Critically, since TIE involves detecting toxicity in a whole sample, not a 
solvent extract, the causal chemicals are characterised through manipulations of an 
environmental sample itself to preserve the link between the sample and the observed 
toxicity (Ankley et al., 2011). Examples of these include pH adjustment and filtration, 
which are then combined with whole organism toxicity tests. For example, if the toxic 
effect is not observed following filtration, it is likely to be caused by particulate 
associated toxicants. After chemical characterisation, phase II identification can be 
directed to identify the causal chemicals within the class identified in phase I, through 
analytical chemistry such as gas chromatography-mass spectrometry (GC-MS). Phase 
III confirmation then involves producing independent lines of evidence to support 
findings from phases I and II. This can involve another whole organism test with 
exposure to the suspected toxicants to determine whether similar toxic effects occur in 
comparison to the original sample (Burgess et al., 2013).  
 
4.1.1.2 Effect Directed Analysis (EDA) 
The key difference between EDA and TIE is that analysis is not directed by whole 
organism tests for toxicity but through in vitro screens for biological activity. 
Consequently, unlike the TIE process, EDA uses extraction and fractionation 
procedures to concentrate the sample for assessment in a solvent extract form. This 
also means that biological samples where chemical concentrations are low, such as 
blood or tissue, can also be assessed through EDA. A basic EDA starts with a sample 
where high biological activity has been detected in an appropriate bioassay. Broad 
spectrum solid phase extraction (SPE) methods are then used to maximise the capture 
of chemicals within the active sample. This is followed by fractionation of the extract by 
high performance liquid chromatography (HPLC) to separate chemicals based on their 
polarity. The fractions are then individually screened in a bioassay and can be further 
fractionated and rescreened if necessary. Chemical analysis, again such as GC-MS, 
can then be used to identify specific chemicals in the active fractions. Like in TIE, 
confirmation is then required, which normally involves a bioassay of the suspected 
chemical standards to determine their contribution to total activity of the active sample 
(Burgess et al., 2013; Hecker and Hollert, 2009). Since there is no whole organism test 
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included within the EDA, this can be added into a hazard confirmation step with 
exposures to chemicals standards.  
 
4.1.2 Effect directed analysis and endocrine disrupting chemicals 
EDA provides a useful assessment technique for assessing endocrine disrupting 
chemicals (EDCs) in complex samples since it can be directed by in vitro bioassays for 
endocrine disrupting activity. In addition, since samples can be concentrated through 
SPE, the accuracy of analytical chemistry is vastly improved. This is particularly 
important for high potency chemicals, such as 17α-ethinylestradiol (EE2), which has a 
lowest observed effect concentration (LOEC) that is below the limits of detection of 
some analytical techniques. The steroid oestrogens were first identified in WWTW 
effluent as the major cause of oestrogenic activity through a process described as a 
“TIE approach modified for our specific needs” (Desbrow et al., 1998). In fact, this is 
more akin to an EDA through its use of extraction, fractionation and direction by an in 
vitro bioassay, the yeast oestrogen screen (YES). The process is shown below in 
Figure 4.1, in which an oestrogenic WWTW effluent was purged with nitrogen to 
remove volatiles and filtered to remove particulates and assessed with the YES 
bioassay. This found that the activity remained in the aqueous phase of the effluent. 
The effluent was then concentrated in a broad spectrum SPE using a variety of elution 
solvents and solvent concentrations to extract a wide polarity range of contaminants 
before the extracts were fractionated with HPLC. YES was then used to direct analysis 
towards active fractions, which underwent reconcentration and further fractionation 
before being analysed with GC-MS, which eventually detected the steroid oestrogens 
oestrone (E1), 17β-oestradiol (E2) and EE2 in active fractions.  
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Figure 4.1 The process employed to identify the causes of oestrogenic activity in 
WWTW effluent which was directed towards the steroid oestrogens (from Desbrow et 
al., 1998). 
 
Further EDA of environmental samples have also identified steroid oestrogens as 
major or even dominant contributors to oestrogenic activity. Indeed, a basic 
fractionation procedure completed on effluent, river and lake water samples in the US 
found that E2 and EE2 accounted for 88-99.5% of total sample activity (Snyder et al., 
2001). However, other xenoestrogens have also been detected in active fractions in 
other studies. In samples from UK estuaries, nonylphenol was found to be a major 
contributor to the activity alongside E2. In addition, the phthalate ester di (2-ethylhexyl) 
phthalate (DEHP) was also thought to significantly contribute to activity but the link 
remained tentative since DEHP is a common laboratory contaminant (Thomas et al., 
2001). Another study of sediments from the River Elbe, Germany, found that mixtures 
of xenoestrogens may contribute to activity to an extent which equals the steroid 
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oestrogens (Schmitt et al., 2012). However, it should be considered that environmental 
samples are unique in their chemical constituents based on their surrounding 
geography, local contaminant sources and the time of sampling. As a result, the 
dominant chemicals may differ between sites. Indeed, a study of sediments from the 
upper Danube River, Germany, found that only 2-6% of oestrogenic activity could be 
linked to the steroid oestrogens, with the rest of the activity coming from unknown 
contaminants (Grund et al., 2011). However, in this case the limits of detection for E2 
and EE2 were higher than those of E1. It is therefore possible that these chemicals 
were present and making significant contributions to activity but were not detected. 
 
4.1.3 Effect directed analysis and anti-androgens 
EDA has also been applied to assess anti-androgenic activity in environmental 
samples through androgen receptor (AR) transfected bioassays such as the yeast 
androgen screen (YAS). Here, the assessment of activity is based on the ability of a 
sample extract to reduce an androgenic response mediated by a background 
concentration of 5α-dihydrotestosterone (DHT) in the yeast cell line. The assay has 
been coupled with targeted chemical analysis, assessing concentrations of a set of 
known anti-androgens within active fractions from environmental samples. This 
identified anti-androgens such as BPA, alkylphenols (monylphenol [NP] and 
octylphenol [OP]) and pesticides (vinclozolin, endosulfan, 
dichlorodiphenyltrichloroethane [DDT], p’p-dichlorodiphenyldichloroethylene [p’p-DDE] 
and iprodione) in river sediments from France and Italy (Kinani et al., 2010; Urbatzka et 
al., 2007). However, these were found to make only minor contributions to the total 
activity, suggesting that other contaminants have a significant role to play (Kinani et al., 
2010). Consequently, broad ranging analytical techniques and chemical identification 
software have been used in EDAs to tentatively identify more unknown chemicals. For 
example, chemical analysis of active fractions from produced water discharges from 
offshore oil production platforms used high resolution time of flight mass spectrometry, 
which detected anti-androgenic polyaromatic hydrocarbons (PAHs) and naphthenic 
acids (Thomas et al., 2009). However, a recent in vivo exposure to commercial 
mixtures of naphthenic acids found no evidence of anti-androgenic effects in fish (Knag 
et al., 2013). PAHs have also been detected in active fractions of river sediments 
alongside alkylphenols and the phthalate ester, DBP (Weiss et al., 2009). This last 
study also highlighted the importance of EDA in assessing endocrine activity in 
samples, where androgenic activity was found in some fractions, which had been 
concealed by the anti-androgenic activity in the total extract. 
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One advantage of EDA is its ability to assess biological samples, such as blood or 
tissue, through the use of sample concentration. The bile of fish exposed to WWTW 
effluent has been successfully used for assessments of EDCs since it bioaccumulates 
contaminants to concentrations greater than those that exist in the effluent itself (Hill et 
al., 2010). Indeed, oestrogenic activity has been identified through EDA in fractions of 
fish bile and shown to contain steroid oestrogens, alkylphenols and BPA (Pettersson et 
al., 2006; Gibson et al., 2005). A similar method has also been completed for 
identifying anti-androgens in fish exposed to anti-androgenic effluent. This identified a 
broad range of chemicals including PAHs, chlorinated PAHs, alkylphenols, BPA and 
isomers of resin acids, as well as chemicals originating from personal care products, 
such as biocides (triclosan and chlorophene) and oxybenzone, which is used in 
sunscreen filters (Rostkowski et al., 2011; Hill et al., 2010). Interestingly, the biocides 
triclosan and chlorophene were shown to be the most potent anti-androgens, 
accounting for 51% of the total activity. However, even with the addition of the other 
identified chemicals only around 60% of the total activity could be accounted for.  
 
4.1.4 Aims and objectives 
The objective of this study was to use EDA in a broad approach to identify anti-
androgenic contaminants in WWTW effluent and river samples from the UK. This 
provides an alternative method for identifying anti-androgenic environmental 
contaminants to complement the targeted approach of assessing the role of 
pharmaceuticals described in Chapters 2 and 3. This chapter aimed to identify other 
anti-androgenic chemicals, quantify their individual potency and determine their 
contribution to anti-androgenic activity.  A similar process is also currently underway 
using WWTW effluents from five South Australian WWTWs.  
 
4.2 Materials and methods 
4.2.1 Effect directed analysis overview 
A schematic of the EDA process is shown in Figure 4.2. In this study, two sets of 
samples were collected from WWTW final effluents and extracted by SPE. One set 
underwent HPLC fractionation and the resultant fractions were analysed in vitro, with 
the yeast androgen screen (YAS), to identify (anti-) androgenic activity. The intention 
was to use the YAS results to direct analysis towards chemicals in active fractions to 
identify the anti-androgenic constituents of the effluent. The fractions also underwent a 
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broad scan by GC-MS, where their constituent chemicals were tentatively identified 
through comparison with a mass spectral library. Literature searches were then used to 
label chemicals identified by GC-MS as those with known anti-androgenic activity. 
These were then tested in the yeast screen to assess their potential contribution to 
anti-androgenic activity seen in the whole effluent extracts, which also underwent 
screening with the YAS. At the same time, some river samples from upstream of 
WWTWs were also collected, extracted and fractionated to assess their chemical 
constituents. SPE, HPLC fractionation and GC-MS were all completed at Severn Trent 
Services, Reading, whilst yeast screening was completed at Brunel University, London.  
Additional background material on SPE, HPLC and yeast screening is provided in 
Appendix 3.  
 
Figure 4.2 The Effect Directed Analysis process used in this study to identify anti-
androgenic chemicals in UK effluent and river water samples.  
 
Solid Phase Extraction
In Vitro 
Bioassay
Effluent
HPLC Fractionation
GC-MS
River Water
Tentative Identification
Literature Search for 
Endocrine Activity
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4.2.2 Sites and sample collection 
Effluent samples from the WWTWs, UK1 and UK3 (Severn-Trent catchment, UK Figure 
4.3), were analysed in this study. These had been previously involved in Chapter 2’s 
predictive modelling approach. UK1 is a relatively rural WWTW located near the town 
of Alfreton, Derbyshire. It served an estimate of 53,695 people with an average 
domestic flow of 8.17 ML/day based on 2009 data and discharges into Alfreton Brook, 
which in turn discharges into the River Amber. The larger WWTW, UK3, is located in 
Longbridge near the town of Warwick, which served an estimated population of 
117,041 with an average domestic flow of 11.41 ML/day, which discharges into the 
larger River Avon. Both employed similar treatment processes which included primary 
settled sewage, secondary biological trickling filter and a tertiary sand filter. These 
WWTWs were chosen since preliminary investigation had identified anti-androgenic 
activity in both final effluents with an average of 407 and 325 µg/L FluEQ for UK1 and 
UK3 respectively (Baynes et al., 2014 personal communication). 
In February 2009, grab samples of final effluent from each WWTW were collected 
using a stainless steel sampling can and transferred into 2.5 L amber glass 
Winchesters containing copper (II) nitrate (0.5 g) and hydrochloric acid (6 mL) as a 
fixative. These were then stored at 4°C to inhibit possible bacterial degradation of 
chemicals. Two replicate samples were collected from each WWTW. One set 
underwent extraction, HPLC fractionation and in vitro screening, whilst the other was 
extracted and screened to assess the activity in the whole effluent sample, to compare 
with the activity of the fractions and the chemicals identified within them. River water 
samples were also collected at this time from upstream of the UK3 discharge point, 
since the Avon provides a good example of a rural, agriculturally impacted river site. To 
compare with this, water samples were also collected from the urban and industrialised 
River Erewash. These samples were collected and preserved using the same method 
as the effluent samples.  
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Figure 4.3 Images of the WWTWs and the waterways they discharge to (sourced from 
Google Maps). 
 
4.2.3 Solid phase extraction (SPE) 
In this EDA approach, SPE was used to capture a broad range of the chemicals 
present in the effluent and river samples and to concentrate them to improve the 
accuracy and detection frequency of GC-MS. The effluent and river samples underwent 
reverse phase SPE on styrene divinyl benzene cartridges (Isolute ENV+), which can 
capture chemicals with a broad range of polarities. Cartridges were attached to an 
extraction manifold and conditioned with 5 mL of ethyl acetate followed by 5 mL of 
methanol and 5 mL of water in sequence. Each 2.5 L sample was then loaded onto the 
cartridge under vacuum before being thoroughly dried. The samples were then eluted 
into collection vessels with 5 mL of dichloromethane and 5 mL of methanol to maximise 
the number of chemicals eluted. The 10 mL extracts were then concentrated by 
UK3 
UK1 
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Turbovap LV automated evaporation system to 1mL before further concentrating them 
with nitrogen blow down equipment to 100 µL in a 1 mL autosampler vial.  
 
4.2.4 Fractionation by high performance liquid chromatography (HPLC) 
This study used reverse phase HPLC fractionation to separate chemicals from the SPE 
extracted samples into fractions based on their polarity using an elutrophic series in the 
polar mobile phase and a non-polar stationary phase. This employed a HPLC system 
(Hewlett Packard 1050 HPLC) with a quaternary pump, column heater and UV 
detector, which was connected to a Dynamax fraction collector (model FC-4). The 
system was maintained at ambient temperature with a C18 based column 
(Phenomenex Gemini 5µm C18 110A, 150mm x 4.6 x 5µm. Part No. 00F-4435-E0). 
The sample was injected at a volume of 95 µL with the mobile phase flowing at 1 
mL/minute, starting as 5% methanol in distilled water and changed linearly to 100% 
methanol after 20 minutes before being maintained at 100% after 27 minutes. Fractions 
of 1 mL were collected every minute for 30 minutes, producing 30 fractions for in vitro 
assessment of anti-androgenic activity and GC-MS analysis.  
 
4.2.5 In vitro identification of anti-androgenic effluent fractions  
Effluent fractions were tested for androgenic and anti-androgenic activity using the in 
vitro yeast androgen screen to direct analysis towards anti-androgenic chemicals. 
Fractions were screened based on the protocol detailed in (Sohoni and Sumpter, 1998) 
to detect androgenic and anti-androgenic activity in YAS. This was completed in a type 
II laminar flow cabinet, where 100 µL of a fraction was serially diluted at 12 
concentrations in 100 µL methanol in 96 well microtitre plates. Duplicate 10 µL aliquots 
of each concentration were then transferred to a second set of plates. These plates 
also contained a blank, solvent control (methanol) and flutamide as a positive control, 
which were run alongside the fractions in duplicate. Like the fractions, flutamide was 
also serial diluted across the wells at concentrations from 50 to 0.02 nM to produce a 
sigmoidal response curve. These were allowed to evaporate to dryness before 200 µL 
of media seeded with 4x107 yeast cells, CPRG and a background concentration of 2 
nM DHT was added to each well. The plates were then placed in a mictotitre plate 
shaker for 2 min before being incubated at 32oC. After 24 hours the plates were shaken 
again to disperse the growing cells and were then returned to the incubator. After 72 
hours the plates were analysed using a Spectramax Plate Reader (Molecular Devices, 
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USA), measuring absorbance at wavelengths of 540 nm for colour change and 620 nm 
for cell turbidity. Each well was corrected for turbidity based on its 540 nm absorbance 
minus (620 nm absorbance – solvent control 620 nm absorbance). In these screens, 
the turbidity reading was essential since toxicity of a chemical can produce a similar 
result to anti-androgenic activity by reducing the number of cells available to produce a 
response. Consequently, if excessive toxicity was identified, the sample was 
discounted since it could not be differentiated from anti-androgenic activity. The same 
method was used to assess whole effluent samples.  
 
4.2.6 Chemical analysis by gas chromatography-gas spectrometry 
(GC/MS) 
Prior to GC-MS, each sample fraction required a solvent exchange. Each fraction was 
added to 200 mL of laboratory blank water, pH adjusted to pH 6.5-7.5. Deuterated 
internal standards, including d6-benzene, d5-chlorobenzene, d10-xylene, d5-phenol, d8-
naphthalene, d34-hexadecane and d10-phenanthrene, were added to each sample 
based on Table 4.1. Each fraction was extracted to 100 mL dichloromethane by liquid-
liquid extraction in a 1 L separating funnel. The pH of the fractions was then readjusted 
to pH 10 and re-extracted with another 100mL of dichloromethane. The two extracts for 
each fraction were then combined and the residual water was frozen out overnight in a 
freezer. The solvent extracts were then concentrated by a Turbovap LV automated 
evaporation system to approximately 0.5 mL before further concentrating them with 
nitrogen blow down equipment to 100 µL in a 1 mL autosampler vial. A blank sample 
was also extracted based on this method for GC-MS and comparison with the fractions. 
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Table 4.1 Internal standards added to fractions prior to GC-MS analysis, including their 
concentrations in the fractions, retention time and mass/charge ratio. 
Internal Standards 
 
Concentration (mg/mL) Retention Time m/z 
d6 benzene 2 4.51 84 
d5 chlorobenzene 2 9.4 117 
d10 p xylene 1 10.07 116 
d5 phenol 8 12.6 99 
d8 naphthalene 1 16.9 136 
d21 BHT 8 22.4 222,240 
d34 hexadecane 1 23.8 66,98 
d10 phenanthrene 2 26.32 188 
d62 squalene 8 35.9 62, 82 
 
GC-MS couples the separation of chemicals by gas chromatography with their 
characterisation by mass spectrometry. In gas chromatography, a sample is injected 
into the instrument, where it is heated on a gradient up to around 300oC and 
transported through a separation column (stationary phase) with up to 60 m length by 
an inert gaseous mobile phase, such as helium. As the mobile phase passes through 
the column, chemicals are separated based on their volatility and their interaction with 
the stationary phase, where those with high volatility move the fastest as they take less 
time to evaporate. The chemicals then pass from the GC to the mass spectrometer, 
which is separated into three main sections: the ion source, mass filter and detector. 
When they enter the ion source, the chemicals are ionised, fragmented and then 
focussed into an accelerated ion beam into the mass filter, which separates the ions 
based on their mass-charge (m/z) ratio. Electromagnets within the filter can be set to 
control which ions will enter the detector, which detects the mixture of molecular and 
fragment ions that create a compound’s unique spectra. Unfragmented molecular ions 
can be identified based on their exact masses.  
In this study, effluent fractions, river water extracts and the blank underwent GC 
(Agilent 6890) with a fused silica capillary column (Aglient J&W DB1 60m x 0.32mm x 
0.25µm film thickness), where 1 µL of each extract or fraction was injected by split-split 
headed injector. The temperature program began at 35oC for 4 minutes followed by an 
increase to 300oC at a rate of 8oC/min, holding at 300oC for 10 minutes. The mobile 
phase was helium with a flow rate of 1.5 mL/min. This was coupled with a quadruple 
mass selective MS detector (Aglient 5973), equipped with an electron ionisation source 
at a temperature of 250oC with an electron energy of 70 eV. Acquisition was achieved 
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by a general scan survey mode which carried out scanning over a range of 500 to 35 u 
(unified mass unit) at a scan speed of 0.5 seconds per decade to give a scan cycle 
time of 0.97 seconds. This broad scanning process aimed to maximise the range of 
chemicals detected in each fraction. 
 
4.2.7 Tentative chemical identification and semi-quantification 
Mass spectra were interpreted by manual searching of the Wiley Register™ of Mass 
Spectral Data and by mass spectral interpretation from first principals. The chemicals 
from all effluent, river and blank fractions were either tentatively identified or labelled as 
unknowns. Concentrations of chemicals of interest were semi-quantified by comparing 
the peak area of the chemical with those of the internal standards detailed above and 
added prior to liquid-liquid extraction. The blank sample was used to identify 
contaminants of the EDA process originating from sample preparation, fraction 
collection and GC-MS.  
 
4.2.8 Identification of anti-androgens 
Literature searching was completed between 2011-12 to identify known anti-androgens 
from those tentatively identified in effluent, river and blank fractions using the Google 
search engine alongside the pubmed database. These searches started with active 
anti-androgenic fractions from WWTW effluents in a targeted approach based on in 
vitro screening (describe below) but were later expanded to all fractions from all 
samples. The search terms employed included “antiandrogen”, “anti-androgen”, 
“androgen”, “androgen receptor” and “endocrine disruption.”  
 
4.2.9 Screening of known and suspected anti-androgens in active 
fractions  
To confirm anti-androgenic activity, standards of compounds previously reported as 
anti-androgenic in the literature or determined to be of interest for screening were 
analysed in YAS. These were purchased from Sigma-Aldrich, UK and made up in 
ethanol. These were first tested in the anti-androgen screen with a DHT raised 
background at six concentrations in a serial dilution (0.5 mM-1.56 µM) as single 
replicates to make a preliminary assessment of their activity. Chemicals reducing the 
raised background were retested at 12 concentrations in duplicate and at 
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concentrations below toxicity, which were specific to each chemical. These assays 
included a flutamide positive control and an ethanol solvent control. FluEQs were 
produced based on the following calculation:  
𝐹𝑙𝑢𝐸𝑄 =
𝑥 (𝑓𝑙𝑢𝑡𝑎𝑚𝑖𝑑𝑒) 𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑡𝑜 𝑝𝑟𝑜𝑑𝑢𝑐𝑒 𝑦
𝑥 (𝑠𝑎𝑚𝑝𝑙𝑒) 𝑟𝑒𝑞𝑢𝑖𝑟𝑒𝑑 𝑡𝑜 𝑝𝑟𝑜𝑑𝑢𝑐𝑒 𝑦
 
Where x is the molar concentration and y is the corrected 540 nm absorbance. The 
linear portion of the flutamide curve (the working range) was used to generate 
comparative data. The concentration of a sample required to produce a given 
absorbance within the working range was used as the basis to determine the 
respective concentration of flutamide required to produce the same absorbance. This 
was calculated using logarithmic regression, as shown in Figure 4.4. This was 
determined at multiple points within the working range to provide an average FluEQ for 
each chemical. For example, in the case of pyrene below, three points were within the 
working range and used to produce the FluEQ.  
 
 
Figure 4.4 Determining the flutamide equivalents of pyrene using logarithmic 
regression. 
 
4.3 Results 
4.3.1 Anti-androgenic activity in WWTW effluent fractions 
Whole effluent extracts from UK1 and UK3 were confirmed as anti-androgenic and 
found to contain 242 and 325 µg/L FluEQ. To direct chemical analysis towards anti-
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androgens, replicate effluent extracts underwent HPLC to produce 30 fractions of each 
effluent sample. These underwent screening in the yeast androgen screen with the 
background raised by DHT to detect anti-androgenic activity. The results of this 
analysis is summarised below in Figure 4.5 and the raw data is available in Appendix 
three. Full sigmoidal dose response curves were not achieved by the concentrations 
tested in the YAS, although the partial curves were indicative of both anti-androgenic 
and androgenic activity co-occurring in both effluents. Indeed, the corrected 
absorbance at 540 nm of the serially diluted fractions diverged from the controls at the 
higher concentrations in the first five wells, where both increases and decreases in 
absorbance occurred. This allowed active fractions to be tentatively identified, although 
accurate quantification and comparison with the activity of the whole effluent extracts 
was not possible. Some confounding factors were identified during this process, 
producing false positive results for some fractions, which were discounted accordingly. 
In particular, the edge effect was observed, which was characterised by a reduction in 
the corrected 540 nm absorption in both the high and low concentration wells on the 
edges of the plates, producing a shallow U shaped curve. As a result, reductions in 540 
nm absorbance in the high concentration wells in some of these cases may have, at 
least in part, been an artefact from the assay procedure and therefore could not be 
confirmed as anti-androgenic activity.  
A similar number of anti-androgenic fractions were identified in the individual effluents, 
nine and six for UK1 and UK3, respectively. Five fractions were also shown to have 
anti-androgenic activity in both effluents. As part of an EDA procedure, active fractions 
could have been further fractionated to narrow down the group of chemicals causing 
the activity. However, in this case the number of active fractions would have made 
further fractionation a time consuming process, with 30 new fractions produced from 
each active fraction and requiring in vitro testing. Consequently, broad scan GC-MS 
was completed on the fractions to tentatively identify their constituent chemicals, 
followed by literature searching to identify known anti-androgens. These then 
underwent confirmation of their activity in the YAS to determine which chemicals, if 
any, could potentially explain a proportion of the total activity that had been previously 
observed. 
188 
 
 
Figure 4.5 A comparison of (anti-) androgenic activity in effluent fractions from the 
WWTWs UK1 and UK3, as indicated by their dose response curves in the YAS. 
 
4.3.2 Identifying and assessing anti-androgens in environmental samples 
The chemicals in fractions from effluents, river samples and the blank were tentatively 
identified from their mass spectra following GC-MS and are summarised in Table 4.2. 
The highest number of chemicals were detected in the effluents, where 1,063 and 982 
were detected in in UK1 and UK3, respectively. As expected the number of chemicals 
in the river samples was lower, with 268 from the Avon and 243 from the Erewash. 136 
possible contaminants were observed in the blank. Although large numbers of 
chemicals were detected, the vast majority could not be identified (84% at UK1 and 
75% at UK3) by this analytical method and the mass spectral library. 
Fraction UK1 (YAS) UK3 (YAS)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29 androgenic
30 anti-androgenic
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Literature searching of the known chemicals found them to have multiple origins. 
Effluents contained a number of chemicals clearly linked to domestic, anthropogenic 
use, including fatty acids, fragrances/flavourings, personal care products and 
pharmaceuticals. Pesticides and a herbicide were also found in effluents and the more 
rural River Avon. Other chemicals identified included plasticisers, flame retardants and 
industrial chemicals used in manufacturing as well as some natural products. 
Interestingly, the sample from the urban River Erewash was found to contain a number 
of PAHs (polyaromatic hydrocarbons), which were not present in the River Avon. 
 
Table 4.2 The number of chemicals in detected effluent, river and blank samples. This 
includes the number of unknown and tentatively identified known chemicals, as well as 
their uses or origins where they could be determined. 
 
Alfreton Longbridge Avon Erewash Blank 
TOTAL 1,064 801 194 241 135 
Unknown chemicals 906 558 127 148 85 
Known chemicals 158 243 67 93 50 
      Anti-Oxidant 0 1 1 2 0 
Fatty Acid 20 27 7 6 0 
Fatty Alcohol 0 0 0 1 0 
Flame Retardant 5 6 2 3 0 
Fragrance/Flavouring 16 25 6 9 5 
Herbicide 0 1 1 0 0 
Industrial Byproduct 1 0 0 0 0 
Industrial Intermediate 2 4 1 1 0 
Organic Synthesis 2 0 2 0 0 
Polyaromatic Hydrocarbons 1 0 0 11 0 
Personal Care Products 11 17 3 3 4 
Pesticide 1 3 0 0 0 
Pharmaceutical 5 8 0 0 0 
Phytochemical 2 3 0 0 0 
Plasticiser 1 3 1 0 0 
Precursor Compound 7 9 7 4 2 
Solvent 3 3 1 4 1 
Surfactant 2 2 0 1 1 
 
Literature searches of compounds by name identified 16 as known anti-androgens. 
These originated from a range of different classes, including fatty acids, flame 
retardants, PAHs, pharmaceuticals and personal care products, pesticides and 
plasticisers. Interestingly, four 5α-reductase inhibitors were also identified alongside the 
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AR antagonists and it was reported that some fatty acid compounds, such as 9-
octadecanoic acid methyl ester, could act through both mechanisms (Selvin et al., 
2009). A similar number of known anti-androgens were identified in the effluent 
samples, with nine found in UK1, 12 in UK3 and seven found in both effluents. In 
comparison, river samples contained fewer known anti-androgenic chemicals, with 
three found in the Avon sample and five in the Erewash, of which only one 
corresponded between the two river samples. Some of these were also detected in the 
WWTW effluents, such as hexadecanoic acid methyl ester. These chemicals are 
summarised in Table 4.3 below.  
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Table 4.3 also includes a few additional chemicals of interest which were taken forward 
to in vitro screening for confirmation of activity to identify other possible anti-androgenic 
chemicals. These included methyl triclosan, terbutryn, ibuprofen methyl ester and 
indomethacin methyl ester. Their screening was justified for a number of different 
reasons. Whilst the anti-microbial agent triclosan is known to be anti-androgenic, there 
was no data available for the activity of its metabolite methyl triclosan, which was 
detected in both effluents. Terbutryn is a pesticide, which has recently been added to 
the EU’s Water Framework Directive as a priority pollutant and therefore warrants 
assessment since many other pesticides are anti-androgenic (Orton et al., 2011). 
Finally, maternal use of the pharmaceutical ibuprofen has been linked to cryptorchidism 
in newborns in an epidemiology study, indicating an anti-androgenic effect (Kristensen 
et al., 2010). Indomethacin has also been demonstrated to be a steroidogenesis 
inhibitor and the metabolites of both chemicals therefore warrant assessment 
(Kristensen et al., 2012). This follows on from the assessments completed in Chapters 
2 and 3 to delve further into whether pharmaceuticals could be part of the anti-
androgen issue. However, indomethacin methyl ester and 11H-benzo[b]fluorine, which 
was anti-androgenic in the AR CALUX assay (Hawliczek et al., 2012), were not 
available for purchase from Sigma-Aldrich and therefore could not be tested in this 
study. This left a total of 24 standards for purchase, in vitro screening and confirmation 
of activity. Out of these tested chemicals, only five were confirmed as anti-androgenic 
in the YAS. These are shown in Table 4.4, whilst the yeast screen results are shown in 
Figure 4.6 and Figure 4.7. 
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Figure 4.6 Responses of active chemicals in the yeast screen. Corrected absorbance 
at 540 nm quantifying colour change. 
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Figure 4.7 Turbidity readings (620 nm) responses from active chemicals in the yeast 
screen showing proliferative and toxic effects. 
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The confirmed anti-androgens included triclosan, chlorophene, methyl triclosan, pyrene 
and tetradecanoic acid, in their order of potency. With the exception of tetradecanoic 
acid, the confirmed anti-androgens were highly potent chemicals, exceeding the 
potency of flutamide. In comparison, 9,12-octadecadienoic acid methyl ester and 
dodecanoic acid were only tentatively quantified since full response curves were not 
achieved. The reduction in absorbance at the highest tested concentrations suggested 
that they were weakly anti-androgenic, although this should be confirmed in further 
testing. When the FluEqs and concentrations of confirmed anti-androgens from the 
samples were assessed, it was found that the total anti-androgenic activity that they 
could explain was incredibly low. Indeed, the confirmed anti-androgens were only 
expected to contribute 778 ng/L and 200 ng/L FluEQ in samples from UK1 and UK3 
respectively. In comparison, anti-androgenic activity equating to 242 and 325 µg/L was 
detected in extracted whole effluent samples from UK1 and UK3. As a result, the 
contribution of the confirmed anti-androgens only equated to 0.08% and 0.24% of the 
total activity identified at UK1 and UK3. Interestingly, only 9,12-octadecadienoic acid 
methyl ester, methyl triclosan and pyrene were detected in the active fractions 
identified during preliminary screening. However, methyl triclosan was identified only in 
an active fraction in UK3 and not UK1, where its concentration was lower. The 
contribution of confirmed anti-androgens in both river samples was also very low, since 
fewer chemicals were detected in these samples. On the Avon, only 18 ng/L FluEQ 
could be expected from the contribution of decanoic acid and tetradecanoic acid, in 
comparison to 74 ng/L on the Erewash, due to the presence of pyrene. The turbidity 
readings were also highly variable between chemicals. Toxicity was observed for 
tetradecanoic acid and triclosan, which also caused proliferation prior to toxicity. When 
anti-androgenic activity was quantified for these chemicals, the wells exhibiting toxicity 
were not used in comparisons to the flutamide curve. For example, tetradecanoic acid 
was toxic from 0.25 mM (2.5x10-4 M) but anti-androgenic from 7.8 µM (7.8x10-6 M). In 
addition, the corrected 540 nm absorbance of methyl triclosan suggested that it was 
androgenic at high concentrations. However, this could have been a result of its 
proliferative effect at these concentrations, increasing the cell numbers to increase the 
540 nm absorbance. Once again the edge effect was also clearly observed in the 
solvent controls from the first two screens, with a reduction in the corrected 540 nm 
absorbance in peripheral wells. As a result, with the exception of 9,12-Octadecadienoic 
methyl ester and dodecanoic acid, the highest concentration wells were not used to 
determine the FluEQ. Consequently, the potency of 9,12-Octadecadienoic methyl ester 
and dodecanoic acid could be slightly overestimated and warrants further assessment.  
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Table 4.4 Chemicals with confirmed anti-androgenic activity in the YAS. This shows 
their retention times (RT) and fragment ions from GC-MS analysis as well as their 
concentrations in the samples. The contribution of each chemical to anti-androgenic 
activity in a sample is indicated based on its potency relative to flutamide and its 
concentration. This is displayed as both ng/L FluEQ and the % of the total activity of 
the whole effluent extracts. Dodecanoic acid and 9,12-Octadecadienoic methyl ester 
are tentatively quantified and confirmed as anti-androgenic since full response curves 
were not achieved.  
 
4.4 Discussion 
4.4.1 Identified anti-androgenic chemicals  
4.4.1.1 Fatty acids 
Lipids and their breakdown products, fatty acids and their methyl and ethyl ester 
derivatives, are major constituents of domestic WWTW effluents, originating from 
soaps, food oils and faecal matter following human excretion (Alves et al., 2001; Prats 
et al., 1999). Since they commonly occur in effluent, fatty acids have been used as 
markers of WWTW effluent contamination in the aquatic and estuarine environment 
(Quemeneur and Marty, 1992). Indeed, a suite of fatty acids were identified in this 
study in effluent and river samples, including pentadecanoic acid, tetradecanoic acid 
methyl ester and dodecanoic acid. These are of particular interest since they were 
recently extracted from a fungus, Ganoderma lucidum used in traditional medicine and 
were found to significantly inhibit 5α-reductase derived from fresh rat liver explants (Liu 
et al., 2009). This tested a suite of fatty acids and found only these saturated fatty acids 
with a carbon chain length of 12-16 and unsaturated fatty acids with a carbon chain of 
18 to be active. Indeed, these results were supported by an independent study which 
used the same method to test these fatty acids after they were extracted from the plant 
saw palmetto (Serenoa repens) (Abe et al., 2009). Saw palmetto has become popular 
as an alternative therapy for benign prostate hyperplasia, which can normally be 
treated with pharmaceutical 5α-reductase inhibitors dutasteride and finasteride. 
However, a recent meta-analysis of long term clinical trials failed to detect any benefit 
of using saw palmetto over the placebo (Tacklind et al., 2012). Whilst their 5α-
reductase activity could not be confirmed in our laboratory, these chemicals were 
tested for AR antagonism in the YAS. This only confirmed weak anti-androgenic activity 
in 9,12-octadecadienoic acid methyl ester, which was considerably less potent than 
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flutamide. Further analysis of dodecanoic acid is also warranted to confirm its anti-
androgenic activity, since a reduction in absorbance was observed at its highest tested 
concentrations but a full response curve was not achieved. In comparison, 
hexadecanoic acid methyl ester and 9-Octadecenoic acid methyl ester were reported 
as anti-androgenic based on Dr Dukes Phytochemical and Ethnobotanical Database 
(Selvin et al., 2009). However, examination of this database yielded no evidence to 
support its assertion that these chemicals were anti-androgenic and failed to cite or 
demonstrate any work that tested this statement. No additional data was available in 
the primary literature to support this assertion. As a result, with the exception of 9,12-
octadecadienoic acid methyl ester and possibly dodecanoic acid, there is little evidence 
to suggest that these chemicals are AR antagonists. Nonetheless, the identification of 
some of these natural chemicals as 5α-reductase inhibitors (Liu et al., 2009) contradicts 
the assumption that anti-androgenic chemicals in the environment are limited only to 
synthetic chemicals.  
 
4.4.1.2 Phosphorous flame retardants 
Phosphorous flame retardants are chemicals which are added to polymers to prevent 
combustion or to delay the spread of fire after ignition (Kemmlein et al., 2003). They 
have become more popular in recent years as alternatives to brominated flame 
retardants, which have seen greater restrictions in the EU and under the Stockholm 
Convention. Since they are not chemically bonded to the final product, they can leach 
out and enter the environment through a number of routes, including WWTW effluent 
(Rodriguez-Mozaz et al., 2007). Concentrations in surface water of up to 379 ng/L have 
been detected, although concentrations in µg/L range have been observed in WWTW 
effluents (van der Veen and de Boer, 2012). As a result, these chemicals are 
widespread contaminants of the aquatic environment, as evidenced by a survey of US 
rivers, which found trischloroethyl phosphate to be one of the most frequently detected 
chemicals (Kolpin et al., 2013). This study identified tri (butoxyethyl) phosphate, Tri-n-
butyl phosphate, triphenyl phosphate and trischloroethyl phosphate as known anti-
androgens, based on the MDA-kb2 breast cancer cell line (Ohyama et al., 2005). 
However, these chemicals were found to be inactive in the YAS. There are no further 
reports of anti-androgenic activity from these chemicals. However, trischloroethyl 
phosphate, also known as tri (2-chloroethyl) phosphate, has gained regulatory interest 
in the European Union (EU) under REACH and has recently been classified as a 
substance of high concern due to its reproductive toxicity (ECHA, 2009). Indeed, 
decreased sperm motility, sperm density and testes weight, as well as increases in 
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sperm abnormalities were observed in mice exposed to tri (2-chloroethyl) phosphate 
(Beth-Hübner, 1999). However, it is not known whether this is through an anti-
androgenic mode of action.  
 
4.4.1.3 Personal care products 
Like pharmaceuticals, a wide range of chemicals originating from personal care 
products have been detected in effluents and surface water, following human use, 
disposal and manufacturing (Boxall et al., 2012). They include UV screens, insect 
repellents, surfactants and other constituents of cleaning products, as well as fragrance 
chemicals and cosmetic products (Caliman and Gavrilescu, 2009). Many are in 
widespread use and as a result, some are high production chemicals, such as linalool, 
which is used as a fragrance agent in cleaning products. Others, such as caffeine, are 
constantly released by the human population and can therefore be seen as pseudo 
persistent chemicals in the receiving environment (Weigel et al., 2002). Of particular 
note in this study was the detection of the synthetic musk galaxolide (HHCB) and the 
biocides chlorophene, chloroxylenol, triclosan and its metabolite methyl triclosan. With 
the exception of methyl triclosan, these chemicals were detected in anti-androgenic 
fractions from fish bile and confirmed as anti-androgenic in the YAS and AR CALUX 
assays by Rostkowski et al. (2011) This study found triclosan and chlorophene to be 
significant contributors, accounting for 51% of the total anti-androgenic activity in fish 
bile (Rostkowski et al., 2011). Our study also found triclosan and chlorophene to be the 
most highly active anti-androgens detected by GC-MS in the fractions, exceeding the 
potency of flutamide. However, they were unlikely to be significant contributors to total 
anti-androgenic activity due to their low concentrations. In further contrast to 
Rostkowski et al., (2011) this study found that triclosan was more potent than 
chlorophene. In addition, methyl triclosan was found for the first time to be anti-
androgenic with a FluEQ of 6.1. However, chloroxylenol was highly toxic in our assay, 
to the extent that anti-androgenic activity could not be confirmed. In addition, no activity 
was detected for HHCB, which was identified during analysis of anti-androgenic 
fractions from river sediment in a previous study and found to be active in the AR 
CALUX assay (Weiss et al., 2011; Schreurs et al., 2005). This could have been a result 
of incompatibility with the yeast screen, possibly due to a lack of permeability of the cell 
wall for this chemical, which would not have occurred in the mammalian CALUX line. 
Further assessment of HHCB, using the solvent dimethyl sulfoxide instead of ethanol, 
could be completed since this can increase cell wall permeability (Beresford et al., 
2000). 
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There is very little literature on the presence of chlorophene in the aquatic environment 
or its effects in fish. However, triclosan has been subject to considerably more 
research. It has been detected in effluents and surface water globally, as well as fish 
bile, human urine and breast milk (von der Ohe et al., 2012; Allmyr et al., 2006; 
Houtman et al., 2004; Kolpin et al., 2002a). It is in high volume use and originates from 
soaps, toothpastes and other personal care products, where it is used as an anti-
septic. There have been few studies of its effects in fish, although so far there is no 
evidence to indicate that exposures to environmentally relevant concentrations can 
cause adverse effects. Indeed, paired medaka showed no differences in egg 
production or fertility in exposures up to 200 µg/L, although hepatic vitellogenin was 
induced at 20 µg/L, where embryo hatching was also adversely affected (Ishibashi et 
al., 2004). Similarly, impairment to swimming behaviour was observed in fathead 
minnows larvae exposed to 75 µg/L (Fritsch et al., 2013). In comparison, effluent 
concentrations are reported from 35 ng to 2.7 µg/L (reviewed in Ying and Kookana, 
2007) and so testing of environmentally relevant concentrations is warranted. So far 
the anti-androgenic activity for triclosan has not yet been confirmed in vivo. However, 
much more concerning is the impact on microalgae, which have been identified as the 
most sensitive species to triclosan, with a predicted no effect concentration for acute 
toxicity of 4.7 ng/L, well within the environmental range (von der Ohe et al., 2012). As a 
result of its toxicity and its widespread contamination to the aquatic environment, 
wildlife and humans, there have been recent calls for regulatory action against triclosan 
(Halden, 2014).  
 
4.4.1.4 Pesticides  
Pesticides, such as DDT and vinclozolin, were amongst the first environmental 
chemicals to be identified as anti-androgens, causing reproductive tract malformations 
in male rodent models (Kelce et al., 1998). Similar effects have also been observed in 
fish models, where reductions in sperm count, testes size, secondary sexual 
characteristics were observed alongside disruption to courtship behaviour (Baatrup and 
Junge, 2001). These chemicals have both agricultural and non-agricultural uses, 
entering the environment through runoff. However, WWTW effluent can also be a 
source, as evidenced by the presence of terbutryn and isoproturon in the UK3 effluent. 
Both of these chemicals are now part of the EU’s Water Framework Directive as priority 
pollutants and isoproturon was withdrawn from the market in 2009. Although many of 
these chemicals have been banned or restricted in some countries, they are still 
detected in the aquatic environment (Baugros et al., 2008). It has been well known for 
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a number of years that many pesticides in current use have endocrine disrupting 
properties and recent studies have found that many pesticides are anti-androgenic. 
Indeed, a study of endocrine activity in in vitro reporter gene assays using Chinese 
hamster ovary cell lines transfected with the human AR found that 66 out of the 200 
tested pesticides were anti-androgenic (Kojima et al., 2004). Of particular concern is 
the presence of this activity in a variety of current use pesticides, many of which are 
detected in the environment (Orton et al., 2011; Aït-Aïssa et al., 2010; Orton et al., 
2009). Out of these chemicals, isoproturon was the only known anti-androgenic 
pesticide detected in this study, in the UK3 fractions. However, its anti-androgenic 
activity was not confirmed at the concentrations employed in this study and it might be 
that greater concentrations are required to illicit a response in the yeast screen. Indeed, 
Orton et al. (2009) detected anti-androgenic activity for isoproturon in the YAS at 250 
µM in comparison to the 0.5 µM tested in this study to avoid toxicity (Orton et al., 
2009). Similarly, no activity was observed in a separate study employing the MDA-kb2 
breast cancer cell line at 1 and 10 µM (Aït-Aïssa et al., 2010). Subsequent analysis of 
the chemicals detected by GC-MS identified additional pesticides, including 
1,3,5,Triazine-2,4,6(1H,3H,5H)-trione, 2,3,4 Trichlorophenol and 2-Ethylhexyl diphenyl 
phosphate, as well as the herbicide 4-Chloro-2-methylphenoxy acetic acid. As a result, 
further assessment is warranted to analyse these chemicals, as is further testing of the 
activity of isoproturon at higher concentrations.  
 
4.4.1.5 Pharmaceuticals 
GC-MS analysis tentatively identified a set of pharmaceuticals in the WWTW effluent 
samples but not at the upstream river sites. They included the non-steroidal anti-
inflammatory inhibitors (NSAIDs) ibuprofen, naproxen and the diclofenac metabolite, 
diclofenac methyl ester. Based on the NHS prescriptions cost analysis for 2009, these 
were amongst the top 100 prescribed pharmaceuticals in the UK (The NHS Information 
Centre, Prescribing Support Unit, 2010). In addition, indomethacin methyl ester, the 
metabolite of another NSAID with a lower prescription rate was also detected. Out of 
this set of pharmaceuticals, indomethacin methyl ester and ibuprofen were of particular 
interest as potential anti-androgens. NSAIDs have recently gained significant interest 
from the human health perspective since the use of ibuprofen, asprin and another 
analgesic, paracetamol, by pregnant women was associated with congenital 
cryptorchidism in male offspring in a dose dependant manner (Kristensen et al., 2010). 
Cryptorchidism is indicative of anti-androgenic demasculinisation and has been 
associated with a number of anti-androgenic chemicals in mammalian studies (Gray et 
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al., 2001). However, it was also been suggested that this could be a result of 
prostaglandin synthesis inhibition by these chemicals. Prostaglandins have been 
shown to play a role in male development, inducing sertoli cell differentiation from 
somatic cells under the regulation of testosterone, demonstrating a role in the action of 
androgens (Adams and McLaren, 2002; Gupta, 1989). Indeed, ibuprofen is the most 
potent prostaglandin synthesis inhibitor of these chemicals and was associated with the 
highest risk of congenital cryptorchidism (Kristensen et al., 2010). Indomethacin was 
also found to have anti-androgenic effects in both foetal rat and adult human testes 
explants, where testosterone production was reduced (Albert et al., 2013; Kristensen et 
al., 2012). This suggests that it could be acting as a steroidogenesis inhibitor to exert 
these effects, but the exact mechanism is still subject to research and indomethacin 
methyl ester was not available for testing in this study. In addition, YAS screening of 
ibuprofen and its metabolite found no evidence of anti-androgenic activity, supporting 
the possibility of its anti-androgenic action through steroidogenesis inhibition. The other 
pharmaceuticals detected in this study, carbamazepine, phenobarbital, primidone and 
ethosuximide, are all used as anti-convulsants and range in their prescriptions. 
However, there was no previously reported anti-androgenic activity for these 
chemicals.  
The anti-androgenic pharmaceuticals targeted by predictive modelling in Chapter 2 
were not detected by this analytical technique, although they were predicted to be 
present in the effluents of UK1 and UK3. GC-MS depends on the volatisation of 
chemicals to a gaseous form for separation prior to analysis by mass spectrometry. It is 
likely that bicalutamide and cyproterone acetate were not possible to volatise during 
this process since they have higher molecular weights and boiling points than the 
pharmaceuticals that were successfully detected. However, the presence of 
pharmaceutical chemicals which can act as steroidogenesis inhibitors demonstrates 
that bicalutamide and cyproterone acetate are not the only pharmaceuticals in the 
environment which can potentially disrupt the androgen signalling pathway.  
 
4.4.1.6 Polyaromatic hydrocarbons 
PAHs are ubiquitous, persistent pollutants originating from incomplete combustion, 
although some are also high production chemicals, such as pyrene (WHO/UNEP, 
2013). Some, including benzo[a]pyrene, are listed under the Water Framework 
Directive as high priority substances due to their toxicity and mutagenicity (Brack et al., 
2007). They are widespread in the environment and are also commonly detected in the 
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human body (Woodruff et al., 2011). Benzo[a]pyrene, chrysene, pyrene and 
fluoranthene were found to be anti-androgenic in Chinese hamster ovarian cell lines, 
transfected with a transient AR (Vinggaard et al., 2000). Here, benzo[a]pyrene was the 
most potent chemical, whilst pyrene was only shown to be moderately active. This 
contrasts with findings from this study, which only confirmed activity in pyrene, which 
was found to be more potent than flutamide. However, another in vitro assessment of 
PAHs, has suggested alternative mechanisms for their anti-androgenic responses. 
Here, PAHs which were anti-androgenic in the LNCaP human prostate cancer cell line 
did not to bind to the AR itself. However, they were aryl hydrocarbon receptor (AhR) 
agonists and it was suggested that this caused activation of the transcription factor 
activator protein-1 (AP-1), which interacted with the AR to inhibit its binding to the 
androgen response element (Kizu et al., 2003a). Indeed, by adding an AhR antagonist 
the anti-androgenic response from the cell line was reversed. In agreement, the study 
by Vinggaard et al., found that some of the most potent AR antagonists were also the 
most potent AhR agonists (Vinggaard et al., 2000). These chemicals included 
Benzo[a]pyrene and chrysene, but not pyrene, which was inactive in the LNCaP cell 
line, suggesting that there may be differences in assay sensitivity between mammalian 
LNCaP cells and the YAS for this chemical (Kizu et al., 2003a). Indeed, pyrene was 
also found to be inactive in the mammalian AR CALUX assay after it was identified in 
anti-androgenic fractions of extracted sediment from Belgium (Weiss et al., 2009).  
 
4.4.2 Contributions to environmental anti-androgenic activity 
Whole effluent extracts from UK1 and UK3 were found to contain 242 µg/L and 325 
µg/L FluEQ respectively, which compare well with anti-androgenic activity detected in a 
UK survey of 43 WWTWs that ranged from 21.3 to 1,231 μg/L FluEQ (Johnson et al., 
2007b). However, the confirmed anti-androgens detected in the fractionated samples 
made very minor contributions to the total activity of extracted whole effluent samples. 
Although some were very potent anti-androgens, the low concentrations at which they 
were present meant that they could only explain 0.08% and 0.24% of the total activity 
in UK1 and UK3. This concurs with previous studies of anti-androgenic activity in 
complex environmental samples where targeted analysis has only been able to explain 
a small proportion of the measured activity (Kinani et al., 2010; Urbatzka et al., 2007). 
A majority of the confirmed anti-androgens were not found in active fractions; further 
indicating the presence of other chemicals which this EDA was unable to detect. Since 
activity was diluted throughout a number of fractions, it is likely that the anti-androgenic 
activity detected originated from a range of chemicals with a range of chemical 
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properties. However, further analysis is required to properly identify these chemicals, 
which will be further discussed. 
It should be considered that assessing chemicals for AR antagonism through the use of 
bioassays will not capture 5α-reductase inhibitors, which were identified in this study by 
literature review. These chemicals can reduce the conversion of testosterone to DHT 
through enzyme inhibition of the two 5α-reductase isoforms and can cause anti-
androgenic effects through this mechanism. DHT is a more potent androgen than 
testosterone and plays an important role in sexual development and the regulation of 
secondary sexual characteristics in vertebrates (Langlois et al., 2010). However, it is 
only recently that DHT was found to be a physiologically important androgen in fish, 
where previously it was assumed that testosterone and 11-ketotestosterone were the 
only functional endogenous androgens (Margiotta-Casaluci and Sumpter, 2011). As a 
result, the presence of 5α-reductase inhibitors, or indeed this activity in effluent, has 
received little attention from the perspective of endocrine disruption in fish. 
Nonetheless, DHT has now been detected in fish, where it is produced mainly in the 
testes in fathead minnows, and 5α-reductase enzymes have been sequenced in 
zebrafish (Margiotta-Casaluci et al., 2013a; Martyniuk et al., 2013). In vivo, DHT was 
found to have a similar potency to 11-ketotestosterone when increasing somatic 
growth, inducing secondary sexual characteristics and disrupting ovarian morphology, 
to the extent that testicular tissue was observed in females (Margiotta-Casaluci and 
Sumpter, 2011). Consequently, physiology and reproductive capacity can be affected 
in fish exposed to 5α-reductase inhibitors, with the pharmaceutical dutasteride causing 
a reduction in fecundity and secondary sexual characteristics in fathead minnows 
(Margiotta-Casaluci et al., 2013b). The effects of these chemicals are better 
characterised in mammalian models, where they have been shown to disrupt 
reproductive development in males, inducing hypospadias, nipple retention and 
reducing ano-genital distance (Bowman et al., 2003). In addition, when incorporated in 
a mixture with AR antagonists and testosterone synthesis inhibitors, additive effects 
and even synergistic effects were observed in endpoints relating to sexual 
development in rats (Christiansen et al., 2009). As a result, 5α-reductase inhibitors 
warrant further research due to their potential impacts in fish and their environmental 
presence.  
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4.4.3 Future considerations for effect directed analysis of environmental 
anti-androgens 
It is clear that further assessment is required to better characterise anti-androgenic 
chemicals in environmental samples. However, as this study has found, the task 
presents a significant challenge. WWTW effluents are complex samples due to the 
large numbers of chemicals present, including metabolites and breakdown products, of 
which many remain uncharacterised. Consequently, EDA still remains a sensible tool 
for use in identifying and targeting chemicals of interest from the plethora available in 
the environment. However, the method needs to be adapted to improve the efficacy of 
this type of assessment for identifying anti-androgens. The results of this study have 
provided a number of insights, which can be used to inform and drive modifications in 
the EDA method. These are discussed below and include changes to sample collection 
and extraction, fractionation, direction of analysis with in vitro bioassays and the final 
chemical identification stage. 
It was clear from the fractionation procedure that the anti-androgenic activity detected 
in the whole effluent sample was diluted out between a number of fractions, indicating 
that chemicals with a range of chemical properties were contributing. As a result, only 
partial dose response curves were achieved when the fractions were tested in the YAS. 
This could also be a result of inevitable chemical loss or degradation during the EDA 
process, resulting in a low recovery of the total activity of the effluent samples. Indeed, 
failure of SPE to capture or elute chemicals and adherence to glassware during sample 
concentration would result in chemical loss. To mitigate against low recovery and 
spread of chemicals throughout the fractions, extraction of greater volumes than the 
2.5 L samples collected in this study could be employed. Indeed, previous studies 
employing EDA have tended to use large volume extractions. When the steroid 
oestrogens were first detected in WWTW effluent fractions a 20 L volume had been 
extracted (Desbrow et al., 1998). In comparison, other studies of anti-androgenic 
activity using EDA began by extracting 10 L of river water samples from Italy, whilst 
Thomas et al. (2009) extracted 50 L of offshore produced water (Thomas et al., 2009; 
Urbatzka et al., 2007). This would also increase concentrations of chemicals in 
fractions for yeast screening, making them more likely to produce full response curves 
to improve the direction of analysis. However, based on the spread of activity in the 
fractions from this study, there is the potential that a large number of chemicals at low 
concentrations could be contributing to the total activity and producing a “something 
from nothing” effect. As a result, some chemicals may not all be present in active 
fractions, as was observed with the potent anti-androgens, triclosan and methyl 
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triclosan, during this study. Future analysis should therefore assess the percentage of 
the total activity recovered in active fractions, by combining active fractions and 
retesting the composite sample in the YAS. Unfortunately, due to limited sample 
volume this could not be completed as part of this study.  
Producing fractions from higher sample volumes may induce toxicity during yeast 
screening, which could mask anti-androgenic activity, as a result of the increased 
chemical concentrations. Arguably, the androgenic activity identified in the fractions in 
this study could also have masked the presence of some chemicals. Indeed, one of the 
more potent anti-androgens, chlorophene, was detected in an androgenic fraction in 
UK1. These masking effects could be avoided through a greater degree of separation, 
which could be achieved by two-dimensional liquid chromatography. This involves the 
application of two independent separation systems to a sample, which significantly 
increases peak capacity (the resolving power) over the one dimensional 
chromatography used in this study (Stoll et al., 2007). Nonetheless, this would produce 
a greater number of fractions for in vitro analysis. 
In vitro bioassays still have the potential to play a key role in directing an EDA for AR 
antagonists, to reduce the number of chemicals for screening and to better identify 
causal chemicals. Indeed, they have been used successfully in a range of similar 
studies identifying endocrine disruptors following effluent fractionation (Rostkowski et 
al., 2011; Weiss et al., 2009; Urbatzka et al., 2007; Desbrow et al., 1998). However, a 
number of confounding factors were observed during this study, which should be 
considered when developing and interpreting EDA approaches to ensure adequate 
direction and confirmation is achieved. Firstly, the edge effect was observed in some 
plates when samples were tested. Here, a decrease in 540 nm absorbance occurred in 
the peripheral wells of the plate to produce a shallow U shaped curve. This is a known 
factor responsible for reducing assay performance in in vitro screens, which has led 
some researchers to avoid using the peripheral wells at the cost of throughput. It can 
be caused by thermal gradients across plates during incubation and one study showed 
that this could be reduced by leaving plates at room temperature prior to incubation 
(Lundholt et al., 2003). The second factor affecting the absorbance was the alterations 
in turbidity caused by proliferative and toxic effects of the chemical standards on the 
yeast cells during confirmation of activity. It was clear that 540 nm values could not be 
sufficiently corrected and highlighted the importance of assessing turbidity alongside 
the AR mediated response to explain the observed effects. This was particularly 
evident for methyl triclosan, where an increase in turbidity was associated with an 
increase in corrected 540 nm absorbance, which alone would otherwise suggest 
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androgenic activity. Toxicity was also evident in the chemical standards, which 
exacerbated the 540 nm absorbance readings. Interestingly, flutamide was also shown 
to be toxic, although this varied between assays even though it was tested at the same 
concentration throughout the study. This has been observed previously by Orton et al., 
who switched to using the anti-androgenic pesticide, procymidone, as a positive 
control, since it was nontoxic to the MDA-kb2 cell line (Orton et al., 2011). This is 
presently being tested in the YAS at Brunel to assess toxicity and anti-androgenic 
activity for its potential use as a positive control. In the case of the chemical standards, 
wells where toxicity was observed were not used to determine the potency of the 
chemical. However, it is plausible that chronic effects could be occurring in the cells 
below the concentrations at which acute toxicity was observed. This could have 
affected the production of enzyme β-galactosidase and could have in turn impacted the 
540 nm absorbance. As a result, the anti-androgenic activity of some chemicals could 
have been overestimated, which could explain why the toxic triclosan was more potent 
than nontoxic chlorophene, in contrast to in vitro screening of anti-androgens by 
Rostkowski et al. (2011). The possibility of chronic effects on cellular machinery is 
presently being tested at Brunel with the use of mitochondrial assays, such as the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Van Meerloo 
et al., 2011). 
Following fractionation and in vitro analysis, this study employed GC-MS and a mass 
spectral library to tentatively identify chemicals within the samples. However, this only 
identified 15-30% of the chemicals detected by GC-MS, the rest were unknown. It 
should be considered that the use of GC-MS in identifying chemicals is limited to 
nonpolar and medium polarity chemicals, which can evaporate without degradation. As 
a result, polar compounds, ionic compounds and those with higher molecular weights, 
such as some pharmaceuticals and personal care products, are less effectively 
analysed (Burgess et al., 2013). This was clearly an issue during this study, where few 
confirmed anti-androgens were found in the active fractions, showing that chemicals 
were being overlooked by this analytical technique. This suggests that further 
fractionation of active fractions to target anti-androgens during this study would not 
have been an effective means of further analysis, if GC-MS was used to detect and 
identify chemicals.  
To improve the detection and identification of chemicals, alternative instrumentation 
could be employed. Some recent research has employed LC-MS to identify individual 
chemicals in complex mixtures. However, at present the spectral libraries associated 
with these techniques are not as extensive as those used for GC-MS, although they 
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are being developed. Alternatively, methods of identification using more sensitive 
analytical procedures, such as time of flight mass spectrometers and the Orbitrap have 
been proposed for use. Indeed, a high-resolution LTQ-Orbitrap has been used in an 
EDA for anti-androgens and identified a set of eight chemicals, including an 
oxygenated polyaromatic hydrocarbon, organophosphates, musks, and steroids (Weiss 
et al., 2011). Time of flight mass spectrometers and the Orbitrap both have a higher 
mass accuracy and resolution than standard mass spectrometers, combined with high 
full spectrum sensitivity, which increases the identification reliability when proposing 
structures (Jernberg et al., 2013; Zwiener and Frimmel, 2004). They can also be used 
alongside accurate mass databases to identify specific chemicals in a similar way to 
the use of spectral libraries with GC-MS (Becue et al., 2011). However, there are 
significantly higher costs associated with operating these instruments, which were 
outside of the budget for this project. 
A final consideration is the environmental media analysed by the EDA process.  The 
bile of fish exposed to WWTW effluent can be used to analyse compounds that are 
bioavailable.  Unlike analysis of effluents, this has the advantage of only assessing 
compounds that are uptaken by fish, which might be more relevant to any biological 
effects observed.  In addition, some compounds bioconcentrate in bile, bringing their 
concentrations above LODs of analytical instruments which may exceed effluent 
concentrations.  This was the case with the equine oestrogen metabolite, 17β-
dihydroequilenin, which was bioconcentrated in bile from a pictogram to low ng/L 
concentration in effluent (Gibson et al., 2005).  Whether this is the case for triclosan, as 
a significant contributor to activity in bile of effluent exposed fish but not our tested 
effluents, remains to be determined (Rostkowski et al., 2011). Nonetheless, 
characterising the contents of WWTWs effluents to determine what compounds are 
released into the environment remains an important line of research.  Particularly given 
that inter and intra species differences in uptake, bioconcentration, metabolism and 
elimination of compounds has been documented (Gibson et al., 2005; Tyler et al., 
2005).   
 
4.4.4 Conclusions 
EDA was used to identify chemicals contributing to ant-androgenic activity in WWTW 
effluents and river water samples through the use of fractionation and the YAS screen. 
Literature searches were employed to identify known anti-androgens, of which of 26 
were identified for further screening. Of these chemicals, five were confirmed as anti-
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androgenic in the YAS and two were tentatively identified. These had a wide range of 
origins and included fatty acids, personal care products, pesticides and PAHs. Some, 
such a triclosan, were highly potent chemicals but due to their low concentrations, the 
confirmed anti-androgens were only considered to make a minor contribution to the 
total anti-androgenic activity (<1%). In addition, only two were detected in active 
fractions from the effluent samples. It was clear that the issue of anti-androgenic 
activity in the environment encompasses chemicals beyond the known anti-androgens 
detected by broad scan GC-MS. More work is therefore required to characterise 
additional chemicals in effluent using more advanced instrumentation to improve the 
detection and identification of the as yet unknown contaminants.  
 
  
211 
 
 
5. CHAPTER 5: GENERAL DISCUSSION AND 
FUTURE PERSPECTIVES  
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5.1 Summary 
Significant progress was made in achieving the overall project aim. To summarise, a 
set of anti-androgenic chemicals with diverse origins were identified in environmental 
samples through predictive modelling and effect directed analysis (EDA). However, 
they were expected to only make a minor contribution to total anti-androgenic activity 
identified in the samples. More work is therefore required to further characterise 
environmental anti-androgens and to identify significant contributors to this activity. An 
EDA of South Australian WWTWs effluents is also still currently underway for 
comparison with the UK scenario. The anti-androgenic pharmaceuticals were assessed 
in vivo and found to have no effect on sexual disruption in fish at environmentally 
relevant concentrations, alone or in combination with steroid oestrogens. However, this 
does not mean that the plethora of anti-androgenic chemicals present in rivers that 
make up the measured activity do not have such effects on wild fish in an 
environmental scenario.  In comparison, mixtures of steroid oestrogens induced an 
environmentally relevant incidence and severity of intersex at concentrations 
comparable with those observed in rivers and WWTW effluents. This supports the 
possibility that steroid oestrogens are major drivers of intersex in wild fish. In addition, 
the use of hydrological modelling predicted that steroid oestrogen concentrations in the 
environment are likely to increase in the future, in the first assessment of future trends 
in concentrations of these chemicals in surface water. The progress in identifying and 
assessing anti-androgens and possible future directions are further discussed below.  
 
5.2 Identifying environmental anti-androgens 
This thesis project employed two methods to identify likely anti-androgenic 
contaminants. The first method employed was predictive modelling of anti-androgenic 
pharmaceuticals, on the basis that one of the potent environmental oestrogens, 17α-
ethinylestradiol (EE2), is an active pharmaceutical ingredient (Caldwell et al., 2012). In 
the absence of any previous recording of these chemicals in the UK and Australia, this 
study predicted that anti-androgenic pharmaceuticals were likely to occur in UK and 
South Australian effluents and rivers in low ng/L concentrations. Differences between 
countries were also predicted due to their differential prescriptions. Further hydrological 
modelling, to put exposure concentrations used in chapter three in context, also found 
that contamination of river catchments across England and Wales by bicalutamide and 
cyproterone acetate was likely to be widespread. However, the median concentrations 
were expected to be below 10 ng/L for both chemicals.  
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The second, broader approach employed EDA to detect anti-androgenic chemicals in 
UK effluents and river samples. This part of the study employed broad scan GC-MS 
alongside chemical identification with mass spectral libraries and literature searching to 
identify known anti-androgens. These included fatty acids, flame retardants, 
polyaromatic hydrocarbons, personal care products and pesticides. In total 24/26 
compounds underwent in vitro screening with the yeast androgen screen, of which 
triclosan, chlorophene, methyl triclosan, pyrene and tetradecanoic acid, were confirmed 
as anti-androgenic. With the exception of tetradecanoic acid, these were highly potent 
chemicals, exceeding the potency of flutamide. In addition, 9,12-octadecadienoic acid 
methyl ester and dodecanoic acid were tentatively identified as anti-androgens since 
full dose response curves were not achieved in this study. Nonetheless, when the 
potencies and concentrations of these chemicals were combined, it became clear that 
they were still likely to make a very minor contribution to the total anti-androgenic 
activity observed in the WWTWs effluents sampled. A similar EDA process was also 
employed using effluents from three of the South Australian WWTW’s involved in the 
modelling analysis in chapter one. However, work is still underway to tentatively identify 
the chemicals in the active fractions from these samples. As a result, although work will 
continue to analyse these samples, at present the question of the identity of anti-
androgenic chemicals in Australian effluents and their potential contribution to total 
activity remains unanswered by this thesis.  
The question of which contaminants are significant contributors to anti-androgenic 
activity is a complex one, which needs to take into account both concentration and in 
vitro potency. Indeed, this study has shown that the relative contribution of high 
potency chemicals, such as triclosan and chlorophene, was limited by their low ng/L 
concentrations. This is also likely to be the case for the anti-androgenic 
pharmaceuticals, modelled in chapters two and three, which were predicted to occur in 
the low ng/L range. However, screening of the pharmaceuticals found bicalutamide to 
be repeatedly inactive in the YAS when serially diluted from 1 mM, whilst cyproterone 
acetate had a reproducible androgenic profile (Figure 5.1). This suggests that they are 
unlikely to contribute to the anti-androgenic activity measured in environmental 
samples by yeast screen. Since bicalutamide is a pure AR antagonist, as indicated by 
preclinical trials with mammalian cell lines (Furr and Tucker, 1995), this response may 
be an issue of cell wall permeability within the yeast screen. Indeed, bicalutamide is 
anti-androgenic in a number of in vitro bioassays and has been used as a positive 
control in an inter-laboratory comparison of four different AR based mammalian cell 
lines (Körner et al., 2004). Interestingly, bicalutamide was also shown to poorly 
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penetrate the blood-brain barrier in tissue distribution studies in rats. This explained the 
peripheral selectivity observed in rats treated with bicalutamide, which was not 
observed in studies of flutamide (Furr and Tucker, 1995). In comparison, there is in 
vivo evidence of androgenic effects of cyproterone acetate, which is a partial agonist 
and was shown to cause a 60% increase in the prostate weight of castrated rats 
following exposure (Poyet and Labrie, 1985). This would explain the induction of a 
maximal response on top of the DHT background in the yeast screen at the 
concentrations tested. 
 
Figure 5.1 Bicalutamide and cyproterone acetate tested in the YAS, serially diluted 
from 1 mM with a background of 2 nM DHT. 
 
If the situation with anti-androgens is similar to that of the steroid oestrogens, where a 
few chemicals explain the vast majority of oestrogenic activity, concentrations of the as 
yet unknown, significant contributors would have to be in µg/L range. This could explain 
the hundreds of µg/L flutamide equivalent activity which has been quantified frequently 
in environmental samples (Johnson et al., 2007b). These chemicals would also need to 
be common contaminants of WWTW effluent and are likely to have a human origin in 
their use due to their frequent association with domestic effluents (Johnson et al., 
2007b). Alternatively, a much larger number of chemicals could be acting additively at 
lower concentrations to cause this response in vitro and the circumstances could even 
be similar to the something from nothing effect documented for oestrogenic EDCs 
(Brian et al., 2005; Silva et al., 2002). This thesis also suggests that significant 
contributors to in vitro activity in effluents may differ from those associated with effects 
in fish. Indeed, whilst triclosan and chlorophene are only likely to play a minor role in 
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the total anti-androgenic activity in effluent (<1%), they were found to explain 51% of 
the total activity detected in fish bile, where they had accumulated (Rostkowski et al., 
2011). As a result, to better understand the risk posed by anti-androgens to fish health, 
further analysis of the possible in vitro-in vivo differences driven by their different 
pharmacokinetic interactions is required.  
In agreement with previous studies, it is clear from these results that currently known 
anti-androgens identified in environmental samples cannot explain the anti-androgenic 
activity detected (Kinani et al., 2010; Urbatzka et al., 2007). Further work is required to 
better characterise the causal chemicals and, although the methodology encountered 
difficulties, EDA remains suitable for this assessment. Indeed, starting with a greater 
extraction volume will benefit the in vitro screening process in accurately identifying 
active HPLC fractions, although biological screening should still be scrutinised for 
confounding factors, particularly toxicity. With better direction of analysis, it will be 
easier to reduce the number of chemicals required for identification and assessment 
out of the thousands found in WWTW effluent. In addition, as more chemicals are 
identified as known anti-androgens, it may become easier to identify contributors to the 
total activity in environmental samples. Indeed, preliminary results from the Tox21 
program found that almost 10% of the 1,462 chemicals tested were anti-androgenic 
androgen receptor (AR) antagonists in vitro, which supports the possibility of a large 
number of contributors to environmental activity (Tice et al., 2013). These are only the 
results from initial phase I testing in a US collaboration aiming to screen thousands of 
chemicals, associated with human exposure, for toxicity. The next stage of screening 
incorporates a library of over 10,000 chemicals including industrial chemicals, 
sunscreen additives, flame retardants, pesticides, plasticizers, solvents, food additives, 
natural product components, drinking water disinfection by-products, preservatives, 
therapeutic agents, and chemical synthesis by-products. As a result, the publically 
available output of high throughput screening programs such as this will be useful in 
identifying more known anti-androgens in the environment. Nonetheless, WWTW 
effluent is a complex mixture of chemicals, their derivatives and transformation 
products, and further screening of chemicals without known activity will still be required.  
The use of more advanced instrumentation can also reduce the number of unknown 
chemicals in complex samples to ease the identification of possible anti-androgens. For 
example, the use of gas chromatography coupled with time of flight mass spectrometry 
has a much higher mass accuracy than standard GC-MS and still allows for the use of 
spectral libraries (Jernberg et al., 2013). Nonetheless, gas chromatography remains 
limited to nonpolar and medium polarity chemicals which can evaporate without 
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degradation (Burgess et al., 2013). To avoid overlooking chemicals, alternative 
methods such as LC-MS/MS or Orbitrap could play an important role, particularly as 
accurate mass databases to identify specific chemicals advance (Becue et al., 2011). 
Indeed, the Orbitrap has been recently employed in an EDA of anti-androgens in river 
sediment samples, identifying anti-androgenic organophosphates, musks, steroids and 
an oxygenated polyaromatic hydrocarbon (Weiss et al., 2011).  
Since anti-androgenic activity in the environment is associated with domestic WWTW 
effluent, environmental anti-androgens are also likely to be associated with human 
exposures (Johnson et al., 2007b). This is well demonstrated by the detection of anti-
androgenic activity in both domestic greywater and wastewater from Beijing, which was 
not completely removed during wastewater treatment (Ma et al., 2013). Indeed, there is 
known human exposure to many of the identified and confirmed anti-androgens from 
this thesis. Some, including polyaromatic hydrocarbons, HHCB and triclosan have also 
been identified in human tissue, serum, urine and breast milk (Moon et al., 2012; von 
der Ohe et al., 2012; Reiner et al., 2007; Somogyi and Beck, 1993). In fact, triclosan is 
now regularly monitored by the US Centres for Disease Control and Prevention as part 
of ongoing assessment of human exposure to chemicals (Centers for Disease Control 
and Prevention, 2013). Interestingly, the research presented in this thesis on anti-
androgens in the environment has found itself in a similar situation to research on the 
implications of anti-androgenic EDCs on human health. Indeed, in a recent study, a 
combination of 22 AR antagonists at concentrations detected in human serum did not 
produce measurable effects in the MDA-kb2 cell line when tested in a mixture at 
concentrations at which they were detected in human serum (Kortenkamp et al., 2014). 
Consequently, there also remains a knowledge gap between the known contaminants 
and the occurrence of reproductive abnormalities associated with testicular dysgenesis 
syndrome. This also suggests that additional chemicals with high potency anti-
androgenic activity or high exposure are required to fill this gap. However, this study 
was based on AR antagonism and does not include alternative modes of anti-
androgenic activity, such as steroidogenesis and prostaglandin synthesis inhibition, 
which may also contribute to the pathologies observed in the human population. This 
limits the results of the study since the human population is known to be exposed to 
some steroidogenesis inhibitors, such as the phthalate esters, which can cause 
cryptorchidism, hypospadias and impaired spermatogenesis in rodents (Sharpe and 
Skakkebaek, 2008).  
Anti-androgenic chemicals with different mechanisms of action have been shown to act 
additively or even synergistically in vivo (Pottinger et al., 2013; Hotchkiss et al., 2010; 
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Christiansen et al., 2009). In this thesis, by identifying anti-androgens by literature 
review, chemicals capable of inhibiting steroidogenesis were identified, such as 5α-
reductase inhibiting fatty acids, which were generally inactive in the yeast screen. So 
far these mechanisms have not been considered as part of the multi-factorial aetiology 
of sexual disruption in the wild fish. Indeed, since 5α-dihydrotestosterone (DHT) was 
not previously thought to be a physiologically important androgen in fish, this 
mechanism of 5α-reductase inhibition has been largely ignored. However, recent 
research has detected DHT and mRNA for isoforms of the 5α-reductase enzyme in fish 
and found that the androgen can cause significant, masculinising affects in vivo 
(Margiotta-Casaluci et al., 2013a; Martyniuk et al., 2013; Margiotta-Casaluci and 
Sumpter, 2011). Furthermore, the pharmaceutical 5α-reductase inhibitor, dutasteride, 
caused reductions in fecundity and secondary sexual characteristics during a fathead 
minnows pair breeding assay (Margiotta-Casaluci et al., 2013b).  
Other steroidogenesis inhibitors have also been linked to effects associated with anti-
androgens and include some pharmaceuticals. For example, clofibrate, gemfibrozil, 
ibuprofen, diclofenac, fluoxetine and fluvoxamide have been linked to the disruption of 
carp steroidogenic enzymes in vitro (Fernandes et al., 2011). The non-steroidal anti-
inflammatory inhibitor (NSAID), indomethacin, was also found to be anti-androgenic in 
both foetal rat and adult human testes explants, where testosterone production was 
reduced (Albert et al., 2013; Kristensen et al., 2012). However, the exact mechanism 
remains to be characterised. Recent research also found that maternal use of 
pharmaceutical analgesics, such as ibuprofen, asprin and paracetamol, was associated 
with cryptorchidism in newborns (Kristensen et al., 2010). Interestingly though, this is 
likely to be a result of prostaglandin synthesis inhibition, rather than a direct effect on 
circulating androgens or AR antagonism. This is thought to occur through direct 
inhibition of cyclooxygenase (COX) enzymes, which mediate the conversion of 
archidonic acid to prostaglandins. Prostaglandins have been shown to play a role in 
male development, inducing Sertoli cell differentiation from somatic cells under the 
regulation of testosterone, demonstrating a role in the action of androgens (Adams and 
McLaren, 2002; Gupta, 1989). Consequently, prostaglandin synthesis inhibition may be 
an additional anti-androgenic mode of action for some EDCs (Kristensen et al., 2011). 
Indeed, a number of known environmental EDCs, including benzophenones, phthalates 
and parabens, were found to be prostaglandin synthesis inhibitors in cell lines and ex 
vivo rat testes (Kristensen et al., 2011). Nonetheless, there is little study of this mode of 
action in environmental samples, and this has not yet been considered within the multi-
factorial aetiology to sexual disruption in fish. It also demonstrates that there are likely 
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to be other pharmaceuticals in the environment with the potential to cause androgen 
disruption other than just bicalutamide and cyproterone acetate. As a result, further 
study to identify and assess additional mechanisms of action is required to determine 
their potential implications for sexual disruption in fish, particularly during early 
development.  
 
5.3 Assessing anti-androgenic pharmaceuticals in vivo 
Research suggests that the steroid oestrogens, 17β-oestradiol (E2), oestrone (E1) and 
EE2 are the major drivers of sexual disruption in wild fish downstream of WWTW 
effluent outfalls (Tanna et al., 2013; Maltret-Geraudie et al., 2008; Jobling et al., 2006; 
Allen et al., 1999). This thesis provides further evidence to support this assertion, 
demonstrating that a mixture of the three steroid oestrogens at concentrations relevant 
to UK rivers and WWTW effluents could induce intersex in Japanese medaka in a dose 
responsive manner. However, whether this was an effect of a combination of the three 
oestrogens or that of a single chemical could not be proven by the experiment 
employed. Nonetheless, combined effects of oestrogenic chemicals have been 
reported in vitro, as well as in fish models for vitellogenin induction and reproductive 
endpoints (Brian et al., 2007; Brian et al., 2005; Rajapakse et al., 2002; Silva et al., 
2002). It remains plausible that this will also be the case for intersex induction.  
Predictive hydrological modelling supports the possibility of a multifactorial aetiology 
behind this condition involving androgen blockade by environmental AR antagonists 
(Jobling et al., 2009). Associations between modelled concentrations of oestrogenic 
chemicals, oestrogenic and anti-androgenic activity at capture sites and the biological 
responses observed in fish (from Jobling et al., 2006) were investigated. The data 
suggested that “anti-androgens are strong causal factors [in the feminisation of wild fish 
in UK rivers], necessary for severe effects to occur” (Jobling et al., 2009). Indeed, 
predicted anti-androgenic activity at capture sites was positively correlated with 
vitellogenin induction, the presence of oocytes, intersex index and feminised ducts. 
There was also evidence of an additive effect of anti-androgenic activity in combination 
with steroid oestrogens influencing the presence of oocytes, intersex index and 
feminised ducts.  
Whilst there is experimental evidence supporting the multi-factorial aetiology behind the 
induction of intersex in fish, there is little physical evidence to support the modelling 
study to suggest that this is occurring in the wild. Since anti-androgenic 
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pharmaceuticals were predicted to be present in the environment, the effects of 
bicalutamide and cyproterone acetate on sexual disruption at relevant concentrations 
were investigated in this project. This also incorporated exposures in combination with 
steroid oestrogens to further explore the possibility of a multi-factorial aetiology in 
sexual disruption. These experiments found no statistically significant effects of the 
chemicals on endpoints including vitellogenin induction, secondary sexual 
characteristics and intersex at their tested concentrations for the experimental 
durations and life stages tested. In combination with oestrogens, vitellogenin induction 
and intersex responses were slightly higher than the oestrogen treatment alone, but 
this was not statistically significant. Although cyproterone acetate has been shown to 
cause changes to plasma sex steroid levels in fish at these concentrations (Sharpe et 
al., 2004), physiological responses, including intersex, have only been observed 
following exposure to concentrations in µg/L (Kiparissis et al., 2003). Similarly for 
bicalutamide, intersex was not observed in an exposure of up to 100 µg/L (Panter et 
al., 2012). As a result, the lack of significant effects observed during this thesis project 
is likely to be due to the comparatively low concentrations of anti-androgenic 
pharmaceuticals employed. This suggests that the presence of these drugs alone are 
unlikely pose an environmental threat to fish health. Nonetheless, these data do not 
refute experimental data indicating a multi-causal aetiology to sexual disruption. Nor do 
they refute the possibility that more complex mixtures of anti-androgenic activity in the 
environment could be a significant driver of sexual disruption alone.  
Theoretically, a multi-factorial aetiology incorporating anti-androgens is well supported. 
Anti-androgenic chemicals can antagonise the AR to block androgen action at target 
sites and can also further disrupt the endogenous hormone balance by blocking the 
negative feedback of testosterone in the brain. This responds with increased release of 
gonadotrophic hormones, which in turn increases circulating concentrations of steroid 
hormones to produce an oestrogenic internal environment due to the continued 
blockade of the AR (Jensen et al., 2004; O'Connor et al., 2002; Staiman and Lowe, 
1997). Consequently, previous research has found that anti-androgenic chemicals 
cause demasculinisation in fish, including reductions in secondary sexual 
characteristics, effects on behaviour, intersex induction and low levels of vitellogenin 
induction (Sebire et al., 2009; Sebire et al., 2008; Kang et al., 2006; Ankley et al., 2004; 
Panter et al., 2004). In addition, at a molecular level, anti-androgens have been shown 
to decrease the expression of multiple genes involved in testicular differentiation 
(Rajakumar et al., 2012; Filby et al., 2007a). However, although there is abundant 
evidence to suggest that anti-androgens can act additively (Pottinger et al., 2013; 
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Hotchkiss et al., 2010; Christiansen et al., 2009; Hass et al., 2007; Earl Gray Jr. et al., 
2006), apart from the experiments described in this thesis there has been little attention 
paid to the possibility of interactions between anti-androgens and oestrogens. There is 
one report of a set of bioavailable anti-androgens enhancing the incidence of ovarian 
cavities in roach in combination with 3 ng/L EE2 (Lange et al., 2012a). However, this 
has not yet been published in full. Nonetheless, mechanistically the possibility of 
combined effects seems plausible. Indeed, an increase in the internal oestrogenic 
environment by anti-androgens through blockade of the AR or feedback on sex 
steroids could be supplemented by exposure to environmental oestrogens. In addition, 
flutamide has been shown to increase the expression of oestrogen receptors β and γ in 
fathead minnows (Filby et al., 2007b) and oestrogen receptor α in a recent study with 
Murray rainbowfish (Bhatia et al., 2014). This may suggest that oestrogens could act 
additively with anti-androgens in a mixture context, possibly with anti-androgens 
sensitising an organism to oestrogenic effects. This could be assessed through 
mechanistic studies with fish, for example by exposing fish to flutamide and E2 alone 
and in combination at a range of doses. This would determine whether androgen 
blockade in conjunction with oestrogen exposure could induce intersex in a mixture 
scenario.  However, increasing appreciation of anti-androgenic chemicals that operate 
without interacting with the AR highlights the possibility that additional modes of action 
may be involved in the multifactorial aetiology to sexual disruption. Indeed, endocrine 
activity of WWTW effluents and their constituent chemicals is not limited to only anti-
androgenic and oestrogenic activity. This has been recently highlighted by an 
assessment of 10 Australian water samples, including WWTW effluent, surface water 
and recycled water, by 103 unique bioassays for a range of biological endpoints 
(Escher et al., 2014). This found that 63% of the assays were active in at least one 
water sample. The most responsive biological endpoints related to xenobiotic 
metabolism, genotoxicity, hormone mediated modes of action and the adaptive stress 
response pathway. As a result, to truly determine whether chemicals in effluent other 
than the steroid oestrogens can cause or contribute to sexual disruption, exposure of 
fish to fractionated WWTW effluent could be employed. This could involve exposure to 
a mixture of the non-oestrogenic fractions alone and in combination with steroid 
oestrogens, as shown in Figure 5.2. 
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Figure 5.2 Experimental design for exposure of Japanese medaka embryos to WWTW 
effluent fractions to assess the multi-factorial aetiology of sexual disruption. 
 
This could also incorporate more modern molecular methods for assessing the intersex 
condition using biomarkers, which have been developed in medaka (Hirakawa et al., 
2012; Zhao and Hu, 2012; Flynn et al., 2010). A number of oocyte genes have been 
proposed as biomarkers, of which one of the most applicable is ovary structure protein 
1 (osp1). Out of a set of candidate genes, osp1 achieved the highest transcriptional 
induction in males following EE2 exposure, which was comparable to that of 
unexposed females. In comparison to histological processing, the gene expression 
correlated well with intersex severity and it was expressed in a dose responsive 
manner to EE2 exposure (Zhao and Hu, 2012). More recently, osp1 has been linked to 
green fluorescent protein (GFP) in transgenic medaka in a newly developed assay. 
This induced intersex following a 90 day exposure to 0.75 ng/L EE2, where individual 
oocytes could be identified in the testes and quantified by fluorescence (Zhao et al., 
2014). This response can also be used in combination with the male sex determining 
dmy gene or secondary sexual characteristics to identify intersex individuals and to 
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quantify severity, avoiding time consuming histological processing. It has also proven 
to be more sensitive than histology, which can produce false negatives due to the 
limited observation of the total gonad area and the difficulties in differentiating the early 
stages of oocyte development from spermatogonia (Zhao et al., 2014). Nonetheless, it 
does not provide as much information as histology, which can identify any other 
abnormal physiology (such as fibrosis) in addition to the intersex endpoint. The GFP 
induction observed in the testis of fish exposed to EE2 by Zhou et al. is displayed 
below in Figure 5.3.  
 
Figure 5.3 Fluorescent microscopy observing the GFP response, linked to the oocyte 
gene osp1, in the excised testes of transgenic Japanese medaka following exposure to 
increasing doses of EE2 (from Zhao et al., 2014). The intersex index is also indicated.  
 
5.4 Future Trends 
This thesis expanded on the aim of identifying and assessing environmental anti-
androgens by analysing future trends in environmental concentrations. This is in fact 
the first analysis of future trends in concentrations of anthropogenic environmental 
contaminants and the first incidence of predictive modelling being adapted for use in 
Australia to assess endocrine disruptors. Predictions found that increasing population 
pressure on WWTWs could increase the concentrations of human derived 
contaminants entering the environment in WWTW effluent in UK and South Australian 
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catchments by 2050. Concurrently, decreasing effluent dilution caused by a climate 
induced reduction in river flow was expected to further increase the concentrations of 
these contaminants in receiving waters. Based on a medium level emissions scenario 
and assuming that current trends for demographic assumptions of fertility, mortality and 
migration would prevail in the future (Projection B), environmental concentrations were 
expected to double. This work focussed on the steroid oestrogens and anti-androgenic 
pharmaceuticals in two catchments only. However, work is underway at the Centre for 
Ecology and Hydrology, Wallingford to expand the hydrological modelling of steroid 
oestrogens under population and climate projections for 2050 to river catchments 
throughout England and Wales. The results so far have been agreeable with those 
described here, predicting modest increases in steroid oestrogen concentrations. 
Indeed, when compared to the maps produced in 2009 (Williams et al., 2009), the 
number of stretches at risk of endocrine disruption were expected to moderately 
increase by 5-7% dependant on the climate projection, whilst stretches at high risk 
increased 2-3% (Keller, 2014 personal communication). 
Increasing concentrations of steroid oestrogens in the future indicate that their 
presence in the environment will be a long term issue, unless mitigating action is taken. 
Due to the natural human origin of E1 and E2 and the importance of the 
pharmaceutical EE2 within society, mitigating these chemicals at source is not 
possible. Instead, improvements in their removal during the wastewater treatment 
process are required. From 2005-10 the UK’s Endocrine Disruption Demonstration 
Program trialled advanced treatment processes, including adsorption onto granular 
activated carbon (GAC) and advanced chemical oxidation with ozone or chlorination. 
These were found to satisfy predicted no effect concentrations (PNECs) for E1 and E2 
(1 and 3 ng/L), whilst the PNEC for EE2 (0.1 ng/L) could be satisfied with limited 
dilution (Butwell et al., 2010). New innovations in wastewater treatment are also being 
assessed and considered for future use, dependant on their ability to remove a range 
of chemicals and their ease of integration into WWTWs, as well as their economic 
costs and carbon footprint. These include the use of ultrasound to enhance 
degradation by UV photo oxidation and ozone, as well as advances in carbon products 
for adsorption, similar to granular activated carbon (Dee et al., 2013). In addition, there 
has been increasing interest in the use of catalysts, such as Fe-TAML, which triggers 
oxidation, to break down these chemicals. Indeed, preliminary data from the use of Fe-
TAML proves highly promising. It was able to rapidly degrade the steroid oestrogens, 
with a half-life of around five minutes, causing a 95% loss in around 15 minutes and a 
concomitant loss of estrogenic activity in vitro (Shappell et al., 2008; Brown, 2006). 
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This suggests that it is not producing any active oestrogenic by-products, which have 
been observed during other treatment processes (Moriyama et al., 2004).  
In 2012, the European Commission proposed to add E2 and EE2 to a list of “priority 
substances” under the Water Framework Directive. This European Union Directive was 
set up in 2000 to provide measures against chemical pollution of surface waters by 
regulating priority substances, which are monitored and controlled by member states 
based on environmental quality standards (EQSs). However, the pharmaceutical and 
water industries lobbied heavily against the proposal and cited insufficient evidence for 
population level effects of sexual disruption (McKie, 2012). In part this was a response 
to the associated cost of upgrading WWTWs to remove these chemicals, which in 
England and Wales was estimated at £30 billion, causing controversy regarding who 
should bear the cost (Owen and Jobling, 2012). Eventually, E2 and EE2 were instead 
adopted under a “watch list” to gather monitoring data to facilitate the determination of 
appropriate measures to address the risk that they pose (European Parliament, 2013). 
They therefore have the potential to be added to the priority substances list with 
defined EQSs in 2016. 
This thesis provides further evidence for the environmental role of steroid oestrogens 
on sexual disruption. In addition, the projected increase in environmental 
concentrations, supported by the extension of this work by the Centre for Ecology and 
Hydrology, suggests that the risk posed to fish by steroid oestrogens is likely to 
increase in the UK in the future. Consequently, from the UK perspective, this research 
supports the addition of E2 and EE2 to the list of priority substances and the 
requirement for mitigation. To broaden this research, the integration of predictive 
hydrological modelling with climate and population change scenarios could be used to 
assess changes to the risk they pose in other European river catchments in the future. 
If the conclusions are similar to the UK, this will provide additional evidence to support 
regulatory action. However, a recent study found that roach populations in effluent 
contaminated river stretches in Southern England were self-sustaining, despite the 
presence of steroid oestrogens and the occurrence of intersex (Hamilton et al., 2014). 
As a result, in the absence of clear population level effects in the wild, regulatory action 
would require the political will to consider sexual disruption as environmental damage 
to be rectified. Alternatively, the precautionary principle enshrined within the European 
Commission’s Action Program for 2020 (European Commission, 2014) would need to 
be acknowledged to legislate on the grounds of avoiding future population level 
damage. 
225 
 
 
The level of increase in the predicted environmental concentrations of these 
contaminants may be a good indicator of the change in concentrations of other 
anthropogenic pollutants. Reductions in available dilution and/or increasing input are 
likely to increase the concentrations of a variety of contaminants, including some 
priority pollutants, such as polyaromatic hydrocarbons. As a result, meeting the 
regulatory requirement of the EQSs may become more difficult without mitigation. 
Furthermore, increasing the concentrations of other chemicals, which are not 
considered as priority pollutants, may produce greater additional risks to fish 
populations. This may be particularly relevant to some pharmaceuticals, which have 
been shown to cause adverse effects in fish at concentrations close to those detected 
in the environment. For example, recent research on synthetic progestagens, which are 
combined with EE2 in the contraceptive pill to inhibit ovulation, has also found that 
these drugs can effect reproduction in fish at low concentrations. Indeed, 
levonorgestrol and gestodene have been shown to decrease egg production in fathead 
minnows at 0.8 and 1 ng/L respectively in two separate studies (Runnalls et al., 2013; 
Zeilinger et al., 2009). Interaction with the AR also occurred to cause masculinisation of 
the secondary sexual characteristics of females. In addition, norethindrone reduced 
egg production in fathead minnows and medaka at 1.2 and 25 ng/L, respectively. There 
is little data available on the environmental presence of progestagens, but they are 
expected to occur in rivers in high pg/L to low ng/L levels (Runnalls et al., 2013), 
potentially within the range of their in vivo effects. Indeed, at present norethindrone has 
a similar annual use to bicalutamide and cyproterone acetate and could therefore occur 
at concentrations similar to those predicted for the anti-androgens during this project. 
Another set of pharmaceuticals of interest are the NSAIDs, of which naproxen, 
ibuprofen, diclofenac and an indomethacin metabolite were detected in WWTW 
effluents, as described in chapter four. These are highly consumed, making up around 
7% of all prescriptions in Europe, and are commonly used by elderly people for pain 
management. In fact, an epidemiology study from the US reported that 70% of people 
over 65 used NSAIDs at least once weekly (Pilotto et al., 2010). Consequently, their 
use in the future could further increase due to the aging population. As a result of their 
widespread use, some NSAIDs have been detected at low µg/L concentrations in the 
aquatic environment and identified in the bile of wild fish downstream of effluent 
discharges (Brozinski et al., 2013). Since they inhibit prostaglandin synthesis there is 
some cause for concern for effects on fish health. Indeed, one study found spawning 
frequency was reduced in medaka at low µg/L concentrations of ibuprofen (Flippin et 
al., 2007). However, this was not replicated in a second study at higher concentrations, 
which found no effect on reproduction in zebrafish, although endogenous prostaglandin 
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was reduced (Morthorst et al., 2013). There has also been data published on effects of 
diclofenac on the kidney and intestinal structure of fish at environmentally relevant 
concentrations (e.g. Mehinto et al., 2010). However, when histology from studies 
reporting effects of diclofenac at low concentrations were reassessed by a panel of 
pathologists, no adverse effects were found below a proposed NOEC of 320 µg/L, 
based on data from two early life stage tests in rainbow trout and zebrafish (Wolf et al., 
2014; Memmert et al., 2013). Nonetheless, diclofenac was added to the watch list by 
the European Commission under the Water Framework Directive in 2012, alongside E2 
and EE2.  
In contrast to the UK and Europe, in Australia there are no regulations or EQSs in 
place for many of the Water Framework Directive’s priority pollutants or the steroid 
oestrogens. Predictive modelling indicates that steroid oestrogen concentrations in 
WWTW effluents in South Australia and discharge in a modelled downstream river 
stretch could put fish at risk of endocrine disruptive effects. This supports analytical 
measurements of steroid oestrogens in WWTW effluents from across Australia, which 
detected them at similar concentrations (Allinson et al., 2010; Mispagel et al., 2009; 
Ying et al., 2009; Ying et al., 2008; Tan et al., 2007; Williams et al., 2007; Braga et al., 
2005; Li et al., 2004). The river concentrations also compare well with those measured 
at five river sites in Queensland at effluent outfalls and 1 km downstream of WWTWs, 
which also indicated a risk of endocrine disruption occurring (Ying et al., 2009). In light 
of the widespread presence of steroid oestrogens in Australian effluents, their detection 
in rivers and their projected increase in concentration in the future, there is a 
requirement for a greater understanding of their effects on wild, native fish species. 
Increasing research has demonstrated a susceptibility of some native species to 
steroid oestrogens, such as barramundi, black bream and Murray rainbowfish (Woods 
and Kumar, 2011; Codi King et al., 2008). However, assessments of the effects of 
whole effluent exposures and studies of wild fish have so far found little evidence of a 
health threat to fish. Indeed, in 2012 the Commonwealth Scientific and Industrial 
Research Organisation (CSIRO) published an impact assessment of treated effluent in 
the aquatic environment. This involved exposures of fish under laboratory conditions 
and in situ at WWTWs using a mobile fish laboratory, as well as an assessment of wild, 
invasive common carp in the River Yarra, Victoria (Kumar et al., 2012). This study 
found no evidence of oestrogenic effects, such as vitellogenin or intersex induction in 
either zebrafish or Murray rainbowfish exposed to 100% WWTW effluent for 28 days. In 
addition, no incidences of vitellogenin induction or gonadal abnormalities were detected 
in carp caught on the River Yarra. As a result, it has been suggested that the risk to 
227 
 
 
fish health indicated by the modelling study in this thesis should be “treated with 
caution pending further research” (Sutcliffe et al., 2013). However, it should be 
considered that the WWTW effluents employed in fish exposures by the CSIRO study 
were all tertiary treated and the steroid oestrogens, E2 and EE2, were not detected 
during the studies, whilst E1 was detected infrequently. The WWTWs discharging into 
the River Yarra were also tertiary treated and no oestrogenic activity was detected at 
the carp capture sites. Without the steroid oestrogens present, it is unsurprising that no 
oestrogenic effects were observed. Consequently, there is a requirement for further 
study of the health effects of WWTW effluent on Australian fish species to examine the 
conclusions of the modelling work. However, this should include assessments of the 
effects of exposing fish to known oestrogenic effluents from WWTWs which do not use 
advanced treatment technologies to analyse worst case scenarios. For assessing 
intersex induction this should also utilise early life studies to ensure that critical stages 
of development are included in the exposure. This thesis has shown that Japanese 
medaka are a highly suitable test species for such a study. However, increasing 
research with the Murray rainbowfish suggests that they have a comparable sensitivity 
to oestrogenic disruption and therefore make a suitable native test species (Woods and 
Kumar, 2011). However, to the author’s knowledge, there is no evidence of intersex 
being induced in this species during in vivo exposures and so this requires further 
development. In terms of field assessments, the capture of wild fish for the assessment 
of reproductive health effects should be focussed on at risk or high risk areas, based 
on low dilution and lower level treatment processes upstream. From this aspect, 
hydrological modelling could be a useful first line tool in identifying oestrogenic WWTW 
effluents and at risk areas in Australian river catchments to guide field assessments. 
Whilst Australian fish species may be considered at risk of endocrine disruption, until 
more direct evidence arises of effects of EDCs in wild species, there is unlikely to be 
any perceived requirement or move towards mitigation. However, increasing interest in 
sustainable wastewater reuse may provide a new impetus towards mitigating 
potentially rising concentrations of EDCs in effluents. Indeed, the interest in using 
reclaimed water for agriculture and supplementing the drinking water supplies will 
make costs associated with mitigation unavoidable to ensure that human health is not 
affected (Falconer et al., 2006). Furthermore, the indigenous communities of Australia 
have strong sensitivities towards water quality, which is causing greater public 
awareness in water quality management and may also influence the likelihood of 
mitigation in the future (Kookana et al., 2013). 
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APPENDIX 1 
6. A simple worked example of effluent modelling at a South 
Australian WWTW 
 
Below is a simple, fictitious worked example of the calculations employed in this study 
to estimate effluent concentrations in the UK and South Australia from cohort data. 
Please note that the calculations below should be taken as a guideline as they are 
worked by hand and will therefore differ from the more extensive calculations 
performed in MS Excel for this project.  
Creating Cohorts 
 
Census data 
Females age 15-50: 300 
Females age ≥ 51: 200 
Males age ≥ 15: 500 
Males and Females age 0: 50 
7.6% of females over 50 using HRT 
 
Cohort Numbers: 
Pregnant females = 50 (based on males and females aged 0)  
Menstrual females = 300 – 50 = 250 
Menopausal females on HRT = 200 × 0.076 = 15 
Menopausal females = 200 – 15 = 185 
Males = 500 
TOTAL POPULATION: 1000 
 
Cohort Percentages: 
Pregnant females = 25.0% 
Menstrual females = 18.5% 
Menopausal females on HRT = 1.5% 
Menopausal females = 5.0% 
Males = 50.0% 
 
 
Calculating the per capita consumption of E1 and E2  
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Where S is the per capita consumption of oestrogen arriving at a WWTW (µg/d), n is 
the number of cohorts and U is the total oestrogen excreted in urine (in free, 
glucuronide and sulphate forms) and faeces for each cohort fraction (fi) of the 
population. A KT value for E2 of 0.5 is incorporated assuming that 50% will be 
degraded to E1 in transit in the sewerage system.  
 
Cohort 
  
Criteria 
  
Number of 
people in 2008 
Census 
Australia 
% of 
population 
Australia 
Mean excretion per 
person (µg/d) 
E2 E1 
Menstrual 
females 
Age 15-50  
(minus pregnant women) 
4797348 24.2% 3.2 
 
11.7 
 
Menopausal 
females 
Age >51  
(minus menopausal women on HRT) 
2718963 13.7% 1.0 
 
1.8 
 
Menopausal 
females on 
HRT 
7.6% UK and 11.8% Australian 
menopausal females (>51)  
363761 1.8% 56.1 
 
28.4 
 
Pregnant 
Females 
1/22 UK and 1/19 Australian 
menstrual females 
 
260101 1.3% 393 
 
550 
 
Males Age 15-50 7777909 39.2% 1.8 
 
2.6 
 
 TOTAL 15918082 
 
   
 
 
SE2 = 0.5 × ((0.242×3.2) + (0.137×1) + (0.018×56.1) + (0.013×393) + (0.392×1.8)) 
SE2 = 0.5 × (0.78 + 0.14 + 1.01 + 5.11 + 0.71) 
SE2 = 0.5 × 97.75 
SE2 = 3.9 µg/d 
 
SE1 = ((0.242×11.7) + (0.137×1.8) + (0.018×28.4) × (0.013×550) × (0.392×2.6)) + 3.9 
SE1 = (2.8 + 0.25 + 0.51 + 7.15 + 1.02) + 3.9 
SE1 = 11.73 + 3.9 
SE1 = 15.63 µg/d 
 
Calculating the per capita consumption of EE2 
Total active compound prescribed (2008) = 5.5kg 
There were 366 days in 2008 
Estimated Population of Australia = 22000000 
Excretion rate = 40% 
 
EE2 consumption per day = 5.5 ÷ 366 = 0.015kg 
EE2 excreted per person = (0.015 × 0.4) ÷ 22000000 
SEE2 = 2.72×10-10(kg/d) 
SEE2 = 0.27 µg/d 
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Calculating Effluent Concentrations using E2 as an example 
 
WWTW Data 
Population served = 2761 
Domestic Flow = 230000 L/day  
Non Domestic Flow = 50000 L/day 
Removal rates (E1, E2, EE2) = 64.7%, 81.7%, 85.2% 
 
Influent Concentration (E2) = (3.9 × 2761) ÷ 230000 = 0.047µg/L = 47ng/L 
 
Effluent Concentration (E2) = ((3.9 × 2761) ÷ 280000) × (1-0.817) × 1000 = 7.02 ng/L 
  
288 
 
 
APPENDIX 2 
 
 
Silylisation Protocol 
 
1. Sample bottles must be clean and dry. If necessary, solvent rinse and 
evaporate off remaining solvent before and heating bottles in a drying oven to 
ensure this. 
 
2. After cooling, fill the clean and dry sample bottles with a small volume of the 
sylilating reagent, Sylon CT (5% dimethyldichlorosilane in toluene from Sigma 
Aldrich, UK). Close the sample bottle and shake to ensure that all the walls are 
covered by the reagent. Leave for 30 minutes and shake periodically.  
 
3. Pour the excess of Sylon TC into a collecting vessel for reuse. 
 
4. Rinse the sample bottle containing the residue Sylon TC twice with a small 
volume of toluene and two times with methanol (dispose of waste toluene and 
waste methanol in chlorinated waste). 
 
5. Finally dry the bottles for three hours at 105oC. 
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Tank conditions from experiment one 
 
Table A2.1 The temperature range in treatment tanks during experiment one  
  Temperature (
o
C) 
  Mean Min Max Range 
Control A 25.3 24.9 26.2 1.3 
Control B 25.2 24.4 26.1 1.7 
Solvent Control A 25.5 25.1 26.2 1.1 
Solvent Control B 25.4 24.5 26.2 1.7 
Anti-Androgen A 25.6 25.2 26.3 1.1 
Anti-Androgen B 25.5 25 26.3 1.3 
Oestrogen A 25.6 25.1 26.4 1.3 
Oestrogen B 25.5 24.9 26.4 1.5 
Mixture A 25.7 25.2 26.4 1.2 
Mixture B 25.5 24.9 26.4 1.5 
Positive Control A 25.6 25.3 26.3 1 
Positive Control B 25.4 25 26.3 1.3 
 
 
Table A2.2 The percentage air saturation in treatment tanks during experiment two, 
based on the measured dissolved oxygen. 
  Dissolved Oxygen: % Air Saturation 
  Mean Min Max Range 
Control A 104% 98% 111% 13% 
Control B 102% 96% 111% 15% 
Solvent Control A 101% 92% 111% 19% 
Solvent Control B 101% 96% 111% 14% 
Anti-Androgen A 99% 87% 113% 26% 
Anti-Androgen B 100% 93% 110% 17% 
Oestrogen A 101% 94% 112% 18% 
Oestrogen B 101% 96% 110% 14% 
Mixture A 102% 95% 113% 19% 
Mixture B 101% 98% 110% 13% 
Positive Control A 101% 95% 113% 18% 
Positive Control B 100% 95% 109% 15% 
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Tank conditions from experiment two 
 
Table A2.4 The temperature range in treatment tanks during experiment two. This was 
the highest in control tank A where mortality occurred.  
 
Temperature (
o
C) 
  Mean Min Max Range  
Control A 25.8 22.1 27.8 5.7 
Control B 26.2 24.9 26.8 1.9 
Solvent Control A 26.0 22.9 26.7 3.8 
Solvent Control B 26.0 25.6 26.5 0.9 
Low Anti-Androgen A 25.9 22.8 26.5 3.7 
Low Anti-Androgen B 26.0 25.2 26.5 1.3 
Low Oestrogen A 26.1 22.5 26.7 4.2 
Low Oestrogen B 26.0 24.9 26.5 1.6 
Low Mixture A 26.2 22.7 26.8 4.1 
Low Mixture B 26.0 25.0 26.5 1.5 
High Oestrogen A 26.2 22.9 26.7 3.8 
High Oestrogen B 25.9 24.9 26.5 1.6 
High Anti-Androgen A 26.1 22.6 26.8 4.2 
High Anti-Androgen B 25.9 24.9 26.5 1.6 
High Mixture A 26.1 22.7 26.8 4.1 
High Mixture B 25.9 24.5 26.4 1.9 
Positive Control A 26.0 23.2 26.9 3.7 
Positive Control B 25.8 25.1 26.4 1.3 
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Table A2.5 The percentage air saturation in treatment tanks during experiment two, 
based on the measured dissolved oxygen.  
 
Dissolved Oxygen: % Air Saturation 
  Mean Min Max Range 
Control A 100% 95% 106% 11% 
Control B 100% 97% 104% 7% 
Solvent Control A 92% 70% 102% 32% 
Solvent Control B 91% 78% 126% 48% 
Low Anti-Androgen A 89% 74% 100% 26% 
Low Anti-Androgen B 89% 77% 109% 32% 
Low Oestrogen A 87% 68% 101% 33% 
Low Oestrogen B 89% 71% 100% 30% 
Low Mixture A 89% 75% 100% 24% 
Low Mixture B 90% 78% 101% 23% 
High Oestrogen A 88% 73% 99% 26% 
High Oestrogen B 90% 75% 100% 26% 
High Anti-Androgen A 89% 75% 100% 25% 
High Anti-Androgen B 90% 73% 101% 27% 
High Mixture A 89% 71% 101% 30% 
High Mixture B 89% 72% 108% 35% 
Positive Control A 91% 79% 100% 21% 
Positive Control B 90% 75% 100% 25% 
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Severe fibrosis in an intersex gonad 
 
 
Figure A2.1 A severely fibrotic gonad with sporadic oocytes. Image (A) was taken at 
x20 magnification, (B) at 100x and (C) at 400x. The gonad has a similar shape to the 
testis of male fish, albeit smaller, and some testicular tissue was observed alongside 
primary oocytes indicating a feminised male. Since oocytes and fibrotic tissue made up 
the majority of the testes and the sperm duct (sd) was empty, this fish was considered 
to be severely feminised with an index of 6.  
 
  
A B 
C 
sd 
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APPENDIX 3 
 
A3.1 Solid phase extraction 
Solid phase extraction (SPE) is an important step in sample preparation for analytical 
chemistry procedures. It is a chromatography method in which analytes in a liquid 
phase are passed through a column containing a solid phase where selective 
partitioning occurs to isolate analytes from the solution. Consequently, SPE can be 
used to “clean up” samples by removing unwanted chemicals or to concentrate and 
enrich samples by capturing analytes present at low concentrations from the liquid 
phase. Specifically, when an aqueous liquid phase is passed through the solid phase, 
its chemical constituents can be captured by retention to the sorbent material within the 
cartridge. The solid phase is then dried to remove the aqueous phase and a low 
volume of solvent is passed through which disrupts the interaction of the chemicals 
with the sorbent and elutes them. SPE is a very versatile technique and can be 
adapted to the needs of the researcher to capture a narrow set of chemicals or a 
broader range depending on the solid phase, solvents and conditions such as pH 
(Koester and Moulik, 2005).  
 
A3.2 Fractionation by high performance liquid chromatography 
Like SPE, high performance liquid chromatography (HPLC) is a chromatography 
method in which a mobile phase is delivered at high pressure through a column 
containing a stationary phase of sorbent material similar to that used in SPE. As the 
mobile phase moves through the stationary phase, different chemicals have different 
affinities for each phase dependant on their polarity. Consequently they move through 
the column with the mobile phase at different speeds, with those with a high affinity to 
the stationary phase moving the slowest. This allows them to be separated based on 
their retention time within the column. Gradient elutions with an elutrophic series of 
changing solvent concentrations can be used in the mobile phase to separate 
chemicals with a wide range of polarity. This is particularly important in EDA for 
maximising the recovery and separation of chemicals from the environmental samples 
in a shorter time period, ensuring that the most non-polar chemicals are eluted.  
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A3.3 Yeast androgen screen  
The recombinant yeast androgen screen (YAS) was developed by Glaxo (now 
GlaxoSmithKline) and is a strain (PGKhAR) of Saccharomyces cerevisiae stably 
transfected with the gene coding for the human androgen receptor (hAR). This is linked 
to a reporter gene, lacZ, through an androgen response element which is capable of 
interacting with the receptor. LacZ codes for the enzyme β-galactosidase, which enters 
the medium in which the cells are maintained and metabolises the chromogenic 
substrate chlorophenol red β-galactopyranoside (CPRG) to produce a yellow to red 
colour change. This response can then be measured by absorbance at 540 nm. 
Consequently, dosing the cells with an androgen will cause receptor binding, enzyme 
production and a colour change in a dose dependant manner, which can be used to 
quantify the activity of a chemical. Whilst this can be used to assess androgens, anti-
androgenic activity can also be quantified by dosing the cells with a concentration of a 
natural AR agonistic ligand, such as DHT, capable of inducing at a submaximal 
response (~65%). If this is dosed in combination with an anti-androgen, inhibition of the 
colour change through androgen receptor antagonism can be used to assess activity 
(Sohoni and Sumpter, 1998; Purvis et al., 1991). 
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A3.4 Testing fractions in the yeast screen: Raw data 
 
 
 
 
Figure A3.1 Results from three yeast androgen screens (A,B &C) assessing fractions 
from UK1 with a DHT raised background (2 nM) to detect anti-androgenic activity. 
Flutamide was used as a positive control at concentrations serially diluted from 50 nM 
(well 1) to 0.02 nM (well 12). Fractions were serially diluted from wells 2 to 12, with well 
1 containing the pure fraction. 
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Figure A3.2 Results from two yeast androgen screens (A&B) assessing fractions from 
UK3 with a DHT raised background (2 nM) to detect anti-androgenic activity. Flutamide 
was used as a positive control at concentrations serially diluted from 50 nM (well 1) to 
0.02 nM (well 12). A methanol blank was also incorporated in these screens. Fractions 
were serially diluted from wells 2 to 12, with well 1 containing the pure fraction. 
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